{
    "data": [
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51603",
            "title": "A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury",
            "affiliation": "China-Japan Union Hospital of Jilin Unversity",
            "timestamp": "2020-03-27"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51584",
            "title": "A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death",
            "affiliation": "Yichang Central people's Hospital",
            "timestamp": "2020-03-27"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51629",
            "title": "Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk",
            "affiliation": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-27"
        },
        {
            "title": "Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322279?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322682?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Biomarkers for SARS-COV-2 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322513?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323345?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321993?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Escin in Covid-19 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322344?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322123?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323644?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322773?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Colchicine Efficacy in COVID-19 Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322565?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322786?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323592?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Simple, Safe, Same: Lung Ultrasound for COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322487?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323527?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322188?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Traditional Chinese Medicine for Severe COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323332?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323228?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323631?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Use of Ascorbic Acid in Patients With COVID 19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04323514?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "title": "Proactive Prophylaxis With Azithromycin and Chloroquine in Hospitalized Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04322396?sfpd_d=200",
            "timestamp": "2020-03-26T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51455",
            "title": "The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak",
            "affiliation": "China European International Business School (CEIBS)",
            "timestamp": "2020-03-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51194",
            "title": "Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third Affiliated Hospital of Sun Yat-sen University",
            "timestamp": "2020-03-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001162-12/DE",
            "title": "An adaptive phase 2/3, randomized, double-blind, placebo-controlled, study assessing efficacy and safety of sarilumab for hospitalized patients with COVID-19",
            "country": "DE",
            "timestamp": "2020-03-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001162-12/FR",
            "title": "An adaptive phase 2/3, randomized, double-blind, placebo-controlled, study assessing efficacy and safety of sarilumab for hospitalized patients with COVID-19",
            "country": "FR",
            "timestamp": "2020-03-26"
        },
        {
            "title": "Behavior, Environment And Treatments for Covid-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321811?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Risk Factors for Community- and Workplace Transmission of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320732?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321928?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "The Impact of Camostat Mesilate on COVID-19 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321096?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321174?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Alliance Covid-19 Brasil II)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321278?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "The Efficacy of Different Anti-viral Drugs in (Severe Acute Respiratory Syndrome-Corona Virus-2) SARS-CoV-2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321616?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Outcomes and Prognostic Factors in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321265?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Hyperimmune Plasma for Critical Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321421?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320511?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Pandemic Response Network",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320862?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320615?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Non-contact Endoscopy at Covid-19 Outbreak",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320953?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Acute Encephalopathy in Critically Ill Patients With SARS-Cov-2 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320472?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "title": "Impact of Swab Site and Sample Collector on Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04321369?sfpd_d=200",
            "timestamp": "2020-03-25T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51559",
            "title": "Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection",
            "affiliation": "Chongqing Medical University",
            "timestamp": "2020-03-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51540",
            "title": "Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-03-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51535",
            "title": "Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "School of Public Health and Management, Chongqing Medical University",
            "timestamp": "2020-03-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51518",
            "title": "Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-03-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51486",
            "title": "Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/DK",
            "title": "A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European U...",
            "country": "DK",
            "timestamp": "2020-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/GB",
            "title": "A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European U...",
            "country": "GB",
            "timestamp": "2020-03-25"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN83971151",
            "timestamp": "2020-03-25",
            "title": "Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients"
        },
        {
            "title": "Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319900?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319172?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320238?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318444?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319211?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318366?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319016?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320056?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Joint Use of Electrocardiogram and Transthoracic Echocardiography in an Observational Study to Monitor Cardio-vascular Events in Patients Diagnosed With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320017?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319315?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318418?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Mindfulness During COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319445?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318431?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04320277?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "title": "A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04319731?sfpd_d=200",
            "timestamp": "2020-03-24T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51473",
            "title": "Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-03-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51509",
            "title": "Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis",
            "affiliation": "Wuhan Third Hospital",
            "timestamp": "2020-03-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49420",
            "title": "A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing you'an Hospital, Capital Medical University",
            "timestamp": "2020-03-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51030",
            "title": "Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Zhengzhou People's Hospital",
            "timestamp": "2020-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001254-22/BE",
            "title": "A prospective, randomized, open-label, interventional study to investigate the efficacy of sargramostim (Leukine®) in improving oxygenation and short- and long-term outcome of COVID-19 patients wit...",
            "country": "BE",
            "timestamp": "2020-03-24"
        },
        {
            "title": "COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318314?sfpd_d=200",
            "timestamp": "2020-03-23T16:00:00+00:00"
        },
        {
            "title": "Awareness Between Pregnant Women Regarding Corona",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04317365?sfpd_d=200",
            "timestamp": "2020-03-23T16:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318015?sfpd_d=200",
            "timestamp": "2020-03-23T16:00:00+00:00"
        },
        {
            "title": "Hypertension in Patients Hospitalized With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04318301?sfpd_d=200",
            "timestamp": "2020-03-23T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51478",
            "title": "A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Xiangya Hospital, Central South University (West Campus of Wuhan Union Hospital)",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51488",
            "title": "A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Nothern Jiangsu People's Hospital",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51112",
            "title": "Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Diagnosis, treatment and Research Center for infectious diseases, the fifth medical center of the PLA",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51442",
            "title": "A medical records based retrospective study for novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Third Hospital & Tongren Hospital of Wuhan University",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51443",
            "title": "Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic",
            "affiliation": "People's hospital of Zhengzhou",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51437",
            "title": "Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51390",
            "title": "The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19)",
            "affiliation": "The People's Hospital of GuangXi Zhuang Autonomous Region",
            "timestamp": "2020-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001010-38/NO",
            "title": "NORWEGIAN CORONAVIRUS DISEASE 2019 (NO COVID-19) STUDY: AN OPEN LABELED RANDOMIZED CONTROLLED PRAGMATIC TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFEC...",
            "country": "NO",
            "timestamp": "2020-03-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51404",
            "title": "Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-03-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51416",
            "title": "Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The third xiangya hospital of Central South University",
            "timestamp": "2020-03-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51032",
            "title": "A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Zhengzhou People's Hospital",
            "timestamp": "2020-03-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51185",
            "title": "Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Fifth Affiliated Hospital of Sun Yat-Sen University",
            "timestamp": "2020-03-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51148",
            "title": "Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Ningbo Kangning Hospital",
            "timestamp": "2020-03-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51136",
            "title": "A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangzhou Eighth People's Hospital",
            "timestamp": "2020-03-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51132",
            "title": "A prognosis study of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Xiangyang 1st People's Hospital",
            "timestamp": "2020-03-22"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN86534580",
            "timestamp": "2020-03-22",
            "title": "A trial evaluating treatments for suspected coronavirus infection in people aged 50 years and above with pre-existing conditions and those aged 65 years and above"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50984",
            "title": "Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period",
            "affiliation": "Hu'nan Cancer Hospital",
            "timestamp": "2020-03-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51348",
            "title": "A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients",
            "affiliation": "HwaMei Hospital, University of Chinese Academy of Sciences",
            "timestamp": "2020-03-21"
        },
        {
            "title": "Norwegian Coronavirus Disease 2019 Study",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316377?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316728?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04317040?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Trial of Treatments for COVID-19 in Hospitalized Adults",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04315948?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04315870?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04315896?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04317092?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "NestCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04315987?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Acute Kidney Injury in Patients Hospitalized With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316299?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Mechanisms for Organ Dysfunction in Covid-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316884?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Predictors of Respiratory Failure in SARS-Cov-2 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316949?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine in ANCA Vasculitis Evaluation",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316494?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine (HCQ) in Combination With Abemaciclib and Endocrine Therapy in HR+/Her 2- Advanced Breast Cancer After a Lead in Dose Escalation Cohort of HCQ and Abemaciclib in Advanced Solid Tumors",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04316169?sfpd_d=200",
            "timestamp": "2020-03-20T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51349",
            "title": "Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.",
            "affiliation": "Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51342",
            "title": "A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51338",
            "title": "A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Changzheng Hospital, Naval Military Medical University, Shanghai",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51331",
            "title": "Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial",
            "affiliation": "Beijing Normal University",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51317",
            "title": "A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangdong Provincial Hospital of Chinese Medicine",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51329",
            "title": "A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Beijing Chao-yang Hospital, Capital Medical University",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51316",
            "title": "Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study",
            "affiliation": "Shenzhen Third People's Hospital",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51311",
            "title": "Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51254",
            "title": "Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-03-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51291",
            "title": "A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",
            "affiliation": "Changzheng Hospital, Naval Military Medical University, Shanghai",
            "timestamp": "2020-03-20"
        },
        {
            "title": "The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04314271?sfpd_d=200",
            "timestamp": "2020-03-19T16:00:00+00:00"
        },
        {
            "title": "Adverse Events Related to Treatments Used Against Coronavirus Disease 2019",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04314817?sfpd_d=200",
            "timestamp": "2020-03-19T16:00:00+00:00"
        },
        {
            "title": "Mechanisms to Morbidity and Mortality for Covid-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04314232?sfpd_d=200",
            "timestamp": "2020-03-19T16:00:00+00:00"
        },
        {
            "title": "Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04315298?sfpd_d=200",
            "timestamp": "2020-03-19T16:00:00+00:00"
        },
        {
            "title": "Tocilizumab for SARS-CoV2 Severe Pneumonitis",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04315480?sfpd_d=200",
            "timestamp": "2020-03-19T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51278",
            "title": "Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "The Fifth Hospital Affiliated to Sun Yat-sen University",
            "timestamp": "2020-03-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51283",
            "title": "Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study ",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51272",
            "title": "Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design",
            "affiliation": "West China Hospital of Sichuan University",
            "timestamp": "2020-03-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51267",
            "title": "A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing Chaoyang Hospital, Capital Medical University",
            "timestamp": "2020-03-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51265",
            "title": "Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-03-19"
        },
        {
            "title": "Sequential Oxygen Therapy Strategy for Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04312100?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "NO Prevention of COVID-19 for Healthcare Providers",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04312243?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "A Phase I Clinical Trial in 18-60 Adults",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04313127?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04313322?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "The Use PUL-042 Inhalation Solution to Prevent COVID-19 in Adults Exposed to SARS-CoV-2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04313023?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04312997?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "Myocardial Damage in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04312464?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "title": "Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04313946?sfpd_d=200",
            "timestamp": "2020-03-18T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50199",
            "title": "Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Second Affiliated Hospital of Nanchang University",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50898",
            "title": "Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study",
            "affiliation": "Shandong Provincial Hospital",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50981",
            "title": "Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP",
            "affiliation": "Shanghai Kongjiang Hospital",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51000",
            "title": "A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",
            "affiliation": "Hu'nan Provincial People's Hospital, Hu'nan Normal University",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51061",
            "title": "Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51059",
            "title": "Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "PLA General Hospital",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51239",
            "title": "Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51240",
            "title": "A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51100",
            "title": "A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine.",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51160",
            "title": "A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV)",
            "affiliation": "The Fifth Affiliated Hospital of Sun Yat-sen University",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51184",
            "title": "Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial",
            "affiliation": "The First Affiliated Hospital of Nanchang University",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51230",
            "title": "Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Anqing Municipal Hospital",
            "timestamp": "2020-03-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51212",
            "title": "A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19)  ",
            "affiliation": "HuiZhou Municipal Central Hospital",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/DE",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "DE",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/ES",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "ES",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/FR",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "FR",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/IT",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "IT",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/NL",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "NL",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/GB",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "GB",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/SE",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19",
            "country": "SE",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/DE",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "DE",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/ES",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "ES",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/FR",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "FR",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/IT",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "IT",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/NL",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "NL",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/GB",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "GB",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/SE",
            "title": "A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate  COVID-19 Compared to Standard of Care Treatment",
            "country": "SE",
            "timestamp": "2020-03-18"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14966673",
            "timestamp": "2020-03-18",
            "title": "Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001110-38/IT",
            "title": "Multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia",
            "country": "IT",
            "timestamp": "2020-03-18"
        },
        {
            "title": "Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04311398?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "title": "Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04310228?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "title": "Losartan for Patients With COVID-19 Requiring Hospitalization",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04312009?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "title": "Losartan for Patients With COVID-19 Not Requiring Hospitalization",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04311177?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "title": "Intravenous Aviptadil for COVID-19 Associated Acute Respiratory Distress",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04311697?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "title": "Yinhu Qingwen Granula for the Treatment of Severe CoVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04310865?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "title": "Effectiveness of an EHR Interface to Reduce Dosage of Hydroxychloroquine",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04310462?sfpd_d=200",
            "timestamp": "2020-03-17T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50696",
            "title": "A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-03-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51139",
            "title": "The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine",
            "timestamp": "2020-03-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51141",
            "title": "Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Foshan First People's Hospital",
            "timestamp": "2020-03-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50476",
            "title": "Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",
            "affiliation": "HwaMei Hospital, University of Chinese Academy of Sciences",
            "timestamp": "2020-03-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51149",
            "title": "An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Xiangya Hospital, Central South University (West Campus of Wuhan Union Hospital)",
            "timestamp": "2020-03-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51154",
            "title": "A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector) ",
            "affiliation": "Jiangsu Provincial Center for Disease Control and Prevention",
            "timestamp": "2020-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001023-14/GB",
            "title": "A randomised double-blind placebo-controlled trial to determine the safety and efficacy of inhaled SNG001 (IFNβ-1a for nebulisation) for the treatment of patients with confirmed SARS-CoV-2 infection",
            "country": "GB",
            "timestamp": "2020-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000919-69/NL",
            "title": "Reducing health care workers absenteeism in SARS-CoV-2 pandemic by enhanced trained immune responses through Bacillus Calmette-Guérin vaccination, a randomized controlled trial (COVID-19).",
            "country": "NL",
            "timestamp": "2020-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001113-21/GB",
            "title": "Randomised Evaluation of COVID-19 Therapy (RECOVERY)",
            "country": "GB",
            "timestamp": "2020-03-17"
        },
        {
            "title": "Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04308668?sfpd_d=200",
            "timestamp": "2020-03-16T16:00:00+00:00"
        },
        {
            "title": "Tetrandrine Tablets Used in the Treatment of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04308317?sfpd_d=200",
            "timestamp": "2020-03-16T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51130",
            "title": "Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors",
            "affiliation": "Jingzhou Mental Health Center",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51064",
            "title": "Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong",
            "affiliation": "The Chinese University of Hong Kong",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50780",
            "title": "Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The affiliated Hospital to Changchun University of Traditional Chinese Medicine",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50462",
            "title": "Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "HwaMei Hospital, University of Chinese Academy of Sciences",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51028",
            "title": "Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Zhengzhou People's Hospital",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51034",
            "title": "Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51126",
            "title": "Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial",
            "affiliation": "Peking University First Hospital",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51073",
            "title": "Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field",
            "affiliation": "Zhengzhou People's Hospital",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51118",
            "title": "Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study",
            "affiliation": "State Key Laboratory of Respiratory Disease, National Clinical Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50960",
            "title": "Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50299",
            "title": "Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Hospital of Changsha",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50662",
            "title": "Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Xiangyang 1st people's Hospital",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50767",
            "title": "Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study",
            "affiliation": "Jinling Hospital, Medical School of Nanjing University",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51107",
            "title": "Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51103",
            "title": "Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling",
            "affiliation": "The First Affiliated Hospital of the Guangzhou Medical University",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51102",
            "title": "A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51025",
            "title": "A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital",
            "affiliation": "Wuhan Third Hospital",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51097",
            "title": "Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",
            "affiliation": "Hubei Cancer Hospital",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51040",
            "title": "Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19) ",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51091",
            "title": "An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT",
            "affiliation": "Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51090",
            "title": "Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of Critical Care Medicine, the Third Affiliated Hospital of Zunyi Medical University",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51083",
            "title": "A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Li Lanjuan",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51081",
            "title": "Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of critical care medicine, the third affiliated hospital of zunyi medical university",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51077",
            "title": "Factors associated with death in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing An Zhen Hospital, Capital Medical University",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49933",
            "title": "Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection  ",
            "affiliation": "Tongji Hospital, Huazhong university of science and technology",
            "timestamp": "2020-03-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51056",
            "title": "Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic",
            "affiliation": "The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51086",
            "title": "Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies",
            "affiliation": "Zhengzhou People's Hospital",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51072",
            "title": "Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19)",
            "affiliation": "Union hospital of Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50904",
            "title": "Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery",
            "affiliation": "Tongren Hospital, Shanghai Jiao Tong University School of Medicine",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51071",
            "title": "Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51054",
            "title": "Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy",
            "affiliation": "Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51050",
            "title": "Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "the First Affiliated Hospital of Xinxiang Medical University",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51047",
            "title": "Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51035",
            "title": "Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit",
            "affiliation": "Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51044",
            "title": "Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51036",
            "title": "The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51009",
            "title": "Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning",
            "affiliation": "Hwa Mei Hospital, University of Chinese Academy of Sciences",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51039",
            "title": "Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",
            "affiliation": "Wuhan Third Hospital",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51037",
            "title": "A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of Critical Care Medicine, The First Affiliated Hospital, Henan Traditional Chinese Medicine University",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50631",
            "title": "Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51048",
            "title": "Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51042",
            "title": "A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route",
            "affiliation": "Tongji hospital, Tongji medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50947",
            "title": "Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Shanghai Ninth People's Hospital",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50986",
            "title": "Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese＆Western Medicine",
            "affiliation": "Hubei 672 Orthopaedics Hospital of Integrated Chinese＆Western Medicine",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51015",
            "title": "A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51019",
            "title": "Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51029",
            "title": "Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Third Hospital",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51026",
            "title": "Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51018",
            "title": "Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial",
            "affiliation": "Maoming People's Hospital",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51007",
            "title": "Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=51004",
            "title": "A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji medical college of HUST",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50998",
            "title": "Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study",
            "affiliation": "The Third Hospital of Wuhan",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50997",
            "title": "Cancelled by the investigator                Study on levels of inflammatory factors in peripheral blood of patients with novel coronavirus pneumonia (COVID-19) and their diagnostic and prognostic value",
            "affiliation": "The Third Affiliated Hospital of Zunyi Medical University",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50994",
            "title": "A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan 3rd Hospital",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50988",
            "title": "clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Shanghai Fifth People's Hospital, Fudan University",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50991",
            "title": "Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Second Hospital of Hebei Medical University",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50982",
            "title": "A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50995",
            "title": "Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50307",
            "title": "A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi",
            "affiliation": "The People's Hospital of Guangxi Zhuang Autonomous Region",
            "timestamp": "2020-03-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50976",
            "title": "The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Cangzhou People's Hospital",
            "timestamp": "2020-03-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50973",
            "title": "A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Changzheng Hospital",
            "timestamp": "2020-03-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50987",
            "title": "A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital",
            "affiliation": "Ningbo First Hospital",
            "timestamp": "2020-03-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50934",
            "title": "Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Huashan Hospital Fudan Universtiy",
            "timestamp": "2020-03-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50968",
            "title": "Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-03-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50961",
            "title": "Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies",
            "affiliation": "The Second Xiangya Hospital of CSU",
            "timestamp": "2020-03-14"
        },
        {
            "title": "Acute Respiratory Failure and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Real Life",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04307459?sfpd_d=200",
            "timestamp": "2020-03-13T16:00:00+00:00"
        },
        {
            "title": "Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04307693?sfpd_d=200",
            "timestamp": "2020-03-13T16:00:00+00:00"
        },
        {
            "title": "Influence of the COvid-19 Epidemic on STRESS",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04308187?sfpd_d=200",
            "timestamp": "2020-03-13T16:00:00+00:00"
        },
        {
            "title": "Clinical Trial on Regularity of TCM Syndrome and Differentiation Treatment of COVID-19.",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04306497?sfpd_d=200",
            "timestamp": "2020-03-13T16:00:00+00:00"
        },
        {
            "title": "Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04306705?sfpd_d=200",
            "timestamp": "2020-03-13T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50964",
            "title": "Cancelled by the investigator                 Clinical guidance of diagnose and treatment for novel coronavirus pneumonia (COVID-19) based on ''Shi-Du-Yi''",
            "affiliation": "The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50852",
            "title": "Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",
            "affiliation": "Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50921",
            "title": "A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shandong Provincial Chest hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50950",
            "title": "Cancelled by the investigator                       Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)''",
            "affiliation": "The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50956",
            "title": "Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study",
            "affiliation": "Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50955",
            "title": "A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",
            "affiliation": "Zhejiang Hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49284",
            "title": "Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Wenzhou Medical University",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50590",
            "title": "A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50648",
            "title": "Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers",
            "affiliation": "Clinical Research Institute, Shenzhen-Peking University-The Hong Kong University of Science & Technology Medical Center",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50705",
            "title": "Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shenzhen Hospital of Southern Medical University",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50945",
            "title": "A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",
            "affiliation": "Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50824",
            "title": "Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third Affiliated Hospital of Sun Yat-sen University",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50901",
            "title": "A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Shandong Provincial Chest hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50925",
            "title": "A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shandong Provincial Chest hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50941",
            "title": "Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of Inner Mongolia University for the Nationalities",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50000",
            "title": "A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hubei Provincial Hospital of TCM",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50910",
            "title": "Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shandong Provincial Chest Hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50857",
            "title": "Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50907",
            "title": "Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Shandong Provincial Chest hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50900",
            "title": "Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).",
            "affiliation": "Shandong Provincial Chest hospital",
            "timestamp": "2020-03-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50896",
            "title": "Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS",
            "affiliation": "Shandong Provincial Chest hospital",
            "timestamp": "2020-03-13"
        },
        {
            "title": "Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04306393?sfpd_d=200",
            "timestamp": "2020-03-12T16:00:00+00:00"
        },
        {
            "title": "Social Media Use During COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04305574?sfpd_d=200",
            "timestamp": "2020-03-12T16:00:00+00:00"
        },
        {
            "title": "Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04305457?sfpd_d=200",
            "timestamp": "2020-03-12T16:00:00+00:00"
        },
        {
            "title": "Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04305106?sfpd_d=200",
            "timestamp": "2020-03-12T16:00:00+00:00"
        },
        {
            "title": "Blood Donor Recruitment During Epidemic of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04306055?sfpd_d=200",
            "timestamp": "2020-03-12T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50338",
            "title": "Auscultatory characteristics of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai First People's Hospital",
            "timestamp": "2020-03-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50759",
            "title": "A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of Guangdong Medical University",
            "timestamp": "2020-03-12"
        },
        {
            "title": "Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04303507?sfpd_d=200",
            "timestamp": "2020-03-11T16:00:00+00:00"
        },
        {
            "title": "Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID19 : A Randomized Control Trial",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04303299?sfpd_d=200",
            "timestamp": "2020-03-11T16:00:00+00:00"
        },
        {
            "title": "A Pilot Study of Sildenafil in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04304313?sfpd_d=200",
            "timestamp": "2020-03-11T16:00:00+00:00"
        },
        {
            "title": "Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04304053?sfpd_d=200",
            "timestamp": "2020-03-11T16:00:00+00:00"
        },
        {
            "title": "Sars-CoV2 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04304690?sfpd_d=200",
            "timestamp": "2020-03-11T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50793",
            "title": "Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management",
            "affiliation": "Hubei Provincial Hospital of TCM",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50867",
            "title": "A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan",
            "affiliation": "Wuhan Hospital of Integrated Traditional Chinese and Western Medicine",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50843",
            "title": "Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50860",
            "title": "A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50850",
            "title": "Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients",
            "affiliation": "Tongji Medical College, HUST",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50083",
            "title": "Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50160",
            "title": "Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau",
            "affiliation": "Ganzi Hospital of West China Hospital, Sichuan University",
            "timestamp": "2020-03-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50001",
            "title": "Cancelled by the investigator                       Application of cas13a-mediated RNA detection in the assay of novel coronavirus nucleic acid (COVID-19)",
            "affiliation": "Affiliated Hospital of Zunyi Medical University",
            "timestamp": "2020-03-11"
        },
        {
            "title": "Expanded Access Remdesivir (RDV; GS-5734™)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04302766?sfpd_d=200",
            "timestamp": "2020-03-10T16:00:00+00:00"
        },
        {
            "title": "Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04302519?sfpd_d=200",
            "timestamp": "2020-03-10T16:00:00+00:00"
        },
        {
            "title": "Accurate Classification System for Patients With COVID-19 Pneumonitis",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04302688?sfpd_d=200",
            "timestamp": "2020-03-10T16:00:00+00:00"
        },
        {
            "title": "An Observational Cohort Study of Clinical Outcomes After Antiviral Treatment of Chronic Hepatitis C",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04301882?sfpd_d=200",
            "timestamp": "2020-03-10T16:00:00+00:00"
        },
        {
            "title": "A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04301908?sfpd_d=200",
            "timestamp": "2020-03-10T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50778",
            "title": "Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First People's Hospital of Jiangxia District, Wuhan",
            "timestamp": "2020-03-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50251",
            "title": "A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Xiangya Hospital of Central South University",
            "timestamp": "2020-03-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50537",
            "title": "Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial",
            "affiliation": "China-Japan friendship hospital",
            "timestamp": "2020-03-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50795",
            "title": "A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third People's Hospital of Shenzhen",
            "timestamp": "2020-03-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50786",
            "title": "Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients",
            "affiliation": "Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology",
            "timestamp": "2020-03-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50781",
            "title": "A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals ",
            "affiliation": "Ningbo First Hospital, Ningbo Hospital of Zhejiang University",
            "timestamp": "2020-03-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50261",
            "title": "Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third Affiliated Hospital of the Second Military Medical University",
            "timestamp": "2020-03-10"
        },
        {
            "title": "Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04299711?sfpd_d=200",
            "timestamp": "2020-03-09T16:00:00+00:00"
        },
        {
            "title": "Safety and Immunity of Covid-19 aAPC Vaccine",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04299724?sfpd_d=200",
            "timestamp": "2020-03-09T16:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50572",
            "title": "Novel coronavirus pneumonia (COVID-19) associated kidney injury in children",
            "affiliation": "Department of Nephrology, Wuhan children's Hospital",
            "timestamp": "2020-03-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50714",
            "title": "The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak",
            "affiliation": "Peking University Third Hospital",
            "timestamp": "2020-03-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50633",
            "title": "The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study",
            "affiliation": "The Sixth Affiliated Hospital of Sun Yat-sen University",
            "timestamp": "2020-03-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50763",
            "title": "An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room",
            "affiliation": "Liaocheng People's Hospital",
            "timestamp": "2020-03-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50730",
            "title": "Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children",
            "affiliation": "Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",
            "timestamp": "2020-03-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/FR",
            "title": "Multi-centre, adaptive, randomized trial of the safety and efficacy of treatments of COVID-19 in hospitalized adults",
            "country": "FR",
            "timestamp": "2020-03-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50727",
            "title": "Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases",
            "affiliation": "The First Affiliated Hospital of Zhengzhou University",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50656",
            "title": "A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Bengbu Medical College",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50713",
            "title": "Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50702",
            "title": "Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "China Academy of Chinese Medical Science",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50228",
            "title": "Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",
            "affiliation": "The First Affiliated Hospital, College of Medicine of Zhejiang University",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50394",
            "title": "The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50693",
            "title": "Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai General Hospital",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50692",
            "title": "Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shandong Provincial Hospital",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50690",
            "title": "Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shandong Provincial Hospital",
            "timestamp": "2020-03-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49953",
            "title": "Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50653",
            "title": "Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50583",
            "title": "A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-03-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50678",
            "title": "Cancelled by the investigator             Epidemiological research of novel coronavirus pneumonia (COVID-19) suspected cases based on virus nucleic acid test combined with low-dose chest CT screening in primary hospital",
            "affiliation": "Guangzhou Panyu Central Hospital",
            "timestamp": "2020-03-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50667",
            "title": "A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",
            "affiliation": "The Third Affiliated Hospital of the Second Military Medical University",
            "timestamp": "2020-03-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50672",
            "title": "Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Anhui Cancer Hospital",
            "timestamp": "2020-03-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49708",
            "title": "Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-07"
        },
        {
            "title": "Stem Cell Educator Therapy Treat the Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04299152?sfpd_d=200",
            "timestamp": "2020-03-06T17:00:00+00:00"
        },
        {
            "title": "Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04298814?sfpd_d=200",
            "timestamp": "2020-03-06T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50126",
            "title": "Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial ",
            "affiliation": "Hubei Hospital of Traditional Chinese Medicine",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50134",
            "title": "Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50541",
            "title": "Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Central Theater General Hospital of PLA",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50623",
            "title": "Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country",
            "affiliation": "Xiamen Medical College，Shijiazhuang Medical College",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50658",
            "title": "Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy",
            "affiliation": "Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50660",
            "title": "Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus ",
            "affiliation": "Guangzhou Eighth People's Hospital",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49790",
            "title": "Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine",
            "affiliation": "Wuhan Red Cross Hospital",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50641",
            "title": "Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The Second Clinical College of Guangzhou University of Chinese Medicine",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=44213",
            "title": "Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Affiliated Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-03-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50608",
            "title": "A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",
            "affiliation": "West China Hospital of Sichuan University",
            "timestamp": "2020-03-06"
        },
        {
            "title": "Medical Masks vs N95 Respirators for COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04296643?sfpd_d=200",
            "timestamp": "2020-03-05T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50604",
            "title": "Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangzhou Eighth People's Hospital",
            "timestamp": "2020-03-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50586",
            "title": "Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",
            "affiliation": "The Second Affiliated Hospital of Wenzhou Medical University",
            "timestamp": "2020-03-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49956",
            "title": "Cancelled by the investigator           Clinical Study of NK Cells in the Treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Hospital of Harbin Medical University",
            "timestamp": "2020-03-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49632",
            "title": "Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-03-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50077",
            "title": "Early risk stratification of the Novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study)",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000890-25/FR",
            "title": "Treatment of Coronavirus SARS-Cov2 Respiratory Infections with Hydroxychloroquine",
            "country": "FR",
            "timestamp": "2020-03-05"
        },
        {
            "title": "Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04295551?sfpd_d=200",
            "timestamp": "2020-03-04T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50547",
            "title": "Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-03-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50549",
            "title": "Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province ",
            "affiliation": "The First Affiliated Hospital of Hu'nan University of traditional Chinese Medicine",
            "timestamp": "2020-03-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50552",
            "title": "A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City",
            "affiliation": "West China Hospital of Sichuan University",
            "timestamp": "2020-03-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50487",
            "title": "To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Huo-Shen-Shan Hospital",
            "timestamp": "2020-03-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50490",
            "title": "Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50507",
            "title": "A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19）",
            "affiliation": "The First Affiliated Hospital of HeNan University of CM",
            "timestamp": "2020-03-04"
        },
        {
            "title": "Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04292327?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "title": "Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04292340?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "title": "Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04293887?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "title": "Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04293692?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "title": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04292899?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "title": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04292730?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "title": "Prognostic Factors of Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04292964?sfpd_d=200",
            "timestamp": "2020-03-03T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50459",
            "title": "Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50263",
            "title": "HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Hubei Shiyan Taihe hospital",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50495",
            "title": "Cancelled by the investigator         A multicentre, randomized, controlled trial for the Ba-Duan-Jin in the adjunctive treatment of patients with common type novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The first affiliated hospital of guangzhou university of Chinese medicine",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50353",
            "title": "A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Peking University First Hospital",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50453",
            "title": "The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50470",
            "title": "Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of Respiratory and Critical Care Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50450",
            "title": "Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50460",
            "title": "Cancelled by the investigator                                    Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50458",
            "title": "oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50455",
            "title": "Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19) ",
            "affiliation": "Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50452",
            "title": "Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College",
            "timestamp": "2020-03-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49753",
            "title": "An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shenyang Sixth People's Hospita",
            "timestamp": "2020-03-03"
        },
        {
            "title": "Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of Novel Coronavirus Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04291729?sfpd_d=200",
            "timestamp": "2020-03-02T17:00:00+00:00"
        },
        {
            "title": "Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04290871?sfpd_d=200",
            "timestamp": "2020-03-02T17:00:00+00:00"
        },
        {
            "title": "Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04290858?sfpd_d=200",
            "timestamp": "2020-03-02T17:00:00+00:00"
        },
        {
            "title": "The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04291053?sfpd_d=200",
            "timestamp": "2020-03-02T17:00:00+00:00"
        },
        {
            "title": "Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04290780?sfpd_d=200",
            "timestamp": "2020-03-02T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50421",
            "title": "Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Maoming People's Hospital",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50082",
            "title": "A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Shanghai University of TCM",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50390",
            "title": "Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation",
            "affiliation": "Affiliated Hospital of Shandong University of Traditional Chinese Medicine",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50378",
            "title": "A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform  ",
            "affiliation": "Dalian Medical University, Dalian, China.",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50387",
            "title": "Cancelled due to lack of patients                                       Investigation on Mental Health Status and Psychological Intervention of Hospitalized Patients with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Yongchuan Hospital,Chongqing Medical University",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50388",
            "title": "Cancelled by the investigator                        Influence of nasal high-fow preoxygenation on video laryngoscope for emergency intubation in patients with critical novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou University of TCM",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50382",
            "title": "Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third Xiangya Hospital, Central South University",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50381",
            "title": "Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19)",
            "affiliation": "The First Affiliated Hospital of Wenzhou Medical University",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50380",
            "title": "Cancelled by the investigator                   Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "the Second Affiliated hospital of Xi'an Jiaotong University",
            "timestamp": "2020-03-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50297",
            "title": "Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Sixth People's Hospital",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50273",
            "title": "Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Fujian Medical University",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50268",
            "title": "Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic",
            "affiliation": "The First Affiliated Hospital of Fujian Medical University",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50174",
            "title": "A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19）",
            "affiliation": "Henan Provincial People's Hospital",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50286",
            "title": "A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform ",
            "affiliation": "Institute of Integrative Medicine of Dalian Medical University, Dalian, China.",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50341",
            "title": "Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Fujian Medical University",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50279",
            "title": "Cancelled by the investigator                               Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Harbin infectious diseases hospital",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50173",
            "title": "A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=30796",
            "title": "A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients ",
            "affiliation": "Lishui Central Hospital",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50224",
            "title": "Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology",
            "affiliation": "Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50278",
            "title": "A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hubei Provincial Hospital Of TCM",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50306",
            "title": "Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Jingzhou First People's Hospital",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50329",
            "title": "Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital of Tongji University",
            "timestamp": "2020-03-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50290",
            "title": "Cancelled by investigator           A randomized, open-label, controlled and single-center trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient ",
            "affiliation": "First people's hospital of Jiangxi district，Wuhan",
            "timestamp": "2020-02-29"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49984",
            "title": "Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of science and technology",
            "timestamp": "2020-02-29"
        },
        {
            "title": "Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04288102?sfpd_d=200",
            "timestamp": "2020-02-28T17:00:00+00:00"
        },
        {
            "title": "Eculizumab (Soliris) in Covid-19 Infected Patients",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04288713?sfpd_d=200",
            "timestamp": "2020-02-28T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49491",
            "title": "microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19)",
            "affiliation": "Nanjing Second Hospital",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48801",
            "title": "A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital of Tongji Medical College; Huazhong Science and Technology University",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50271",
            "title": "Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui",
            "affiliation": "the First Affiliated Hospital Division of Life Sciences and Medicine University of Science and Technology of China",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50274",
            "title": "Cancelled by the investigator                               Clinical research of 6-minute walk training on motor function of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital)",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49779",
            "title": "Cancelled by the investigator                          Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "The Second Affiliated Hospital of Xi'an Medical University",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50241",
            "title": "Clinical application of inhaled acetylcysteine solution in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science & Technology",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50214",
            "title": "Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Second Affiliated hospital of Anhui Medical University",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50227",
            "title": "A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang",
            "affiliation": "Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50231",
            "title": "Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50240",
            "title": "Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients",
            "affiliation": "Xinyang Central Hospital",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50247",
            "title": "Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period",
            "affiliation": "West China Hospital of Sichuan University",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50255",
            "title": "Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Affiliated Hospital of Changchun University of traditional Chinese Medicine",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50248",
            "title": "Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50222",
            "title": "Cancelled by the investigator                               Mechanism of novel coronavirus pneumonia (COVID-19) virus with silent latent immune system induced by envelope protein and vaccine development",
            "affiliation": "Luohu hospital group medical center of Shenzhen University",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50223",
            "title": "Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Li Caixia",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49653",
            "title": "Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third Affiliated Hospital of Sun Yat-sen University",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50022",
            "title": "Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high risk novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Nanjing Second Hospital",
            "timestamp": "2020-02-28"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50258",
            "title": "Cancelled, due to modify the protocol                                          A single-center, open-label and single arm trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment&",
            "affiliation": "First people's hospital of Jiangxi district，Wuhan",
            "timestamp": "2020-02-28"
        },
        {
            "title": "The Clinical Study of Carrimycin on Treatment Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04286503?sfpd_d=200",
            "timestamp": "2020-02-27T17:00:00+00:00"
        },
        {
            "title": "Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04287686?sfpd_d=200",
            "timestamp": "2020-02-27T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50195",
            "title": "Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-02-27"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50175",
            "title": "Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China",
            "affiliation": "Xiamen University",
            "timestamp": "2020-02-27"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50202",
            "title": "Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial",
            "affiliation": "China Academy of Chinese Medical Sciences",
            "timestamp": "2020-02-27"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50119",
            "title": "Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19)",
            "affiliation": "Xianning Central Hospital",
            "timestamp": "2020-02-27"
        },
        {
            "title": "The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04285190?sfpd_d=200",
            "timestamp": "2020-02-26T17:00:00+00:00"
        },
        {
            "title": "Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04285801?sfpd_d=200",
            "timestamp": "2020-02-26T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49691",
            "title": "Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Harbin Medical University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50161",
            "title": "ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Department of critical care, Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50140",
            "title": "Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic",
            "affiliation": "Beijing Geriatric Hospital",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50136",
            "title": "Clinical study for combination of anti-viral drugs and type I interferon and inflammation inhibitor TFF2 in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49963",
            "title": "A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuxi Fifth People's Hospital",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50130",
            "title": "Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau",
            "affiliation": "Ganzi Hospital of West China Hospital, Sichuan University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49918",
            "title": "Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",
            "affiliation": "Shanghai Changzheng Hospital",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49887",
            "title": "A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "The Fourth Affiliated Hospital of Harbin Medical University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50006",
            "title": "The coagulation function of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Puren Hospital of Wuhan City",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50089",
            "title": "Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome",
            "affiliation": "Shanghai University of Traditional Chinese Medicine",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50137",
            "title": "the Efficacy and Safety of Favipiravir for novel coronavirus–infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50143",
            "title": "Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid",
            "affiliation": "Ganzi Hospital of West China Hospital, Sichuan University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49855",
            "title": "The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",
            "affiliation": "The Fourth Hospital of Hebei Medical University",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49945",
            "title": "Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49968",
            "title": "Cancelled by the investigator                Clinical study of mesenchymal stem cells in treating severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-26"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50026",
            "title": "Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey",
            "affiliation": "NA",
            "timestamp": "2020-02-26"
        },
        {
            "title": "Humanistic Care in Patients With Coronavirus Disease 2019",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04283825?sfpd_d=200",
            "timestamp": "2020-02-25T17:00:00+00:00"
        },
        {
            "title": "Humanistic Care in Healthcare Workers in Coronavirus Disease 2019",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04283838?sfpd_d=200",
            "timestamp": "2020-02-25T17:00:00+00:00"
        },
        {
            "title": "Study for Novel Coronavirus Pneumonia (NCP)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04283396?sfpd_d=200",
            "timestamp": "2020-02-25T17:00:00+00:00"
        },
        {
            "title": "A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04282902?sfpd_d=200",
            "timestamp": "2020-02-25T17:00:00+00:00"
        },
        {
            "title": "Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04283461?sfpd_d=200",
            "timestamp": "2020-02-25T17:00:00+00:00"
        },
        {
            "title": "CT Scores Predict Mortality in 2019-nCoV Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04284046?sfpd_d=200",
            "timestamp": "2020-02-25T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50048",
            "title": "Cancelled due to lack of participants                                        Study for the Impact of Novel Coronavirus Pneumonia (COVID-19) to the Health of the elderly People",
            "affiliation": "The Thirteenth People's Hospital of Chongqing",
            "timestamp": "2020-02-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50071",
            "title": "Cancelled by the investigator               Study for sleep status of medical staffs of hospitals administrating suspected cases of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Guangzhou Panyu Central Hospital",
            "timestamp": "2020-02-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50110",
            "title": "Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine",
            "timestamp": "2020-02-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50115",
            "title": "Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Fifth People's Hospital of Ganzhou",
            "timestamp": "2020-02-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50107",
            "title": "Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19)",
            "affiliation": "The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",
            "timestamp": "2020-02-25"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49883",
            "title": "A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Central South Hospital of Wuhan University",
            "timestamp": "2020-02-25"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN15724013",
            "timestamp": "2020-02-25",
            "title": "H-PRIME"
        },
        {
            "title": "A New Screening Strategy for 2019 Novel Coronavirus Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04281693?sfpd_d=200",
            "timestamp": "2020-02-24T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50025",
            "title": "Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50057",
            "title": "Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Jingzhou First People's Hospital",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50058",
            "title": "The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "West China Hospital of Sichuan University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50059",
            "title": "Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Nanchang University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49229",
            "title": "Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration",
            "affiliation": "Hunan yuanpin Cell Biotechnology Co., Ltd",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50017",
            "title": "Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49433",
            "title": "Cancelled by the investigator                   A real world study for Compound Houttuyniae Mixture for prevention of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49567",
            "title": "Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49696",
            "title": "Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The 5th Medical Center Chinese PLA General Hospital",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49947",
            "title": "Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Tianjin University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49983",
            "title": "A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU",
            "affiliation": "Wuhan Jin Yin-tan hospital",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50031",
            "title": "A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49570",
            "title": "Cancelled by the investigator                     Study for the water extract of soybean in the treatment of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Cancelled",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50004",
            "title": "Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Chinese PLA General Hospital",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50007",
            "title": "Cancelled by the investigator             Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The Second Affiliated Hospital of Xi'an Jiaotong University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50005",
            "title": "Cancelled by the investigator          Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "the Second Affiliated hospital of Xi'an Jiaotong University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50002",
            "title": "Cancelled by the investigator                  A randomized controlled trial for high-dose Vitamin C in the treatment of severe and critical novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "The Second Affiliated Hospital Of Xi'an Jiaotong University",
            "timestamp": "2020-02-24"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49594",
            "title": "Cancelled by the investigator                   A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shenzhen national medicine inheritance medical research institute co. LTD",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49762",
            "title": "A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49901",
            "title": "Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Nanchang University",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49964",
            "title": "A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49987",
            "title": "Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Peking University People's Hospital",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49988",
            "title": "Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir",
            "affiliation": "The Third People's Hospital of Shenzhen",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49747",
            "title": "A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tianjin Huanhu Hospital",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49794",
            "title": "Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19)",
            "affiliation": "Peking University First Hospital",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49845",
            "title": "A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia",
            "affiliation": "The First Affiliated Hospital of Nanchang University",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49970",
            "title": "Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",
            "affiliation": "Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49932",
            "title": "Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Second Hospital of Shanxi Medical University",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49880",
            "title": "Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques ",
            "affiliation": "Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49914",
            "title": "A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19)",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-23"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49889",
            "title": "A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Changzheng Hospital",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49902",
            "title": "Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Sixth Medical Center of PLA General Hospital",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49919",
            "title": "Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49934",
            "title": "Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science & Technology",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49948",
            "title": "Cancelled by the investigator               Study for the false positive rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-19) in different inpatients",
            "affiliation": "Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49952",
            "title": "A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression",
            "affiliation": "The First Hospital of Shanxi Medical University",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49915",
            "title": "Cancelled by the investigator             Randomized controlled trial for the efficacy of dihydroartemisinine piperaquine in the treatment of mild/common novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Nanchang University",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49831",
            "title": "A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49904",
            "title": "Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science & Technology",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49864",
            "title": "Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49869",
            "title": "A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",
            "affiliation": "Zhongshan Hospital Affiliated to Xiamen University",
            "timestamp": "2020-02-22"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49910",
            "title": "A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-22"
        },
        {
            "title": "Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04279795?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04279782?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "NK Cells Treatment for Novel Coronavirus Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04280224?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "Clinical Outcomes of Patients With COVID19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04280913?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "Fingolimod in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04280588?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "Adaptive COVID-19 Treatment Trial (ACTT)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04280705?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "The Investigation of the Neonates With or With Risk of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04279899?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "title": "Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04279197?sfpd_d=200",
            "timestamp": "2020-02-21T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49861",
            "title": "A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19)",
            "affiliation": "First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49866",
            "title": "Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",
            "affiliation": "Peking University Third Hospital",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49891",
            "title": "A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49544",
            "title": "Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Hospital of Xuzhou Medical University",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49647",
            "title": "Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",
            "affiliation": "Tongde Hospital of Zhejiang Province",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49703",
            "title": "A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49816",
            "title": "Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions",
            "affiliation": "Xi'an Chest Hospital",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49806",
            "title": "Cancelled by the investigator                              A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV",
            "affiliation": "The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital)",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49824",
            "title": "A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-02-21"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49899",
            "title": "Cancelled due to lack of patient                                                                A Medical Records Based Study for Construction and Analysis of Diagnosis Predictive&",
            "affiliation": "Chongqing Liangjiang New Area first people's Hospital",
            "timestamp": "2020-02-21"
        },
        {
            "title": "Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04278963?sfpd_d=200",
            "timestamp": "2020-02-20T17:00:00+00:00"
        },
        {
            "title": "The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04277663?sfpd_d=200",
            "timestamp": "2020-02-20T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49841",
            "title": "A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49840",
            "title": "Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "West China Hospital",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49852",
            "title": "Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial",
            "affiliation": "Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49797",
            "title": "A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "First Affiliated Hospital of Anhui Medical University",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49690",
            "title": "A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients",
            "affiliation": "Department of respiratory and critical care medicine, Tongji Hospital, Tongji Medical College, Huazhong University of science and technology",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49812",
            "title": "The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Second Hospital of University of South China, Hengyang",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49798",
            "title": "Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Department of Ultrasound Imaging, Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49802",
            "title": "Cancelled due to lack of patient                               Effect of early pulmonary training on lung function and quality of life for novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "Wuhan Fourth Hospital",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49510",
            "title": "A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing Chaoyang Hospital, Capital Medical University",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49768",
            "title": "The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",
            "affiliation": "Zhongshan Hospital Fudan University",
            "timestamp": "2020-02-20"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49800",
            "title": "Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-20"
        },
        {
            "title": "A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04276987?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04275388?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04276688?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04275414?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "Immunity and Safety of Covid-19 Synthetic Minigene Vaccine",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04276896?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "The COVID-19 Mobile Health Study (CMHS)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04275947?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04275245?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "title": "HYDROxychloroquine in Syndrome Primary AntiPhospholipid",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04275778?sfpd_d=200",
            "timestamp": "2020-02-19T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49799",
            "title": "Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangxi medical uniwresity",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49796",
            "title": "A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.",
            "affiliation": "Chinese PLA General Hospital",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49718",
            "title": "Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19)",
            "affiliation": "The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49777",
            "title": "A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49426",
            "title": "Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak",
            "affiliation": "The Fifth Affiliated Hospital of Sun Yat-Sen University",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49619",
            "title": "Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49737",
            "title": "A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49669",
            "title": "Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49783",
            "title": "Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49770",
            "title": "Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49738",
            "title": "Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital)",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49748",
            "title": "An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",
            "affiliation": "Nanchang Ninth Hospital",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49717",
            "title": "A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai 10th people's hospital",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49418",
            "title": "Study on anxiety of different populations under novel coronavirus (COVID-19) infection",
            "affiliation": "Shanghai General Hospital of Shanghai Jiaotong University",
            "timestamp": "2020-02-19"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49723",
            "title": "The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",
            "affiliation": "Health commission of Heilongjiang province",
            "timestamp": "2020-02-19"
        },
        {
            "title": "Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Novel Coronavirus Severe Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04273646?sfpd_d=200",
            "timestamp": "2020-02-18T17:00:00+00:00"
        },
        {
            "title": "Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04273763?sfpd_d=200",
            "timestamp": "2020-02-18T17:00:00+00:00"
        },
        {
            "title": "Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04274322?sfpd_d=200",
            "timestamp": "2020-02-18T17:00:00+00:00"
        },
        {
            "title": "Efficacy and Safety of Corticosteroids in COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04273321?sfpd_d=200",
            "timestamp": "2020-02-18T17:00:00+00:00"
        },
        {
            "title": "The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04273529?sfpd_d=200",
            "timestamp": "2020-02-18T17:00:00+00:00"
        },
        {
            "title": "The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04273581?sfpd_d=200",
            "timestamp": "2020-02-18T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50323",
            "title": "Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hu'nan university of chinese medicine",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49309",
            "title": "Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial ",
            "affiliation": "Shanghai University of TCM",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49435",
            "title": "A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49574",
            "title": "A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Zhongshan Hospital Affiliated to Xiamen University",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49666",
            "title": "A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Nanchang University",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49674",
            "title": "Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49720",
            "title": "A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Chinese PLA General Hospital",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49218",
            "title": "Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49711",
            "title": "Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49712",
            "title": "Cancelled by the investigator              Study on the effect of human placenta biological preparation on the defense of immune function against novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangzhou reborn health management consultation co., LTD",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49724",
            "title": "Study for using multiomics in the diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49692",
            "title": "Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49702",
            "title": "A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49592",
            "title": "Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Hospital of Jilin University",
            "timestamp": "2020-02-18"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49321",
            "title": "A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Qingdao East Sea Pharmaceutical Co., Ltd.",
            "timestamp": "2020-02-18"
        },
        {
            "title": "Prognositc Factors in COVID-19 Patients Complicated With Hypertension",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04272710?sfpd_d=200",
            "timestamp": "2020-02-17T17:00:00+00:00"
        },
        {
            "title": "Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04270383?sfpd_d=200",
            "timestamp": "2020-02-17T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49664",
            "title": "A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49639",
            "title": "Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province",
            "affiliation": "The First Affiliated Hospital of Hu'nan University of traditional Chinese Medicine",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49636",
            "title": "Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns",
            "affiliation": "West China Second Hospital, Sichuan University",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49635",
            "title": "A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department",
            "affiliation": "Department of Anesthesiology, Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49633",
            "title": "Cancelled by the investigator                         An observational study of high-dose Vitamin C in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Second Affiliated Hospital Of Xi'an Jiaotong University",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49618",
            "title": "Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19)",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49531",
            "title": "Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging",
            "affiliation": "West China Second University Hospital, Sichuan University",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49402",
            "title": "Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",
            "affiliation": "Hubei Hospital of Traditional Chinese Medicine",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49217",
            "title": "Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49630",
            "title": "Cancelled due to lack of patient                         Medical records based study for epidemiological and clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Chongqing",
            "affiliation": "Chongqing Three Gorges Central Hospital(Chongqing University Three Gorges Hospital  )",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=50325",
            "title": "Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet",
            "affiliation": "Hubei Provincial Hospital of TCM",
            "timestamp": "2020-02-17"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49181",
            "title": "A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Emergency Department of Zhongnan hospital of Wuhan University",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49599",
            "title": "A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49596",
            "title": "A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49612",
            "title": "A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19) ",
            "affiliation": "HwaMei Hospital, University of Chinese Academy of Sciences",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49607",
            "title": "A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",
            "affiliation": "HwaMei Hospital, University of Chinese Academy of Sciences",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49587",
            "title": "Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49595",
            "title": "A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49377",
            "title": "Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49536",
            "title": "Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial ",
            "affiliation": "Peking University Third Hospital",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49482",
            "title": "Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial ",
            "affiliation": "Peking University Third Hospital",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49432",
            "title": "Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) ",
            "affiliation": "Affiliated Hospital of Changchun University of traditional Chinese Medicine",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49569",
            "title": "Cancelled by investigator                Single arm study for the efficacy and safety of GD31 in patients with novel coronavirus pneumonia (COVID-19)  ",
            "affiliation": "Guangzhou Eighth People's Hospital",
            "timestamp": "2020-02-16"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49563",
            "title": "Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Jiangsu Institute of Parasitic Diseases",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49486",
            "title": "A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",
            "affiliation": "Huangshi Hospital of Traditional Chinese Medicine",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49524",
            "title": "Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",
            "affiliation": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49514",
            "title": "The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",
            "affiliation": "Beijing You'an Hospital, Capital Medical University",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49519",
            "title": "Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics",
            "affiliation": "Enze Hospital of Taizhou Enze Medical Center (Group)",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49545",
            "title": "Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients",
            "affiliation": "Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49543",
            "title": "A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Medical College of Zhejiang University",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49532",
            "title": "A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "People's Hospital of Guangshan County",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49534",
            "title": "A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Zhongshan Hospital, Fudan University",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49533",
            "title": "Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49530",
            "title": "Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhengzhou University",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49439",
            "title": "An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Ningbo First Hospital",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49495",
            "title": "Cancelled by the investigator          A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Jingzhou Central Hospital",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49511",
            "title": "A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",
            "affiliation": "The Fifth Affiliated Hospital of Sun Yat-Sen University",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49520",
            "title": "Cancelled due to lack of patient                                 Medical records based study for Heart-type fatty acid-binding protein on prognosis of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Chongqing Three Gorges Central Hospital",
            "timestamp": "2020-02-15"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49481",
            "title": "Cancelled by the investigator            A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in serious/critically ill patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Jingzhou Central Hospital",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49502",
            "title": "A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection",
            "affiliation": "Nanjing Second Hospital",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49306",
            "title": "Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation",
            "affiliation": "Deyang Integrated Traditional Chinese and Western Medicine Hospital",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49492",
            "title": "Cancelled by investigator                                      A cox regression analysis of prognosis of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Asia General Hospital",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49490",
            "title": "Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients ",
            "affiliation": "Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49382",
            "title": "Cancelled by the investigator            Clinical Study for Umbilical Cord Blood Plasma in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Guangzhou reborn health management consultation co., LTD",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49384",
            "title": "Cancelled by the investigator                    Clinical Study of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Guangzhou reborn health management consultation co., LTD",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49389",
            "title": "Cancelled by the investigator                      Clinical Study for Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Guangzhou reborn health management consultation co., LTD",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49346",
            "title": "Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangdong Provincial Hospital of Chinese Medicine",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49387",
            "title": "Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Children's Hospital of Fudan University",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49425",
            "title": "Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49374",
            "title": "Cancelled by the investigator               Clinical Study for Umbilical Cord Blood Mononuclear Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Guangzhou reborn health management consultation co., LTD",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49355",
            "title": "Cancelled by the investigator                     Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Guangzhou reborn health management consultation co., LTD",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49407",
            "title": "Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein",
            "affiliation": "Shenzhen Second People's Hospital",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49161",
            "title": "Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49188",
            "title": "Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49178",
            "title": "Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-02-14"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49428",
            "title": "A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19) ",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-14"
        },
        {
            "title": "Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04269525?sfpd_d=200",
            "timestamp": "2020-02-13T17:00:00+00:00"
        },
        {
            "title": "Immunoregulatory Therapy for 2019-nCoV",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04268537?sfpd_d=200",
            "timestamp": "2020-02-13T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49453",
            "title": "Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Pulmonary Hospital",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49348",
            "title": "Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of He'nan University of Chinese Medicine",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49452",
            "title": "Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial",
            "affiliation": "Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49445",
            "title": "Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19)",
            "affiliation": "Zhejiang Provincial People's Hospital",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49138",
            "title": "A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49220",
            "title": "A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49378",
            "title": "Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging",
            "affiliation": "Wuxi People's Hospital",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49422",
            "title": "Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Shanghai University of TCM",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49380",
            "title": "A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",
            "affiliation": "Huangshi Hospital of Traditional Chinese Medicine",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49342",
            "title": "A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated of Wenzhou Medical University",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49412",
            "title": "Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49415",
            "title": "Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Enze Hospital of Taizhou Enze Medical Center (Group)",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49131",
            "title": "A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49409",
            "title": "A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital)",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49388",
            "title": "Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004284-30/DE",
            "title": "Effectiveness of Canakinumab for first line steroid free treatment in systemic onset juvenile idiopathic arthritis / juvenile Still’s disease",
            "country": "DE",
            "timestamp": "2020-02-13"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49408",
            "title": "The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",
            "affiliation": "China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49400",
            "title": "Cancelled due to lack of patient                Clinical study on the safety and effectiveness of Hydroxychloroquine Sulfate tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Chongqing Medical University",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49295",
            "title": "Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients ",
            "affiliation": "Department of Critical Care Medicine, West China Hospital of Sichuan University",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49081",
            "title": "Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial",
            "affiliation": "China-Japan friendship hospital",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49222",
            "title": "Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49301",
            "title": "A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College of HUST",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49370",
            "title": "Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-12"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49354",
            "title": "Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine",
            "timestamp": "2020-02-12"
        },
        {
            "title": "Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04264533?sfpd_d=200",
            "timestamp": "2020-02-11T17:00:00+00:00"
        },
        {
            "title": "Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04264858?sfpd_d=200",
            "timestamp": "2020-02-11T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49287",
            "title": "Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine",
            "timestamp": "2020-02-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49263",
            "title": "Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",
            "affiliation": "The Fifth Affiliated Hospital Sun Yat-Sen University",
            "timestamp": "2020-02-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49317",
            "title": "Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients（randomized open-label control clinical trial）",
            "affiliation": "The First Hospital of Peking University",
            "timestamp": "2020-02-11"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49283",
            "title": "A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-02-11"
        },
        {
            "title": "Clinical Characterisation Protocol for Severe Emerging Infections",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04262921?sfpd_d=200",
            "timestamp": "2020-02-10T17:00:00+00:00"
        },
        {
            "title": "Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04261907?sfpd_d=200",
            "timestamp": "2020-02-10T17:00:00+00:00"
        },
        {
            "title": "The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04263402?sfpd_d=200",
            "timestamp": "2020-02-10T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49279",
            "title": "Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48868",
            "title": "Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First People's Hospital of Huaihua",
            "timestamp": "2020-02-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49302",
            "title": "Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49250",
            "title": "A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital affiliated to Tongji medical college of HUST",
            "timestamp": "2020-02-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49219",
            "title": "Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath",
            "affiliation": "Shenzhen Third People's Hospital",
            "timestamp": "2020-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-004468-23/GB",
            "title": "Comparison of abatacept with tumor necrosis factor inhibitors in the treatment of rheumatoid arthritis pain: A phase IV trial",
            "country": "GB",
            "timestamp": "2020-02-10"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49074",
            "title": " Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Central Theater General Hospital of PLA",
            "timestamp": "2020-02-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49086",
            "title": "A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Pulmonary Hosptial",
            "timestamp": "2020-02-09"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49187",
            "title": "Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",
            "affiliation": "The Fifth Affiliated Hospital Sun Yat-Sen University",
            "timestamp": "2020-02-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49224",
            "title": "A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia ",
            "affiliation": "West China Hospital, Sichuan University",
            "timestamp": "2020-02-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49127",
            "title": "An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangdong Provincial Hospital of Chinese Medicine",
            "timestamp": "2020-02-08"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49215",
            "title": "Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial",
            "affiliation": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-08"
        },
        {
            "title": "Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04259892?sfpd_d=200",
            "timestamp": "2020-02-07T17:00:00+00:00"
        },
        {
            "title": "Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia Caused by 2019-nCoV ( HC-nCoV )",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04261517?sfpd_d=200",
            "timestamp": "2020-02-07T17:00:00+00:00"
        },
        {
            "title": "A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04260308?sfpd_d=200",
            "timestamp": "2020-02-07T17:00:00+00:00"
        },
        {
            "title": "Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04260594?sfpd_d=200",
            "timestamp": "2020-02-07T17:00:00+00:00"
        },
        {
            "title": "The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04261426?sfpd_d=200",
            "timestamp": "2020-02-07T17:00:00+00:00"
        },
        {
            "title": "A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04261270?sfpd_d=200",
            "timestamp": "2020-02-07T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49155",
            "title": "A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Guangdong Provincial Hospital of Chinese Medicine",
            "timestamp": "2020-02-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49170",
            "title": "Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-02-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49177",
            "title": "Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-02-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49132",
            "title": "A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Shanghai Public Health Clinical Center",
            "timestamp": "2020-02-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49165",
            "title": "Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",
            "timestamp": "2020-02-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49146",
            "title": "Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital, College of Medicine, Zhejiang University",
            "timestamp": "2020-02-07"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49051",
            "title": "A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-07"
        },
        {
            "title": "Severe 2019-nCoV Remdesivir RCT",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04257656?sfpd_d=200",
            "timestamp": "2020-02-06T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49145",
            "title": "A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Fifth Affiliated Hospital of Sun Yat-Sen University",
            "timestamp": "2020-02-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49075",
            "title": "A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Zhejiang University School of Medicine",
            "timestamp": "2020-02-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48985",
            "title": "Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population",
            "affiliation": "Hubei Provincial Hospital of TCM",
            "timestamp": "2020-02-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48988",
            "title": "Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population",
            "affiliation": "Hubei Provincial Hospital of TCM",
            "timestamp": "2020-02-06"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49042",
            "title": "Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The Third People's Hospital of Shenzhen",
            "timestamp": "2020-02-06"
        },
        {
            "title": "Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With 2019 Novel Coronavirus",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04252118?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04252885?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04251871?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04252274?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "2019-nCoV Outbreak and Cardiovascular Diseases",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04255940?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04256395?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "Washed Microbiota Transplantation for Patients With 2019-nCoV Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04251767?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "Mild/Moderate 2019-nCoV Remdesivir RCT",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04252664?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04255017?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "title": "A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04254874?sfpd_d=200",
            "timestamp": "2020-02-05T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49104",
            "title": "An open, prospective, multicenter clinical study for the efficacy and safety of Reduning injection in the treatment of ovel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing hospital of Traditional Chinese Medicine; Hubei Integrated Traditional Chinese and Western Medicine Hospital",
            "timestamp": "2020-02-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49088",
            "title": "Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",
            "affiliation": "Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49045",
            "title": "The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49080",
            "title": "Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",
            "affiliation": "Zhejiang Chinese Medical University",
            "timestamp": "2020-02-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49065",
            "title": "A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",
            "affiliation": "The First Affiliated Hospital of Medical College of Zhejiang University",
            "timestamp": "2020-02-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=41760",
            "title": "Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial",
            "affiliation": "Xiangyang First People's Hospital",
            "timestamp": "2020-02-05"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49062",
            "title": "Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial",
            "affiliation": "Xiangyang 1st People's Hospital",
            "timestamp": "2020-02-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48880",
            "title": "Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48792",
            "title": "Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48775",
            "title": "Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49014",
            "title": "Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49015",
            "title": "Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",
            "affiliation": "The First Affiliated Hospital, Zhejiang University School of Medicine",
            "timestamp": "2020-02-04"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=49013",
            "title": "A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",
            "affiliation": "The First Hospital Affiliated to Zhejiang University's Medical School",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48968",
            "title": "Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Sun Yat sen Memorial Hospital of Sun Yat sen University",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48992",
            "title": "A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Zhongnan Hospital of Wuhan University",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48991",
            "title": "A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48860",
            "title": "Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",
            "affiliation": "Zhejiang Chinese Medical University",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48861",
            "title": "Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",
            "affiliation": "Zhejiang Chinese Medical University",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48809",
            "title": "A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Hospital of Changsha; The Second Xiangya Hospital of Central South University",
            "timestamp": "2020-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000586-20/FR",
            "title": "A Phase 3 Randomized, Active-Controlled, Open-Label Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL) Once-Daily in Participants With HIV-1 Virologically Suppressed on Antiretr...",
            "country": "FR",
            "timestamp": "2020-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000586-20/GB",
            "title": "A Phase 3 Randomized, Active-Controlled, Open-Label Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL) Once-Daily in Participants With HIV-1 Virologically Suppressed on Antiretr...",
            "country": "GB",
            "timestamp": "2020-02-03"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48971",
            "title": "Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",
            "affiliation": "1. Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48931",
            "title": "Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial ",
            "affiliation": "1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48965",
            "title": "Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children",
            "affiliation": "Wuhan Hospital of Integrated Traditional Chinese and Western Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48773",
            "title": "Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia (COVID-19) in the Community Population",
            "affiliation": "Hospital of Chengdu University of Traditional Chinese Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48919",
            "title": "A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48922",
            "title": "Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of He'nan University of Chinese Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48927",
            "title": "A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48930",
            "title": "The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period ",
            "affiliation": "1. Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48929",
            "title": "The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period",
            "affiliation": "1.Xinhua affiliated hospital, Hubei University of Chinese Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western Medicine",
            "timestamp": "2020-02-02"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48904",
            "title": "Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University/Beijing institute of Traditional Chinese MedHubei integrated traditional Chinese and Western Medicine Hospital",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48911",
            "title": "A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Beijing hospital of Traditional Chinese medicine; Hubei integrated traditional Chinese and Western Medicine Hospital",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48913",
            "title": "A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hubei Provincial Integrated Hospital of traditional Chinese and Western Medicine",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48884",
            "title": "A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Hospital of He'nan University of Chinese Medicine",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48827",
            "title": "Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population",
            "affiliation": "Wuhan 1st Hospital",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48889",
            "title": "A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hebei Yiling Hospital, Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48898",
            "title": "A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hebei Yiling Hospital、Renmin Hospital of Wuhan University",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48881",
            "title": "A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "The First Afflicated Hospital of Guangzhou University of Chinese Medicine",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48907",
            "title": "Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Affiliated Zhongshan Hospital of Dalian University",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48902",
            "title": "Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Hubei Integrated Hospital of Traditional Chinese and Western Medicine",
            "timestamp": "2020-02-01"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48886",
            "title": "Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial",
            "affiliation": "Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine",
            "timestamp": "2020-01-30"
        },
        {
            "title": "Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04245631?sfpd_d=200",
            "timestamp": "2020-01-29T17:00:00+00:00"
        },
        {
            "title": "Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04246723?sfpd_d=200",
            "timestamp": "2020-01-29T17:00:00+00:00"
        },
        {
            "title": "Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04246359?sfpd_d=200",
            "timestamp": "2020-01-29T17:00:00+00:00"
        },
        {
            "title": "Tofacitinib for Immune Skin Conditions in Down Syndrome",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04246372?sfpd_d=200",
            "timestamp": "2020-01-29T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48824",
            "title": "Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)",
            "affiliation": "China Academy of Chinese Medical Sciences",
            "timestamp": "2020-01-29"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48782",
            "title": "Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",
            "affiliation": "Chongqing Public Health Medical Center",
            "timestamp": "2020-01-29"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48777",
            "title": "Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial ",
            "affiliation": "Chongqing Public Health Medical Center",
            "timestamp": "2020-01-29"
        },
        {
            "title": "Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04244591?sfpd_d=200",
            "timestamp": "2020-01-28T17:00:00+00:00"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48768",
            "title": "A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19)",
            "affiliation": "The First Affiliated Hospital of Guangzhou Medical University",
            "timestamp": "2020-01-27"
        },
        {
            "url": "http://www.chictr.org.cn/showprojen.aspx?proj=48684",
            "title": "A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",
            "affiliation": "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
            "timestamp": "2020-01-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001268-40/GB",
            "title": "Hydroxychloroquine in ANCA Vasculitis Evaluation - A Multicentre, Randomised, Double-blind, Placebo-controlled Trial",
            "country": "GB",
            "timestamp": "2020-01-23"
        },
        {
            "title": "Tuberculosis Infection In Children Visiting Friends and Relatives",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04236765?sfpd_d=200",
            "timestamp": "2020-01-22T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-003405-94/HU",
            "title": "A multicenter, randomized, double-blind, placebo-controlled, dose-finding clinical trial inpatients with active psoriatic arthritis to investigate efficacy, tolerability, safety,\npharmacokinetics a...",
            "country": "HU",
            "timestamp": "2020-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-003405-94/ES",
            "title": "A multicenter, randomized, double-blind, placebo-controlled, dose-finding clinical trial inpatients with active psoriatic arthritis to investigate efficacy, tolerability, safety,\npharmacokinetics a...",
            "country": "ES",
            "timestamp": "2020-01-20"
        },
        {
            "title": "Second-line Switch to Dolutegravir Study",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04229290?sfpd_d=200",
            "timestamp": "2020-01-18T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-002713-19/GB",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Efficacy and Safety of VIB4920 in subjects with Sjögren’s Syndrome (SS)",
            "country": "GB",
            "timestamp": "2020-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-002713-19/PL",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Efficacy and Safety of VIB4920 in subjects with Sjögren’s Syndrome (SS)",
            "country": "PL",
            "timestamp": "2020-01-15"
        },
        {
            "title": "Hydroxychloroquine and Unexplained Recurrent Miscarriage",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04228263?sfpd_d=200",
            "timestamp": "2020-01-14T17:00:00+00:00"
        },
        {
            "title": "Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *Due to COVID-19 Outbreak in United States the Investigators Have Paused All In-person Enrollment and Will Re-evaluate on May 1st*",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04226157?sfpd_d=200",
            "timestamp": "2020-01-13T17:00:00+00:00"
        },
        {
            "title": "Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04226950?sfpd_d=200",
            "timestamp": "2020-01-13T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004701-11/BG",
            "title": "A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with an Interferon Beta 1a (Avonex®), in Participants with Relapsin...",
            "country": "BG",
            "timestamp": "2020-01-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004700-19/BG",
            "title": "A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with an Interferon Beta 1a (Avonex®), in Participants with Relapsin...",
            "country": "BG",
            "timestamp": "2020-01-10"
        },
        {
            "title": "TES Artemether-lumefantrine for Pf and Chloroquine (CQ) for Pv",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04222088?sfpd_d=200",
            "timestamp": "2020-01-09T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-001992-35/ES",
            "title": "A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without M7824 (bintrafusp alfa) as First-line Treatment of Biliary Tract Cancer",
            "country": "ES",
            "timestamp": "2020-01-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-002843-81/FR",
            "title": "Switch to Tenofovir Alafenamide (TAF), Emtricitabine (FTC), Bictegravir (BIC)(Biktarvy®) in HIV-1-infected patients over 65 years old at risk of polymedication",
            "country": "FR",
            "timestamp": "2020-01-07"
        },
        {
            "title": "Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced Malignancies",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04214418?sfpd_d=200",
            "timestamp": "2020-01-02T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002279-16/DE",
            "title": "A MulticenteR, Open-Label, First-in-Human, PhaSe Ib/IIa Trial of EO2401, a Novel Multipeptide Therapeutic VAccine, with and without PD-1 Check Point Inhibitor, FoLlowing Standard Treatment in PatIe...",
            "country": "DE",
            "timestamp": "2020-01-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002279-16/ES",
            "title": "A MulticenteR, Open-Label, First-in-Human, PhaSe Ib/IIa Trial of EO2401, a Novel Multipeptide Therapeutic VAccine, with and without PD-1 Check Point Inhibitor, FoLlowing Standard Treatment in PatIe...",
            "country": "ES",
            "timestamp": "2020-01-02"
        },
        {
            "title": "A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04208061?sfpd_d=200",
            "timestamp": "2019-12-23T17:00:00+00:00"
        },
        {
            "title": "Study of the Role of Interferon αon the Endothelial Dysfunction During Septic Shock",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04204694?sfpd_d=200",
            "timestamp": "2019-12-19T17:00:00+00:00"
        },
        {
            "title": "A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04201457?sfpd_d=200",
            "timestamp": "2019-12-17T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003811-23/DE",
            "title": "A Multi-Center, Open Label Study to Assess the Safety, Steady­ State Pharmacokinetics and Pharmacodynamics of IMG-7289 in Patients with Myelofibrosis",
            "country": "DE",
            "timestamp": "2019-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/GB",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "GB",
            "timestamp": "2019-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/DE",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "DE",
            "timestamp": "2019-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/ES",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "ES",
            "timestamp": "2019-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/PL",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "PL",
            "timestamp": "2019-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/BG",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "BG",
            "timestamp": "2019-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/EE",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "EE",
            "timestamp": "2019-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000867-26/HU",
            "title": "A 52-week, phase 3, multicentre, randomised, double blind, efficacy and safety study, comparing GSK3196165 with placebo and with tofacitinib in combination with conventional synthetic DMARDs, in pa...",
            "country": "HU",
            "timestamp": "2019-12-10"
        },
        {
            "title": "GastrOesophageal Varices After Sustained Virological Response",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04191018?sfpd_d=200",
            "timestamp": "2019-12-09T17:00:00+00:00"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN51287266",
            "timestamp": "2019-12-06",
            "title": "Aspergillosis in patients with severe influenza or coronavirus"
        },
        {
            "title": "Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04183491?sfpd_d=200",
            "timestamp": "2019-12-03T17:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000868-18/GB",
            "title": "A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in par...",
            "country": "GB",
            "timestamp": "2019-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000868-18/PL",
            "title": "A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in par...",
            "country": "PL",
            "timestamp": "2019-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000868-18/LT",
            "title": "A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in par...",
            "country": "LT",
            "timestamp": "2019-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000868-18/ES",
            "title": "A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in par...",
            "country": "ES",
            "timestamp": "2019-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000868-18/CZ",
            "title": "A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in par...",
            "country": "CZ",
            "timestamp": "2019-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000868-18/HU",
            "title": "A 24-week, phase 3, multicentre, randomised, double-blind, efficacy and safety study, comparing GSK3196165 with placebo and with sarilumab, in combination with conventional synthetic DMARDs, in par...",
            "country": "HU",
            "timestamp": "2019-12-02"
        },
        {
            "title": "A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04170829?sfpd_d=200",
            "timestamp": "2019-11-20T17:00:00+00:00"
        },
        {
            "title": "Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04163107?sfpd_d=200",
            "timestamp": "2019-11-14T17:00:00+00:00"
        },
        {
            "title": "Anti-Inflammatory Drug and Endothelial Function",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04161339?sfpd_d=200",
            "timestamp": "2019-11-13T17:00:00+00:00"
        },
        {
            "title": "Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04153201?sfpd_d=200",
            "timestamp": "2019-11-06T17:00:00+00:00"
        },
        {
            "title": "Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04147208?sfpd_d=200",
            "timestamp": "2019-11-01T16:00:00+00:00"
        },
        {
            "title": "Ulixertinib (BVD-523) and Hydroxychloroquine in Patients w Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04145297?sfpd_d=200",
            "timestamp": "2019-10-30T16:00:00+00:00"
        },
        {
            "title": "Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04144140?sfpd_d=200",
            "timestamp": "2019-10-30T16:00:00+00:00"
        },
        {
            "title": "A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04138199?sfpd_d=200",
            "timestamp": "2019-10-24T16:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005028-11/GB",
            "title": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)",
            "country": "GB",
            "timestamp": "2019-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005028-11/CZ",
            "title": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)",
            "country": "CZ",
            "timestamp": "2019-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005028-11/AT",
            "title": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)",
            "country": "AT",
            "timestamp": "2019-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005028-11/HU",
            "title": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)",
            "country": "HU",
            "timestamp": "2019-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005028-11/PL",
            "title": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)",
            "country": "PL",
            "timestamp": "2019-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005028-11/ES",
            "title": "A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE)",
            "country": "ES",
            "timestamp": "2019-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004244-33/DE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosis",
            "country": "DE",
            "timestamp": "2019-10-21"
        },
        {
            "title": "Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04132505?sfpd_d=200",
            "timestamp": "2019-10-18T16:00:00+00:00"
        },
        {
            "title": "Study of Safety and Immunogenicity of BVRS-GamVac",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04130594?sfpd_d=200",
            "timestamp": "2019-10-17T16:00:00+00:00"
        },
        {
            "title": "Study of Safety and Immunogenicity of BVRS-GamVac-Combi",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04128059?sfpd_d=200",
            "timestamp": "2019-10-16T16:00:00+00:00"
        },
        {
            "title": "Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04120883?sfpd_d=200",
            "timestamp": "2019-10-09T16:00:00+00:00"
        },
        {
            "title": "Randomized, Double-blind, Placebo-controlled, Phase Ib Study to Assess the Safety and Immunogenicity of MVA-MERS-S_DF-1",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04119440?sfpd_d=200",
            "timestamp": "2019-10-08T16:00:00+00:00"
        },
        {
            "title": "MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polcythemia Vera",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04116502?sfpd_d=200",
            "timestamp": "2019-10-04T16:00:00+00:00"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN61522291",
            "timestamp": "2019-10-04",
            "title": "VIETNarms"
        },
        {
            "title": "A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04109092?sfpd_d=200",
            "timestamp": "2019-09-30T16:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-001485-15/FR",
            "title": "A Multicenter, Open-label, Randomized Phase 2b Clinical Study to Assess Efficacy and Safety of Bulevirtide in Combination with Pegylated Interferon alfa-2a in Patients with Chronic Hepatitis Delta",
            "country": "FR",
            "timestamp": "2019-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004175-12/HU",
            "title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTH...",
            "country": "HU",
            "timestamp": "2019-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004175-12/BG",
            "title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTH...",
            "country": "BG",
            "timestamp": "2019-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004175-12/PT",
            "title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTH...",
            "country": "PT",
            "timestamp": "2019-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004175-12/DE",
            "title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTH...",
            "country": "DE",
            "timestamp": "2019-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004175-12/PL",
            "title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTH...",
            "country": "PL",
            "timestamp": "2019-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004175-12/ES",
            "title": "A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTH...",
            "country": "ES",
            "timestamp": "2019-09-23"
        },
        {
            "title": "Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04093323?sfpd_d=200",
            "timestamp": "2019-09-18T16:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000328-16/DE",
            "title": "A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy",
            "country": "DE",
            "timestamp": "2019-09-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000328-16/HU",
            "title": "A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy",
            "country": "HU",
            "timestamp": "2019-09-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000328-16/FR",
            "title": "A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy",
            "country": "FR",
            "timestamp": "2019-09-17"
        },
        {
            "title": "Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive",
            "url": "https://clinicaltrials.gov/ct2/show/NCT04088019?sfpd_d=200",
            "timestamp": "2019-09-12T16:00:00+00:00"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003150-16/AT",
            "title": "Copanlisib and Rituximab in Marginal Zone Lymphoma Patients",
            "country": "AT",
            "timestamp": "2019-09-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12885480",
            "timestamp": "2019-08-28",
            "title": "Ruxolitinib versus hydroxycarbamide or interferon as first-line therapy in high-risk polcythemia vera"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN47127434",
            "timestamp": "2019-08-14",
            "title": "A trial to look for markers in the tumour cells and blood which signal that trial treatments are working in a patient with triple negative breast cancer, for whom upfront chemotherapy has not provided the maximum expected benefit"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN78466206",
            "timestamp": "2019-08-13",
            "title": "The quality of life of multiple sclerosis patients in Europe"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004293-10/CZ",
            "title": "A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects with Active Psoriatic Arthritis (PsA)",
            "country": "CZ",
            "timestamp": "2019-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004293-10/HU",
            "title": "A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects with Active Psoriatic Arthritis (PsA)",
            "country": "HU",
            "timestamp": "2019-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004293-10/ES",
            "title": "A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects with Active Psoriatic Arthritis (PsA)",
            "country": "ES",
            "timestamp": "2019-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001789-41/FR",
            "title": "Trial Of Imatinib After Ponatinib Induction (Tipi) - A multicentre, open label phase II trial evaluating the safety and efficacy of ponatinib induction followed by imatinib maintenance in adult pat...",
            "country": "FR",
            "timestamp": "2019-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001840-23/3rd",
            "title": "An exploratory study of the biologic effects of Nivolumab and Ipilimumab Monotherapy and Nivolumab in Combination with Ipilimumab Treatment in Subjects with Advanced melanoma (Unresectable or metas...",
            "country": "Outside EU/EEA",
            "timestamp": "2019-07-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10891611",
            "timestamp": "2019-07-04",
            "title": "Does eating artisanal bread affect metabolism, inflammation or gut flora in people with metabolic syndrome?"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN16371380",
            "timestamp": "2019-06-27",
            "title": "BIO-FLARE"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002804-29/DE",
            "title": "A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS",
            "country": "DE",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002804-29/GB",
            "title": "A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS",
            "country": "GB",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002804-29/CZ",
            "title": "A MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS",
            "country": "CZ",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002322-20/DE",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE ...",
            "country": "DE",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002322-20/GB",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE ...",
            "country": "GB",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002322-20/FR",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE ...",
            "country": "FR",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002322-20/HU",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE ...",
            "country": "HU",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002322-20/ES",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE ...",
            "country": "ES",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002322-20/CZ",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ACTIVE REFERENCE (ADALIMUMAB) STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE ...",
            "country": "CZ",
            "timestamp": "2019-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003877-91/DE",
            "title": "Sequential B cell/T cell therapy to re-induce humoral immune tolerance in ACPA-positive Rheumatoid Arthritis (TOLERA): a prospective randomized controlled open-label single-centre clinical trial in...",
            "country": "DE",
            "timestamp": "2019-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001044-54/FI",
            "title": "A STUDY OF EFFICACY AND SAFETY OF LONG-ACTING LOW DOSE ROPEGINTERFERON IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH BOSUTINIB FROM DIAGNOSIS: \r\nA RANDOMIZED PROSPECTIVE TRIAL",
            "country": "FI",
            "timestamp": "2019-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001044-54/DK",
            "title": "A STUDY OF EFFICACY AND SAFETY OF LONG-ACTING LOW DOSE ROPEGINTERFERON IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH BOSUTINIB FROM DIAGNOSIS: \r\nA RANDOMIZED PROSPECTIVE TRIAL",
            "country": "DK",
            "timestamp": "2019-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/DE",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "DE",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/HU",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "HU",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/GB",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "GB",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/BG",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "BG",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/FR",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "FR",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/ES",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "ES",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/CZ",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "CZ",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003065-95/NL",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS",
            "country": "NL",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/DE",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "DE",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/CZ",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "CZ",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/FR",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "FR",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/HU",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "HU",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/GB",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "GB",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/BG",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "BG",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003064-13/NL",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE\r\nEFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS",
            "country": "NL",
            "timestamp": "2019-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003933-14/LV",
            "title": "A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males with active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosin...",
            "country": "LV",
            "timestamp": "2019-05-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003933-14/EE",
            "title": "A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males with active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosin...",
            "country": "EE",
            "timestamp": "2019-05-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003933-14/BG",
            "title": "A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males with active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosin...",
            "country": "BG",
            "timestamp": "2019-05-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003933-14/ES",
            "title": "A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males with active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosin...",
            "country": "ES",
            "timestamp": "2019-05-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003167-54/GB",
            "title": "A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared...",
            "country": "GB",
            "timestamp": "2019-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003167-54/FR",
            "title": "A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared...",
            "country": "FR",
            "timestamp": "2019-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003167-54/BG",
            "title": "A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared...",
            "country": "BG",
            "timestamp": "2019-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003167-54/GR",
            "title": "A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared...",
            "country": "GR",
            "timestamp": "2019-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003167-54/ES",
            "title": "A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared...",
            "country": "ES",
            "timestamp": "2019-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003167-54/SE",
            "title": "A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID with and without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared...",
            "country": "SE",
            "timestamp": "2019-05-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10280992",
            "timestamp": "2019-04-25",
            "title": "Rivaroxaban for stroke patients with antiphospholipid syndrome"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002077-21/GB",
            "title": "PHOENIX Trial: A pre-surgical window of opportunity and post-surgical adjuvant biomarker study of DNA damage response inhibition and/or anti-PD-L1 immunotherapy in patients with neoadjuvant chemoth...",
            "country": "GB",
            "timestamp": "2019-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004523-36/DE",
            "title": "Safety and protective efficacy of a simplified Plasmodium falciparum sporozoite Chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany",
            "country": "DE",
            "timestamp": "2019-04-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003707-19/FR",
            "title": "A Phase II, Multicenter, Open label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or are Intolera...",
            "country": "FR",
            "timestamp": "2019-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003707-19/DE",
            "title": "A Phase II, Multicenter, Open label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or are Intolera...",
            "country": "DE",
            "timestamp": "2019-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003707-19/GB",
            "title": "A Phase II, Multicenter, Open label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or are Intolera...",
            "country": "GB",
            "timestamp": "2019-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003707-19/ES",
            "title": "A Phase II, Multicenter, Open label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or are Intolera...",
            "country": "ES",
            "timestamp": "2019-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004854-12/NL",
            "title": "An Open-label Single-arm Pharmacokinetic Trial, Investigating the Effect of CYP3A4 inhibitor Ritonavir on the Pharmacokinetics of Erlotinib",
            "country": "NL",
            "timestamp": "2019-04-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN20647977",
            "timestamp": "2019-04-05",
            "title": "Examining whether any interactions occur between the antibiotic Ciprofloxacin and the antimalarial treatment Chloroquine/Proguanil"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001030-94/FR",
            "title": "Efficacy and safety of pegylated-proline-interferon alpha 2B (AOP2014) in maintaining deep molecular remissions in patients with chronic myeloid leukemia (CML) who discontinue ABL-kinase inhibitory...",
            "country": "FR",
            "timestamp": "2019-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002977-24/ES",
            "title": "A Phase IIA, open-label study to evaluate the immunogenicity and safety of sequential use of GSK's investigational vaccine GSK3277511A when administered to healthy smokers and ex-smokers aged 50 to...",
            "country": "ES",
            "timestamp": "2019-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002977-24/FI",
            "title": "A Phase IIA, open-label study to evaluate the immunogenicity and safety of sequential use of GSK's investigational vaccine GSK3277511A when administered to healthy smokers and ex-smokers aged 50 to...",
            "country": "FI",
            "timestamp": "2019-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002977-24/FR",
            "title": "A Phase IIA, open-label study to evaluate the immunogenicity and safety of sequential use of GSK's investigational vaccine GSK3277511A when administered to healthy smokers and ex-smokers aged 50 to...",
            "country": "FR",
            "timestamp": "2019-04-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12816166",
            "timestamp": "2019-03-31",
            "title": "Comparison of two adjunctive systemic antibiotic regimens to initial therapy for periodontitis patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/GB",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "GB",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/AT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "AT",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/BE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "BE",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/HU",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "HU",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/CZ",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "CZ",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/GR",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "GR",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/NL",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "NL",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005026-37/HR",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "HR",
            "timestamp": "2019-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003653-16/BE",
            "title": "Abatacept in patients with Birdshot HLA A29 uveitis: A Phase II\nProspective 0pen Label Interventional Proof-of-Concept Study",
            "country": "BE",
            "timestamp": "2019-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000305-23/BG",
            "title": "A Randomized Double-Blind Phase 1b/2 Combined Staggered Multiple Dose Escalation Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care",
            "country": "BG",
            "timestamp": "2019-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000305-23/HU",
            "title": "A Randomized Double-Blind Phase 1b/2 Combined Staggered Multiple Dose Escalation Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care",
            "country": "HU",
            "timestamp": "2019-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003753-13/FR",
            "title": "Multicentre, randomized, prospective trial comparing the efficacy and safety of Infliximab to tocilizumab in refractory or relapsing Takayasu arteritis",
            "country": "FR",
            "timestamp": "2019-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000659-42/SE",
            "title": "HYDROXYCHLOROQUINE FOR PREVENTION OF ABNORMAL GLUCOSE\nTOLERANCE AND DIABETES IN INDIVIDUALS AT-RISK FOR TYPE 1\nDIABETES MELLITUS",
            "country": "SE",
            "timestamp": "2019-03-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000659-42/GB",
            "title": "HYDROXYCHLOROQUINE FOR PREVENTION OF ABNORMAL GLUCOSE\nTOLERANCE AND DIABETES IN INDIVIDUALS AT-RISK FOR TYPE 1\nDIABETES MELLITUS",
            "country": "GB",
            "timestamp": "2019-03-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12196200",
            "timestamp": "2019-03-11",
            "title": "Can we use estrogen-containing therapy to improve pain in women after menopause with hand osteoarthritis? (HOPE-e study)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002306-31/HU",
            "title": "A Phase 2, Multicenter, Double-Blind, Parallel Group Long Term Extension Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial with ABBV-105 Give...",
            "country": "HU",
            "timestamp": "2019-03-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002306-31/GB",
            "title": "A Phase 2, Multicenter, Double-Blind, Parallel Group Long Term Extension Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial with ABBV-105 Give...",
            "country": "GB",
            "timestamp": "2019-03-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002306-31/ES",
            "title": "A Phase 2, Multicenter, Double-Blind, Parallel Group Long Term Extension Study in Rheumatoid Arthritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial with ABBV-105 Give...",
            "country": "ES",
            "timestamp": "2019-03-08"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17896007",
            "timestamp": "2019-02-25",
            "title": "Optimal timing of anticoagulation after acute ischaemic stroke"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN68270067",
            "timestamp": "2019-02-13",
            "title": "Clinical trial for patients with TKI resistant chronic myeloid leukaemia  in chronic or accelerated phase"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003083-30/BE",
            "title": "The effect of hydroxychloroquine sulphate on hedonic food intake, appetite-related sensations and gastrointestinal hormone release in healthy female subjects",
            "country": "BE",
            "timestamp": "2019-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001625-96/BE",
            "title": "The effect of hydroxychloroquine sulphate on hedonic food intake, appetite-related sensations and gastrointestinal hormone release in overweight female subject",
            "country": "BE",
            "timestamp": "2019-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003169-82/GB",
            "title": "A Phase III, Open Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination wit...",
            "country": "GB",
            "timestamp": "2019-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003169-82/DE",
            "title": "A Phase III, Open Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination wit...",
            "country": "DE",
            "timestamp": "2019-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003169-82/FR",
            "title": "A Phase III, Open Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination wit...",
            "country": "FR",
            "timestamp": "2019-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003169-82/PL",
            "title": "A Phase III, Open Label, Randomized, Parallel Group Study to Evaluate the Efficacy and Safety of Intrapleural Administration of Adenovirus-Delivered Interferon Alpha-2b (rAd-IFN) in Combination wit...",
            "country": "PL",
            "timestamp": "2019-01-30"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN41325341",
            "timestamp": "2019-01-29",
            "title": "Prednisolone in adrenal insufficiency disease"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004543-20/ES",
            "title": "EFFECTS OF ABATACEPT ON THE PROGRESSION TO RHEUMATOID ARTHRITIS  IN PATIENTS WITH PALINDROMIC RHEUMATISM (PALABA).",
            "country": "ES",
            "timestamp": "2019-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002251-14/GB",
            "title": "Localized on site testing and treatment of hepatitis C in homeless persons in London: a pilot non-randomised phase 4 interventional clinical trial of grazoprevir and elbasvir ± ribavirin in partici...",
            "country": "GB",
            "timestamp": "2019-01-02"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14843579",
            "timestamp": "2019-01-02",
            "title": "German translation, cultural adaption and validation of the Unidimensional Self-Efficacy scale for Multiple Sclerosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001808-11/GB",
            "title": "A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in subjects with moderate to severe syste...",
            "country": "GB",
            "timestamp": "2018-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001808-11/ES",
            "title": "A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in subjects with moderate to severe syste...",
            "country": "ES",
            "timestamp": "2018-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001808-11/HU",
            "title": "A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in subjects with moderate to severe syste...",
            "country": "HU",
            "timestamp": "2018-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001808-11/BG",
            "title": "A Phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of cenerimod in subjects with moderate to severe syste...",
            "country": "BG",
            "timestamp": "2018-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001672-38/CZ",
            "title": "A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemi...",
            "country": "CZ",
            "timestamp": "2018-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001672-38/HU",
            "title": "A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemi...",
            "country": "HU",
            "timestamp": "2018-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001672-38/ES",
            "title": "A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemi...",
            "country": "ES",
            "timestamp": "2018-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001672-38/BG",
            "title": "A Two-Part, Randomized, Open-label, Multicenter, Phase 2a/2b Study of the Efficacy, Safety, and Pharmacokinetics of KRT-232 Compared to Ruxolitinib in Patients with Phlebotomy-Dependent Polycythemi...",
            "country": "BG",
            "timestamp": "2018-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003249-41/BE",
            "title": "A multicentre phase IIa study to evaluate the efficacy and tolerability of ModraDoc006/r in patients with recurrent or metastatic HER-2 negative breast cancer, suitable for treatment with a taxane",
            "country": "BE",
            "timestamp": "2018-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003249-41/DK",
            "title": "A multicentre phase IIa study to evaluate the efficacy and tolerability of ModraDoc006/r in patients with recurrent or metastatic HER-2 negative breast cancer, suitable for treatment with a taxane",
            "country": "DK",
            "timestamp": "2018-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003249-41/ES",
            "title": "A multicentre phase IIa study to evaluate the efficacy and tolerability of ModraDoc006/r in patients with recurrent or metastatic HER-2 negative breast cancer, suitable for treatment with a taxane",
            "country": "ES",
            "timestamp": "2018-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004610-26/GB",
            "title": "Evaluating the Long Term Immunogenicity of adenoviral and MVA vectored Ebola vaccine schedules and response to late boosting with AD26.ZEBOV vaccine: an open-label clinical trial",
            "country": "GB",
            "timestamp": "2018-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002520-16/SE",
            "title": "A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in...",
            "country": "SE",
            "timestamp": "2018-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002520-16/DE",
            "title": "A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in...",
            "country": "DE",
            "timestamp": "2018-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002520-16/ES",
            "title": "A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in...",
            "country": "ES",
            "timestamp": "2018-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002520-16/FR",
            "title": "A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in...",
            "country": "FR",
            "timestamp": "2018-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002520-16/GB",
            "title": "A Phase 3 Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in...",
            "country": "GB",
            "timestamp": "2018-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-002591-40/FR",
            "title": "Evaluation of bronchial remodeling during mepolizumab treatment in severe eosinophilic asthma",
            "country": "FR",
            "timestamp": "2018-11-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004974-16/GB",
            "title": "DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMISED CLINICAL DOSE-RANGING STUDY TREATING MODERATE-SEVERE TRAUMATIC BRAIN INJURY PATIENTS WITH RECOMBINANT HUMAN INTERLEUKIN 1 RECEPTOR ANTAGONIST.",
            "country": "GB",
            "timestamp": "2018-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000309-21/ES",
            "title": "An Open-Label, Multi-Center Trial of INO-5401 + INO-9012 in Combination with Atezolizumab in Subjects with Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma",
            "country": "ES",
            "timestamp": "2018-10-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003741-42/3rd",
            "title": "A Phase 2, Open-label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Subjects Underg...",
            "country": "Outside EU/EEA",
            "timestamp": "2018-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003741-42/results",
            "title": "A Phase 2, Open-label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Subjects Underg...",
            "country": "View results",
            "timestamp": "2018-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001358-84/FR",
            "title": "Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 positive subjects commencing Antiretroviral Therapy",
            "country": "FR",
            "timestamp": "2018-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003051-35/DE",
            "title": "Efficacy of BELImumab for therapy-resistant SKIN manifestations in patients with lupus erythematosus (LE): A phase III, multicenter, randomized, double-blind, placebo-controlled, 24-week trial (BEL...",
            "country": "DE",
            "timestamp": "2018-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005047-32/DK",
            "title": "A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R-) Patients Awaiting Kidney Transplantation from Living CMV-Sero...",
            "country": "DK",
            "timestamp": "2018-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005047-32/BE",
            "title": "A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R-) Patients Awaiting Kidney Transplantation from Living CMV-Sero...",
            "country": "BE",
            "timestamp": "2018-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005047-32/FR",
            "title": "A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R-) Patients Awaiting Kidney Transplantation from Living CMV-Sero...",
            "country": "FR",
            "timestamp": "2018-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005047-32/AT",
            "title": "A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R-) Patients Awaiting Kidney Transplantation from Living CMV-Sero...",
            "country": "AT",
            "timestamp": "2018-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005047-32/DE",
            "title": "A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R-) Patients Awaiting Kidney Transplantation from Living CMV-Sero...",
            "country": "DE",
            "timestamp": "2018-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005047-32/NL",
            "title": "A Randomized, Placebo-Controlled, Phase 2 Study of HB-101, a Bivalent Cytomegalovirus (CMV) Vaccine, in CMV-Seronegative Recipient (R-) Patients Awaiting Kidney Transplantation from Living CMV-Sero...",
            "country": "NL",
            "timestamp": "2018-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005027-25/ES",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3\nStudy of Baricitinib in Patients with Systemic Lupus Erythematosus",
            "country": "ES",
            "timestamp": "2018-09-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17100273",
            "timestamp": "2018-09-17",
            "title": "A pilot study to assess shortened therapy for hepatitis C infected adults in Vietnam"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003114-10/DE",
            "title": "An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess its Efficacy, Safety, Impact on Quality of Life...",
            "country": "DE",
            "timestamp": "2018-09-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003114-10/ES",
            "title": "An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess its Efficacy, Safety, Impact on Quality of Life...",
            "country": "ES",
            "timestamp": "2018-09-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003114-10/GB",
            "title": "An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess its Efficacy, Safety, Impact on Quality of Life...",
            "country": "GB",
            "timestamp": "2018-09-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003114-10/IT",
            "title": "An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess its Efficacy, Safety, Impact on Quality of Life...",
            "country": "IT",
            "timestamp": "2018-09-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004750-42/ES",
            "title": "EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE...",
            "country": "ES",
            "timestamp": "2018-09-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14274380",
            "timestamp": "2018-08-24",
            "title": "Ustekinumab in adolescents with recent-onset type 1 diabetes"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10481319",
            "timestamp": "2018-08-17",
            "title": "Re-evaluating Optimal Vaccine Schedules Against Ebola (REVOLVE)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001292-21/FR",
            "title": "Disease modifying therapies withdrawal in inactive Secondary Progressive Multiple Sclerosis patients older than 50 years",
            "country": "FR",
            "timestamp": "2018-07-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN15434137",
            "timestamp": "2018-07-12",
            "title": "Re-evaluating optimal vaccine schedules against Ebola in Senegal"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004112-19/GB",
            "title": "Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects with\nAdvanced Gastrointestinal Malignancies Focusing on Hepatocellular Carcinoma",
            "country": "GB",
            "timestamp": "2018-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001362-25/DK",
            "title": "Randomized autologous hematopoietic stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab for patients with relapsing remitting Multiple Sclerosis",
            "country": "DK",
            "timestamp": "2018-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001362-25/NL",
            "title": "Randomized autologous hematopoietic stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab for patients with relapsing remitting Multiple Sclerosis",
            "country": "NL",
            "timestamp": "2018-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001440-18/NL",
            "title": "Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls",
            "country": "NL",
            "timestamp": "2018-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001944-36/ES",
            "title": "A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid Arthritis With Inadequate Response to Standard of Care Therapy",
            "country": "ES",
            "timestamp": "2018-05-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001944-36/PL",
            "title": "A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid Arthritis With Inadequate Response to Standard of Care Therapy",
            "country": "PL",
            "timestamp": "2018-05-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001944-36/BG",
            "title": "A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects with Active Rheumatoid Arthritis With Inadequate Response to Standard of Care Therapy",
            "country": "BG",
            "timestamp": "2018-05-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003149-56/DE",
            "title": "OBINUTUZUMAB in MARGINAL ZONE LYMPHOMA",
            "country": "DE",
            "timestamp": "2018-05-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003230-93/HU",
            "title": "A randomized, placebo-controlled, patient and investigator blinded study investigating the safety, tolerability, pharmacokinetics and preliminary efficacy of multiple doses of CFZ533 in patients wi...",
            "country": "HU",
            "timestamp": "2018-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003230-93/DE",
            "title": "A randomized, placebo-controlled, patient and investigator blinded study investigating the safety, tolerability, pharmacokinetics and preliminary efficacy of multiple doses of CFZ533 in patients wi...",
            "country": "DE",
            "timestamp": "2018-05-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN42218549",
            "timestamp": "2018-04-24",
            "title": "Improving diagnosis and treatment of HIV-associated Tuberculous meningitis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/GB",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "GB",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/LT",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "LT",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/FI",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "FI",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/DE",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "DE",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/CZ",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "CZ",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/ES",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "ES",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/PT",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "PT",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/PL",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "PL",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/SK",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "SK",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/BE",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "BE",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/NL",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "NL",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002761-63/EE",
            "title": "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VGX-3100 DELIVERED INTRAMUSCULARLY FOLLOWED BY ELECTROPORATION WITH CELLECTRA™ 5PSP FOR THE TREATMENT OF HPV-16 AND/OR H...",
            "country": "EE",
            "timestamp": "2018-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002564-40/DE",
            "title": "A Phase 1b/2a Study to Evaluate the Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy.",
            "country": "DE",
            "timestamp": "2018-04-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002256-25/GB",
            "title": "HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies",
            "country": "GB",
            "timestamp": "2018-03-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002256-25/DK",
            "title": "HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies",
            "country": "DK",
            "timestamp": "2018-03-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003634-93/GB",
            "title": "A Phase 2/3 (Adaptive Design) Study of the Concomitant Administration of Indoximod or Placebo plus Pembrolizumab or Nivolumab in Adult Patients with Unresectable Stage III or Stage IV Malignant Mel...",
            "country": "GB",
            "timestamp": "2018-02-28"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN21654693",
            "timestamp": "2018-02-12",
            "title": "Vaccination against chickenpox in immunosuppressed children with rheumatic diseases"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001647-12/ES",
            "title": "A Phase 2a, Open-Label, Study Evaluating the Safety and Anti-Viral Activity of ARB-001467 in Non-Cirrhotic, HBeAg-Negative Subjects with Chronic HBV Infection (Genotype A or B) in Combination with ...",
            "country": "ES",
            "timestamp": "2018-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001647-12/PL",
            "title": "A Phase 2a, Open-Label, Study Evaluating the Safety and Anti-Viral Activity of ARB-001467 in Non-Cirrhotic, HBeAg-Negative Subjects with Chronic HBV Infection (Genotype A or B) in Combination with ...",
            "country": "PL",
            "timestamp": "2018-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001566-21/DK",
            "title": "Effect of Low-dose Interferon-alfa2a on post-operative immune suppression - a randomized trial",
            "country": "DK",
            "timestamp": "2018-01-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14784018",
            "timestamp": "2018-01-19",
            "title": "Trial of different drug and treatment combinations for patients who are considering further therapy to treat their ovarian cancer"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003050-32/DE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-\r\nControlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab\r\nAdministered in Combination with Rituximab to Adult Subject...",
            "country": "DE",
            "timestamp": "2018-01-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003050-32/NL",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-\r\nControlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab\r\nAdministered in Combination with Rituximab to Adult Subject...",
            "country": "NL",
            "timestamp": "2018-01-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003050-32/ES",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-\r\nControlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab\r\nAdministered in Combination with Rituximab to Adult Subject...",
            "country": "ES",
            "timestamp": "2018-01-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000285-30/3rd",
            "title": "Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected adults, adolescents and children aged 3 years and above.",
            "country": "Outside EU/EEA",
            "timestamp": "2018-01-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003006-16/DE",
            "title": "A Phase IIb Clinical Study to Assess the Pharmacokinetics, Safety, and Efficacy of the Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Participants Aged 3 to less than 18 Years with Chro...",
            "country": "DE",
            "timestamp": "2017-12-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003006-16/SE",
            "title": "A Phase IIb Clinical Study to Assess the Pharmacokinetics, Safety, and Efficacy of the Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Participants Aged 3 to less than 18 Years with Chro...",
            "country": "SE",
            "timestamp": "2017-12-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003006-16/PL",
            "title": "A Phase IIb Clinical Study to Assess the Pharmacokinetics, Safety, and Efficacy of the Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Participants Aged 3 to less than 18 Years with Chro...",
            "country": "PL",
            "timestamp": "2017-12-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003006-16/3rd",
            "title": "A Phase IIb Clinical Study to Assess the Pharmacokinetics, Safety, and Efficacy of the Combination Regimen of Elbasvir (EBR)/Grazoprevir (GZR) in Participants Aged 3 to less than 18 Years with Chro...",
            "country": "Outside EU/EEA",
            "timestamp": "2017-12-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001717-92/AT",
            "title": "A randomised, double-blind, placebo-controlled Phase II study to target the type I IFN receptor by administrating Anifrolumab in RA patients with a high IFN signature (TarIFNiRA)",
            "country": "AT",
            "timestamp": "2017-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001203-79/HU",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects with Systemic Lupus Erythematosus",
            "country": "HU",
            "timestamp": "2017-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001203-79/PL",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects with Systemic Lupus Erythematosus",
            "country": "PL",
            "timestamp": "2017-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001203-79/ES",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BMS-986165 in Subjects with Systemic Lupus Erythematosus",
            "country": "ES",
            "timestamp": "2017-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003679-75/GB",
            "title": "A randomised, double-blind, placebo-controlled study, in COPD patients with and without a confirmed respiratory virus infection assessing anti-viral biomarker responses and clinical effects of inha...",
            "country": "GB",
            "timestamp": "2017-12-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN11965217",
            "timestamp": "2017-11-30",
            "title": "A trial to assess whether the addition of atezolizumab to current standard treatment for patients with relapsed or refractory Diffuse Large B-Cell Lymphoma, who are not able to have high dose therapy, improves survival outcomes"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001929-40/NL",
            "title": "A prospective, randomized pilot study of the immunomodulatory effects of azithromycin in adults with pulmonary tuberculosis",
            "country": "NL",
            "timestamp": "2017-11-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN22964075",
            "timestamp": "2017-10-20",
            "title": "Children with HIV in Africa – pharmacokinetics and acceptability of simple second-line antiretroviral regimens"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000880-34/GB",
            "title": "A Phase IIB, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine G...",
            "country": "GB",
            "timestamp": "2017-10-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000880-34/BE",
            "title": "A Phase IIB, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine G...",
            "country": "BE",
            "timestamp": "2017-10-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000880-34/ES",
            "title": "A Phase IIB, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine G...",
            "country": "ES",
            "timestamp": "2017-10-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000880-34/DE",
            "title": "A Phase IIB, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine G...",
            "country": "DE",
            "timestamp": "2017-10-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000880-34/FR",
            "title": "A Phase IIB, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine G...",
            "country": "FR",
            "timestamp": "2017-10-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005389-51/FR",
            "title": "Safety and Efficacy of tocilizuMAb versus placebo in Polymyalgia rHeumatica with glucocORticoid dEpendence SEMAPHORE",
            "country": "FR",
            "timestamp": "2017-10-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN38690336",
            "timestamp": "2017-10-06",
            "title": "Is it safe to add cediranib to weekly paclitaxel chemotherapy in women with ovarian cancer who are at risk of developing malignant bowel obstruction?"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002634-24/SE",
            "title": "MultipleMS – Multiple-omics approach to accelerate personalised medicine in a prospective cohort of newly diagnosed MS and CIS patients.",
            "country": "SE",
            "timestamp": "2017-09-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/DK",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "DK",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/DE",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "DE",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/FI",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "FI",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/CZ",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "CZ",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/GB",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "GB",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/ES",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "ES",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/PT",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "PT",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/NL",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "NL",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/BE",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "BE",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/HU",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "HU",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/PL",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "PL",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/SE",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "SE",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000431-14/HR",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects with Active Ankylosing Spondylitis",
            "country": "HR",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000957-37/CZ",
            "title": "A Multicenter, Phase 2A, Randomized, Investigator-Blind, Subject-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Subjects with Active Ankylo...",
            "country": "CZ",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000957-37/DE",
            "title": "A Multicenter, Phase 2A, Randomized, Investigator-Blind, Subject-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Subjects with Active Ankylo...",
            "country": "DE",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000957-37/GR",
            "title": "A Multicenter, Phase 2A, Randomized, Investigator-Blind, Subject-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Subjects with Active Ankylo...",
            "country": "GR",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000957-37/NL",
            "title": "A Multicenter, Phase 2A, Randomized, Investigator-Blind, Subject-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Subjects with Active Ankylo...",
            "country": "NL",
            "timestamp": "2017-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/HU",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "HU",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/ES",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "ES",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/SE",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "SE",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/GB",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "GB",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/AT",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "AT",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/CZ",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "CZ",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/FI",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "FI",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/DK",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "DK",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/BE",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "BE",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/FR",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "FR",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/PT",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "PT",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001176-31/results",
            "title": "BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies",
            "country": "View results",
            "timestamp": "2017-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004876-23/GB",
            "title": "A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ...",
            "country": "GB",
            "timestamp": "2017-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004876-23/ES",
            "title": "A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ...",
            "country": "ES",
            "timestamp": "2017-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004876-23/DE",
            "title": "A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ...",
            "country": "DE",
            "timestamp": "2017-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004876-23/BG",
            "title": "A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ...",
            "country": "BG",
            "timestamp": "2017-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004876-23/PL",
            "title": "A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ...",
            "country": "PL",
            "timestamp": "2017-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004876-23/results",
            "title": "A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ...",
            "country": "View results",
            "timestamp": "2017-09-13"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN16320634",
            "timestamp": "2017-08-18",
            "title": "Does cediranib together with paclitaxel chemotherapy, or cediranib and olaparib, treat advanced endometrial cancer better than paclitaxel chemotherapy?"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001804-31/3rd",
            "title": "Ph3 trial of Glivec in CML-CP patients previously untreated with IFN-alfa",
            "country": "Outside EU/EEA",
            "timestamp": "2017-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001804-31/results",
            "title": "Ph3 trial of Glivec in CML-CP patients previously untreated with IFN-alfa",
            "country": "View results",
            "timestamp": "2017-08-10"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10577372",
            "timestamp": "2017-08-09",
            "title": "Study of treatment of patients with Opisthorchis felineus infection"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004834-11/DK",
            "title": "A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 o...",
            "country": "DK",
            "timestamp": "2017-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004834-11/BG",
            "title": "A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 o...",
            "country": "BG",
            "timestamp": "2017-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004834-11/PL",
            "title": "A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 o...",
            "country": "PL",
            "timestamp": "2017-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004834-11/CZ",
            "title": "A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 o...",
            "country": "CZ",
            "timestamp": "2017-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004834-11/GB",
            "title": "A randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy, safety and pharmacokinetics of oral CR6086 administered at the doses of 30, 90 o...",
            "country": "GB",
            "timestamp": "2017-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000040-17/FR",
            "title": "Randomized, open-label and multicentric trial evaluating the non-inferiority of antiretroviral treatment taken 4 consecutive days per week versus continuous therapy 7/7 days per week in HIV-1 infec...",
            "country": "FR",
            "timestamp": "2017-07-02"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17257070",
            "timestamp": "2017-06-27",
            "title": "The influences of smartphone use on the status of the tear film and the ocular surface"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001861-25/SE",
            "title": "A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd® Therapy Administered into Lymph Nodes Combined with Oral Vitamin D to Investigate the Impact ...",
            "country": "SE",
            "timestamp": "2017-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001861-25/CZ",
            "title": "A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd® Therapy Administered into Lymph Nodes Combined with Oral Vitamin D to Investigate the Impact ...",
            "country": "CZ",
            "timestamp": "2017-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001861-25/ES",
            "title": "A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd® Therapy Administered into Lymph Nodes Combined with Oral Vitamin D to Investigate the Impact ...",
            "country": "ES",
            "timestamp": "2017-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001861-25/NL",
            "title": "A Phase IIb, 2-Arm, Randomized, Double-blind, Placebo-Controlled, Multicentre Study to Optimize Diamyd® Therapy Administered into Lymph Nodes Combined with Oral Vitamin D to Investigate the Impact ...",
            "country": "NL",
            "timestamp": "2017-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004574-17/ES",
            "title": "A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "ES",
            "timestamp": "2017-06-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004574-17/HU",
            "title": "A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "HU",
            "timestamp": "2017-06-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004574-17/DE",
            "title": "A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "DE",
            "timestamp": "2017-06-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004574-17/BE",
            "title": "A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "BE",
            "timestamp": "2017-06-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004574-17/FR",
            "title": "A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-220 IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "FR",
            "timestamp": "2017-06-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-005197-35/IE",
            "title": "A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma.",
            "country": "IE",
            "timestamp": "2017-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003587-39/SE",
            "title": "COMBAT-MS (COMparison Between All immunoTherapies for Multiple Sclerosis)\n\nA prospective long-term cohort study of safety, efficacy and patient’s satisfaction of MS disease modulatory treatments in...",
            "country": "SE",
            "timestamp": "2017-05-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000328-85/FI",
            "title": "Randomized comparative trial between abrupt and tapered mode of discontinuation of longterm hormone therapy: Impact on endothelial function, recurrence of vasomotor symptoms and quality of life",
            "country": "FI",
            "timestamp": "2017-05-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004182-60/SE",
            "title": "A Multicenter, Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection",
            "country": "SE",
            "timestamp": "2017-05-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004182-60/ES",
            "title": "A Multicenter, Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection",
            "country": "ES",
            "timestamp": "2017-05-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004182-60/DE",
            "title": "A Multicenter, Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection",
            "country": "DE",
            "timestamp": "2017-05-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004182-60/PL",
            "title": "A Multicenter, Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection",
            "country": "PL",
            "timestamp": "2017-05-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004182-60/GR",
            "title": "A Multicenter, Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection",
            "country": "GR",
            "timestamp": "2017-05-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004182-60/results",
            "title": "A Multicenter, Open-Label, Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults with Chronic Hepatitis C Virus Genotype 1 – 6 Infection",
            "country": "View results",
            "timestamp": "2017-05-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004187-56/DE",
            "title": "International cooperative Phase III trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children and adolescents < ...",
            "country": "DE",
            "timestamp": "2017-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-005081-60/ES",
            "title": "MULTICENTER CLINICAL TRIAL TO DETERMINE THE INFLUENCE OF TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN THE GLOMERULAR AND TUBULAR FUNCTION OF PATIENTS WITH CHRONIC HCV HEPATITIS",
            "country": "ES",
            "timestamp": "2017-04-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-000347-41/NL",
            "title": "Safety of extended use of the weekly oral docetaxel formulation ModraDoc006/r in patients with advanced solid tumours",
            "country": "NL",
            "timestamp": "2017-04-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004223-23/IT",
            "title": "A pilot, open-label, single arm, multicenter study to evaluate safety, tolerability, pharmacokinetics and efficacy of intravenous administrations of NI-0501, an anti-interferon gamma (anti-IFNγ) mo...",
            "country": "IT",
            "timestamp": "2017-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004223-23/FR",
            "title": "A pilot, open-label, single arm, multicenter study to evaluate safety, tolerability, pharmacokinetics and efficacy of intravenous administrations of NI-0501, an anti-interferon gamma (anti-IFNγ) mo...",
            "country": "FR",
            "timestamp": "2017-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004223-23/GB",
            "title": "A pilot, open-label, single arm, multicenter study to evaluate safety, tolerability, pharmacokinetics and efficacy of intravenous administrations of NI-0501, an anti-interferon gamma (anti-IFNγ) mo...",
            "country": "GB",
            "timestamp": "2017-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004223-23/ES",
            "title": "A pilot, open-label, single arm, multicenter study to evaluate safety, tolerability, pharmacokinetics and efficacy of intravenous administrations of NI-0501, an anti-interferon gamma (anti-IFNγ) mo...",
            "country": "ES",
            "timestamp": "2017-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004223-23/NL",
            "title": "A pilot, open-label, single arm, multicenter study to evaluate safety, tolerability, pharmacokinetics and efficacy of intravenous administrations of NI-0501, an anti-interferon gamma (anti-IFNγ) mo...",
            "country": "NL",
            "timestamp": "2017-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004981-24/DK",
            "title": "Hydroxychloroquin (Plaquenil) treatment of recurrent pregnancy loss –  a randomized, double blinded, placebo controlled study",
            "country": "DK",
            "timestamp": "2017-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003828-23/DE",
            "title": "A pilot open-label study to assess the efficacy and safety of tocilizumab (TCZ) in patients with active Schnitzler’s syndrome (SchS)",
            "country": "DE",
            "timestamp": "2017-04-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/ES",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "ES",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/DE",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "DE",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/GB",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "GB",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/NO",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "NO",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/GR",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "GR",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/PT",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "PT",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/NL",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "NL",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/BE",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "BE",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/BG",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "BG",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/3rd",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "Outside EU/EEA",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/FR",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "FR",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/PL",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "PL",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/AT",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "AT",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003100-30/IT",
            "title": "A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclero...",
            "country": "IT",
            "timestamp": "2017-04-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10751859",
            "timestamp": "2017-04-03",
            "title": "A phase II clinical trial of  Detection of Apoptosing Retinal Cells (DARC II)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-005056-13/NL",
            "title": "M17DOC: Multicenter safety, feasibility and pharmacokinetic phase I trial of ModraDoc006/r in patients with metastatic castration-resistant prostate cancer",
            "country": "NL",
            "timestamp": "2017-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003489-25/BE",
            "title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage...",
            "country": "BE",
            "timestamp": "2017-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003489-25/results",
            "title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage...",
            "country": "View results",
            "timestamp": "2017-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003625-42/GB",
            "title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir for 12 Weeks in Subjects with Chronic HCV Infection Who are on Dialysis for End Stage Renal Di...",
            "country": "GB",
            "timestamp": "2017-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003625-42/ES",
            "title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir for 12 Weeks in Subjects with Chronic HCV Infection Who are on Dialysis for End Stage Renal Di...",
            "country": "ES",
            "timestamp": "2017-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003625-42/results",
            "title": "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir for 12 Weeks in Subjects with Chronic HCV Infection Who are on Dialysis for End Stage Renal Di...",
            "country": "View results",
            "timestamp": "2017-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003192-22/BE",
            "title": "A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection.",
            "country": "BE",
            "timestamp": "2017-03-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003192-22/results",
            "title": "A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection.",
            "country": "View results",
            "timestamp": "2017-03-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002858-20/ES",
            "title": "A phase II study of durvalumab (MEDI4736) plus tremelimumab for the treatment of patients with advanced neuroendocrine neoplasms of gastroenteropancreatic or lung origin (the DUNE trial).",
            "country": "ES",
            "timestamp": "2017-03-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002845-46/GB",
            "title": "A Phase 2a, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335 and Odalasvir, with or without Simeprevir, in Treatment-Naïve Subjects with Genotype ...",
            "country": "GB",
            "timestamp": "2017-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002845-46/results",
            "title": "A Phase 2a, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335 and Odalasvir, with or without Simeprevir, in Treatment-Naïve Subjects with Genotype ...",
            "country": "View results",
            "timestamp": "2017-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003637-14/EE",
            "title": "A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 16 weeks to subjects with moderately to severely active ...",
            "country": "EE",
            "timestamp": "2017-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003637-14/ES",
            "title": "A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 16 weeks to subjects with moderately to severely active ...",
            "country": "ES",
            "timestamp": "2017-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003637-14/CZ",
            "title": "A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 16 weeks to subjects with moderately to severely active ...",
            "country": "CZ",
            "timestamp": "2017-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003637-14/BE",
            "title": "A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 16 weeks to subjects with moderately to severely active ...",
            "country": "BE",
            "timestamp": "2017-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003637-14/BG",
            "title": "A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 16 weeks to subjects with moderately to severely active ...",
            "country": "BG",
            "timestamp": "2017-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003637-14/results",
            "title": "A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 16 weeks to subjects with moderately to severely active ...",
            "country": "View results",
            "timestamp": "2017-01-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN32224252",
            "timestamp": "2017-01-26",
            "title": "Immunmonitoring in kidney transplant recipients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002446-23/GB",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children with Chronic HCV Infection",
            "country": "GB",
            "timestamp": "2017-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002446-23/BE",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children with Chronic HCV Infection",
            "country": "BE",
            "timestamp": "2017-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002446-23/3rd",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children with Chronic HCV Infection",
            "country": "Outside EU/EEA",
            "timestamp": "2017-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002446-23/IT",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children with Chronic HCV Infection",
            "country": "IT",
            "timestamp": "2017-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000925-38/GB",
            "title": "GO-8: Gene therapy for haemophilia A using a novel serotype 8 capsid pseudotyped adeno-associated viral vector encoding Factor VIII-V3",
            "country": "GB",
            "timestamp": "2017-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/SE",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "SE",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/GB",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "GB",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/DE",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "DE",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/ES",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "ES",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/AT",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "AT",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/NL",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "NL",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/BE",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "BE",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002522-36/FR",
            "title": "An open label phase II study to evaluate the efficacy and safety of PDR001 in patients with advanced or metastatic, well-differentiated, non-functional neuroendocrine tumors of pancreatic, gastroin...",
            "country": "FR",
            "timestamp": "2016-12-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001406-42/DK",
            "title": "Statin- and bisphosphonate treatment in patients with the Philadelphia-negative chronic myeloproliferative neoplasms -  essential thrombocytosis, polycythemia vera and hypercellular myelofibrosis.",
            "country": "DK",
            "timestamp": "2016-12-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000899-25/FI",
            "title": "A Phase II Double-blind, Randomised, Parallel Group 2:1 Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Prevention of Multi-Organ Fail...",
            "country": "FI",
            "timestamp": "2016-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000899-25/EE",
            "title": "A Phase II Double-blind, Randomised, Parallel Group 2:1 Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Prevention of Multi-Organ Fail...",
            "country": "EE",
            "timestamp": "2016-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000899-25/LT",
            "title": "A Phase II Double-blind, Randomised, Parallel Group 2:1 Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Prevention of Multi-Organ Fail...",
            "country": "LT",
            "timestamp": "2016-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000899-25/GB",
            "title": "A Phase II Double-blind, Randomised, Parallel Group 2:1 Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Prevention of Multi-Organ Fail...",
            "country": "GB",
            "timestamp": "2016-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003246-93/HU",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab following subcutaneous administration in ...",
            "country": "HU",
            "timestamp": "2016-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003246-93/PL",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab following subcutaneous administration in ...",
            "country": "PL",
            "timestamp": "2016-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-003246-93/results",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab following subcutaneous administration in ...",
            "country": "View results",
            "timestamp": "2016-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003140-39/BG",
            "title": "A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects with Active Rheumatoid Arthrit...",
            "country": "BG",
            "timestamp": "2016-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003140-39/PL",
            "title": "A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects with Active Rheumatoid Arthrit...",
            "country": "PL",
            "timestamp": "2016-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003140-39/results",
            "title": "A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects with Active Rheumatoid Arthrit...",
            "country": "View results",
            "timestamp": "2016-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001804-12/DE",
            "title": "A multicenter, open label Phase I/II study to determine the safety and immune modulating effects of the therapeutic Human Papilloma Virus Type 16 (HPV16) E6/E7 Synthetic Long Peptides Vaccine (ISA1...",
            "country": "DE",
            "timestamp": "2016-12-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001804-12/NL",
            "title": "A multicenter, open label Phase I/II study to determine the safety and immune modulating effects of the therapeutic Human Papilloma Virus Type 16 (HPV16) E6/E7 Synthetic Long Peptides Vaccine (ISA1...",
            "country": "NL",
            "timestamp": "2016-12-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001804-12/BE",
            "title": "A multicenter, open label Phase I/II study to determine the safety and immune modulating effects of the therapeutic Human Papilloma Virus Type 16 (HPV16) E6/E7 Synthetic Long Peptides Vaccine (ISA1...",
            "country": "BE",
            "timestamp": "2016-12-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001804-12/results",
            "title": "A multicenter, open label Phase I/II study to determine the safety and immune modulating effects of the therapeutic Human Papilloma Virus Type 16 (HPV16) E6/E7 Synthetic Long Peptides Vaccine (ISA1...",
            "country": "View results",
            "timestamp": "2016-12-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/HU",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "HU",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/DE",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "DE",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/LV",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "LV",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/PT",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "PT",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/SE",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "SE",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/ES",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "ES",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/CZ",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "CZ",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/BE",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "BE",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/NL",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "NL",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/SK",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "SK",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000933-37/BG",
            "title": "A Phase 3, Randomized, Active-Controlled, Double Blind Study Comparing ABT-494 to Abatacept in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response or Intoleran...",
            "country": "BG",
            "timestamp": "2016-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/HU",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "HU",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/ES",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "ES",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/CZ",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "CZ",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/DE",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "DE",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/BG",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "BG",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/GB",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "GB",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001102-42/results",
            "title": "A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN SUBJECTS WITH ACTIVE ANKYLOSING SPOND...",
            "country": "View results",
            "timestamp": "2016-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001330-97/FR",
            "title": "Prévention des Fausses Couches Spontanées Répétées par Hydroxychloroquine. \r\nEssai thérapeutique multicentrique, randomisé, en double insu, contre placebo.",
            "country": "FR",
            "timestamp": "2016-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004170-15/GB",
            "title": "A multicentre, randomised trial comparing combination gemcitabine/carboplatin and hydroxychloroquine versus carboplatin/etoposide therapy alone in small cell lung cancer (SCLC)",
            "country": "GB",
            "timestamp": "2016-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004243-39/NL",
            "title": "A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection.",
            "country": "NL",
            "timestamp": "2016-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004243-39/GB",
            "title": "A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection.",
            "country": "GB",
            "timestamp": "2016-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001039-11/GB",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF GDC-0853 IN PATIENTS WITH\r\nMODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "GB",
            "timestamp": "2016-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001039-11/PT",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF GDC-0853 IN PATIENTS WITH\r\nMODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "PT",
            "timestamp": "2016-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001039-11/ES",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF GDC-0853 IN PATIENTS WITH\r\nMODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "ES",
            "timestamp": "2016-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001039-11/BG",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF GDC-0853 IN PATIENTS WITH\r\nMODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "BG",
            "timestamp": "2016-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001039-11/DE",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF GDC-0853 IN PATIENTS WITH\r\nMODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS",
            "country": "DE",
            "timestamp": "2016-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002180-33/PL",
            "title": "Multiple sclerosis therapy with transdermal myelin peptide stimulation.",
            "country": "PL",
            "timestamp": "2016-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000434-21/PT",
            "title": "PLENO – Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients with Relapsing Remitting Multiple Sclerosis (MS) Transitioning from Current...",
            "country": "PT",
            "timestamp": "2016-11-14"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN84346215",
            "timestamp": "2016-11-11",
            "title": "Nucleos(t)ide withdrawal in Hepatitis B virus infection (NUC-B)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000620-26/BE",
            "title": "A Phase II/III, Open-label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (MK-3682 + Grazoprevir + MK-8408 Fixed Dose Combination) in Subjects with Chronic H...",
            "country": "BE",
            "timestamp": "2016-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002700-78/BE",
            "title": "Supersaturation and precipitation of ritonavir in the gastrointestinal tract of healthy volunteers",
            "country": "BE",
            "timestamp": "2016-10-28"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14654848",
            "timestamp": "2016-10-10",
            "title": "Vaccination against prostate cancer"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN74587134",
            "timestamp": "2016-10-05",
            "title": "A study to see how [14C]-S-033188 is taken up, broken down and removed from the body"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001586-87/GB",
            "title": "A Phase 2, Double Blind, Placebo Controlled Study of RSLV-132 in Subjects with Primary Sjogren’s Syndrome",
            "country": "GB",
            "timestamp": "2016-09-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000117-76/ES",
            "title": "A Phase 1/2, randomized, observer-blind, controlled, multi-center, dose-escalation study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ respiratory syncytial virus (RSV) ...",
            "country": "ES",
            "timestamp": "2016-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000117-76/PL",
            "title": "A Phase 1/2, randomized, observer-blind, controlled, multi-center, dose-escalation study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ respiratory syncytial virus (RSV) ...",
            "country": "PL",
            "timestamp": "2016-09-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN58774519",
            "timestamp": "2016-09-22",
            "title": "Personalised cancer vaccines"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/GB",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "GB",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/DE",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "DE",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/NL",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "NL",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/ES",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "ES",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/AT",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "AT",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/BE",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "BE",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/PL",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "PL",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000807-99/GR",
            "title": "A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB-IVB) mycosis fungoides (MF) ...",
            "country": "GR",
            "timestamp": "2016-09-15"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN16067611",
            "timestamp": "2016-09-06",
            "title": "Enhanced epidermal antigen specific immunotherapy trial - Type 1 Diabetes"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001010-17/GB",
            "title": "Nucleos(t)ide withdrawal in HBeAg negative hepatitis B virus infection to promote HBsAg clearance. (NUC-B)",
            "country": "GB",
            "timestamp": "2016-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000785-37/3rd",
            "title": "A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection",
            "country": "Outside EU/EEA",
            "timestamp": "2016-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-000785-37/BE",
            "title": "A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection",
            "country": "BE",
            "timestamp": "2016-08-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12811193",
            "timestamp": "2016-08-26",
            "title": "HBsAg clearance with pegylated interferon and tenofovir combination"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/LV",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "LV",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/EE",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "EE",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/HU",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "HU",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/CZ",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "CZ",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/BG",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "BG",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/ES",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "ES",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-002125-11/results",
            "title": "A Randomized, Parallel-Group, Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safety between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients with Active Rheumatoid Arthritis",
            "country": "View results",
            "timestamp": "2016-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001532-35/HU",
            "title": "A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis.",
            "country": "HU",
            "timestamp": "2016-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001532-35/BG",
            "title": "A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis.",
            "country": "BG",
            "timestamp": "2016-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-001532-35/results",
            "title": "A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis.",
            "country": "View results",
            "timestamp": "2016-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004197-42/DE",
            "title": "A proof of concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs combined with metronomic temozolomide (CUSP9v3 Treatment Protocol) for ...",
            "country": "DE",
            "timestamp": "2016-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004863-35/FI",
            "title": "A prospective phase II study to assess the minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible patients",
            "country": "FI",
            "timestamp": "2016-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004863-35/SE",
            "title": "A prospective phase II study to assess the minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible patients",
            "country": "SE",
            "timestamp": "2016-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004863-35/LT",
            "title": "A prospective phase II study to assess the minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible patients",
            "country": "LT",
            "timestamp": "2016-08-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN63321797",
            "timestamp": "2016-07-22",
            "title": "Immunological effects of local low-dose immunotherapy in early stage melanoma patients"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17414946",
            "timestamp": "2016-07-19",
            "title": "Interferon-β treatment for Ebola virus disease"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN16273289",
            "timestamp": "2016-07-18",
            "title": "Improving the radical cure of vivax malaria (IMPROV)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003147-19/GR",
            "title": "Novel Oral Nutraceutical Intervention NEUROASPIS PLP10® for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Multicenter, Parallel-group, Phase III, Double-blind, Randomized, Placebo-Cont...",
            "country": "GR",
            "timestamp": "2016-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004717-25/IT",
            "title": "The benefit/risk profile of pegylated proline-Interferon alpha-2b (AOP2014) added to the best available strategy based on phlebotomies in low-risk patients with Polycythemia Vera (PV). The Low-PV r...",
            "country": "IT",
            "timestamp": "2016-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/IT",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "IT",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/ES",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "ES",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/DE",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "DE",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/GR",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "GR",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/AT",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "AT",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/GB",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "GB",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/SE",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "SE",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004842-92/PL",
            "title": "A three arms prospective, randomized phase II study to evaluate the best sequential approach with combo immunotherapy (ipilimumab/nivolumab) and combo target therapy (LGX818/MEK162) in patients wit...",
            "country": "PL",
            "timestamp": "2016-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000194-12/IT",
            "title": "Isoquercetin as an adjunct therapy in patients with kidney cancer receiving first-line sunitinib: a phase I/II trial",
            "country": "IT",
            "timestamp": "2016-06-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN65011803",
            "timestamp": "2016-06-20",
            "title": "Effects of tamoxifen in patients with myeloproliferratIve disorders"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003562-90/FR",
            "title": "A phase IV open-label, multicentre, international trial of paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin for people with chronic hepatitis C virus genotype 1 infection and...",
            "country": "FR",
            "timestamp": "2016-06-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003562-90/results",
            "title": "A phase IV open-label, multicentre, international trial of paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin for people with chronic hepatitis C virus genotype 1 infection and...",
            "country": "View results",
            "timestamp": "2016-06-17"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17372582",
            "timestamp": "2016-05-31",
            "title": "Plasmodium Sp. Sporozoites immunization of human volunteers"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004613-24/NL",
            "title": "Hit hard and early. The effect of high dose methylprednisolon on nailfold capillary changes and biomarkers in early SSc: a 12-week randomized double-blind placebo-controlled trial.",
            "country": "NL",
            "timestamp": "2016-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002133-22/ES",
            "title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Single-Agent MLN0128 and the Combination of MLN0128+MLN1117 Compared With Everolimus in the Treatment of Adult Patients With Advan...",
            "country": "ES",
            "timestamp": "2016-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002133-22/FR",
            "title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Single-Agent MLN0128 and the Combination of MLN0128+MLN1117 Compared With Everolimus in the Treatment of Adult Patients With Advan...",
            "country": "FR",
            "timestamp": "2016-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002133-22/PL",
            "title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Single-Agent MLN0128 and the Combination of MLN0128+MLN1117 Compared With Everolimus in the Treatment of Adult Patients With Advan...",
            "country": "PL",
            "timestamp": "2016-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005497-38/GB",
            "title": "Effects of TAMoxifen on the Mutant Allele Burden and Disease Course in Patients with MyeloprolifeRatIve Neoplasms",
            "country": "GB",
            "timestamp": "2016-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004195-30/BE",
            "title": "A multi-center, randomized, double-blind, placebo-controlled Phase IIa trial to compare the safety of ABX464 given at a fixed dose to placebo in fully controlled HIV infected patients treated with ...",
            "country": "BE",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004195-30/ES",
            "title": "A multi-center, randomized, double-blind, placebo-controlled Phase IIa trial to compare the safety of ABX464 given at a fixed dose to placebo in fully controlled HIV infected patients treated with ...",
            "country": "ES",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004195-30/FR",
            "title": "A multi-center, randomized, double-blind, placebo-controlled Phase IIa trial to compare the safety of ABX464 given at a fixed dose to placebo in fully controlled HIV infected patients treated with ...",
            "country": "FR",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003436-13/HU",
            "title": "A RANDOMIZED PHASE 2 TRIAL OF AXITINIB AND TRC105 VERSUS AXITINIB ALONE  (INCLUDING A LEAD-IN PHASE 1B DOSE-ESCALATION PORTION) IN PATIENTS WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA",
            "country": "HU",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003436-13/GB",
            "title": "A RANDOMIZED PHASE 2 TRIAL OF AXITINIB AND TRC105 VERSUS AXITINIB ALONE  (INCLUDING A LEAD-IN PHASE 1B DOSE-ESCALATION PORTION) IN PATIENTS WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA",
            "country": "GB",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003436-13/PL",
            "title": "A RANDOMIZED PHASE 2 TRIAL OF AXITINIB AND TRC105 VERSUS AXITINIB ALONE  (INCLUDING A LEAD-IN PHASE 1B DOSE-ESCALATION PORTION) IN PATIENTS WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA",
            "country": "PL",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003436-13/CZ",
            "title": "A RANDOMIZED PHASE 2 TRIAL OF AXITINIB AND TRC105 VERSUS AXITINIB ALONE  (INCLUDING A LEAD-IN PHASE 1B DOSE-ESCALATION PORTION) IN PATIENTS WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA",
            "country": "CZ",
            "timestamp": "2016-05-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN92746680",
            "timestamp": "2016-05-06",
            "title": "Clinical efficacy and mechanistic evaluation of Eplerenone for central serous chorio-retinopathy – the VICI randomised trial"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003260-20/NL",
            "title": "CHAMP: Children with Arthritis: Monotherapy or Polytherapy. A multicentre, single-blinded, randomized treat to target, one-year follow-up clinical trial in patients with recent onset Juvenile Idiop...",
            "country": "NL",
            "timestamp": "2016-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/DE",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "DE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/BE",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "BE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/IE",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "IE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/ES",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "ES",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/DK",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "DK",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/CZ",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "CZ",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/SE",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "SE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/GB",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "GB",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/HU",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "HU",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/SK",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "SK",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/PT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "PT",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/LV",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "LV",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/AT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "AT",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/FI",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "FI",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/GR",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "GR",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/BG",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "BG",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/SI",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "SI",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003335-35/IT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo on Stable Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) in Subjects with Moderately ...",
            "country": "IT",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/SE",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "SE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/NL",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "NL",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/DK",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "DK",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/IE",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "IE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/ES",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "ES",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/PL",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "PL",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/FR",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "FR",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004991-31/BE",
            "title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab (MK-3475) in Combination With Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma (Keynote-252 ...",
            "country": "BE",
            "timestamp": "2016-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000359-26/ES",
            "title": "Phase I/II safety, tolerability and initial efficacy study of adeno-associated viral vector serotype 9 containing human sulfamidase gene after intracerebroventricular administration to patients wit...",
            "country": "ES",
            "timestamp": "2016-04-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN37915093",
            "timestamp": "2016-04-14",
            "title": "STOP HCV-1 – Stratified Treatment Optimisation for HCV-1"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003527-57/3rd",
            "title": "An Open-label, Exploratory Study to Establish the Safety and Efficacy of 3 Months Treatment With Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever",
            "country": "Outside EU/EEA",
            "timestamp": "2016-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003527-57/results",
            "title": "An Open-label, Exploratory Study to Establish the Safety and Efficacy of 3 Months Treatment With Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever",
            "country": "View results",
            "timestamp": "2016-04-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000111-41/ES",
            "title": "An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Ombitasvir (OBV), Paritaprevir (PTV), Ritonavir (RTV) With or Without Dasabuvir (DSV) and With or Without ...",
            "country": "ES",
            "timestamp": "2016-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000111-41/DE",
            "title": "An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Ombitasvir (OBV), Paritaprevir (PTV), Ritonavir (RTV) With or Without Dasabuvir (DSV) and With or Without ...",
            "country": "DE",
            "timestamp": "2016-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000111-41/BE",
            "title": "An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Ombitasvir (OBV), Paritaprevir (PTV), Ritonavir (RTV) With or Without Dasabuvir (DSV) and With or Without ...",
            "country": "BE",
            "timestamp": "2016-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001778-17/FI",
            "title": "A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni...",
            "country": "FI",
            "timestamp": "2016-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001778-17/EE",
            "title": "A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni...",
            "country": "EE",
            "timestamp": "2016-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001778-17/CZ",
            "title": "A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni...",
            "country": "CZ",
            "timestamp": "2016-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001778-17/GB",
            "title": "A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni...",
            "country": "GB",
            "timestamp": "2016-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001778-17/DE",
            "title": "A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni...",
            "country": "DE",
            "timestamp": "2016-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001778-17/ES",
            "title": "A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogeni...",
            "country": "ES",
            "timestamp": "2016-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004953-26/BE",
            "title": "CMV specific T cell therapy for the treatment of relapsing or therapy refractory CMV infection after allogeneic stem cell transplantation with a CMV-positive donor.",
            "country": "BE",
            "timestamp": "2016-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004406-42/ES",
            "title": "CLINICAL TRIAL TO ASSEES THE NON-INFERIORITY OF THE SUSPENSION OF PROPHYLACTIC TREATMENT WITH VALGANCICLOVIR IN  \r\nKIDNEY TRANSPLANT CMV-seropositive PATIENTS, WHO MANTEIN CD8+ CMV- CELLULAR IMMUNI...",
            "country": "ES",
            "timestamp": "2016-03-10"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN49793874",
            "timestamp": "2016-03-09",
            "title": "Comparing the effects of infliximab and alpha interferon in the treatment of Behçet’s Disease"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004347-12/FR",
            "title": "Exploratory Study of Inecalcitol in Imatinib-Treated\nResidual Chronic Myeloid Leukaemia: INIM Study",
            "country": "FR",
            "timestamp": "2016-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003934-28/GB",
            "title": "Enhanced Epidermal Antigen Specific Immunotherapy trial -1 (EE-ASI-1): A Phase 1a study of gold nanoparticles administered intradermally by microneedles to deliver immunotherapy with a proinsulin d...",
            "country": "GB",
            "timestamp": "2016-03-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003934-28/SE",
            "title": "Enhanced Epidermal Antigen Specific Immunotherapy trial -1 (EE-ASI-1): A Phase 1a study of gold nanoparticles administered intradermally by microneedles to deliver immunotherapy with a proinsulin d...",
            "country": "SE",
            "timestamp": "2016-03-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/GB",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "GB",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/IT",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "IT",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/AT",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "AT",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/CZ",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "CZ",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/DE",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "DE",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/ES",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "ES",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003632-23/SE",
            "title": "A Phase 2/3, Open-label, Single Arm, Multicentre Study to Assess Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Multiple Administrations of NI-0501, an Anti-interferon Gamma (An...",
            "country": "SE",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004400-30/SE",
            "title": "A phase IIIB, open, long term extension study to evaluate the persistence of immune responses and the safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A, at Months 108 and 12...",
            "country": "SE",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004400-30/DE",
            "title": "A phase IIIB, open, long term extension study to evaluate the persistence of immune responses and the safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A, at Months 108 and 12...",
            "country": "DE",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004400-30/CZ",
            "title": "A phase IIIB, open, long term extension study to evaluate the persistence of immune responses and the safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A, at Months 108 and 12...",
            "country": "CZ",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004400-30/results",
            "title": "A phase IIIB, open, long term extension study to evaluate the persistence of immune responses and the safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A, at Months 108 and 12...",
            "country": "View results",
            "timestamp": "2016-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005390-36/GB",
            "title": "Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab (IFX) verses alpha interferon (aIFN), with genotyping and metabolomic profiling, towards a str...",
            "country": "GB",
            "timestamp": "2016-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004011-20/GB",
            "title": "A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching from Regimens Consisting of Boosted Atazanavir or Darunavir plus either Emtricitabine/Tenofovir or Abacavir/...",
            "country": "GB",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004011-20/DE",
            "title": "A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching from Regimens Consisting of Boosted Atazanavir or Darunavir plus either Emtricitabine/Tenofovir or Abacavir/...",
            "country": "DE",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004011-20/ES",
            "title": "A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching from Regimens Consisting of Boosted Atazanavir or Darunavir plus either Emtricitabine/Tenofovir or Abacavir/...",
            "country": "ES",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004011-20/BE",
            "title": "A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching from Regimens Consisting of Boosted Atazanavir or Darunavir plus either Emtricitabine/Tenofovir or Abacavir/...",
            "country": "BE",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001249-26/DE",
            "title": "A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-...",
            "country": "DE",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001249-26/ES",
            "title": "A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-...",
            "country": "ES",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001249-26/GB",
            "title": "A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-...",
            "country": "GB",
            "timestamp": "2016-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005260-15/DE",
            "title": "A Phase III Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients with Modera...",
            "country": "DE",
            "timestamp": "2016-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005260-15/FI",
            "title": "A Phase III Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients with Modera...",
            "country": "FI",
            "timestamp": "2016-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005260-15/BE",
            "title": "A Phase III Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients with Modera...",
            "country": "BE",
            "timestamp": "2016-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005260-15/ES",
            "title": "A Phase III Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients with Modera...",
            "country": "ES",
            "timestamp": "2016-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005260-15/CZ",
            "title": "A Phase III Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients with Modera...",
            "country": "CZ",
            "timestamp": "2016-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005260-15/results",
            "title": "A Phase III Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients with Modera...",
            "country": "View results",
            "timestamp": "2016-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001072-22/FI",
            "title": "Clinical and virological efficacy of pegylated interferon alpha in the treatment of rhinovirus infection in patients with primary hypogammaglobulinemia: \r\nrandomized controlled trial",
            "country": "FI",
            "timestamp": "2016-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003187-37/GB",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) with and without Ribavirin (RBV)...",
            "country": "GB",
            "timestamp": "2016-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003187-37/results",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) with and without Ribavirin (RBV)...",
            "country": "View results",
            "timestamp": "2016-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004702-42/HU",
            "title": "A Multi-Center, Parallel Group, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of a Single Subcutaneous Injection of RG-101 Combined with Oral GSK2878175 Taken Once Daily for 6, 9, o...",
            "country": "HU",
            "timestamp": "2016-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004702-42/GR",
            "title": "A Multi-Center, Parallel Group, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of a Single Subcutaneous Injection of RG-101 Combined with Oral GSK2878175 Taken Once Daily for 6, 9, o...",
            "country": "GR",
            "timestamp": "2016-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004702-42/ES",
            "title": "A Multi-Center, Parallel Group, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of a Single Subcutaneous Injection of RG-101 Combined with Oral GSK2878175 Taken Once Daily for 6, 9, o...",
            "country": "ES",
            "timestamp": "2016-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/SK",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "SK",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/ES",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "ES",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/BG",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "BG",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/CZ",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "CZ",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/DK",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "DK",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/BE",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "BE",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/IE",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "IE",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/PT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "PT",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/GB",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "GB",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/PL",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "PL",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/LV",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "LV",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/FI",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "FI",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/NO",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "NO",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/LT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "LT",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/HU",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "HU",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/GR",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "GR",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/AT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "AT",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/HR",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "HR",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003332-13/IT",
            "title": "A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Dose of Conventional Synthetic Disease...",
            "country": "IT",
            "timestamp": "2016-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000233-73/FI",
            "title": "HYDROXYCHLOROQUINE IN ACUTE CORONARY SYNDROME:  PREVENTION OF RECURRENT CARDIOVASCULAR EVENTS",
            "country": "FI",
            "timestamp": "2016-01-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003370-33/DE",
            "title": "An Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Adults With Genotype 1b Hepatitis C Virus (HCV) Without Cir...",
            "country": "DE",
            "timestamp": "2016-01-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003370-33/GB",
            "title": "An Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Adults With Genotype 1b Hepatitis C Virus (HCV) Without Cir...",
            "country": "GB",
            "timestamp": "2016-01-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003370-33/ES",
            "title": "An Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Adults With Genotype 1b Hepatitis C Virus (HCV) Without Cir...",
            "country": "ES",
            "timestamp": "2016-01-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003370-33/IT",
            "title": "An Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Adults With Genotype 1b Hepatitis C Virus (HCV) Without Cir...",
            "country": "IT",
            "timestamp": "2016-01-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003370-33/results",
            "title": "An Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Adults With Genotype 1b Hepatitis C Virus (HCV) Without Cir...",
            "country": "View results",
            "timestamp": "2016-01-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005004-28/GB",
            "title": "Stratified Treatment OPtimisation for HCV-1 (STOPHCV-1)",
            "country": "GB",
            "timestamp": "2015-12-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005004-28/results",
            "title": "Stratified Treatment OPtimisation for HCV-1 (STOPHCV-1)",
            "country": "View results",
            "timestamp": "2015-12-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001420-29/DK",
            "title": "T cell therapy in combination with peginterferon for metastatic malignant melanoma",
            "country": "DK",
            "timestamp": "2015-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001420-29/results",
            "title": "T cell therapy in combination with peginterferon for metastatic malignant melanoma",
            "country": "View results",
            "timestamp": "2015-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004116-38/SE",
            "title": "RItuximab versus FUmarate in Newly Diagnosed Multiple Sclerosis – RIFUND-MS\nA randomized phase 3 study comparing Rituximab with Dimethyl Fumarate in early Relapsing-Remitting Multiple Sclerosis\n\nOb...",
            "country": "SE",
            "timestamp": "2015-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001476-37/ES",
            "title": "SMILE: Strategy for Maintenance of HIV suppression with elvitegravir+darunavir/ritonavir in children (PENTA 17) - \r\nA two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating safety ...",
            "country": "ES",
            "timestamp": "2015-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001476-37/PT",
            "title": "SMILE: Strategy for Maintenance of HIV suppression with elvitegravir+darunavir/ritonavir in children (PENTA 17) - \r\nA two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating safety ...",
            "country": "PT",
            "timestamp": "2015-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001476-37/GB",
            "title": "SMILE: Strategy for Maintenance of HIV suppression with elvitegravir+darunavir/ritonavir in children (PENTA 17) - \r\nA two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating safety ...",
            "country": "GB",
            "timestamp": "2015-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001476-37/BE",
            "title": "SMILE: Strategy for Maintenance of HIV suppression with elvitegravir+darunavir/ritonavir in children (PENTA 17) - \r\nA two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating safety ...",
            "country": "BE",
            "timestamp": "2015-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001476-37/DE",
            "title": "SMILE: Strategy for Maintenance of HIV suppression with elvitegravir+darunavir/ritonavir in children (PENTA 17) - \r\nA two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating safety ...",
            "country": "DE",
            "timestamp": "2015-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001476-37/FR",
            "title": "SMILE: Strategy for Maintenance of HIV suppression with elvitegravir+darunavir/ritonavir in children (PENTA 17) - \r\nA two-arm, Phase 2/3 multicentre, open-label, randomised study evaluating safety ...",
            "country": "FR",
            "timestamp": "2015-12-16"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN36702813",
            "timestamp": "2015-12-11",
            "title": "A low FODMAP diet for diarrhoea predominant functional gastrointestinal disorders in neuroendocrine tumour patients"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN58955026",
            "timestamp": "2015-12-02",
            "title": "Treating neovascular age-related macular degeneration with aflibercept"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003077-15/DE",
            "title": "A Phase 2, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Activity of Titrating-Dose Lonafarnib in Combination with Ritonavir in Patients Chronically Infected w...",
            "country": "DE",
            "timestamp": "2015-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001341-86/DE",
            "title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Syste...",
            "country": "DE",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001341-86/BE",
            "title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Syste...",
            "country": "BE",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001341-86/HR",
            "title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Syste...",
            "country": "HR",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001341-86/ES",
            "title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Syste...",
            "country": "ES",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001341-86/BG",
            "title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Syste...",
            "country": "BG",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001341-86/results",
            "title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Syste...",
            "country": "View results",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004692-22/IT",
            "title": "MARAT Study “Pharmacokinetics of MARaviroc and boosted ATazanavir dual regimen in stable HIV-infected patients”",
            "country": "IT",
            "timestamp": "2015-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003662-87/DK",
            "title": "Pseudomonas Aeruginosa - Inhalation treatment, biomarkers and quality of life",
            "country": "DK",
            "timestamp": "2015-11-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003804-21/DE",
            "title": "Multi-centre, Randomized, Double-blind, Placebo-Controlled Pilot Safety and Efficacy Study of 8 Weeks of Treatment with DFD-07 for Actinic Keratosis of the Face and Scalp",
            "country": "DE",
            "timestamp": "2015-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002159-89/NL",
            "title": "Brimonidine Tartrate for the Treatment of Injection Related Erythema Associated with Sub-cutaneous Administration of Peginterferon beta-1a",
            "country": "NL",
            "timestamp": "2015-11-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN76212203",
            "timestamp": "2015-11-03",
            "title": "The evaluation of a training for patients with hepatitis C to improve their quality of life"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/HU",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "HU",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/PT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "PT",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/BE",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "BE",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/AT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "AT",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/SE",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "SE",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/DE",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "DE",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/LT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "LT",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/ES",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "ES",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/PL",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "PL",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/GB",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "GB",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/IT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "IT",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002087-17/results",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus Genotype 1 Infection (ENDURANCE-1)",
            "country": "View results",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001625-16/GB",
            "title": "A Phase 2, Single-Arm, Open-Label Study to Evaluate the Safety and Tolerability of PBI-4050 and of its Effects on the Inflammatory, Fibrosis,Diabetes and Obesity Biomarkers in Subjects with Alström...",
            "country": "GB",
            "timestamp": "2015-10-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14265371",
            "timestamp": "2015-10-14",
            "title": "A trial to determine bexarotene's safety and tolerability and its ability to promote brain repair in patients with multiple sclerosis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN23257928",
            "timestamp": "2015-10-05",
            "title": "The adjunctive effects of Omega-3 dietary supplementation in the treatment of periodontitis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002682-30/ES",
            "title": "Raltegravir-based regimen versus raltegravir-based regimen plus atorvastatin for reducing ?inflamaging? (aging-related complication) in HIV-infected patients older than 60 years.",
            "country": "ES",
            "timestamp": "2015-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002682-30/results",
            "title": "Raltegravir-based regimen versus raltegravir-based regimen plus atorvastatin for reducing ?inflamaging? (aging-related complication) in HIV-infected patients older than 60 years.",
            "country": "View results",
            "timestamp": "2015-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002012-33/ES",
            "title": "An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infec...",
            "country": "ES",
            "timestamp": "2015-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002012-33/results",
            "title": "An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infec...",
            "country": "View results",
            "timestamp": "2015-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001049-10/ES",
            "title": "Open-label Study to Evaluate the Safety and Efficacy of the Combination of Ombitasvir, Paritaprevir/r ± Dasabuvir with Ribavirin (RBV) in Adult Patients with GT1 or GT4 Chronic HCV Infection and Re...",
            "country": "ES",
            "timestamp": "2015-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001049-10/results",
            "title": "Open-label Study to Evaluate the Safety and Efficacy of the Combination of Ombitasvir, Paritaprevir/r ± Dasabuvir with Ribavirin (RBV) in Adult Patients with GT1 or GT4 Chronic HCV Infection and Re...",
            "country": "View results",
            "timestamp": "2015-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003140-12/NL",
            "title": "Optimizing DMARD-therapy for primary Sjogren's Syndrome - Leflunomide and Hydroxychloroquine combination therapy for patients with primary Sjogren's Syndrome",
            "country": "NL",
            "timestamp": "2015-09-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003250-41/GB",
            "title": "Protection induced by Live Attenuated Influenza Vaccine (LAIV or Fluenz Tetra) - applied epidemiological study",
            "country": "GB",
            "timestamp": "2015-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-003250-41/results",
            "title": "Protection induced by Live Attenuated Influenza Vaccine (LAIV or Fluenz Tetra) - applied epidemiological study",
            "country": "View results",
            "timestamp": "2015-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004830-25/NO",
            "title": "Kidney Cancer Integrated Therapy (KIT) - Personalized integrated therapy for patients with advanced kidney cancer",
            "country": "NO",
            "timestamp": "2015-09-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/LT",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "LT",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/BE",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "BE",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/ES",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "ES",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/CZ",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "CZ",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/DE",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "DE",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/BG",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "BG",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004632-19/results",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "View results",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000372-95/CZ",
            "title": "A Phase II Multicenter, Randomized, Double-blind, Placebo controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects with Moderate ...",
            "country": "CZ",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000372-95/DE",
            "title": "A Phase II Multicenter, Randomized, Double-blind, Placebo controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects with Moderate ...",
            "country": "DE",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000372-95/PT",
            "title": "A Phase II Multicenter, Randomized, Double-blind, Placebo controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects with Moderate ...",
            "country": "PT",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000372-95/HU",
            "title": "A Phase II Multicenter, Randomized, Double-blind, Placebo controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects with Moderate ...",
            "country": "HU",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000372-95/ES",
            "title": "A Phase II Multicenter, Randomized, Double-blind, Placebo controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects with Moderate ...",
            "country": "ES",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000372-95/results",
            "title": "A Phase II Multicenter, Randomized, Double-blind, Placebo controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX 0061 Administered Subcutaneously in Subjects with Moderate ...",
            "country": "View results",
            "timestamp": "2015-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/DE",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "DE",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/AT",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "AT",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/DK",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "DK",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/BE",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "BE",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/IT",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "IT",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/ES",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "ES",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005550-18/PL",
            "title": "A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and...",
            "country": "PL",
            "timestamp": "2015-08-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005143-24/GB",
            "title": "A Multipart, Open-label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With and Without Dasabuvir Coadministered With and Without Ribavirin in Adults With Genotype 1...",
            "country": "GB",
            "timestamp": "2015-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005143-24/ES",
            "title": "A Multipart, Open-label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With and Without Dasabuvir Coadministered With and Without Ribavirin in Adults With Genotype 1...",
            "country": "ES",
            "timestamp": "2015-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005143-24/results",
            "title": "A Multipart, Open-label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir With and Without Dasabuvir Coadministered With and Without Ribavirin in Adults With Genotype 1...",
            "country": "View results",
            "timestamp": "2015-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001467-39/ES",
            "title": "A phase II study to evaluate the safety and efficacy of lenvatinib in patients with advanced grade 1/2 neuroendocrine neoplasmas of pancreatic and extrapancreatic origin.",
            "country": "ES",
            "timestamp": "2015-07-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001467-39/AT",
            "title": "A phase II study to evaluate the safety and efficacy of lenvatinib in patients with advanced grade 1/2 neuroendocrine neoplasmas of pancreatic and extrapancreatic origin.",
            "country": "AT",
            "timestamp": "2015-07-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000815-15/IT",
            "title": "Effects of a late add-on therapy of pegylated interferon (peg-IFNA) to ongoing nucleos(t)ide\r\nanalogs (NUCs) in patients with chronic hepatitis B (CHB).",
            "country": "IT",
            "timestamp": "2015-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003876-38/DE",
            "title": "A randomized, double- blind, controlled, parallel-group, multicenter study to assess the safety and immunogenicity of transitioning to GP2013 or re-treatment with Rituxan® or MabThera® in patients ...",
            "country": "DE",
            "timestamp": "2015-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003876-38/HU",
            "title": "A randomized, double- blind, controlled, parallel-group, multicenter study to assess the safety and immunogenicity of transitioning to GP2013 or re-treatment with Rituxan® or MabThera® in patients ...",
            "country": "HU",
            "timestamp": "2015-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003876-38/PL",
            "title": "A randomized, double- blind, controlled, parallel-group, multicenter study to assess the safety and immunogenicity of transitioning to GP2013 or re-treatment with Rituxan® or MabThera® in patients ...",
            "country": "PL",
            "timestamp": "2015-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003876-38/results",
            "title": "A randomized, double- blind, controlled, parallel-group, multicenter study to assess the safety and immunogenicity of transitioning to GP2013 or re-treatment with Rituxan® or MabThera® in patients ...",
            "country": "View results",
            "timestamp": "2015-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/GB",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "GB",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/DE",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "DE",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/HU",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "HU",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/PL",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "PL",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/RO",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "RO",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/IT",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "IT",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004633-96/results",
            "title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus",
            "country": "View results",
            "timestamp": "2015-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/DE",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "DE",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/LV",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "LV",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/HU",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "HU",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/CZ",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "CZ",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/ES",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "ES",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/BG",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "BG",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003558-15/results",
            "title": "A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "View results",
            "timestamp": "2015-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001103-31/GB",
            "title": "A Phase 2a, Randomized, Double-blind, Placebo-controlled Assessment of the Safety and Protective Efficacy of FF-3 Dry Powder Administered by Nasal Inhalation for 5 Days to Healthy Adult Subjects wh...",
            "country": "GB",
            "timestamp": "2015-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001103-31/results",
            "title": "A Phase 2a, Randomized, Double-blind, Placebo-controlled Assessment of the Safety and Protective Efficacy of FF-3 Dry Powder Administered by Nasal Inhalation for 5 Days to Healthy Adult Subjects wh...",
            "country": "View results",
            "timestamp": "2015-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002132-25/DE",
            "title": "RUXOlitinib versus BEst Available Therapy in patients with high-risk polycythemia vera or high-risk essential thrombocythemia – The RUXO-BEAT Trial",
            "country": "DE",
            "timestamp": "2015-06-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000360-34/DE",
            "title": "DUALIS\r\nA prospective, multicenter, randomized, open-label trial to assess the safety, tolerability and efficacy of dual therapy with boosted Darunavir + Dolutegravir when switching from standard o...",
            "country": "DE",
            "timestamp": "2015-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000251-24/ES",
            "title": "Impact of extremely early antiretroviral therapy to reduce VIral REservoir and induce functional CURE of HIV-1 infection. A pilot comparative study.",
            "country": "ES",
            "timestamp": "2015-06-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001956-31/DK",
            "title": "Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variants",
            "country": "DK",
            "timestamp": "2015-06-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001956-31/results",
            "title": "Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variants",
            "country": "View results",
            "timestamp": "2015-06-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005084-32/GB",
            "title": "A randomized, double-blind, placebo-controlled, parallel group, multi-centre Phase IIa study in asthma patients comparing the efficacy and safety of once daily inhaled Interferon beta-1a to placebo...",
            "country": "GB",
            "timestamp": "2015-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005084-32/ES",
            "title": "A randomized, double-blind, placebo-controlled, parallel group, multi-centre Phase IIa study in asthma patients comparing the efficacy and safety of once daily inhaled Interferon beta-1a to placebo...",
            "country": "ES",
            "timestamp": "2015-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005084-32/FR",
            "title": "A randomized, double-blind, placebo-controlled, parallel group, multi-centre Phase IIa study in asthma patients comparing the efficacy and safety of once daily inhaled Interferon beta-1a to placebo...",
            "country": "FR",
            "timestamp": "2015-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005084-32/results",
            "title": "A randomized, double-blind, placebo-controlled, parallel group, multi-centre Phase IIa study in asthma patients comparing the efficacy and safety of once daily inhaled Interferon beta-1a to placebo...",
            "country": "View results",
            "timestamp": "2015-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004820-24/ES",
            "title": "Cost-effectiveness of different  antiretroviral treatment in patients HIV naive. Randomized clinical, not masked, trial comparing DRVr3TC, ABC3TC (Kivexa) RPV, or EVG COBI FTC TDF (Stribild) for 48...",
            "country": "ES",
            "timestamp": "2015-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001055-12/IT",
            "title": "Flu-like syndrome Inhibition Giving anti-histaminic Therapy. Randomized cross-over, single-center, randomized, placebo-controlled, double-blind study to evaluate the efficacy of cetirizine on Flu-l...",
            "country": "IT",
            "timestamp": "2015-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001055-12/results",
            "title": "Flu-like syndrome Inhibition Giving anti-histaminic Therapy. Randomized cross-over, single-center, randomized, placebo-controlled, double-blind study to evaluate the efficacy of cetirizine on Flu-l...",
            "country": "View results",
            "timestamp": "2015-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/BE",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "BE",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/GB",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "GB",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/ES",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "ES",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/BG",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "BG",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/GR",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "GR",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/FR",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "FR",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004939-39/results",
            "title": "Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi...",
            "country": "View results",
            "timestamp": "2015-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005555-80/ES",
            "title": "Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study",
            "country": "ES",
            "timestamp": "2015-05-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005555-80/results",
            "title": "Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study",
            "country": "View results",
            "timestamp": "2015-05-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005388-34/IT",
            "title": "Single arm prospective clinical study to evaluate the efficacy  of combination therapy sofosbuvir+ribavirin+peg-interferon in experienced patients with HCV-GT1",
            "country": "IT",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/HU",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "HU",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/SK",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "SK",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/AT",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "AT",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/CZ",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "CZ",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/BG",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "BG",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/PL",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "PL",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001356-31/results",
            "title": "An open-label, single arm, Phase III study to assess the self-administration of AOP2014 using a pre-filled pen, developed for the treatment of Polycythemia Vera patients",
            "country": "View results",
            "timestamp": "2015-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003481-25/DE",
            "title": "A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on Immune-Modulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis",
            "country": "DE",
            "timestamp": "2015-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003481-25/results",
            "title": "A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on Immune-Modulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis",
            "country": "View results",
            "timestamp": "2015-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004250-34/ES",
            "title": "A Phase 2, Open-label, Single-arm Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of 12 Weeks Treatment With Simeprevir and Daclatasvir in Subjects With Chronic Hepatit...",
            "country": "ES",
            "timestamp": "2015-05-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005418-45/SE",
            "title": "Improved cardiovascular risk factors and inflammatory markers in Rheumatoid Arthritis and Systemic Lupus Erythematosus? New aspects of Hydroxychloroquine – an interventional study (HCQCVDRASLE)",
            "country": "SE",
            "timestamp": "2015-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005418-45/results",
            "title": "Improved cardiovascular risk factors and inflammatory markers in Rheumatoid Arthritis and Systemic Lupus Erythematosus? New aspects of Hydroxychloroquine – an interventional study (HCQCVDRASLE)",
            "country": "View results",
            "timestamp": "2015-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005341-44/AT",
            "title": "Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma",
            "country": "AT",
            "timestamp": "2015-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000274-35/ES",
            "title": "An open-label, randomized, controlled clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged viro...",
            "country": "ES",
            "timestamp": "2015-04-23"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10361292",
            "timestamp": "2015-04-20",
            "title": "A study for patients with advanced pancreatic cancer looking at adding olaparib to chemotherapy with radiotherapy (chemoradiation)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14616088",
            "timestamp": "2015-04-16",
            "title": "Comparison of the pharmacokinetic profiles of separately administered sublingual  testosterone followed by a sildenafil citrate tablet, versus sublingual testosterone and sildenafil citrate combined in a fixed-dose combination tablet"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002808-25/NL",
            "title": "Immune phenotyping in chronic hepatitis C patients treated with Sofosbuvir and Daclatasvir combination with or without Ribavirin for 12 or 24 weeks -SODA study",
            "country": "NL",
            "timestamp": "2015-04-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004906-14/3rd",
            "title": "An Open Label, Non-Comparative Study To Evaluate Parasitological Clearance Rates and Pharmacokinetics of Azithromycin and Chloroquine Following Administration of a Fixed Dose Combination of Azithro...",
            "country": "Outside EU/EEA",
            "timestamp": "2015-04-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004906-14/results",
            "title": "An Open Label, Non-Comparative Study To Evaluate Parasitological Clearance Rates and Pharmacokinetics of Azithromycin and Chloroquine Following Administration of a Fixed Dose Combination of Azithro...",
            "country": "View results",
            "timestamp": "2015-04-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004163-21/3rd",
            "title": "Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa",
            "country": "Outside EU/EEA",
            "timestamp": "2015-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004163-21/results",
            "title": "Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa",
            "country": "View results",
            "timestamp": "2015-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004952-80/3rd",
            "title": "Phase 3, Open-Label, Randomized, Comparative Study to Evaluate Azithromycin plus Chloroquine and Sulfadoxine plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Mala...",
            "country": "Outside EU/EEA",
            "timestamp": "2015-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004952-80/results",
            "title": "Phase 3, Open-Label, Randomized, Comparative Study to Evaluate Azithromycin plus Chloroquine and Sulfadoxine plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Mala...",
            "country": "View results",
            "timestamp": "2015-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003735-32/SK",
            "title": "A 96-weeks, prospective, multicentre, randomised, open label, active-controlled, parallel groups, phase 2b/3 study to compare efficacy and safety of masitinib to first line treatment, in patients w...",
            "country": "SK",
            "timestamp": "2015-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003735-32/GR",
            "title": "A 96-weeks, prospective, multicentre, randomised, open label, active-controlled, parallel groups, phase 2b/3 study to compare efficacy and safety of masitinib to first line treatment, in patients w...",
            "country": "GR",
            "timestamp": "2015-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005589-31/DK",
            "title": "4 Week treatment for Injecting Drug Users with chronic hepatitis C \n\nA phase 4, post marketing randomized clinical open label trial comparing 4 weeks of Ledipasvir/Sofosbuvir (co-formulated) and Ri...",
            "country": "DK",
            "timestamp": "2015-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003145-99/GB",
            "title": "A randomised placebo-controlled study of the safety and tolerability of a retinoid-X receptor agonist's ability to promote remyelination in people with relapsing-remitting multiple sclerosis alread...",
            "country": "GB",
            "timestamp": "2015-03-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14138956",
            "timestamp": "2015-03-19",
            "title": "Stereotactic body radiation therapy pre-operatively for borderline resectable pancreatic cancer"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005134-64/3rd",
            "title": "Phase I/II Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, ATAZANAVIR, ATV, REYATAZ™) in Combination Regimens in Antiretroviral Therapy (ART)-Naïve and Exper...",
            "country": "Outside EU/EEA",
            "timestamp": "2015-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005134-64/results",
            "title": "Phase I/II Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, ATAZANAVIR, ATV, REYATAZ™) in Combination Regimens in Antiretroviral Therapy (ART)-Naïve and Exper...",
            "country": "View results",
            "timestamp": "2015-03-13"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN11193709",
            "timestamp": "2015-03-06",
            "title": "SMILE"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004510-28/SE",
            "title": "An open-label, randomized, controlled, multicenter, phase II study evaluating safety and efficacy of intratumorally administered Intuvax pre-nephrectomy followed by Sunitinib post-nephrectomy, comp...",
            "country": "SE",
            "timestamp": "2015-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004510-28/CZ",
            "title": "An open-label, randomized, controlled, multicenter, phase II study evaluating safety and efficacy of intratumorally administered Intuvax pre-nephrectomy followed by Sunitinib post-nephrectomy, comp...",
            "country": "CZ",
            "timestamp": "2015-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004510-28/HU",
            "title": "An open-label, randomized, controlled, multicenter, phase II study evaluating safety and efficacy of intratumorally administered Intuvax pre-nephrectomy followed by Sunitinib post-nephrectomy, comp...",
            "country": "HU",
            "timestamp": "2015-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004510-28/LV",
            "title": "An open-label, randomized, controlled, multicenter, phase II study evaluating safety and efficacy of intratumorally administered Intuvax pre-nephrectomy followed by Sunitinib post-nephrectomy, comp...",
            "country": "LV",
            "timestamp": "2015-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004510-28/GB",
            "title": "An open-label, randomized, controlled, multicenter, phase II study evaluating safety and efficacy of intratumorally administered Intuvax pre-nephrectomy followed by Sunitinib post-nephrectomy, comp...",
            "country": "GB",
            "timestamp": "2015-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004510-28/ES",
            "title": "An open-label, randomized, controlled, multicenter, phase II study evaluating safety and efficacy of intratumorally administered Intuvax pre-nephrectomy followed by Sunitinib post-nephrectomy, comp...",
            "country": "ES",
            "timestamp": "2015-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002281-70/ES",
            "title": "Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV-1?infected patients (<100 CD4+ T cells/?L) taking antiretroviral regimens based on dolutegravir or ritonavir-boosted daru...",
            "country": "ES",
            "timestamp": "2015-02-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN62125126",
            "timestamp": "2015-02-19",
            "title": "The formation of carbamazepine metabolites and carbamazepine-protein conjugates in epilepsy patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004736-23/3rd",
            "title": "A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subj...",
            "country": "Outside EU/EEA",
            "timestamp": "2015-02-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004736-23/results",
            "title": "A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subj...",
            "country": "View results",
            "timestamp": "2015-02-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000725-37/3rd",
            "title": "A Phase 1 Study to Evaluate the Bioavailability of Boosted Age-Appropriate Pediatric Elvitegravir (EVG) Tablet or Suspension Formulation Compared with Adult EVG 150 mg Tablets in Healthy Adult Volu...",
            "country": "Outside EU/EEA",
            "timestamp": "2015-02-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000725-37/results",
            "title": "A Phase 1 Study to Evaluate the Bioavailability of Boosted Age-Appropriate Pediatric Elvitegravir (EVG) Tablet or Suspension Formulation Compared with Adult EVG 150 mg Tablets in Healthy Adult Volu...",
            "country": "View results",
            "timestamp": "2015-02-18"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN69497594",
            "timestamp": "2015-02-18",
            "title": "Is there a rebound increase in platelet aggregation following withdrawal of aspirin or ticagrelor in patients who have recently undergone PCI?"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003052-31/BE",
            "title": "A Phase 3, randomized, active-controlled, open-label study to evaluate the efficacy, safety and tolerability of switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) o...",
            "country": "BE",
            "timestamp": "2015-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003052-31/SE",
            "title": "A Phase 3, randomized, active-controlled, open-label study to evaluate the efficacy, safety and tolerability of switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) o...",
            "country": "SE",
            "timestamp": "2015-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003052-31/GB",
            "title": "A Phase 3, randomized, active-controlled, open-label study to evaluate the efficacy, safety and tolerability of switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) o...",
            "country": "GB",
            "timestamp": "2015-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003052-31/ES",
            "title": "A Phase 3, randomized, active-controlled, open-label study to evaluate the efficacy, safety and tolerability of switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) o...",
            "country": "ES",
            "timestamp": "2015-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003052-31/PL",
            "title": "A Phase 3, randomized, active-controlled, open-label study to evaluate the efficacy, safety and tolerability of switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) o...",
            "country": "PL",
            "timestamp": "2015-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003052-31/FR",
            "title": "A Phase 3, randomized, active-controlled, open-label study to evaluate the efficacy, safety and tolerability of switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) o...",
            "country": "FR",
            "timestamp": "2015-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/CZ",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "CZ",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/LT",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "LT",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/ES",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "ES",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/NO",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "NO",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/HU",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "HU",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/DK",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "DK",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/PL",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "PL",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003836-38/results",
            "title": "A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR...",
            "country": "View results",
            "timestamp": "2015-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003924-34/ES",
            "title": "A phase II trial to assess the activity and safety of Palbociclib in patients with well- and moderately-differentiated metastatic pancreatic neuroendocrine tumors (pNET).",
            "country": "ES",
            "timestamp": "2015-02-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002508-26/IT",
            "title": "Outcome-related factors in patients with metastatic renal cell carcinoma treated with everolimus after failure of a first-line treatment with VEGF inhibitor",
            "country": "IT",
            "timestamp": "2015-02-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003578-17/3rd",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children with Chronic HCV-Infection",
            "country": "Outside EU/EEA",
            "timestamp": "2015-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003578-17/GB",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children with Chronic HCV-Infection",
            "country": "GB",
            "timestamp": "2015-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003578-17/results",
            "title": "A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination in Adolescents and Children with Chronic HCV-Infection",
            "country": "View results",
            "timestamp": "2015-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005129-10/FI",
            "title": "Multiple Sclerosis and Menopause: the effect of hormone replacement therapy on clinical picture and immunology of multiple sclerosis",
            "country": "FI",
            "timestamp": "2015-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004072-30/ES",
            "title": "A phase II trial to assess the activity and safety of TH-302 in combination with sunitinib in patients with well- and moderately-differentiated metastatic pancreatic neuroendocrine tumors (pNET) pr...",
            "country": "ES",
            "timestamp": "2015-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003255-54/CZ",
            "title": "A Double-blind, Randomised, Comparative Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Evaluation of RGB-03 and MabThera® Combined with Methotrexate in Rheumatoid Arthritis Patients",
            "country": "CZ",
            "timestamp": "2015-01-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003714-40/DE",
            "title": "Hydroxychloroquine in pediatric ILD START randomized controlled in parallel-group, then switch placebo to active drug, and STOP randomized controlled in parallel-group\r\nto evaluate the efficacy and...",
            "country": "DE",
            "timestamp": "2015-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003714-40/GB",
            "title": "Hydroxychloroquine in pediatric ILD START randomized controlled in parallel-group, then switch placebo to active drug, and STOP randomized controlled in parallel-group\r\nto evaluate the efficacy and...",
            "country": "GB",
            "timestamp": "2015-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003714-40/AT",
            "title": "Hydroxychloroquine in pediatric ILD START randomized controlled in parallel-group, then switch placebo to active drug, and STOP randomized controlled in parallel-group\r\nto evaluate the efficacy and...",
            "country": "AT",
            "timestamp": "2015-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003714-40/ES",
            "title": "Hydroxychloroquine in pediatric ILD START randomized controlled in parallel-group, then switch placebo to active drug, and STOP randomized controlled in parallel-group\r\nto evaluate the efficacy and...",
            "country": "ES",
            "timestamp": "2015-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/DE",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "DE",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/HU",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "HU",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/BG",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "BG",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/CZ",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "CZ",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/DK",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "DK",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/RO",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "RO",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004019-37/results",
            "title": "A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate",
            "country": "View results",
            "timestamp": "2015-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004613-93/3rd",
            "title": "Open label study to evaluate the effect, safety and tolerability of 250µg (8 MIU) interferon beta 1b (Betaferon) given subcutaneously every other day (for 24 weeks) in patients of Chinese origin wi...",
            "country": "Outside EU/EEA",
            "timestamp": "2015-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004613-93/results",
            "title": "Open label study to evaluate the effect, safety and tolerability of 250µg (8 MIU) interferon beta 1b (Betaferon) given subcutaneously every other day (for 24 weeks) in patients of Chinese origin wi...",
            "country": "View results",
            "timestamp": "2015-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/AT",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "AT",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/GB",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "GB",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/DE",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "DE",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/DK",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "DK",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/ES",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "ES",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/RO",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "RO",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001127-69/PT",
            "title": "A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg On...",
            "country": "PT",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001478-32/FR",
            "title": "An Exploratory Study to Evaluate the Kinetics of Viral Load Decline with Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy with Low Dose Ribavirin (RBV), Full Dose RBV or RB...",
            "country": "FR",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001478-32/results",
            "title": "An Exploratory Study to Evaluate the Kinetics of Viral Load Decline with Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Therapy with Low Dose Ribavirin (RBV), Full Dose RBV or RB...",
            "country": "View results",
            "timestamp": "2015-01-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005545-20/BE",
            "title": "The CaStOR study\nCarcinoid Tumors after failure of Somatostatin analogs: a randomized phase III of Octreotide Lutate Peptid Receptor radionuclide Therapy (PRRT) versus inteRferon α-2b",
            "country": "BE",
            "timestamp": "2014-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/DE",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "DE",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/BE",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "BE",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/AT",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "AT",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/ES",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "ES",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/IT",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "IT",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/GR",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "GR",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/FR",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "FR",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001496-31/results",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Coadministered with Ribavirin in Adults with Genotype 4 Chronic Hepatitis C Virus  Infection and C...",
            "country": "View results",
            "timestamp": "2014-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001012-19/NL",
            "title": "Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis",
            "country": "NL",
            "timestamp": "2014-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003147-35/GB",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of the Co-Administration of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) With Sofosbuvir (SOF) With or Without Ribavirin (R...",
            "country": "GB",
            "timestamp": "2014-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003147-35/results",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of the Co-Administration of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) With Sofosbuvir (SOF) With or Without Ribavirin (R...",
            "country": "View results",
            "timestamp": "2014-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000453-37/IT",
            "title": "Sequential treatment with nucleotide analogue and peg-interferon in patients with HBV-related chronic hepatitis.",
            "country": "IT",
            "timestamp": "2014-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001081-99/BE",
            "title": "A clinical trial to document safety and radiological disease activity in patients with relapsing-remitting multiple sclerosis treated with autologous CD4+ cells, stimulated and expanded ex vivo by ...",
            "country": "BE",
            "timestamp": "2014-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001111-39/NL",
            "title": "Once daily DArunavir/ritonavir in HIV-infected children 6-12 years old: a PHarmacokiNEtic validation of model-based dosing recommendations (DAPHNE)",
            "country": "NL",
            "timestamp": "2014-12-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001111-39/results",
            "title": "Once daily DArunavir/ritonavir in HIV-infected children 6-12 years old: a PHarmacokiNEtic validation of model-based dosing recommendations (DAPHNE)",
            "country": "View results",
            "timestamp": "2014-12-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002720-27/ES",
            "title": "Simplification from Tenofovir plus Lamivudine or Emtricitabine plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir plus Lamivudine in Virologically-Suppressed-HIV-Infected Adu...",
            "country": "ES",
            "timestamp": "2014-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001348-39/ES",
            "title": "A Phase II, randomized clinical trial to assess the impact of antiretroviral therapy over viral load in seminal fluid in antiretroviral-naive HIV-positive patients",
            "country": "ES",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/SE",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "SE",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/ES",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "ES",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/BE",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "BE",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/DE",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "DE",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/AT",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "AT",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/GR",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "GR",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/IT",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "IT",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/FI",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "FI",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/CZ",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "CZ",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/PT",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "PT",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000185-22/HU",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial of Talimogene Laherparepvec in Combination With MK-3475 for Treatment of Previously Untreated, Unresected, Stage IIIB to IVM1c Melanoma",
            "country": "HU",
            "timestamp": "2014-12-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN15280205",
            "timestamp": "2014-11-28",
            "title": "Dose-finding and pharmacokinetic studies of praziquantel in children infected with schistosomes"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001477-13/DE",
            "title": "An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin in Adults with Genotype 1 and Ombitasvir/Paritabprevir/Ritonavir with Ribav...",
            "country": "DE",
            "timestamp": "2014-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001477-13/results",
            "title": "An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin in Adults with Genotype 1 and Ombitasvir/Paritabprevir/Ritonavir with Ribav...",
            "country": "View results",
            "timestamp": "2014-11-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/EE",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "EE",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/PT",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "PT",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/LV",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "LV",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/SE",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "SE",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/NL",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "NL",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/BG",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "BG",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/PL",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "PL",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/ES",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "ES",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/LT",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "LT",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/HU",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "HU",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/GB",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "GB",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/HR",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "HR",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002320-27/results",
            "title": "A Phase 3, multi-center, randomized, Double-Blind, double-dummy, active controlled, parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing multiple scl...",
            "country": "View results",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003894-41/IT",
            "title": "Effect of a Peg-interferon alfa 2A pulse on HBV-specific T cell responses in chronic hepatitis HBeAg negative patients under long-term nucleos(t)ide treatment",
            "country": "IT",
            "timestamp": "2014-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000307-32/DE",
            "title": "A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab Alone in Subjects With Unresected, Stage IIIB-IV Me...",
            "country": "DE",
            "timestamp": "2014-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002378-26/SE",
            "title": "Switch To RItuXimab in MS extension\nAn extension study of STRIX-MS - a phase 2 open label study of Rituximab in MS patients previously treated with self-injectibles using a target based therapy app...",
            "country": "SE",
            "timestamp": "2014-11-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002378-26/results",
            "title": "Switch To RItuXimab in MS extension\nAn extension study of STRIX-MS - a phase 2 open label study of Rituximab in MS patients previously treated with self-injectibles using a target based therapy app...",
            "country": "View results",
            "timestamp": "2014-11-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/DE",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "DE",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/IE",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "IE",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/GB",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "GB",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/SE",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "SE",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/ES",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "ES",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/HU",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "HU",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/IT",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "IT",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/NL",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "NL",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/AT",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "AT",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/GR",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "GR",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001114-26/results",
            "title": "A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remi...",
            "country": "View results",
            "timestamp": "2014-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/HU",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "HU",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/AT",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "AT",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/CZ",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "CZ",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/PL",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "PL",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/SK",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "SK",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/BG",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "BG",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/ES",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "ES",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001357-17/DE",
            "title": "An open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of AOP2014 and standard first line treatment (BAT) in patients with Polycythemia Vera who previously partici...",
            "country": "DE",
            "timestamp": "2014-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003347-35/DK",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT3,...",
            "country": "DK",
            "timestamp": "2014-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003347-35/GB",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT3,...",
            "country": "GB",
            "timestamp": "2014-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003347-35/DE",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT3,...",
            "country": "DE",
            "timestamp": "2014-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003347-35/IT",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT3,...",
            "country": "IT",
            "timestamp": "2014-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003347-35/results",
            "title": "A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-3682 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT3,...",
            "country": "View results",
            "timestamp": "2014-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004268-38/HU",
            "title": "Individual Patient Access to AbbVie ABT-450/ritopnavir/ABT-267 and ABT-333 Coadministeres with ribavirin (RBV) in Adult Liver Transplant Recipient with Genotype 1 Hepatitis C Virus Infection",
            "country": "HU",
            "timestamp": "2014-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001290-14/RO",
            "title": "Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart™",
            "country": "RO",
            "timestamp": "2014-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001290-14/results",
            "title": "Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart™",
            "country": "View results",
            "timestamp": "2014-10-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-004111-37/HU",
            "title": "Individual Patient Access to AbbVie ABT-450/rítonavir/ABT-267 and ABT\n333 Coadministered witb Ribavirín (RBV) in Patient with Genotype 1 Hepatitis C Vírus\nInfection witb Cirrhosis",
            "country": "HU",
            "timestamp": "2014-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001081-42/DE",
            "title": "Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection with Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study",
            "country": "DE",
            "timestamp": "2014-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001683-35/DE",
            "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of\r\nSofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic...",
            "country": "DE",
            "timestamp": "2014-10-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001683-35/GB",
            "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of\r\nSofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic...",
            "country": "GB",
            "timestamp": "2014-10-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001683-35/IT",
            "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of\r\nSofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic...",
            "country": "IT",
            "timestamp": "2014-10-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001683-35/BE",
            "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of\r\nSofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic...",
            "country": "BE",
            "timestamp": "2014-10-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001683-35/FR",
            "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of\r\nSofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic...",
            "country": "FR",
            "timestamp": "2014-10-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001683-35/results",
            "title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of\r\nSofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic...",
            "country": "View results",
            "timestamp": "2014-10-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003084-37/CZ",
            "title": "A phase I/II study to evaluate safety and efficacy of DCVAC/LuCa added to standard first line chemotherapy with carboplatin and paclitaxel +/- immune enhancers (interferon-α and hydroxychloroquine)...",
            "country": "CZ",
            "timestamp": "2014-10-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-003084-37/SK",
            "title": "A phase I/II study to evaluate safety and efficacy of DCVAC/LuCa added to standard first line chemotherapy with carboplatin and paclitaxel +/- immune enhancers (interferon-α and hydroxychloroquine)...",
            "country": "SK",
            "timestamp": "2014-10-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001953-18/BE",
            "title": "An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ ABT-450/ Ritonavir and Dasabuvir in Adults with Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosi...",
            "country": "BE",
            "timestamp": "2014-10-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001953-18/results",
            "title": "An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ ABT-450/ Ritonavir and Dasabuvir in Adults with Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosi...",
            "country": "View results",
            "timestamp": "2014-10-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000706-34/GB",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO ASSESS THE IMMUNE RESPONSE FOLLOWING ADMINISTRATION OF ZOSTER VACCINE TO SUBJECTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB (C...",
            "country": "GB",
            "timestamp": "2014-10-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000706-34/results",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO ASSESS THE IMMUNE RESPONSE FOLLOWING ADMINISTRATION OF ZOSTER VACCINE TO SUBJECTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB (C...",
            "country": "View results",
            "timestamp": "2014-10-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003300-21/3rd",
            "title": "A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety of Atazanavir (ATV) Capsule Boosted with Ritonavir (RTV) with an Optimized NRTI Background Therapy, in ...",
            "country": "Outside EU/EEA",
            "timestamp": "2014-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003300-21/results",
            "title": "A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety of Atazanavir (ATV) Capsule Boosted with Ritonavir (RTV) with an Optimized NRTI Background Therapy, in ...",
            "country": "View results",
            "timestamp": "2014-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001546-34/DE",
            "title": "Neoadjuvant treatment with the combination of Vemurafenib, Cobimetinib and Atezolizumab in limited metastasis of malignant melanoma (AJCC stage IIIC/IV) and integrated biomarker study: A single arm...",
            "country": "DE",
            "timestamp": "2014-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001546-34/AT",
            "title": "Neoadjuvant treatment with the combination of Vemurafenib, Cobimetinib and Atezolizumab in limited metastasis of malignant melanoma (AJCC stage IIIC/IV) and integrated biomarker study: A single arm...",
            "country": "AT",
            "timestamp": "2014-10-02"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN36667085",
            "timestamp": "2014-09-26",
            "title": "Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition - an early phase trial"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002095-93/GB",
            "title": "A Randomized, Open Label, Phase 4 Study Evaluating the Renal Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF or  other Tenofovir DF-containing Regimens (Ritonavir-boosted Atazanavir  p...",
            "country": "GB",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002095-93/BE",
            "title": "A Randomized, Open Label, Phase 4 Study Evaluating the Renal Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF or  other Tenofovir DF-containing Regimens (Ritonavir-boosted Atazanavir  p...",
            "country": "BE",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002095-93/ES",
            "title": "A Randomized, Open Label, Phase 4 Study Evaluating the Renal Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF or  other Tenofovir DF-containing Regimens (Ritonavir-boosted Atazanavir  p...",
            "country": "ES",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002095-93/IE",
            "title": "A Randomized, Open Label, Phase 4 Study Evaluating the Renal Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF or  other Tenofovir DF-containing Regimens (Ritonavir-boosted Atazanavir  p...",
            "country": "IE",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-002095-93/results",
            "title": "A Randomized, Open Label, Phase 4 Study Evaluating the Renal Effect of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF or  other Tenofovir DF-containing Regimens (Ritonavir-boosted Atazanavir  p...",
            "country": "View results",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/BE",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "BE",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/IT",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "IT",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/DE",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "DE",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/GB",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "GB",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/ES",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "ES",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/NL",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "NL",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/AT",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "AT",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/DK",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "DK",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/PT",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "PT",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/IE",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "IE",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/SE",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "SE",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/FI",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "FI",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/HU",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "HU",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/CZ",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "CZ",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/GR",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "GR",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/PL",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "PL",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001286-28/results",
            "title": "A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Tre...",
            "country": "View results",
            "timestamp": "2014-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/PT",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "PT",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/GB",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "GB",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/IE",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "IE",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/AT",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "AT",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/ES",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "ES",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/IT",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "IT",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/SE",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "SE",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/BE",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "BE",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/FI",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "FI",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/NL",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "NL",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/BG",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "BG",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/PL",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "PL",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/DK",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "DK",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001022-14/GR",
            "title": "An Open-Label, Multicenter Study to Evaluate Long-Term Outcomes with ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepa...",
            "country": "GR",
            "timestamp": "2014-09-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN82138287",
            "timestamp": "2014-09-18",
            "title": "A Mechanistic Study Of Mifamurtide (MTPPE) In Patients With Metastatic And/Or Recurrent Osteosarcoma"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/HU",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "HU",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/IT",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "IT",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/GB",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "GB",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/ES",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "ES",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/DE",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "DE",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/PL",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "PL",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000443-33/results",
            "title": "A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Rheumatoid Arthritis and Inadequate Response to Treat...",
            "country": "View results",
            "timestamp": "2014-09-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN77186750",
            "timestamp": "2014-08-27",
            "title": "Dose-finding and pharmacokinetic studies of praziquantel in patients infected with Opisthorchis viverrini"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001682-27/GB",
            "title": "A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed\nDose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 24 Weeks in Subje...",
            "country": "GB",
            "timestamp": "2014-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001682-27/IT",
            "title": "A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed\nDose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 24 Weeks in Subje...",
            "country": "IT",
            "timestamp": "2014-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001682-27/FR",
            "title": "A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed\nDose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 24 Weeks in Subje...",
            "country": "FR",
            "timestamp": "2014-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001682-27/results",
            "title": "A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed\nDose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 24 Weeks in Subje...",
            "country": "View results",
            "timestamp": "2014-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001367-13/AT",
            "title": "An open-label, prospective, single-centre, phase II study to assess dose and dose interval requirements with respect to efficacy and safety of AOP2014, PEG-Proline-Interferon alpha-2b, in patients ...",
            "country": "AT",
            "timestamp": "2014-08-08"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN97420179",
            "timestamp": "2014-07-31",
            "title": "The influence of ivabradine in a healthy volunteer pain model"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001301-40/GB",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of Concomitant Administration of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01¬B + ChAd63 and...",
            "country": "GB",
            "timestamp": "2014-07-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001301-40/results",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of Concomitant Administration of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01¬B + ChAd63 and...",
            "country": "View results",
            "timestamp": "2014-07-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN24987553",
            "timestamp": "2014-07-29",
            "title": "CAM2038, pharmacokinetics (PK), bioavailability and safety in healthy volunteers"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004808-19/GB",
            "title": "A multi-center, randomized, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary S...",
            "country": "GB",
            "timestamp": "2014-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004808-19/HU",
            "title": "A multi-center, randomized, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary S...",
            "country": "HU",
            "timestamp": "2014-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004808-19/DE",
            "title": "A multi-center, randomized, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary S...",
            "country": "DE",
            "timestamp": "2014-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004808-19/results",
            "title": "A multi-center, randomized, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary S...",
            "country": "View results",
            "timestamp": "2014-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001193-34/ES",
            "title": "COMPARISON OF TWO ANTIRETROVIRAL ALTERNATIVE COMBINATIONS IN HIV-1 POST-EXPOSURE PROPHYLAXIS: TENOFOVIR+EMTRICITABINE (TRUVADA®) + LOPINAVIR/RITONAVIR (KALETRA®) VS TENOFOVIR+EMTRICITABINA+ COBICIS...",
            "country": "ES",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/BE",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "BE",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/HU",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "HU",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/GB",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "GB",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/IT",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "IT",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/ES",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "ES",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/RO",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "RO",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/DK",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "DK",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/NL",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "NL",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004497-10/results",
            "title": "A Randomized, Double-Blind, Parallel-Group, Phase 3 Study to Demonstrate Noninferiority in Efficacy and to Assess the Safety of CT-P13 Compared to Remicade in Patients With Active Crohn’s Disease",
            "country": "View results",
            "timestamp": "2014-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000533-12/DE",
            "title": "A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Two Patient Groups with Acromegaly and Neuroendocrine Tumours (NE...",
            "country": "DE",
            "timestamp": "2014-07-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000533-12/IT",
            "title": "A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Two Patient Groups with Acromegaly and Neuroendocrine Tumours (NE...",
            "country": "IT",
            "timestamp": "2014-07-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000533-12/results",
            "title": "A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Two Patient Groups with Acromegaly and Neuroendocrine Tumours (NE...",
            "country": "View results",
            "timestamp": "2014-07-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000515-14/ES",
            "title": "Comparative, randomized, open study to evaluate maintenance with Darunavir/ritonavir once daily plus Lamivudine once daily versus continuing Darunavir/ritonavir once-daily plus Tenofovir/Emtricitab...",
            "country": "ES",
            "timestamp": "2014-06-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/NL",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "NL",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/PT",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "PT",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/BG",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "BG",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/BE",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "BE",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/DE",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "DE",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/HU",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "HU",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/ES",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "ES",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/GR",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "GR",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002622-23/results",
            "title": "Safety and Efficacy of BI 695500 in patients with moderately to severely active rheumatoid arthritis: an open-label extension trial",
            "country": "View results",
            "timestamp": "2014-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003126-83/DE",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "DE",
            "timestamp": "2014-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003126-83/BG",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "BG",
            "timestamp": "2014-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003126-83/HU",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "HU",
            "timestamp": "2014-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003126-83/GR",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "GR",
            "timestamp": "2014-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003126-83/ES",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "ES",
            "timestamp": "2014-06-23"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN81883379",
            "timestamp": "2014-06-12",
            "title": "Systemic therapy for vulval erosive lichen planus"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000824-12/DK",
            "title": "A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavi...",
            "country": "DK",
            "timestamp": "2014-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000824-12/ES",
            "title": "A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavi...",
            "country": "ES",
            "timestamp": "2014-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000824-12/FI",
            "title": "A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavi...",
            "country": "FI",
            "timestamp": "2014-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000824-12/PL",
            "title": "A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavi...",
            "country": "PL",
            "timestamp": "2014-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000824-12/NL",
            "title": "A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavi...",
            "country": "NL",
            "timestamp": "2014-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000824-12/results",
            "title": "A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Subjects who have Failed Prior Treatment with Pegylated Interferon and Ribavi...",
            "country": "View results",
            "timestamp": "2014-06-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/SE",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "SE",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/BE",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "BE",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/IT",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "IT",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/HU",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "HU",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/DK",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "DK",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/CZ",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "CZ",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/PL",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "PL",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/GB",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "GB",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/ES",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "ES",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/FR",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "FR",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002318-11/DE",
            "title": "Open-Label, Randomized, Multicenter, Multiple-Dose, Active Controlled, Parallel-Group, Efficacy and Safety Study of BG00012 in Children From 10 to Less Than 18 Years of Age With Relapsing-Remitting...",
            "country": "DE",
            "timestamp": "2014-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001417-32/DE",
            "title": "A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheuma...",
            "country": "DE",
            "timestamp": "2014-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001417-32/HU",
            "title": "A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheuma...",
            "country": "HU",
            "timestamp": "2014-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001417-32/LT",
            "title": "A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheuma...",
            "country": "LT",
            "timestamp": "2014-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001417-32/ES",
            "title": "A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheuma...",
            "country": "ES",
            "timestamp": "2014-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001417-32/BG",
            "title": "A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheuma...",
            "country": "BG",
            "timestamp": "2014-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001417-32/results",
            "title": "A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheuma...",
            "country": "View results",
            "timestamp": "2014-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003984-72/LV",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 with Background Methotrexate (MTX) in Subjects with Active Rheumatoid Arthritis (RA) ...",
            "country": "LV",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003984-72/HU",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 with Background Methotrexate (MTX) in Subjects with Active Rheumatoid Arthritis (RA) ...",
            "country": "HU",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003984-72/CZ",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 with Background Methotrexate (MTX) in Subjects with Active Rheumatoid Arthritis (RA) ...",
            "country": "CZ",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003984-72/SK",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 with Background Methotrexate (MTX) in Subjects with Active Rheumatoid Arthritis (RA) ...",
            "country": "SK",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003984-72/ES",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 with Background Methotrexate (MTX) in Subjects with Active Rheumatoid Arthritis (RA) ...",
            "country": "ES",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003984-72/results",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 with Background Methotrexate (MTX) in Subjects with Active Rheumatoid Arthritis (RA) ...",
            "country": "View results",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004213-41/ES",
            "title": "A Phase II Clinical Trial to Study the Efficacy and Safety of the combination regimen of MK-5172 + MK-8742 + Ribavirin (R) in Subjects with Chronic Hepatitis C Virus Infection who failed prior Dire...",
            "country": "ES",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004213-41/AT",
            "title": "A Phase II Clinical Trial to Study the Efficacy and Safety of the combination regimen of MK-5172 + MK-8742 + Ribavirin (R) in Subjects with Chronic Hepatitis C Virus Infection who failed prior Dire...",
            "country": "AT",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004213-41/results",
            "title": "A Phase II Clinical Trial to Study the Efficacy and Safety of the combination regimen of MK-5172 + MK-8742 + Ribavirin (R) in Subjects with Chronic Hepatitis C Virus Infection who failed prior Dire...",
            "country": "View results",
            "timestamp": "2014-05-30"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN48776874",
            "timestamp": "2014-05-29",
            "title": "Evaluation of a new self applied treatment for early stage pre cancerous disease of the cervix"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001030-29/SE",
            "title": "A Phase III, Double-blind, Lot-to-Lot Consistency Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of V212 in Healthy Adults",
            "country": "SE",
            "timestamp": "2014-05-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001030-29/results",
            "title": "A Phase III, Double-blind, Lot-to-Lot Consistency Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of V212 in Healthy Adults",
            "country": "View results",
            "timestamp": "2014-05-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN41550730",
            "timestamp": "2014-05-19",
            "title": "A Phase I, randomized, open-label, active-controlled, three-way treatment trial assessing pharmacokinetics, bioavailability and safety of three doses of CAM2038 q1w (once-weekly) (buprenorphine FluidCrystal® injection depot), versus active comparators, intravenous and sublingual buprenorphine, in healthy volunteers under naltrexone blockage"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000496-64/ES",
            "title": "Viral suppression in Cerebrospinal Fluid in HIV-1 infected patients receiving Ritonavir-boosted Atazanavir plus lamivudine dual theraphy. SCALA study",
            "country": "ES",
            "timestamp": "2014-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004974-82/FR",
            "title": "PETALS study : PEgylated interferon-alpha2a and TAsigna® for first Line therapy of Philadelphia chromosome-positive chronic phase CML patientS",
            "country": "FR",
            "timestamp": "2014-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000547-32/GB",
            "title": "A Randomised Controlled Trial of Adjunctive Systemic Therapy for Vulval Erosive Lichen Planus",
            "country": "GB",
            "timestamp": "2014-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000547-32/results",
            "title": "A Randomised Controlled Trial of Adjunctive Systemic Therapy for Vulval Erosive Lichen Planus",
            "country": "View results",
            "timestamp": "2014-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003704-39/GB",
            "title": "An open label study examining the efficacy and cardiovascular risk of immediate versus deferred switch from a boosted PI to dolutegravir (DTG) in HIV infected patients with stable virological suppr...",
            "country": "GB",
            "timestamp": "2014-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003704-39/BE",
            "title": "An open label study examining the efficacy and cardiovascular risk of immediate versus deferred switch from a boosted PI to dolutegravir (DTG) in HIV infected patients with stable virological suppr...",
            "country": "BE",
            "timestamp": "2014-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003704-39/ES",
            "title": "An open label study examining the efficacy and cardiovascular risk of immediate versus deferred switch from a boosted PI to dolutegravir (DTG) in HIV infected patients with stable virological suppr...",
            "country": "ES",
            "timestamp": "2014-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003704-39/IT",
            "title": "An open label study examining the efficacy and cardiovascular risk of immediate versus deferred switch from a boosted PI to dolutegravir (DTG) in HIV infected patients with stable virological suppr...",
            "country": "IT",
            "timestamp": "2014-04-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003751-38/FR",
            "title": "A multicenter, open-label, randomized, 2-arm, phase II trial of  pharmacodynamics, pharmacokinetics and safety of two dose regimens of  DEB025/alisporivir in combination with ribavirin therapy in c...",
            "country": "FR",
            "timestamp": "2014-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003751-38/results",
            "title": "A multicenter, open-label, randomized, 2-arm, phase II trial of  pharmacodynamics, pharmacokinetics and safety of two dose regimens of  DEB025/alisporivir in combination with ribavirin therapy in c...",
            "country": "View results",
            "timestamp": "2014-03-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003780-65/IT",
            "title": "A Phase IIb, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Clazakizumab in Subjects with Moderate to Severe Active Rheumatoid Arthritis who have ...",
            "country": "IT",
            "timestamp": "2014-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003780-65/HU",
            "title": "A Phase IIb, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Clazakizumab in Subjects with Moderate to Severe Active Rheumatoid Arthritis who have ...",
            "country": "HU",
            "timestamp": "2014-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003780-65/results",
            "title": "A Phase IIb, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Clazakizumab in Subjects with Moderate to Severe Active Rheumatoid Arthritis who have ...",
            "country": "View results",
            "timestamp": "2014-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/EE",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "EE",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/LV",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "LV",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/BG",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "BG",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/HU",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "HU",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/ES",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "ES",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/PT",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "PT",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002351-15/AT",
            "title": "A Phase III, Randomized, Double-Blind, Double Dummy, Multicenter Trial Comparing the Efficacy and Safety of 2 Doses of Daily Oral ONO 4641 (0.05 mg and 0.1 mg) versus Interferon-β-1a 30 µg IM Weekl...",
            "country": "AT",
            "timestamp": "2014-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004630-25/3rd",
            "title": "A Phase II, open label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV in combination with low-dose ritonavir (DRV/rtv) in treatment-experienced HIV-1 infect...",
            "country": "Outside EU/EEA",
            "timestamp": "2014-02-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004630-25/results",
            "title": "A Phase II, open label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV in combination with low-dose ritonavir (DRV/rtv) in treatment-experienced HIV-1 infect...",
            "country": "View results",
            "timestamp": "2014-02-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003452-21/ES",
            "title": "BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain.",
            "country": "ES",
            "timestamp": "2014-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003452-21/DE",
            "title": "BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain.",
            "country": "DE",
            "timestamp": "2014-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003452-21/IT",
            "title": "BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain.",
            "country": "IT",
            "timestamp": "2014-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003452-21/results",
            "title": "BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain.",
            "country": "View results",
            "timestamp": "2014-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004988-32/NL",
            "title": "Rotterdam Observational Study in CIDP of Pharmacokinetics of Intravenous γ-globulin",
            "country": "NL",
            "timestamp": "2014-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002291-41/IT",
            "title": "A Randomized, Open Label, Multi-Center Phase 2 Study of nab-Paclitaxel versus Epigenetic Modifying Therapy of CC-486 with nab-Paclitaxel in Subjects with Chemotherapy Naïve Metastatic Melanoma",
            "country": "IT",
            "timestamp": "2014-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003730-33/IT",
            "title": "Phase I-II study of the combination vemurafenib plus PEG-interferon in advanced melanoma patients harboring the V600BRAF mutation",
            "country": "IT",
            "timestamp": "2014-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003410-41/AT",
            "title": "A phase III randomized, multicenter, double-blind, active controlled study to compare the efficacy and safety of two different anagrelide formulations in patients with Essential Thrombocythemia (TE...",
            "country": "AT",
            "timestamp": "2014-01-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003410-41/LT",
            "title": "A phase III randomized, multicenter, double-blind, active controlled study to compare the efficacy and safety of two different anagrelide formulations in patients with Essential Thrombocythemia (TE...",
            "country": "LT",
            "timestamp": "2014-01-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003410-41/BG",
            "title": "A phase III randomized, multicenter, double-blind, active controlled study to compare the efficacy and safety of two different anagrelide formulations in patients with Essential Thrombocythemia (TE...",
            "country": "BG",
            "timestamp": "2014-01-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003410-41/PL",
            "title": "A phase III randomized, multicenter, double-blind, active controlled study to compare the efficacy and safety of two different anagrelide formulations in patients with Essential Thrombocythemia (TE...",
            "country": "PL",
            "timestamp": "2014-01-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003410-41/results",
            "title": "A phase III randomized, multicenter, double-blind, active controlled study to compare the efficacy and safety of two different anagrelide formulations in patients with Essential Thrombocythemia (TE...",
            "country": "View results",
            "timestamp": "2014-01-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005450-30/AT",
            "title": "Anti-Biopharmaceutical Immunization: Prediction and analysis of clinical relevance to minimize the risk of immunization in multiple sclerosis patients on interferon-beta treatment",
            "country": "AT",
            "timestamp": "2014-01-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005450-30/SE",
            "title": "Anti-Biopharmaceutical Immunization: Prediction and analysis of clinical relevance to minimize the risk of immunization in multiple sclerosis patients on interferon-beta treatment",
            "country": "SE",
            "timestamp": "2014-01-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004626-28/FI",
            "title": "Does targeting of S1P receptors reduce microglial activation in multiple sclerosis?",
            "country": "FI",
            "timestamp": "2013-12-20"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN23400701",
            "timestamp": "2013-12-19",
            "title": "ChILD-EU database and observational study"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002991-42/NL",
            "title": "Effect of ASV and DCV therapy on the quality of immune status in chronic HCV patients\r\n\r\nInvestigator initiated research proposal nr. AI447-108",
            "country": "NL",
            "timestamp": "2013-12-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000750-21/GB",
            "title": "The HALT-LTBI study: Phase IV, multi-site, unblinded, randomised trial of prophylactic daily  rifampicin/isoniazid vs. weekly rifapentine/isoniazid  for latent tuberculosis infection (LTBI)",
            "country": "GB",
            "timestamp": "2013-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000750-21/results",
            "title": "The HALT-LTBI study: Phase IV, multi-site, unblinded, randomised trial of prophylactic daily  rifampicin/isoniazid vs. weekly rifapentine/isoniazid  for latent tuberculosis infection (LTBI)",
            "country": "View results",
            "timestamp": "2013-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002458-66/FR",
            "title": "A Phase 3 Evaluation of a daclatasvir/asunaprevir/BMS-791325 Fixed Dose Combination in Subjects with Genotype 1 Chronic Hepatitis C and Compensated Cirrhosis",
            "country": "FR",
            "timestamp": "2013-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002458-66/results",
            "title": "A Phase 3 Evaluation of a daclatasvir/asunaprevir/BMS-791325 Fixed Dose Combination in Subjects with Genotype 1 Chronic Hepatitis C and Compensated Cirrhosis",
            "country": "View results",
            "timestamp": "2013-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002468-20/FR",
            "title": "A Phase 3 Evaluation of a daclatasvir/asunaprevir/BMS-791325 Fixed Dose Combination in Non-cirrhotic Subjects with Genotype 1 Chronic Hepatitis C",
            "country": "FR",
            "timestamp": "2013-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002468-20/results",
            "title": "A Phase 3 Evaluation of a daclatasvir/asunaprevir/BMS-791325 Fixed Dose Combination in Non-cirrhotic Subjects with Genotype 1 Chronic Hepatitis C",
            "country": "View results",
            "timestamp": "2013-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001564-37/AT",
            "title": "One arm, Open label, Interventional, non-comparative Study to assess Changes in Lipids and Lipoproteins in HIV infected Women with Hyperlipidemia after Switch from boosted Protease Inhibitors to Ra...",
            "country": "AT",
            "timestamp": "2013-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001564-37/results",
            "title": "One arm, Open label, Interventional, non-comparative Study to assess Changes in Lipids and Lipoproteins in HIV infected Women with Hyperlipidemia after Switch from boosted Protease Inhibitors to Ra...",
            "country": "View results",
            "timestamp": "2013-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/BE",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "BE",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/SE",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "SE",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/FI",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "FI",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/NL",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "NL",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/ES",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "ES",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/GB",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "GB",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002082-19/DK",
            "title": "A Multinational, Multicenter, Randomized, Double-Blind,  Parallel-Group, Active-Control (Rater Blinded) Study, to Evaluate the Efficacy, Safety and Tolerability of 2 Doses of Oral administration of...",
            "country": "DK",
            "timestamp": "2013-11-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000626-63/IT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "IT",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000626-63/GB",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "GB",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000626-63/DE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "DE",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000626-63/ES",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "ES",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000626-63/PL",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "PL",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/IT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "IT",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/GB",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "GB",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/DE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "DE",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/ES",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "ES",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/PL",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "PL",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/BG",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "BG",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000636-10/results",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg...",
            "country": "View results",
            "timestamp": "2013-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005973-21/IT",
            "title": "A prospective, randomized, open-label trial of two abacavir/lamivudine based regimen (ABC/3TC + darunavir/ritonavir or ABC/3TC + raltegravir) in late presenter naïve patients (with CD4 count <200 c...",
            "country": "IT",
            "timestamp": "2013-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003729-27/GB",
            "title": "Telaprevir in patients with genotype 3 HCV : pilot clinical study to evaluate efficacy and predictability of therapy in patients who have failed to respond to pegylated interferon and ribavirin",
            "country": "GB",
            "timestamp": "2013-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003729-27/results",
            "title": "Telaprevir in patients with genotype 3 HCV : pilot clinical study to evaluate efficacy and predictability of therapy in patients who have failed to respond to pegylated interferon and ribavirin",
            "country": "View results",
            "timestamp": "2013-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003658-26/NL",
            "title": "Treat-to-target strategy for early RA patients in usual clinical practice:\nThe COBRA Cohort Study",
            "country": "NL",
            "timestamp": "2013-11-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004043-23/BE",
            "title": "A Phase I/IIa Study Assessing Single and Multiple Doses of IDX21437 in Healthy and HCV-Infected Subjects",
            "country": "BE",
            "timestamp": "2013-11-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004043-23/results",
            "title": "A Phase I/IIa Study Assessing Single and Multiple Doses of IDX21437 in Healthy and HCV-Infected Subjects",
            "country": "View results",
            "timestamp": "2013-11-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004165-41/GB",
            "title": "Hematopoietic Stem Cell Therapy for Patients with Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study",
            "country": "GB",
            "timestamp": "2013-11-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003295-12/DK",
            "title": "Combination Therapy Interferon Alpha + JAK1-2 Inhibitor in The Ph-Negative Chronic Myeloid Neoplasms",
            "country": "DK",
            "timestamp": "2013-10-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN82148651",
            "timestamp": "2013-10-28",
            "title": "Age-related macular degeneration (AMD) Light trial"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN77854383",
            "timestamp": "2013-10-25",
            "title": "Pain reduction with oral methotrexate in knee osteoarthritis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN70833965",
            "timestamp": "2013-10-25",
            "title": "A phase II double-blind, randomised controlled trial of VEGF inhibitor axitinib monotherapy with early dynamic contrast-enhanced ultrasound monitoring in chemo-refractory third-line metastatic colorectal cancer"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN28440672",
            "timestamp": "2013-10-25",
            "title": "MS-SMART"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/GB",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "GB",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/IE",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "IE",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/DE",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "DE",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/ES",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "ES",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/HU",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "HU",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/AT",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "AT",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/BE",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "BE",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/DK",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "DK",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/PT",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "PT",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/PL",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "PL",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/CZ",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "CZ",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/IT",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "IT",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003073-26/results",
            "title": "A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatme...",
            "country": "View results",
            "timestamp": "2013-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001969-16/IT",
            "title": "A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (B...",
            "country": "IT",
            "timestamp": "2013-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001969-16/DE",
            "title": "A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (B...",
            "country": "DE",
            "timestamp": "2013-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001969-16/ES",
            "title": "A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (B...",
            "country": "ES",
            "timestamp": "2013-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001969-16/3rd",
            "title": "A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (B...",
            "country": "Outside EU/EEA",
            "timestamp": "2013-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001969-16/results",
            "title": "A Phase 2/3 Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (B...",
            "country": "View results",
            "timestamp": "2013-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005823-34/GB",
            "title": "A Phase IIIb, randomized, open-label study of the safety and\r\nefficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in...",
            "country": "GB",
            "timestamp": "2013-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005823-34/IT",
            "title": "A Phase IIIb, randomized, open-label study of the safety and\r\nefficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in...",
            "country": "IT",
            "timestamp": "2013-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005823-34/ES",
            "title": "A Phase IIIb, randomized, open-label study of the safety and\r\nefficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in...",
            "country": "ES",
            "timestamp": "2013-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005823-34/PT",
            "title": "A Phase IIIb, randomized, open-label study of the safety and\r\nefficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in...",
            "country": "PT",
            "timestamp": "2013-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005823-34/FR",
            "title": "A Phase IIIb, randomized, open-label study of the safety and\r\nefficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in...",
            "country": "FR",
            "timestamp": "2013-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005823-34/results",
            "title": "A Phase IIIb, randomized, open-label study of the safety and\r\nefficacy of dolutegravir/abacavir/lamivudine once daily compared to atazanavir and ritonavir plus tenofovir/emtricitabine once daily in...",
            "country": "View results",
            "timestamp": "2013-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001999-38/BE",
            "title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs’ TNF-Kinoid in Adult Subjects with Active Rheumatoid Arthritis despite Methotrexate Therapy",
            "country": "BE",
            "timestamp": "2013-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001999-38/HU",
            "title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs’ TNF-Kinoid in Adult Subjects with Active Rheumatoid Arthritis despite Methotrexate Therapy",
            "country": "HU",
            "timestamp": "2013-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001999-38/CZ",
            "title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs’ TNF-Kinoid in Adult Subjects with Active Rheumatoid Arthritis despite Methotrexate Therapy",
            "country": "CZ",
            "timestamp": "2013-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001999-38/PL",
            "title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs’ TNF-Kinoid in Adult Subjects with Active Rheumatoid Arthritis despite Methotrexate Therapy",
            "country": "PL",
            "timestamp": "2013-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002641-11/GB",
            "title": "A Phase 3B Randomized, Open-Label, Multi-Center Trial Assessing Sofosbuvir + Ribavirin for 16 or 24 Weeks and Sofosbuvir + Pegylated Interferon + Ribavirin for 12 Weeks in Subjects with Genotype 2 ...",
            "country": "GB",
            "timestamp": "2013-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002641-11/results",
            "title": "A Phase 3B Randomized, Open-Label, Multi-Center Trial Assessing Sofosbuvir + Ribavirin for 16 or 24 Weeks and Sofosbuvir + Pegylated Interferon + Ribavirin for 12 Weeks in Subjects with Genotype 2 ...",
            "country": "View results",
            "timestamp": "2013-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001141-14/AT",
            "title": "A PHASE 4, BLOOD SAMPLE COLLECTION STUDY FOR EXPLORATORY EVALUATION OF THE ASSOCIATION OF SINGLE NUCLEOTIDE\r\nPOLYMORPHISMS WITH TREATMENT RESPONSES FROM SUBJECTS WITH HBEANTIGEN POSITIVE OR NEGATIV...",
            "country": "AT",
            "timestamp": "2013-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001141-14/DE",
            "title": "A PHASE 4, BLOOD SAMPLE COLLECTION STUDY FOR EXPLORATORY EVALUATION OF THE ASSOCIATION OF SINGLE NUCLEOTIDE\r\nPOLYMORPHISMS WITH TREATMENT RESPONSES FROM SUBJECTS WITH HBEANTIGEN POSITIVE OR NEGATIV...",
            "country": "DE",
            "timestamp": "2013-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001141-14/BG",
            "title": "A PHASE 4, BLOOD SAMPLE COLLECTION STUDY FOR EXPLORATORY EVALUATION OF THE ASSOCIATION OF SINGLE NUCLEOTIDE\r\nPOLYMORPHISMS WITH TREATMENT RESPONSES FROM SUBJECTS WITH HBEANTIGEN POSITIVE OR NEGATIV...",
            "country": "BG",
            "timestamp": "2013-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001141-14/IT",
            "title": "A PHASE 4, BLOOD SAMPLE COLLECTION STUDY FOR EXPLORATORY EVALUATION OF THE ASSOCIATION OF SINGLE NUCLEOTIDE\r\nPOLYMORPHISMS WITH TREATMENT RESPONSES FROM SUBJECTS WITH HBEANTIGEN POSITIVE OR NEGATIV...",
            "country": "IT",
            "timestamp": "2013-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001141-14/GR",
            "title": "A PHASE 4, BLOOD SAMPLE COLLECTION STUDY FOR EXPLORATORY EVALUATION OF THE ASSOCIATION OF SINGLE NUCLEOTIDE\r\nPOLYMORPHISMS WITH TREATMENT RESPONSES FROM SUBJECTS WITH HBEANTIGEN POSITIVE OR NEGATIV...",
            "country": "GR",
            "timestamp": "2013-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001141-14/FR",
            "title": "A PHASE 4, BLOOD SAMPLE COLLECTION STUDY FOR EXPLORATORY EVALUATION OF THE ASSOCIATION OF SINGLE NUCLEOTIDE\r\nPOLYMORPHISMS WITH TREATMENT RESPONSES FROM SUBJECTS WITH HBEANTIGEN POSITIVE OR NEGATIV...",
            "country": "FR",
            "timestamp": "2013-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005671-14/GB",
            "title": "A phase III, randomised, open-label, multicentre clinical trial to assess the safety and immunogenicity of GSK Biologicals’ HZ/su candidate vaccine when administered subcutaneously as compared to i...",
            "country": "GB",
            "timestamp": "2013-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005671-14/results",
            "title": "A phase III, randomised, open-label, multicentre clinical trial to assess the safety and immunogenicity of GSK Biologicals’ HZ/su candidate vaccine when administered subcutaneously as compared to i...",
            "country": "View results",
            "timestamp": "2013-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000834-36/NL",
            "title": "Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia.",
            "country": "NL",
            "timestamp": "2013-09-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003403-19/SE",
            "title": "Study of T- and B-cell immunity after vaccination with a virosomebased influenza vaccine (Inflexal V) in patients who have undergone hematopoietic allogeneic stem cell transplantation.",
            "country": "SE",
            "timestamp": "2013-09-25"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14354426",
            "timestamp": "2013-09-18",
            "title": "Botswana-Baylor ANtiretroviral Assessment"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000245-39/DE",
            "title": "Rescue effect of daily infusions with Legalon® SIL in Hepatitis C Virus-infected patients who are incomplete responders to standard pegylated interferon/ribavirin (dual therapy) or pegylated interf...",
            "country": "DE",
            "timestamp": "2013-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000245-39/AT",
            "title": "Rescue effect of daily infusions with Legalon® SIL in Hepatitis C Virus-infected patients who are incomplete responders to standard pegylated interferon/ribavirin (dual therapy) or pegylated interf...",
            "country": "AT",
            "timestamp": "2013-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001314-42/SE",
            "title": "Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion\r\nto Nulojix® (belatacept)-based Immunosuppression",
            "country": "SE",
            "timestamp": "2013-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001314-42/AT",
            "title": "Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion\r\nto Nulojix® (belatacept)-based Immunosuppression",
            "country": "AT",
            "timestamp": "2013-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001314-42/DE",
            "title": "Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion\r\nto Nulojix® (belatacept)-based Immunosuppression",
            "country": "DE",
            "timestamp": "2013-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001314-42/FR",
            "title": "Evaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion\r\nto Nulojix® (belatacept)-based Immunosuppression",
            "country": "FR",
            "timestamp": "2013-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000547-85/ES",
            "title": "MULTICENTRE STUDY TO ASSESS CHANGES IN BONE MINERAL DENSITY OF THE SWITCH FROM PROTEASE INHIBITORS TO DOLUTEGRAVIR IN HIV-1-INFECTED SUBJECTS WITH LOW BONE MINERAL DENSITY",
            "country": "ES",
            "timestamp": "2013-09-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000547-85/results",
            "title": "MULTICENTRE STUDY TO ASSESS CHANGES IN BONE MINERAL DENSITY OF THE SWITCH FROM PROTEASE INHIBITORS TO DOLUTEGRAVIR IN HIV-1-INFECTED SUBJECTS WITH LOW BONE MINERAL DENSITY",
            "country": "View results",
            "timestamp": "2013-09-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001191-38/ES",
            "title": "Multicentric, randomized, open-label, controlled study, of 12 months of follow-up to assess the effect in renal function of a immunosuppressive treatment based on  tacrolimus minimization in combin...",
            "country": "ES",
            "timestamp": "2013-08-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001191-38/results",
            "title": "Multicentric, randomized, open-label, controlled study, of 12 months of follow-up to assess the effect in renal function of a immunosuppressive treatment based on  tacrolimus minimization in combin...",
            "country": "View results",
            "timestamp": "2013-08-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/BE",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "BE",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/GB",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "GB",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/AT",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "AT",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/IT",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "IT",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/ES",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "ES",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/DE",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "DE",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004905-29/results",
            "title": "A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chro...",
            "country": "View results",
            "timestamp": "2013-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-002349-12/IT",
            "title": "“Switching HIV-positive Women With Undetectable Viremia on Tenofovir/Emtricitabine plus Boosted Atazanavir to RALtegravir (400 mg twice-daily) plus Boosted ATazanavir (300/100 mg once-daily): A Pil...",
            "country": "IT",
            "timestamp": "2013-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001419-21/DE",
            "title": "An open label, randomised, non-inferiority trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatiti...",
            "country": "DE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000280-84/FI",
            "title": "COBRA: TOL+ INTERFERON-alpha COMBINED WITH VEMURAFENIB (BRAF-mutation positive patients) OR TOL + INTERFERON- alpha (BRAF-mutation negative patients) FOR PATIENTS WITH ADVANCED MELANOMA AS 1st CHEM...",
            "country": "FI",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/HU",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "HU",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/CZ",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "CZ",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/IT",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "IT",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/SK",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "SK",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/AT",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "AT",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/BG",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "BG",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/DE",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "DE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/PL",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "PL",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/ES",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "ES",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/BE",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "BE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005259-18/results",
            "title": "A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera",
            "country": "View results",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/HU",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "HU",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/AT",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "AT",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/SE",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "SE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/BE",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "BE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/CZ",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "CZ",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/PT",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "PT",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/IE",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "IE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/IT",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "IT",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/NL",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "NL",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/SK",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "SK",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/GB",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "GB",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/ES",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "ES",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/DE",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "DE",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/DK",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "DK",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/FI",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "FI",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-001010-14/PL",
            "title": "A Phase 3, Randomized, Controlled Study of Cabozantinib (XL184) vs Everolimus in Subjects with Metastatic Renal Cell Carcinoma that has Progressed after Prior VEGFR Tyrosine Kinase Inhibitor Therapy",
            "country": "PL",
            "timestamp": "2013-08-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/GB",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "GB",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/BE",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "BE",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/IT",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "IT",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/DE",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "DE",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/ES",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "ES",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/FR",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "FR",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003280-22/results",
            "title": "Phase 3 open label study evaluating the efficacy and safety of pegylated interferon lambda-1a, in combination with ribavirin and daclatasvir, for treatment of chronic HCV infection with treatment n...",
            "country": "View results",
            "timestamp": "2013-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003508-11/CZ",
            "title": "A Double-Blinded, Randomized Control Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a Compared to Peginterferon alfa-2a, Each in Combination with Ribavirin, in the Treatment of N...",
            "country": "CZ",
            "timestamp": "2013-08-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003508-11/PL",
            "title": "A Double-Blinded, Randomized Control Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a Compared to Peginterferon alfa-2a, Each in Combination with Ribavirin, in the Treatment of N...",
            "country": "PL",
            "timestamp": "2013-08-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003508-11/results",
            "title": "A Double-Blinded, Randomized Control Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a Compared to Peginterferon alfa-2a, Each in Combination with Ribavirin, in the Treatment of N...",
            "country": "View results",
            "timestamp": "2013-08-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002798-80/ES",
            "title": "A Phase 3 Randomized Placebo Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults with Active Psoriatic Arthritis",
            "country": "ES",
            "timestamp": "2013-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002798-80/DE",
            "title": "A Phase 3 Randomized Placebo Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults with Active Psoriatic Arthritis",
            "country": "DE",
            "timestamp": "2013-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002798-80/GR",
            "title": "A Phase 3 Randomized Placebo Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults with Active Psoriatic Arthritis",
            "country": "GR",
            "timestamp": "2013-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002798-80/IT",
            "title": "A Phase 3 Randomized Placebo Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults with Active Psoriatic Arthritis",
            "country": "IT",
            "timestamp": "2013-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002798-80/CZ",
            "title": "A Phase 3 Randomized Placebo Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults with Active Psoriatic Arthritis",
            "country": "CZ",
            "timestamp": "2013-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002798-80/PL",
            "title": "A Phase 3 Randomized Placebo Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults with Active Psoriatic Arthritis",
            "country": "PL",
            "timestamp": "2013-08-02"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN60655195",
            "timestamp": "2013-08-01",
            "title": "SPIRIT 3"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005591-33/AT",
            "title": "Response-guided triple therapy using boceprevir in combination with PEGIFN/RBV in HIV/HCV coinfected patients",
            "country": "AT",
            "timestamp": "2013-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005591-33/results",
            "title": "Response-guided triple therapy using boceprevir in combination with PEGIFN/RBV in HIV/HCV coinfected patients",
            "country": "View results",
            "timestamp": "2013-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004766-17/IT",
            "title": "Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma (CTCL)",
            "country": "IT",
            "timestamp": "2013-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004766-17/ES",
            "title": "Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma (CTCL)",
            "country": "ES",
            "timestamp": "2013-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004766-17/NL",
            "title": "Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma (CTCL)",
            "country": "NL",
            "timestamp": "2013-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004766-17/DK",
            "title": "Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma (CTCL)",
            "country": "DK",
            "timestamp": "2013-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004766-17/GB",
            "title": "Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma (CTCL)",
            "country": "GB",
            "timestamp": "2013-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004766-17/DE",
            "title": "Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma (CTCL)",
            "country": "DE",
            "timestamp": "2013-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000486-37/ES",
            "title": "Rosuvastatin versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults.",
            "country": "ES",
            "timestamp": "2013-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005525-75/GB",
            "title": "An open label, randomised, pilot trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatitis C genoty...",
            "country": "GB",
            "timestamp": "2013-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005525-75/results",
            "title": "An open label, randomised, pilot trial of pegylated interferon, ribavirin and telaprevir versus pegylated interferon and ribavirin alone in the response guided treatment of acute hepatitis C genoty...",
            "country": "View results",
            "timestamp": "2013-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000773-71/DK",
            "title": "A multicenter phase II study evaluating the efficacy and tolerability of vemurafenib in combination with Pegylated Interferon and Interleukin-2 in patients with BRAF-mutated metastatic melanoma",
            "country": "DK",
            "timestamp": "2013-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000492-32/FI",
            "title": "T cell and interferon expression in tonsils after sublingual\nimmunotherapy and/or nasal live attenuated influenza vaccine",
            "country": "FI",
            "timestamp": "2013-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/BE",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "BE",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/SE",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "SE",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/PT",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "PT",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/HU",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "HU",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/CZ",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "CZ",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/NO",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "NO",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/AT",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "AT",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/FI",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "FI",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/DK",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "DK",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/GB",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "GB",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/ES",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "ES",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/IT",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "IT",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/SI",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "SI",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/PL",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "PL",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005262-35/results",
            "title": "BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi...",
            "country": "View results",
            "timestamp": "2013-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005086-12/AT",
            "title": "Active-controlled phase IIIb study to investigate the ability of the HAP score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis.",
            "country": "AT",
            "timestamp": "2013-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005086-12/HU",
            "title": "Active-controlled phase IIIb study to investigate the ability of the HAP score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis.",
            "country": "HU",
            "timestamp": "2013-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005086-12/DE",
            "title": "Active-controlled phase IIIb study to investigate the ability of the HAP score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis.",
            "country": "DE",
            "timestamp": "2013-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005086-12/BG",
            "title": "Active-controlled phase IIIb study to investigate the ability of the HAP score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis.",
            "country": "BG",
            "timestamp": "2013-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005086-12/PL",
            "title": "Active-controlled phase IIIb study to investigate the ability of the HAP score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis.",
            "country": "PL",
            "timestamp": "2013-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005086-12/results",
            "title": "Active-controlled phase IIIb study to investigate the ability of the HAP score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis.",
            "country": "View results",
            "timestamp": "2013-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003389-42/FR",
            "title": "A phase II study to assess the efficacy and safety of frontline combination of dasatinib (SPRYCEL®) and pegylated-interferon alpha 2b (Peg-IFNα2b) therapy in patients newly diagnosed with chronic p...",
            "country": "FR",
            "timestamp": "2013-06-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN82177408",
            "timestamp": "2013-06-26",
            "title": "To investigate the ability of the Heidelberg Assay Panel (HAP) score to predict responders to Octagam 5% in patients with early relapsing multiple sclerosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004556-11/IT",
            "title": "Randomized,multicenter,open-label, study of monoterapy with darunavir/ritonavir or lopinavir/ritonavir vs standard of care in virologically suppressed HIV-infected patients.",
            "country": "IT",
            "timestamp": "2013-06-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004556-11/results",
            "title": "Randomized,multicenter,open-label, study of monoterapy with darunavir/ritonavir or lopinavir/ritonavir vs standard of care in virologically suppressed HIV-infected patients.",
            "country": "View results",
            "timestamp": "2013-06-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/IT",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "IT",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/CZ",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "CZ",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/DE",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "DE",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/ES",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "ES",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/AT",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "AT",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/SE",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "SE",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/GB",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "GB",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/FR",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "FR",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005753-23/NL",
            "title": "A multicentre study for the long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody.",
            "country": "NL",
            "timestamp": "2013-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/CZ",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "CZ",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/IT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "IT",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/NL",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "NL",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/HU",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "HU",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/ES",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "ES",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/GB",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "GB",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006262-40/results",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of ...",
            "country": "View results",
            "timestamp": "2013-06-18"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN74084226",
            "timestamp": "2013-06-12",
            "title": "De-escalation and stopping treatment of imatinib, nilotinib or sprycel in chronic myeloid leukaemia"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005672-42/GB",
            "title": "A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race With Systemic Lupus...",
            "country": "GB",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005672-42/results",
            "title": "A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race With Systemic Lupus...",
            "country": "View results",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/AT",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "AT",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/BE",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "BE",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/CZ",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "CZ",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/GB",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "GB",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/PL",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "PL",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/IT",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "IT",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/ES",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "ES",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004695-11/results",
            "title": "A Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic He...",
            "country": "View results",
            "timestamp": "2013-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001689-16/DE",
            "title": "Prospective randomized, double-blind, and placebo-controlled clinical trial with hydroxychloroquine (HCQ) in patients with erosive-inflammatory osteoarthritis (OA) of the finger joints (acronym: OA...",
            "country": "DE",
            "timestamp": "2013-06-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN10524984",
            "timestamp": "2013-06-04",
            "title": "Laser for Early Age related macular Degeneration"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/DE",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "DE",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/IT",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "IT",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/CZ",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "CZ",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/HU",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "HU",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/PL",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "PL",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/SE",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "SE",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/ES",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "ES",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/IE",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "IE",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/GB",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "GB",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/FI",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "FI",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/GR",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "GR",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/FR",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "FR",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/DK",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "DK",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003176-39/results",
            "title": "A Multicenter, Open-Label, Extension Study to Evaluate the Long Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects With Multiple Sclerosis Who Hav...",
            "country": "View results",
            "timestamp": "2013-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001410-41/IT",
            "title": "Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alfa in patients with metastati...",
            "country": "IT",
            "timestamp": "2013-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004040-30/AT",
            "title": "Natalizumab de-escalation to interferon-beta-1b in patients with\r\nrelapsing-remitting multiple sclerosis: A multicenter study",
            "country": "AT",
            "timestamp": "2013-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000393-30/GB",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01B + ChAd63 and MVA encoding ME-TRAP and also ...",
            "country": "GB",
            "timestamp": "2013-05-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000393-30/results",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of the Combination Malaria Vaccine Candidate Regimen of RTS,S/AS01B + ChAd63 and MVA encoding ME-TRAP and also ...",
            "country": "View results",
            "timestamp": "2013-05-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/IT",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "IT",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/BE",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "BE",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/ES",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "ES",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/HU",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "HU",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/BG",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "BG",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/GR",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "GR",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/GB",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "GB",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/SK",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "SK",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/HR",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "HR",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002714-40/results",
            "title": "A PHASE 2/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED (PART A) AND DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE CONTROLLED (PART B), PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY...",
            "country": "View results",
            "timestamp": "2013-05-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN34010937",
            "timestamp": "2013-05-08",
            "title": "STOPMiP"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004257-29/IE",
            "title": "A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma",
            "country": "IE",
            "timestamp": "2013-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004257-29/3rd",
            "title": "A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma",
            "country": "Outside EU/EEA",
            "timestamp": "2013-05-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN99153976",
            "timestamp": "2013-05-03",
            "title": "Amiloride Clinical Trial in Optic Neuritis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN79871784",
            "timestamp": "2013-05-02",
            "title": "Efficacy and safety of gabapentin versus placebo to prevent the incidence of postherpetic neuralgia"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003738-18/HU",
            "title": "A Randomized, Open-Labeled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with Ribavirin Compared to Telaprevir Co-administered with Pegylated In...",
            "country": "HU",
            "timestamp": "2013-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003738-18/FI",
            "title": "A Randomized, Open-Labeled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with Ribavirin Compared to Telaprevir Co-administered with Pegylated In...",
            "country": "FI",
            "timestamp": "2013-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003738-18/SK",
            "title": "A Randomized, Open-Labeled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with Ribavirin Compared to Telaprevir Co-administered with Pegylated In...",
            "country": "SK",
            "timestamp": "2013-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003738-18/PL",
            "title": "A Randomized, Open-Labeled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with Ribavirin Compared to Telaprevir Co-administered with Pegylated In...",
            "country": "PL",
            "timestamp": "2013-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003738-18/results",
            "title": "A Randomized, Open-Labeled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with Ribavirin Compared to Telaprevir Co-administered with Pegylated In...",
            "country": "View results",
            "timestamp": "2013-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003501-10/ES",
            "title": "Efficacy of dual antiretroviral treatment with maraviroc plus ritonavir-boosted darunavir in early rescue therapy in patients with HIV-1 infection: pilot, multicenter, randomized, controlled and op...",
            "country": "ES",
            "timestamp": "2013-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003754-84/HU",
            "title": "A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with and without Ribavirin Compared to Telaprevir Co-administered with Pe...",
            "country": "HU",
            "timestamp": "2013-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003754-84/FI",
            "title": "A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with and without Ribavirin Compared to Telaprevir Co-administered with Pe...",
            "country": "FI",
            "timestamp": "2013-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003754-84/SK",
            "title": "A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with and without Ribavirin Compared to Telaprevir Co-administered with Pe...",
            "country": "SK",
            "timestamp": "2013-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003754-84/PL",
            "title": "A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with and without Ribavirin Compared to Telaprevir Co-administered with Pe...",
            "country": "PL",
            "timestamp": "2013-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003754-84/results",
            "title": "A Randomized, Open-Label Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 and ABT-333 Co-administered with and without Ribavirin Compared to Telaprevir Co-administered with Pe...",
            "country": "View results",
            "timestamp": "2013-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002635-28/IT",
            "title": "ASSESSMENT OF THE EFFICACY OF SUBTENON NATURAL LEUCOCYTIC INTERFERON-α (IFNα) FOR THE TREATMENT OF DIABETIC MACULAR EDEMA (DME): A PILOT STUDY.",
            "country": "IT",
            "timestamp": "2013-04-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005522-29/GB",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "GB",
            "timestamp": "2013-04-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005522-29/results",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "View results",
            "timestamp": "2013-04-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/ES",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "ES",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/DE",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "DE",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/GB",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "GB",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/IT",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "IT",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/IE",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "IE",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/FR",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "FR",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003534-17/results",
            "title": "A phase II randomised, double-blind and placebo-controlled study of BI 207127 in combination with faldaprevir and ribavirin in patients with moderate hepatic impairment (Child-Pugh B) with genotype...",
            "country": "View results",
            "timestamp": "2013-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/BE",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "BE",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/SE",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "SE",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/NO",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "NO",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/IT",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "IT",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/GB",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "GB",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/ES",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "ES",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/DE",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "DE",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/DK",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "DK",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/FR",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "FR",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004544-30/results",
            "title": "A phase III, randomised, open label, active-controlled study of an\r\ninterferon-free regimen of BI 207127 in combination with Faldaprevir\r\nand Ribavirin compared to Telaprevir in combination with pe...",
            "country": "View results",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004321-25/NL",
            "title": "A phase II, single arm, multicenter study of nilotinib in combination with pegylated interferon α2b in patients with suboptimal molecular response or stable detectable molecular residual disease af...",
            "country": "NL",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004321-25/SE",
            "title": "A phase II, single arm, multicenter study of nilotinib in combination with pegylated interferon α2b in patients with suboptimal molecular response or stable detectable molecular residual disease af...",
            "country": "SE",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004321-25/NO",
            "title": "A phase II, single arm, multicenter study of nilotinib in combination with pegylated interferon α2b in patients with suboptimal molecular response or stable detectable molecular residual disease af...",
            "country": "NO",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002183-27/GB",
            "title": "Can netazepide eradicate the inflammatory response of the gastric mucosa to H. pylori infection?",
            "country": "GB",
            "timestamp": "2013-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003057-29/CZ",
            "title": "A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED, ASCENDING MULTIPLE DOSE STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS",
            "country": "CZ",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003057-29/SK",
            "title": "A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED, ASCENDING MULTIPLE DOSE STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS",
            "country": "SK",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003057-29/HU",
            "title": "A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED, ASCENDING MULTIPLE DOSE STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS",
            "country": "HU",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003057-29/results",
            "title": "A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED, ASCENDING MULTIPLE DOSE STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS",
            "country": "View results",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/IT",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "IT",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/LT",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "LT",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/SK",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "SK",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/LV",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "LV",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/ES",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "ES",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/DE",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "DE",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/BG",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "BG",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/PL",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "PL",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/AT",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "AT",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/NL",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "NL",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/SE",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "SE",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/GB",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "GB",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/RO",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "RO",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/EE",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "EE",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005677-23/HR",
            "title": "A two-year, double-blind, randomized, multicenter, active controlled\r\nstudy to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly ...",
            "country": "HR",
            "timestamp": "2013-04-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004124-38/DE",
            "title": "Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 with Atazanavir +/- Ritonavir (Open-L...",
            "country": "DE",
            "timestamp": "2013-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004124-38/GB",
            "title": "Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 with Atazanavir +/- Ritonavir (Open-L...",
            "country": "GB",
            "timestamp": "2013-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004124-38/results",
            "title": "Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 with Atazanavir +/- Ritonavir (Open-L...",
            "country": "View results",
            "timestamp": "2013-03-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN82366390",
            "timestamp": "2013-03-20",
            "title": "Radical cure for vivax malaria in Indonesia 2"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN06166891",
            "timestamp": "2013-03-19",
            "title": "MINERAL (Magnetic-resonance Image of Nutraceutical Efficacy on Relapsing-ms Autoimmune Lesions) study"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/SE",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "SE",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/GB",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "GB",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/HU",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "HU",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/DE",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "DE",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/AT",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "AT",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/IT",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "IT",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/ES",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "ES",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002019-25/results",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-administered with Ribavirin (RBV) in Treatme...",
            "country": "View results",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003463-22/ES",
            "title": "MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who...",
            "country": "ES",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003463-22/IT",
            "title": "MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who...",
            "country": "IT",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003463-22/NL",
            "title": "MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who...",
            "country": "NL",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003463-22/FR",
            "title": "MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who...",
            "country": "FR",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003463-22/RO",
            "title": "MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who...",
            "country": "RO",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003463-22/results",
            "title": "MAGNITUDE - A Phase 3 Evaluation of the Safety and Efficacy of Lambda/RBV/DCV in Treatment Naïve Subjects with Chronic HCV Infection, who have Underlying Mild or Moderate Hemophilia or Patients who...",
            "country": "View results",
            "timestamp": "2013-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001725-26/DE",
            "title": "A Phase I/II Gene Therapy trial for X-CGD with a SIN gamma retroviral vector",
            "country": "DE",
            "timestamp": "2013-03-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003575-11/AT",
            "title": "A randomized, double-blind, placebo controlled trial to evaluate the effects of vitamin D supplementation on androgen levels in hypogonadal men",
            "country": "AT",
            "timestamp": "2013-03-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/PT",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "PT",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/BE",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "BE",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/HU",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "HU",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/AT",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "AT",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/IT",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "IT",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/ES",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "ES",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/PL",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "PL",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003687-52/results",
            "title": "A Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of the Combination of ABT-450/Ritonavir/ABT-267 (ABT 450/r/ABT-267) and ABT-333 With and Without Ribavirin (RBV) in ...",
            "country": "View results",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001881-14/IT",
            "title": "A phase II clinical trial to evaluate the safety and efficacy of interferon gamma in elevating frataxin levels in Friedreich ataxia patients",
            "country": "IT",
            "timestamp": "2013-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004792-39/ES",
            "title": "Open-label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adul...",
            "country": "ES",
            "timestamp": "2013-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004792-39/GB",
            "title": "Open-label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adul...",
            "country": "GB",
            "timestamp": "2013-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004792-39/DE",
            "title": "Open-label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adul...",
            "country": "DE",
            "timestamp": "2013-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004792-39/results",
            "title": "Open-label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adul...",
            "country": "View results",
            "timestamp": "2013-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007612-29/DE",
            "title": "Immunotherapy with CD19ζ chimeric antigen receptor gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphoblastic leukaemia",
            "country": "DE",
            "timestamp": "2013-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007612-29/GB",
            "title": "Immunotherapy with CD19ζ chimeric antigen receptor gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphoblastic leukaemia",
            "country": "GB",
            "timestamp": "2013-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007612-29/results",
            "title": "Immunotherapy with CD19ζ chimeric antigen receptor gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphoblastic leukaemia",
            "country": "View results",
            "timestamp": "2013-02-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN04379941",
            "timestamp": "2013-02-26",
            "title": "The HALT Latent Tuberculosis study"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/BE",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "BE",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/HU",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "HU",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/CZ",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "CZ",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/DE",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "DE",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/ES",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "ES",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/IT",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "IT",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000610-11/results",
            "title": "A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoi...",
            "country": "View results",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/CZ",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "CZ",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/BE",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "BE",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/HU",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "HU",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/ES",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "ES",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/IT",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "IT",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/SE",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "SE",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/EE",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "EE",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/NO",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "NO",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/FI",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "FI",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/NL",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "NL",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/GB",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "GB",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/PL",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "PL",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003536-23/results",
            "title": "A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intoleran...",
            "country": "View results",
            "timestamp": "2013-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003724-20/HU",
            "title": "A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate Multiple Dose Levels of IPI- 145 with Background Methotrexate in Subjects with Active Rheumatoid Arthritis and an...",
            "country": "HU",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003724-20/DE",
            "title": "A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate Multiple Dose Levels of IPI- 145 with Background Methotrexate in Subjects with Active Rheumatoid Arthritis and an...",
            "country": "DE",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003724-20/BG",
            "title": "A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate Multiple Dose Levels of IPI- 145 with Background Methotrexate in Subjects with Active Rheumatoid Arthritis and an...",
            "country": "BG",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003724-20/RO",
            "title": "A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate Multiple Dose Levels of IPI- 145 with Background Methotrexate in Subjects with Active Rheumatoid Arthritis and an...",
            "country": "RO",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003724-20/results",
            "title": "A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate Multiple Dose Levels of IPI- 145 with Background Methotrexate in Subjects with Active Rheumatoid Arthritis and an...",
            "country": "View results",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/DE",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "DE",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/HU",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "HU",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/SE",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "SE",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/ES",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "ES",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/GR",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "GR",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/EE",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "EE",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/CZ",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "CZ",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/PL",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "PL",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001645-41/results",
            "title": "An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus.",
            "country": "View results",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000994-30/AT",
            "title": "A randomized, double‐blind, placebo controlled trial to evaluate the effects of vitamin D supplementation on metabolic and fertility parameters in PCOS women",
            "country": "AT",
            "timestamp": "2013-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003595-39/ES",
            "title": "A randomized, pilot clinical trial designed to compare, in human immunodeficiency virus infected patients who never have received antiretroviral therapy, the evolution of cerebral function and the ...",
            "country": "ES",
            "timestamp": "2013-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/LT",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "LT",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/CZ",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "CZ",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/HU",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "HU",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/ES",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "ES",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/DE",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "DE",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/PT",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "PT",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/GR",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "GR",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/AT",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "AT",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/IT",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "IT",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/SK",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "SK",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/PL",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "PL",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003538-16/results",
            "title": "A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing The Efficacy and Safety of Sarilumab Added To non-biologic DMARD Therapy In Patients With Rheumatoid Arthritis Who Are Inade...",
            "country": "View results",
            "timestamp": "2013-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-005192-14/IT",
            "title": "Strategic study of dual-therapy with darunavir/ritonavir and rilpivirine QD versus triple-therapy in patients with suppressed viral load: virological efficacy and evaluation of non-HIV related morb...",
            "country": "IT",
            "timestamp": "2013-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/SE",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "SE",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/DE",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "DE",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/ES",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "ES",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/CZ",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "CZ",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/BG",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "BG",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/GB",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "GB",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003627-38/results",
            "title": "Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis",
            "country": "View results",
            "timestamp": "2013-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002772-13/IT",
            "title": "A multi-centre single-arm study to evaluate the efficacy and safety of BOCEPREVIR 44 weeks in addition to standard of care (SOC) in previously treatment failure (relapser, non-responders, both part...",
            "country": "IT",
            "timestamp": "2013-01-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002772-13/results",
            "title": "A multi-centre single-arm study to evaluate the efficacy and safety of BOCEPREVIR 44 weeks in addition to standard of care (SOC) in previously treatment failure (relapser, non-responders, both part...",
            "country": "View results",
            "timestamp": "2013-01-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/DE",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "DE",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/GB",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "GB",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/CZ",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "CZ",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/PT",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "PT",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/IE",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "IE",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/NL",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "NL",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/IT",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "IT",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/DK",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "DK",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/ES",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "ES",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002035-29/results",
            "title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the\r\nEfficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267)\r\nand ABT-333 Co administered with Ribavirin (RBV) in Treat...",
            "country": "View results",
            "timestamp": "2013-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000586-20/PL",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral\nEfficacy, Safety, and Tolerability of Tenofovir Disoproxil\nFumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection",
            "country": "PL",
            "timestamp": "2013-01-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000586-20/BG",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral\nEfficacy, Safety, and Tolerability of Tenofovir Disoproxil\nFumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection",
            "country": "BG",
            "timestamp": "2013-01-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000586-20/3rd",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral\nEfficacy, Safety, and Tolerability of Tenofovir Disoproxil\nFumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection",
            "country": "Outside EU/EEA",
            "timestamp": "2013-01-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/HU",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "HU",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/LT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "LT",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/CZ",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "CZ",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/EE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "EE",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/ES",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "ES",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/IT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "IT",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/PT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "PT",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/BG",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "BG",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/SK",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "SK",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/PL",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "PL",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/RO",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "RO",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005667-25/results",
            "title": "A Randomized, Double-Blind, Placebo-Controlled 52-Week Study\r\nto Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab",
            "country": "View results",
            "timestamp": "2013-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004980-39/GB",
            "title": "A double blind randomised controlled trial on neuroprotection of amiloride in optic neuritis",
            "country": "GB",
            "timestamp": "2013-01-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005409-65/ES",
            "title": "A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti...",
            "country": "ES",
            "timestamp": "2013-01-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005409-65/IT",
            "title": "A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti...",
            "country": "IT",
            "timestamp": "2013-01-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005409-65/DE",
            "title": "A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti...",
            "country": "DE",
            "timestamp": "2013-01-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005409-65/PL",
            "title": "A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti...",
            "country": "PL",
            "timestamp": "2013-01-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005409-65/GB",
            "title": "A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti...",
            "country": "GB",
            "timestamp": "2013-01-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005409-65/results",
            "title": "A Phase 3 Evaluation of Daclatasvir in Combination with Peginterferon Lambda-1a and Ribavirin (RBV) or Telaprevir in Combination with Peginterferon Alfa-2a and RBV in Patients with Chronic Hepatiti...",
            "country": "View results",
            "timestamp": "2013-01-18"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN83765567",
            "timestamp": "2013-01-16",
            "title": "Evaluation of patient adherence to artemether-lumefantrine (AL) obtained from public and private drug outlets in Tanzania"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004602-97/ES",
            "title": "?Vitamin D as add-on treatment for relapsing-remitting multiple sclerosis: an unicentric, randomized, double-blinded, placebo-controlled clinical trial?",
            "country": "ES",
            "timestamp": "2013-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/BE",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "BE",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/DE",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "DE",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/GB",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "GB",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/ES",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "ES",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/IT",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "IT",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/FR",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "FR",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003088-23/results",
            "title": "A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered\r\nwith Ribavirin (RBV) in Adults with Genotype 1 Chroni...",
            "country": "View results",
            "timestamp": "2012-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002874-30/GB",
            "title": "AN OPEN LABEL RANDOMISED PHASE II STUDY COMPARING AZD2014 VERSUS EVEROLIMUS IN PATIENTS WITH ADVANCED METASTATIC RENAL CANCER AND PROGRESSION ON VEGF TARGETED THERAPY",
            "country": "GB",
            "timestamp": "2012-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002874-30/results",
            "title": "AN OPEN LABEL RANDOMISED PHASE II STUDY COMPARING AZD2014 VERSUS EVEROLIMUS IN PATIENTS WITH ADVANCED METASTATIC RENAL CANCER AND PROGRESSION ON VEGF TARGETED THERAPY",
            "country": "View results",
            "timestamp": "2012-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001020-35/NO",
            "title": "A randomized phase II trial comparing bevacizumab monotherapy with dacarbazine (DTIC) in treatment of malignant melanoma, focusing on angiogenic markers and prevention of hypertension.",
            "country": "NO",
            "timestamp": "2012-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/DE",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "DE",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/PT",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "PT",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/GB",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "GB",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/ES",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "ES",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/IE",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "IE",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/IT",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "IT",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/NL",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "NL",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/HU",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "HU",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/AT",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "AT",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003533-41/results",
            "title": "A Phase III, Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1 HCV Infec...",
            "country": "View results",
            "timestamp": "2012-12-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/BE",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "BE",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/GB",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "GB",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/DE",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "DE",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/AT",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "AT",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/IT",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "IT",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/DK",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "DK",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/ES",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "ES",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/NL",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "NL",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/PT",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "PT",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/PL",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "PL",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010273-20/results",
            "title": "Adjuvant peginterferon alfa-2b for 2 years vs Observation in patients with an ulcerated primary cutaneous melanoma with T(2-4)bN0M0: a randomized phase III trial of the EORTC Melanoma Group.",
            "country": "View results",
            "timestamp": "2012-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004416-66/GB",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches using the ChAd63 and MVA vectors encoding the antigens ME-TRAP, CS and AMA1.",
            "country": "GB",
            "timestamp": "2012-11-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004416-66/results",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches using the ChAd63 and MVA vectors encoding the antigens ME-TRAP, CS and AMA1.",
            "country": "View results",
            "timestamp": "2012-11-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN27564683",
            "timestamp": "2012-11-22",
            "title": "Eradicate Hepatitis C Virus"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006187-47/DK",
            "title": "A 48-Week, Randomized, Open-Label Phase 3b Study Comparing the Antiviral Efficacy and Safety of ATV/RTV Plus 3TC with ATV/RTV plus TDF/FTC in HIV-1-Infected, Treatment-Naive Subjects, Followed by a...",
            "country": "DK",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006187-47/results",
            "title": "A 48-Week, Randomized, Open-Label Phase 3b Study Comparing the Antiviral Efficacy and Safety of ATV/RTV Plus 3TC with ATV/RTV plus TDF/FTC in HIV-1-Infected, Treatment-Naive Subjects, Followed by a...",
            "country": "View results",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/GB",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "GB",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/BE",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "BE",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/FI",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "FI",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/NL",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "NL",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/IT",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "IT",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/GR",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "GR",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004885-14/results",
            "title": "A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combina...",
            "country": "View results",
            "timestamp": "2012-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002663-10/GB",
            "title": "A phase IV, open-label single-arm study investigating the pharmacokinetics and pharmacodynamics of the antiretroviral combination of rilpivirine and ritonavir-boosted darunavir in therapy-naive HIV...",
            "country": "GB",
            "timestamp": "2012-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002663-10/results",
            "title": "A phase IV, open-label single-arm study investigating the pharmacokinetics and pharmacodynamics of the antiretroviral combination of rilpivirine and ritonavir-boosted darunavir in therapy-naive HIV...",
            "country": "View results",
            "timestamp": "2012-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002491-14/NL",
            "title": "The effects of interferon-gamma on sepsis-induced immunoparalysis, a randomised double-blind placebo-controlled pilot (Phase IIIb) study",
            "country": "NL",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/DE",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "DE",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/AT",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "AT",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/BE",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "BE",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/PT",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "PT",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/CZ",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "CZ",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/ES",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "ES",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/IT",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "IT",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/PL",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "PL",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/NO",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "NO",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024260-17/GB",
            "title": "A Phase 3 Study to Assess the Efficacy and Safety of Boceprevir in Combination with Peginterferon alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1",
            "country": "GB",
            "timestamp": "2012-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003708-11/BE",
            "title": "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtrici...",
            "country": "BE",
            "timestamp": "2012-11-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003708-11/GB",
            "title": "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtrici...",
            "country": "GB",
            "timestamp": "2012-11-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003708-11/PT",
            "title": "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtrici...",
            "country": "PT",
            "timestamp": "2012-11-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003708-11/IT",
            "title": "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtrici...",
            "country": "IT",
            "timestamp": "2012-11-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003708-11/FR",
            "title": "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtrici...",
            "country": "FR",
            "timestamp": "2012-11-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003708-11/results",
            "title": "A Randomized, Double-blind Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtrici...",
            "country": "View results",
            "timestamp": "2012-11-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005989-38/NO",
            "title": "A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ΑLPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA",
            "country": "NO",
            "timestamp": "2012-11-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005989-38/FI",
            "title": "A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ΑLPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA",
            "country": "FI",
            "timestamp": "2012-11-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005989-38/SE",
            "title": "A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ΑLPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA",
            "country": "SE",
            "timestamp": "2012-11-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005989-38/DK",
            "title": "A SAFETY AND EFFICACY STUDY OF ADDING LOW DOSE PEGYLATED IFN-ΑLPHA 2B TO STANDARD DOSE DASATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA",
            "country": "DK",
            "timestamp": "2012-11-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004787-30/DE",
            "title": "Modification of the visual outcome after optic neuritis in CIS or MS by Gilenya®",
            "country": "DE",
            "timestamp": "2012-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000880-28/IT",
            "title": "Bendamustine and Rituximab for the treatment of Splenic Marginal Zone Lymphoma.  The IELSG-36 phase II prospective study.",
            "country": "IT",
            "timestamp": "2012-10-25"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN91859104",
            "timestamp": "2012-10-24",
            "title": "Does hydroxychloroquine provide effective pain relief for people with hand osteoarthritis?"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000091-41/GB",
            "title": "A randomised phase 2 trial investigating the additional benefit of hydroxychloroquine(HCQ) to short  course radiotherapy (SCRT) in patients aged 70 years and older with high grade gliomas (HGG)",
            "country": "GB",
            "timestamp": "2012-10-22"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN68222801",
            "timestamp": "2012-10-18",
            "title": "Rivaroxaban in Antiphospholipid Syndrome (RAPS)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/BE",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "BE",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/DE",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "DE",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/PT",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "PT",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/GB",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "GB",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/ES",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "ES",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/GR",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "GR",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/IT",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "IT",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003535-27/results",
            "title": "A phase III randomised, partially double-blind and placebo-controlled study of  BI 207127 in combination with faldaprevir and ribavirin for chronic genotype 1 hepatitis C infection in an extended p...",
            "country": "View results",
            "timestamp": "2012-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006260-52/BE",
            "title": "A multi-center, randomized, double blind, placebo-controlled Phase I/II trial to compare the safety, tolerability and immunogenicity of the therapeutic THV01 vaccination at 5x10E6 TU, 5x10E7 TU or ...",
            "country": "BE",
            "timestamp": "2012-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006260-52/FR",
            "title": "A multi-center, randomized, double blind, placebo-controlled Phase I/II trial to compare the safety, tolerability and immunogenicity of the therapeutic THV01 vaccination at 5x10E6 TU, 5x10E7 TU or ...",
            "country": "FR",
            "timestamp": "2012-10-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN87032740",
            "timestamp": "2012-10-09",
            "title": "Study of co-trimoxazole in advanced pulmonary fibrosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000955-15/IT",
            "title": "A phase IIa open-label, single arm, multi-center trial evaluating the safety of standard antiviral therapy (pegylated interferon and ribavirin) plus deferasirox in thalassemia patients with transfu...",
            "country": "IT",
            "timestamp": "2012-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-003151-11/IT",
            "title": "An open-label, single-arm, phase II, prospective, pilot study of tocilizumab in patients with Erdheim-Chester disease.",
            "country": "IT",
            "timestamp": "2012-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002326-75/GB",
            "title": "A multicentre, open label, early stopping design, proof of concept study with tasquinimod in treating patients with advanced or metastatic hepatocellular, ovarian, renal cell and gastric carcinomas.",
            "country": "GB",
            "timestamp": "2012-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002326-75/BE",
            "title": "A multicentre, open label, early stopping design, proof of concept study with tasquinimod in treating patients with advanced or metastatic hepatocellular, ovarian, renal cell and gastric carcinomas.",
            "country": "BE",
            "timestamp": "2012-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002326-75/ES",
            "title": "A multicentre, open label, early stopping design, proof of concept study with tasquinimod in treating patients with advanced or metastatic hepatocellular, ovarian, renal cell and gastric carcinomas.",
            "country": "ES",
            "timestamp": "2012-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002326-75/results",
            "title": "A multicentre, open label, early stopping design, proof of concept study with tasquinimod in treating patients with advanced or metastatic hepatocellular, ovarian, renal cell and gastric carcinomas.",
            "country": "View results",
            "timestamp": "2012-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001437-16/DE",
            "title": "A 3-year, multi-center study to evaluate optical coherence tomography as an outcome measure in patients with multiple sclerosis",
            "country": "DE",
            "timestamp": "2012-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000523-40/BE",
            "title": "A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of G...",
            "country": "BE",
            "timestamp": "2012-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000523-40/DE",
            "title": "A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of G...",
            "country": "DE",
            "timestamp": "2012-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000523-40/BG",
            "title": "A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of G...",
            "country": "BG",
            "timestamp": "2012-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000523-40/results",
            "title": "A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of G...",
            "country": "View results",
            "timestamp": "2012-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002515-25/ES",
            "title": "Pharmacokinetic interactions  between Telaprevir and not powered Atazanavir with ritonavir in co-infected patients with HIV and HCV genotype 1 in treatment for chronic liver disease by HCV",
            "country": "ES",
            "timestamp": "2012-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006020-20/HU",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "HU",
            "timestamp": "2012-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006020-20/CZ",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "CZ",
            "timestamp": "2012-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006020-20/PL",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "PL",
            "timestamp": "2012-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006020-20/BG",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "BG",
            "timestamp": "2012-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006020-20/results",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "View results",
            "timestamp": "2012-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001012-56/DE",
            "title": "A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms",
            "country": "DE",
            "timestamp": "2012-08-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001012-56/ES",
            "title": "A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms",
            "country": "ES",
            "timestamp": "2012-08-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001012-56/SE",
            "title": "A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms",
            "country": "SE",
            "timestamp": "2012-08-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001012-56/AT",
            "title": "A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms",
            "country": "AT",
            "timestamp": "2012-08-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001012-56/IT",
            "title": "A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms",
            "country": "IT",
            "timestamp": "2012-08-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006070-73/DE",
            "title": "A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients with Rheumatoid ...",
            "country": "DE",
            "timestamp": "2012-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006070-73/CZ",
            "title": "A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients with Rheumatoid ...",
            "country": "CZ",
            "timestamp": "2012-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006070-73/BG",
            "title": "A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients with Rheumatoid ...",
            "country": "BG",
            "timestamp": "2012-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006070-73/results",
            "title": "A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients with Rheumatoid ...",
            "country": "View results",
            "timestamp": "2012-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024262-22/DE",
            "title": "Treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotini...",
            "country": "DE",
            "timestamp": "2012-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024262-22/CZ",
            "title": "Treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotini...",
            "country": "CZ",
            "timestamp": "2012-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002555-42/BE",
            "title": "A Phase IIa, open-label trial to evaluate the safety, tolerability and efficacy of a 12 weeks combination therapy of TMC647055 and TMC435 with and without GSK2336805 with a pharmacokinetic enhancer...",
            "country": "BE",
            "timestamp": "2012-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002555-42/DE",
            "title": "A Phase IIa, open-label trial to evaluate the safety, tolerability and efficacy of a 12 weeks combination therapy of TMC647055 and TMC435 with and without GSK2336805 with a pharmacokinetic enhancer...",
            "country": "DE",
            "timestamp": "2012-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002555-42/results",
            "title": "A Phase IIa, open-label trial to evaluate the safety, tolerability and efficacy of a 12 weeks combination therapy of TMC647055 and TMC435 with and without GSK2336805 with a pharmacokinetic enhancer...",
            "country": "View results",
            "timestamp": "2012-08-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000649-11/GB",
            "title": "A phase IV, open-label, single centre, single-arm, pilot study to assess Cerebrospinal fluid INflammatory markers after Addition of Maraviroc to MONotherapy darunavir/ritonavir – The CINAMMON Study...",
            "country": "GB",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000649-11/ES",
            "title": "A phase IV, open-label, single centre, single-arm, pilot study to assess Cerebrospinal fluid INflammatory markers after Addition of Maraviroc to MONotherapy darunavir/ritonavir – The CINAMMON Study...",
            "country": "ES",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000649-11/results",
            "title": "A phase IV, open-label, single centre, single-arm, pilot study to assess Cerebrospinal fluid INflammatory markers after Addition of Maraviroc to MONotherapy darunavir/ritonavir – The CINAMMON Study...",
            "country": "View results",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/SE",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "SE",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/AT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "AT",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/BE",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "BE",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/NL",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "NL",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/IT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "IT",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/PT",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "PT",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005740-95/results",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Antiviral Activity of the Combination of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With and Without Ribavirin ...",
            "country": "View results",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022293-14/ES",
            "title": "Optimized Phase III Trial of Immuno-stimulation with Maraviroc, a CCR5 antagonist, combined with Anti Retroviral Therapy (cART) in advanced, Late diagnosed HIV-1 infected patients with an AIDS-defi...",
            "country": "ES",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022293-14/IT",
            "title": "Optimized Phase III Trial of Immuno-stimulation with Maraviroc, a CCR5 antagonist, combined with Anti Retroviral Therapy (cART) in advanced, Late diagnosed HIV-1 infected patients with an AIDS-defi...",
            "country": "IT",
            "timestamp": "2012-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002777-56/IT",
            "title": "Cross-sectional multicenter study evaluating the IL28B polymorphism in patients with HBeAg-negative chronic hepatitis B treated with pegylated interferon alfa-2a in the course of Peg.Be.Liver study",
            "country": "IT",
            "timestamp": "2012-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002777-56/results",
            "title": "Cross-sectional multicenter study evaluating the IL28B polymorphism in patients with HBeAg-negative chronic hepatitis B treated with pegylated interferon alfa-2a in the course of Peg.Be.Liver study",
            "country": "View results",
            "timestamp": "2012-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005912-27/DE",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,\r\nMULTICENTER PHASE II STUDY EVALUATING THE EFFICACY\r\nAND SAFETY OF ONARTUZUMAB IN COMBINATION WITH\r\nBEVACIZUMAB OR ONARTUZUMAB MONOTHERAPY IN\r\nPATIEN...",
            "country": "DE",
            "timestamp": "2012-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005912-27/ES",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,\r\nMULTICENTER PHASE II STUDY EVALUATING THE EFFICACY\r\nAND SAFETY OF ONARTUZUMAB IN COMBINATION WITH\r\nBEVACIZUMAB OR ONARTUZUMAB MONOTHERAPY IN\r\nPATIEN...",
            "country": "ES",
            "timestamp": "2012-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005912-27/GB",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,\r\nMULTICENTER PHASE II STUDY EVALUATING THE EFFICACY\r\nAND SAFETY OF ONARTUZUMAB IN COMBINATION WITH\r\nBEVACIZUMAB OR ONARTUZUMAB MONOTHERAPY IN\r\nPATIEN...",
            "country": "GB",
            "timestamp": "2012-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005912-27/IT",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,\r\nMULTICENTER PHASE II STUDY EVALUATING THE EFFICACY\r\nAND SAFETY OF ONARTUZUMAB IN COMBINATION WITH\r\nBEVACIZUMAB OR ONARTUZUMAB MONOTHERAPY IN\r\nPATIEN...",
            "country": "IT",
            "timestamp": "2012-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005912-27/results",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,\r\nMULTICENTER PHASE II STUDY EVALUATING THE EFFICACY\r\nAND SAFETY OF ONARTUZUMAB IN COMBINATION WITH\r\nBEVACIZUMAB OR ONARTUZUMAB MONOTHERAPY IN\r\nPATIEN...",
            "country": "View results",
            "timestamp": "2012-08-17"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN73411795",
            "timestamp": "2012-08-16",
            "title": "Efficacy of switch to lopinavir/ritonavir in improving cognitive function in efavirenz treated patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002541-37/BE",
            "title": "A Phase II, open label, mono-centric study to evaluate the kinetics of mRNA expression after two doses of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 in healthy BCG-primed, HIV-...",
            "country": "BE",
            "timestamp": "2012-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-002541-37/results",
            "title": "A Phase II, open label, mono-centric study to evaluate the kinetics of mRNA expression after two doses of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 in healthy BCG-primed, HIV-...",
            "country": "View results",
            "timestamp": "2012-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/GB",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "GB",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/ES",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "ES",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/DE",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "DE",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/BE",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "BE",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/HU",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "HU",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/SE",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "SE",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/AT",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "AT",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/NL",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "NL",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/IT",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "IT",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/CZ",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "CZ",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/IE",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "IE",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/SK",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "SK",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/PT",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "PT",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005393-32/results",
            "title": "An Open-Label Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Direct-Acting Antiviral Agent (DAA) Treatment in Combination with Peginterferon α-2a and Ribavirin (pegIFN/RBV...",
            "country": "View results",
            "timestamp": "2012-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005581-37/GB",
            "title": "Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients",
            "country": "GB",
            "timestamp": "2012-08-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005581-37/results",
            "title": "Efficacy of Switch to Lopinavir/Ritonavir in Improving Cognitive function in Efavirenz treated patients",
            "country": "View results",
            "timestamp": "2012-08-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/HU",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "HU",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/PL",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "PL",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/DE",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "DE",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/SK",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "SK",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/IT",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "IT",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/ES",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "ES",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/GB",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "GB",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004915-22/BE",
            "title": "A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF CP-690,550 FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS (JIA)",
            "country": "BE",
            "timestamp": "2012-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006018-15/BE",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "BE",
            "timestamp": "2012-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006018-15/CZ",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "CZ",
            "timestamp": "2012-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006018-15/PL",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "PL",
            "timestamp": "2012-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006018-15/HU",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "HU",
            "timestamp": "2012-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006018-15/BG",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "BG",
            "timestamp": "2012-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006018-15/results",
            "title": "A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis ...",
            "country": "View results",
            "timestamp": "2012-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005475-16/GB",
            "title": "A Phase 1/2 Randomized, Dose-finding Study of MEDI-551 in Subjects with Relapsing-Remitting Multiple Sclerosis",
            "country": "GB",
            "timestamp": "2012-07-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005475-16/results",
            "title": "A Phase 1/2 Randomized, Dose-finding Study of MEDI-551 in Subjects with Relapsing-Remitting Multiple Sclerosis",
            "country": "View results",
            "timestamp": "2012-07-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/LT",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "LT",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/DE",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "DE",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/GB",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "GB",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/AT",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "AT",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/ES",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "ES",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/PT",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "PT",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/BE",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "BE",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/IT",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "IT",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/NL",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "NL",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022243-38/results",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "View results",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022242-24/LT",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "LT",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022242-24/BG",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "BG",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022242-24/results",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Activ...",
            "country": "View results",
            "timestamp": "2012-07-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001096-39/SK",
            "title": "An International, Multi-Center Study Evaluating the Correlation of IL28B Genotypes with Chronic Hepatitis C Disease Characteristics and Patient Demographics",
            "country": "SK",
            "timestamp": "2012-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000638-21/DE",
            "title": "A Randomized, Open-Label, Multicenter Study of the Safety, Efficacy, and Tolerability of Combination Treatment of Setrobuvir, Danoprevir, Ritonavir, and Copegus® with or without Mericitabine in Tre...",
            "country": "DE",
            "timestamp": "2012-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000638-21/PL",
            "title": "A Randomized, Open-Label, Multicenter Study of the Safety, Efficacy, and Tolerability of Combination Treatment of Setrobuvir, Danoprevir, Ritonavir, and Copegus® with or without Mericitabine in Tre...",
            "country": "PL",
            "timestamp": "2012-07-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN51069819",
            "timestamp": "2012-06-29",
            "title": "TAILoR - (TelmisArtan and InsuLin Resistance in HIV)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000935-18/GB",
            "title": "TAILoR – (TelmisArtan and InsuLin Resistance in HIV): A Dose-Ranging Phase II Randomised Open-Labelled Trial of Telmisartan as a strategy for the Reduction of Insulin Resistance in HIV-Positive Ind...",
            "country": "GB",
            "timestamp": "2012-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000935-18/results",
            "title": "TAILoR – (TelmisArtan and InsuLin Resistance in HIV): A Dose-Ranging Phase II Randomised Open-Labelled Trial of Telmisartan as a strategy for the Reduction of Insulin Resistance in HIV-Positive Ind...",
            "country": "View results",
            "timestamp": "2012-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005939-78/DE",
            "title": "A prospective, open-label, multicenter, randomized phase II trial: \r\nSequential therapy with BEvacizumab, RAd001 (everolimus) and AxiTinib in metastatic renal cell carcinoma (mRCC) (BERAT study)",
            "country": "DE",
            "timestamp": "2012-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004300-38/GB",
            "title": "HERO:Hydroxychloroquine Effectiveness in Reducing Symptoms of hand OA, a randomised, double-blind, placebo-controlled trial",
            "country": "GB",
            "timestamp": "2012-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000420-15/DE",
            "title": "A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04236921 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)",
            "country": "DE",
            "timestamp": "2012-06-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000420-15/HU",
            "title": "A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04236921 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)",
            "country": "HU",
            "timestamp": "2012-06-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000420-15/results",
            "title": "A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-04236921 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)",
            "country": "View results",
            "timestamp": "2012-06-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12600624",
            "timestamp": "2012-06-19",
            "title": "INTENSIFY"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021624-99/DE",
            "title": "A multi-centre, non-controlled, non-randomised  IST to evaluate the plasma level of antiretroviral substances, the viral resistance profile and their impact on the clinical response in HIV infected...",
            "country": "DE",
            "timestamp": "2012-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/GB",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "GB",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/ES",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "ES",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/PL",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "PL",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/NL",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "NL",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/IT",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "IT",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/3rd",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "Outside EU/EEA",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000368-88/results",
            "title": "A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Sta...",
            "country": "View results",
            "timestamp": "2012-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002656-14/GB",
            "title": "A randomised, prospective study, assessing changes in cerebral function in treatment naive HIV-1 infected subjects commencing either boosted atazanavir with Truvada or boosted darunavir with maravi...",
            "country": "GB",
            "timestamp": "2012-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002656-14/results",
            "title": "A randomised, prospective study, assessing changes in cerebral function in treatment naive HIV-1 infected subjects commencing either boosted atazanavir with Truvada or boosted darunavir with maravi...",
            "country": "View results",
            "timestamp": "2012-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/DE",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "DE",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/AT",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "AT",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/ES",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "ES",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/PL",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "PL",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/IT",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "IT",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/GR",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "GR",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/FI",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "FI",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/BE",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "BE",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/NL",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "NL",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005293-31/results",
            "title": "A Long-Term Follow-Up Study of Subjects Who Participated in a Clinical Trial in which Peginterferon Lambda-1a (BMS-914143) was Administered for the Treatment of Chronic Hepatitis C\r\n\r\nRevised Proto...",
            "country": "View results",
            "timestamp": "2012-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005762-38/ES",
            "title": "A Randomized, Open-Label Study to Evaluate the\nSafety and Efficacy of Coadministration of ABT-450\nwith Ritonavir (ABT-450/r) and ABT-267 in Adults\nwith Chronic Hepatitis C Virus Infection (PEARL-I)",
            "country": "ES",
            "timestamp": "2012-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005762-38/HU",
            "title": "A Randomized, Open-Label Study to Evaluate the\nSafety and Efficacy of Coadministration of ABT-450\nwith Ritonavir (ABT-450/r) and ABT-267 in Adults\nwith Chronic Hepatitis C Virus Infection (PEARL-I)",
            "country": "HU",
            "timestamp": "2012-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005762-38/IT",
            "title": "A Randomized, Open-Label Study to Evaluate the\nSafety and Efficacy of Coadministration of ABT-450\nwith Ritonavir (ABT-450/r) and ABT-267 in Adults\nwith Chronic Hepatitis C Virus Infection (PEARL-I)",
            "country": "IT",
            "timestamp": "2012-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005762-38/results",
            "title": "A Randomized, Open-Label Study to Evaluate the\nSafety and Efficacy of Coadministration of ABT-450\nwith Ritonavir (ABT-450/r) and ABT-267 in Adults\nwith Chronic Hepatitis C Virus Infection (PEARL-I)",
            "country": "View results",
            "timestamp": "2012-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000322-21/NL",
            "title": "Controlled human malaria infection after immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylaxis",
            "country": "NL",
            "timestamp": "2012-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000322-21/results",
            "title": "Controlled human malaria infection after immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylaxis",
            "country": "View results",
            "timestamp": "2012-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024557-36/GB",
            "title": "A phase IV open-label multicentre, international trial of response guided treatment with directly observed pegylated interferon alfa 2b and self-administered ribavirin for patients with chronic HCV...",
            "country": "GB",
            "timestamp": "2012-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024557-36/BE",
            "title": "A phase IV open-label multicentre, international trial of response guided treatment with directly observed pegylated interferon alfa 2b and self-administered ribavirin for patients with chronic HCV...",
            "country": "BE",
            "timestamp": "2012-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024557-36/DE",
            "title": "A phase IV open-label multicentre, international trial of response guided treatment with directly observed pegylated interferon alfa 2b and self-administered ribavirin for patients with chronic HCV...",
            "country": "DE",
            "timestamp": "2012-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024557-36/results",
            "title": "A phase IV open-label multicentre, international trial of response guided treatment with directly observed pegylated interferon alfa 2b and self-administered ribavirin for patients with chronic HCV...",
            "country": "View results",
            "timestamp": "2012-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004720-35/SE",
            "title": "A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two d...",
            "country": "SE",
            "timestamp": "2012-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004720-35/IS",
            "title": "A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two d...",
            "country": "IS",
            "timestamp": "2012-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004720-35/DK",
            "title": "A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two d...",
            "country": "DK",
            "timestamp": "2012-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004720-35/FI",
            "title": "A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two d...",
            "country": "FI",
            "timestamp": "2012-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004720-35/NO",
            "title": "A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two d...",
            "country": "NO",
            "timestamp": "2012-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004720-35/NL",
            "title": "A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two d...",
            "country": "NL",
            "timestamp": "2012-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004903-20/NL",
            "title": "Hydroxychloroquine as an anti-autophagy and chromatin modulating drug in combination with erlotinib in non-small cell lung cancer (NSCLC) patients: a single-center single arm open-label phase II trial",
            "country": "NL",
            "timestamp": "2012-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/DE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "DE",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/HU",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "HU",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/AT",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "AT",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/CZ",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "CZ",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/SE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "SE",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/BE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "BE",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/PT",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "PT",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/ES",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "ES",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/DK",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "DK",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/GB",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "GB",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/BG",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "BG",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/IT",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "IT",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/PL",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "PL",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003814-18/results",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with Sys...",
            "country": "View results",
            "timestamp": "2012-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006272-39/ES",
            "title": "CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY AND ECONOMIC IMPACT OF REDUCING DOSES OF DARUNAVIR IN PATIENTS INFECTED WITH HIV TREATED WITH DARUNAVIR / RITONAVIR ONCE A DAY",
            "country": "ES",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006272-39/results",
            "title": "CLINICAL TRIAL TO EVALUATE THE EFFICACY, SAFETY AND ECONOMIC IMPACT OF REDUCING DOSES OF DARUNAVIR IN PATIENTS INFECTED WITH HIV TREATED WITH DARUNAVIR / RITONAVIR ONCE A DAY",
            "country": "View results",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/BE",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "BE",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/AT",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "AT",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/DE",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "DE",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/CZ",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "CZ",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/HU",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "HU",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/ES",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "ES",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/GB",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "GB",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/IT",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "IT",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/NO",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "NO",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/NL",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "NL",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/GR",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "GR",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/SK",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "SK",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002887-26/PL",
            "title": "A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of ...",
            "country": "PL",
            "timestamp": "2012-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005606-30/GB",
            "title": "Keratinocyte Growth Factor - promoting thymic reconstitution and preventing autoimmunity after alemtuzumab (Campath-1H) treatment of multiple sclerosis. CAM-THY",
            "country": "GB",
            "timestamp": "2012-04-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005606-30/results",
            "title": "Keratinocyte Growth Factor - promoting thymic reconstitution and preventing autoimmunity after alemtuzumab (Campath-1H) treatment of multiple sclerosis. CAM-THY",
            "country": "View results",
            "timestamp": "2012-04-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004529-28/HU",
            "title": "A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug...",
            "country": "HU",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004529-28/PL",
            "title": "A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug...",
            "country": "PL",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004529-28/CZ",
            "title": "A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug...",
            "country": "CZ",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004529-28/BG",
            "title": "A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug...",
            "country": "BG",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004529-28/results",
            "title": "A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug...",
            "country": "View results",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004810-41/AT",
            "title": "An international, multicenter, open-label study evaluating sustained virological response and safety with Boceprevir in triple combination therapy with Peginterferon alfa-2a (40KD) and Ribavirin in...",
            "country": "AT",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004810-41/HU",
            "title": "An international, multicenter, open-label study evaluating sustained virological response and safety with Boceprevir in triple combination therapy with Peginterferon alfa-2a (40KD) and Ribavirin in...",
            "country": "HU",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004810-41/ES",
            "title": "An international, multicenter, open-label study evaluating sustained virological response and safety with Boceprevir in triple combination therapy with Peginterferon alfa-2a (40KD) and Ribavirin in...",
            "country": "ES",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004810-41/PL",
            "title": "An international, multicenter, open-label study evaluating sustained virological response and safety with Boceprevir in triple combination therapy with Peginterferon alfa-2a (40KD) and Ribavirin in...",
            "country": "PL",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004810-41/DE",
            "title": "An international, multicenter, open-label study evaluating sustained virological response and safety with Boceprevir in triple combination therapy with Peginterferon alfa-2a (40KD) and Ribavirin in...",
            "country": "DE",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004810-41/results",
            "title": "An international, multicenter, open-label study evaluating sustained virological response and safety with Boceprevir in triple combination therapy with Peginterferon alfa-2a (40KD) and Ribavirin in...",
            "country": "View results",
            "timestamp": "2012-04-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005636-26/NL",
            "title": "Effect of Telaprevir in triple therapy for chronic hepatitis C patients on Intrahepatic immunological Mechanisms",
            "country": "NL",
            "timestamp": "2012-04-13"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN13074752",
            "timestamp": "2012-04-03",
            "title": "Europe - Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Rifabutin Pharmacokinetics (PK) substudy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002392-41/HU",
            "title": "A PHASE II, DOUBLE-BLIND, CONTROLLED, MULTI-CENTER, RANDOMIZED, LONG TERM SAFETY TRIAL OF Z102 AND PREDNISONE (5 MG OR 7.5 MG) IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS",
            "country": "HU",
            "timestamp": "2012-03-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002392-41/BG",
            "title": "A PHASE II, DOUBLE-BLIND, CONTROLLED, MULTI-CENTER, RANDOMIZED, LONG TERM SAFETY TRIAL OF Z102 AND PREDNISONE (5 MG OR 7.5 MG) IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS",
            "country": "BG",
            "timestamp": "2012-03-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004396-36/DE",
            "title": "Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the treatment of advanced / metasta...",
            "country": "DE",
            "timestamp": "2012-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004396-36/AT",
            "title": "Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the treatment of advanced / metasta...",
            "country": "AT",
            "timestamp": "2012-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004396-36/NL",
            "title": "Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the treatment of advanced / metasta...",
            "country": "NL",
            "timestamp": "2012-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004396-36/results",
            "title": "Phase III randomized sequential open-label study to evaluate the efficacy and safety of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the treatment of advanced / metasta...",
            "country": "View results",
            "timestamp": "2012-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005981-39/ES",
            "title": "Pilot simplification study to Lopinavir/ritonavir 800/200 mg monotherapy regimen once daily",
            "country": "ES",
            "timestamp": "2012-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005055-14/SE",
            "title": "A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks...",
            "country": "SE",
            "timestamp": "2012-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005055-14/EE",
            "title": "A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks...",
            "country": "EE",
            "timestamp": "2012-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005055-14/IT",
            "title": "A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks...",
            "country": "IT",
            "timestamp": "2012-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005055-14/ES",
            "title": "A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks...",
            "country": "ES",
            "timestamp": "2012-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005055-14/NL",
            "title": "A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks...",
            "country": "NL",
            "timestamp": "2012-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005055-14/results",
            "title": "A Phase 3, Multicenter, Randomized, Active-Controlled Study to Investigate the Safety and Efficacy of PSI-7977 and Ribavirin for 12 Weeks Compared to Pegylated Interferon and Ribavirin for 24 Weeks...",
            "country": "View results",
            "timestamp": "2012-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004150-26/DE",
            "title": "A Multicenter, Open-Label, Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2 and Ribavirin) in Subjects With Genotype 1 Chronic...",
            "country": "DE",
            "timestamp": "2012-03-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004150-26/GB",
            "title": "A Multicenter, Open-Label, Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2 and Ribavirin) in Subjects With Genotype 1 Chronic...",
            "country": "GB",
            "timestamp": "2012-03-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004150-26/PL",
            "title": "A Multicenter, Open-Label, Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2 and Ribavirin) in Subjects With Genotype 1 Chronic...",
            "country": "PL",
            "timestamp": "2012-03-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004150-26/results",
            "title": "A Multicenter, Open-Label, Phase 2b Pilot Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir, Peginterferon-Alfa-2 and Ribavirin) in Subjects With Genotype 1 Chronic...",
            "country": "View results",
            "timestamp": "2012-03-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN63350011",
            "timestamp": "2012-03-09",
            "title": "Tolerability and completion of Maraviroc compared to Kaletra® in combination with Truvada® for HIV Post Exposure Prophylaxis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002793-23/GB",
            "title": "A Phase 3 Evaluation of Daclatasvir (BMS-790052) in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Chronic Hepatitis C Genotype 4\r\n\r\nRevised Protocol Number ...",
            "country": "GB",
            "timestamp": "2012-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002793-23/ES",
            "title": "A Phase 3 Evaluation of Daclatasvir (BMS-790052) in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Chronic Hepatitis C Genotype 4\r\n\r\nRevised Protocol Number ...",
            "country": "ES",
            "timestamp": "2012-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002793-23/IT",
            "title": "A Phase 3 Evaluation of Daclatasvir (BMS-790052) in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Chronic Hepatitis C Genotype 4\r\n\r\nRevised Protocol Number ...",
            "country": "IT",
            "timestamp": "2012-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002793-23/GR",
            "title": "A Phase 3 Evaluation of Daclatasvir (BMS-790052) in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Chronic Hepatitis C Genotype 4\r\n\r\nRevised Protocol Number ...",
            "country": "GR",
            "timestamp": "2012-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002793-23/results",
            "title": "A Phase 3 Evaluation of Daclatasvir (BMS-790052) in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Chronic Hepatitis C Genotype 4\r\n\r\nRevised Protocol Number ...",
            "country": "View results",
            "timestamp": "2012-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-006350-87/IT",
            "title": "HydrOxychloRoqUine and Sorafenib in  locally advanced or Metastatic  Hepatocellular Carcinoma as First line therapy: a multi-center phase II trial",
            "country": "IT",
            "timestamp": "2012-03-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004501-24/GB",
            "title": "Phase II study to evaluate the safety, tolerability and efficacy of CT-011 administered intravenously to patients with metastatic\r\nmelanoma",
            "country": "GB",
            "timestamp": "2012-03-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004928-35/SE",
            "title": "Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects with Ge...",
            "country": "SE",
            "timestamp": "2012-02-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004928-35/GB",
            "title": "Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects with Ge...",
            "country": "GB",
            "timestamp": "2012-02-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004928-35/ES",
            "title": "Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects with Ge...",
            "country": "ES",
            "timestamp": "2012-02-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004928-35/PL",
            "title": "Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects with Ge...",
            "country": "PL",
            "timestamp": "2012-02-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004928-35/results",
            "title": "Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects with Ge...",
            "country": "View results",
            "timestamp": "2012-02-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005477-24/GB",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of Two Prime-boost Malaria Vaccine Candidates: ChAd63 and MVA encoding ME-TRAP and the same Viral Vectors encoding CS",
            "country": "GB",
            "timestamp": "2012-02-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005477-24/results",
            "title": "A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of Two Prime-boost Malaria Vaccine Candidates: ChAd63 and MVA encoding ME-TRAP and the same Viral Vectors encoding CS",
            "country": "View results",
            "timestamp": "2012-02-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004653-31/DE",
            "title": "A multicenter, single-arm trial evaluating the safety and efficacy of DEB025/Alisporivir in combination with pegylated interferon-α2a and ribavirin (peg-IFNα2a/RBV) in protease inhibitor treatment ...",
            "country": "DE",
            "timestamp": "2012-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004653-31/ES",
            "title": "A multicenter, single-arm trial evaluating the safety and efficacy of DEB025/Alisporivir in combination with pegylated interferon-α2a and ribavirin (peg-IFNα2a/RBV) in protease inhibitor treatment ...",
            "country": "ES",
            "timestamp": "2012-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004653-31/GB",
            "title": "A multicenter, single-arm trial evaluating the safety and efficacy of DEB025/Alisporivir in combination with pegylated interferon-α2a and ribavirin (peg-IFNα2a/RBV) in protease inhibitor treatment ...",
            "country": "GB",
            "timestamp": "2012-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004653-31/IT",
            "title": "A multicenter, single-arm trial evaluating the safety and efficacy of DEB025/Alisporivir in combination with pegylated interferon-α2a and ribavirin (peg-IFNα2a/RBV) in protease inhibitor treatment ...",
            "country": "IT",
            "timestamp": "2012-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004653-31/results",
            "title": "A multicenter, single-arm trial evaluating the safety and efficacy of DEB025/Alisporivir in combination with pegylated interferon-α2a and ribavirin (peg-IFNα2a/RBV) in protease inhibitor treatment ...",
            "country": "View results",
            "timestamp": "2012-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002010-37/NL",
            "title": "A Multi-center, Randomized, Open-label study for Induction of HBsAg decline using an add-on treatment of peginterferon alfa-2a in HBeAg-negative chronic hepatitis B patients treated with nucleos(t)...",
            "country": "NL",
            "timestamp": "2012-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002024-40/ES",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BMS-817399 in Adults with Active, Moderate to Severe Rheumato...",
            "country": "ES",
            "timestamp": "2012-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002024-40/results",
            "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BMS-817399 in Adults with Active, Moderate to Severe Rheumato...",
            "country": "View results",
            "timestamp": "2012-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004171-36/CZ",
            "title": "A Randomized, Double-blind, Parallel Group, Multicenter Trial to Compare the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of SAIT101 to MabThera® in Subjects with Severe Rheumatoid Arthr...",
            "country": "CZ",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004171-36/GB",
            "title": "A Randomized, Double-blind, Parallel Group, Multicenter Trial to Compare the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of SAIT101 to MabThera® in Subjects with Severe Rheumatoid Arthr...",
            "country": "GB",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004171-36/HU",
            "title": "A Randomized, Double-blind, Parallel Group, Multicenter Trial to Compare the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of SAIT101 to MabThera® in Subjects with Severe Rheumatoid Arthr...",
            "country": "HU",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004171-36/ES",
            "title": "A Randomized, Double-blind, Parallel Group, Multicenter Trial to Compare the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of SAIT101 to MabThera® in Subjects with Severe Rheumatoid Arthr...",
            "country": "ES",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004171-36/PL",
            "title": "A Randomized, Double-blind, Parallel Group, Multicenter Trial to Compare the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of SAIT101 to MabThera® in Subjects with Severe Rheumatoid Arthr...",
            "country": "PL",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019500-23/IT",
            "title": "Single Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High Risk Polycythemia Vera or High Risk Essential Thrombocythemia who are Either Hydroxyurea Resistant or Intolerant ...",
            "country": "IT",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019501-41/IT",
            "title": "Randomized Trial of Pegylated Interferon Alfa-2a versus Hydroxyurea Therapy in the Treatment of High Risk Polycythemia Vera and High Risk Essential Thrombocythemia",
            "country": "IT",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019501-41/SE",
            "title": "Randomized Trial of Pegylated Interferon Alfa-2a versus Hydroxyurea Therapy in the Treatment of High Risk Polycythemia Vera and High Risk Essential Thrombocythemia",
            "country": "SE",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019501-41/GB",
            "title": "Randomized Trial of Pegylated Interferon Alfa-2a versus Hydroxyurea Therapy in the Treatment of High Risk Polycythemia Vera and High Risk Essential Thrombocythemia",
            "country": "GB",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019501-41/DE",
            "title": "Randomized Trial of Pegylated Interferon Alfa-2a versus Hydroxyurea Therapy in the Treatment of High Risk Polycythemia Vera and High Risk Essential Thrombocythemia",
            "country": "DE",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005607-32/NL",
            "title": "LOWERING VIRAL LOAD WITH NUCLEOS(T)IDE ANALOGUES PRIOR TO PEGINTERFERON ALFA-2B TREATMENT TO INCREASE SUSTAINED RESPONSE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (PEGON-STUDY)",
            "country": "NL",
            "timestamp": "2012-02-15"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN49989464",
            "timestamp": "2012-02-14",
            "title": "Activity of sorafenib in schwannomas"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/DE",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "DE",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/AT",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "AT",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/ES",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "ES",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/GB",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "GB",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/IT",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "IT",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/DK",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "DK",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004237-14/results",
            "title": "A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared with Telaprevir in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis-C\r\nRevised Prot...",
            "country": "View results",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/GB",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "GB",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/BE",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "BE",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/DE",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "DE",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/PL",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "PL",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/IT",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "IT",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/BG",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "BG",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002732-70/results",
            "title": "A Phase IIIb Parallel Group, Open Label Study of Pegylated Interferon alfa-2a Monotherapy (PEG-IFN, Ro 25-8310) Compared to Untreated Control in Children with HBeAg Positive Chronic Hepatitis B in ...",
            "country": "View results",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/DE",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "DE",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/IE",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "IE",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/SE",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "SE",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/IT",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "IT",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/GB",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "GB",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/DK",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "DK",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005287-21/ES",
            "title": "A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatiti...",
            "country": "ES",
            "timestamp": "2012-02-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN55287110",
            "timestamp": "2012-02-03",
            "title": "Anti-CD20 monoclonal antibody therapy for type II mixed cryoglobulinemia syndrome"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN74331412",
            "timestamp": "2012-02-02",
            "title": "Vascular Function Intervention Trial in sickle cell disease"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002781-21/GB",
            "title": "A clinical study to evaluate the biological effects of administering rimantadine in patients with hepatitis C virus (HCV) infection alongside standard combination therapy with pegylated interferon ...",
            "country": "GB",
            "timestamp": "2012-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002781-21/results",
            "title": "A clinical study to evaluate the biological effects of administering rimantadine in patients with hepatitis C virus (HCV) infection alongside standard combination therapy with pegylated interferon ...",
            "country": "View results",
            "timestamp": "2012-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002683-24/ES",
            "title": "A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the safety and efficacy of NU100 in patients with relapsing forms of multiple sclerosis",
            "country": "ES",
            "timestamp": "2012-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002683-24/HU",
            "title": "A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the safety and efficacy of NU100 in patients with relapsing forms of multiple sclerosis",
            "country": "HU",
            "timestamp": "2012-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002683-24/IT",
            "title": "A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the safety and efficacy of NU100 in patients with relapsing forms of multiple sclerosis",
            "country": "IT",
            "timestamp": "2012-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002683-24/BG",
            "title": "A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the safety and efficacy of NU100 in patients with relapsing forms of multiple sclerosis",
            "country": "BG",
            "timestamp": "2012-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003629-86/ES",
            "title": "A Phase IIIb, randomized, open-label study of the safety and efficacy of GSK1349572 (dolutegravir, DTG) 50 mg once daily compared to darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily each admini...",
            "country": "ES",
            "timestamp": "2012-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003629-86/IT",
            "title": "A Phase IIIb, randomized, open-label study of the safety and efficacy of GSK1349572 (dolutegravir, DTG) 50 mg once daily compared to darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily each admini...",
            "country": "IT",
            "timestamp": "2012-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003629-86/results",
            "title": "A Phase IIIb, randomized, open-label study of the safety and efficacy of GSK1349572 (dolutegravir, DTG) 50 mg once daily compared to darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily each admini...",
            "country": "View results",
            "timestamp": "2012-01-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004129-28/SK",
            "title": "Study To Evaluate Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Ritonavir-Boosted DANOPREVIR in Combination With Peginterferon Alfa-2a Plus Ribavirin in Treatment-naive Patients ...",
            "country": "SK",
            "timestamp": "2012-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004129-28/results",
            "title": "Study To Evaluate Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Ritonavir-Boosted DANOPREVIR in Combination With Peginterferon Alfa-2a Plus Ribavirin in Treatment-naive Patients ...",
            "country": "View results",
            "timestamp": "2012-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/BE",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "BE",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/DE",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "DE",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/ES",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "ES",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/AT",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "AT",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/PT",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "PT",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/GB",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "GB",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/IT",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "IT",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004483-30/results",
            "title": "A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF)...",
            "country": "View results",
            "timestamp": "2012-01-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/BE",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "BE",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/GB",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "GB",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/IE",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "IE",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/DE",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "DE",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/ES",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "ES",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/AT",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "AT",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/HU",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "HU",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/DK",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "DK",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/IT",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "IT",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/SE",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "SE",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/PL",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "PL",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001635-23/results",
            "title": "PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects",
            "country": "View results",
            "timestamp": "2012-01-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003067-30/DE",
            "title": "A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) ...",
            "country": "DE",
            "timestamp": "2012-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003067-30/ES",
            "title": "A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) ...",
            "country": "ES",
            "timestamp": "2012-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003067-30/GB",
            "title": "A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) ...",
            "country": "GB",
            "timestamp": "2012-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003067-30/BE",
            "title": "A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) ...",
            "country": "BE",
            "timestamp": "2012-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003067-30/IT",
            "title": "A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) ...",
            "country": "IT",
            "timestamp": "2012-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003067-30/results",
            "title": "A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) ...",
            "country": "View results",
            "timestamp": "2012-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/GB",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "GB",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/AT",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "AT",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/ES",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "ES",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/LV",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "LV",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/SK",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "SK",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/LT",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "LT",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/PL",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "PL",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/IT",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "IT",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004468-31/results",
            "title": "An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patients With Rheumatoid Arthritis Who Were Treated With ...",
            "country": "View results",
            "timestamp": "2012-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003799-35/ES",
            "title": "Comparison of two antiretroviral regimens in HIV Post-exposure Prophylaxis: TDF-FTC (Truvada®) + Lopinavir/ritonavir (kaletra®) versus TDF-FTC (Truvada®) + raltegravir (Isentress®)",
            "country": "ES",
            "timestamp": "2012-01-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN87590288",
            "timestamp": "2012-01-04",
            "title": "The effect of ivabradine on hemodynamics in patients with chronic heart failure"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002812-10/DE",
            "title": "A prospective, randomised, open-label phase IIb clinical trial assessing the effect of pegylated Interferon alfa-2a (Pegasys®) 180 µg once weekly for 48 weeks in addition to an ongoing nucelos(t)id...",
            "country": "DE",
            "timestamp": "2012-01-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002178-22/ES",
            "title": "A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose-finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in ...",
            "country": "ES",
            "timestamp": "2011-12-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002178-22/CZ",
            "title": "A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose-finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in ...",
            "country": "CZ",
            "timestamp": "2011-12-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002178-22/PL",
            "title": "A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose-finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in ...",
            "country": "PL",
            "timestamp": "2011-12-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002178-22/GB",
            "title": "A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose-finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in ...",
            "country": "GB",
            "timestamp": "2011-12-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/ES",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "ES",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/CZ",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "CZ",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/DE",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "DE",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/HU",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "HU",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/SK",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "SK",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/BG",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "BG",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023782-22/results",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU...",
            "country": "View results",
            "timestamp": "2011-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003447-21/GB",
            "title": "Randomised controlled trial of the tolerability and completion of maraviroc compared to Kaletra© in combination with Truvada© for HIV post-exposure prophylaxis",
            "country": "GB",
            "timestamp": "2011-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003447-21/results",
            "title": "Randomised controlled trial of the tolerability and completion of maraviroc compared to Kaletra© in combination with Truvada© for HIV post-exposure prophylaxis",
            "country": "View results",
            "timestamp": "2011-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004268-31/DK",
            "title": "Adalimumab (Humira) in the treatment of chronic pouchitis",
            "country": "DK",
            "timestamp": "2011-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022455-31/GB",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 with Ritonavir (ABT 450/r) in Combination with ABT-267 and/or ABT 333 With a...",
            "country": "GB",
            "timestamp": "2011-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022455-31/ES",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 with Ritonavir (ABT 450/r) in Combination with ABT-267 and/or ABT 333 With a...",
            "country": "ES",
            "timestamp": "2011-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022455-31/results",
            "title": "A Randomized, Open-Label, Multicenter Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics, of ABT-450 with Ritonavir (ABT 450/r) in Combination with ABT-267 and/or ABT 333 With a...",
            "country": "View results",
            "timestamp": "2011-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002715-28/GB",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL\r\nGROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE\r\nOF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN\r\nCOMBINATION WITH TELAPRE...",
            "country": "GB",
            "timestamp": "2011-12-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002715-28/DE",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL\r\nGROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE\r\nOF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN\r\nCOMBINATION WITH TELAPRE...",
            "country": "DE",
            "timestamp": "2011-12-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002715-28/ES",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL\r\nGROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE\r\nOF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN\r\nCOMBINATION WITH TELAPRE...",
            "country": "ES",
            "timestamp": "2011-12-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002715-28/IT",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL\r\nGROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE\r\nOF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN\r\nCOMBINATION WITH TELAPRE...",
            "country": "IT",
            "timestamp": "2011-12-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002715-28/results",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL\r\nGROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE\r\nOF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN\r\nCOMBINATION WITH TELAPRE...",
            "country": "View results",
            "timestamp": "2011-12-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000436-28/PL",
            "title": "A PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, RANDOMIZED WITHDRAWAL DESIGN TRIAL USING ADAPTIVE RANDOMIZATION COMPARING Z102 WITH PLACEBO IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOI...",
            "country": "PL",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000436-28/HU",
            "title": "A PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, RANDOMIZED WITHDRAWAL DESIGN TRIAL USING ADAPTIVE RANDOMIZATION COMPARING Z102 WITH PLACEBO IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOI...",
            "country": "HU",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000436-28/BG",
            "title": "A PHASE II, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, RANDOMIZED WITHDRAWAL DESIGN TRIAL USING ADAPTIVE RANDOMIZATION COMPARING Z102 WITH PLACEBO IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOI...",
            "country": "BG",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/DE",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "DE",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/HU",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "HU",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/SE",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "SE",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/FI",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "FI",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/BE",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "BE",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/ES",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "ES",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/GB",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "GB",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/AT",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "AT",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/DK",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "DK",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/NL",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "NL",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/PT",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "PT",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/PL",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "PL",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/IT",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "IT",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021785-30/results",
            "title": "A MULTICENTER, RANDOMIZED, DOUBLE BLIND, COMPARATIVE TRIAL OF MARAVIROC + DARUNAVIR/RITONAVIR VERSUS EMTRICITABINE/TENOFOVIR + DARUNAVIR/RITONAVIR FOR THE TREATMENT OF ANTIRETROVIRAL NAÏVE HIV INFE...",
            "country": "View results",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005270-35/IT",
            "title": "HIV-infected pregnant women treated with HAART: registry of pharmacokinetic  parameters of new and commonly used antiretrovirals",
            "country": "IT",
            "timestamp": "2011-12-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003570-89/NL",
            "title": "The effect of interferon beta-1a treatment on functional adaptation in Multiple Sclerosis (MS)",
            "country": "NL",
            "timestamp": "2011-12-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002748-28/DE",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) Compared with GS-5885, GS-9451 with Tegobuvir or RBV in Treatment-Experienced Subject...",
            "country": "DE",
            "timestamp": "2011-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002748-28/results",
            "title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) Compared with GS-5885, GS-9451 with Tegobuvir or RBV in Treatment-Experienced Subject...",
            "country": "View results",
            "timestamp": "2011-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003298-26/NL",
            "title": "A phase IV, randomized, open label, cross-over, intervention trial to investigate the effect of the switch of lopinavir-ritonavir to raltegravir on endothelial function, chronic inflammation, immun...",
            "country": "NL",
            "timestamp": "2011-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-005036-26/GB",
            "title": "An Exploratory Phase IIa Study to Investigate the Biological Activity of Oral FX125L in Adult Patients with Chronic Inflammatory Disease",
            "country": "GB",
            "timestamp": "2011-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004464-30/ES",
            "title": "Impact of Raltegravir Intensification on HIV-1-infected Subjects with Complete Viral Suppression under Monotherapy with Protease Inhibitors. A 24-week controlled, open-label, proof-of-concept pilot...",
            "country": "ES",
            "timestamp": "2011-11-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/DE",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "DE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/GB",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "GB",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/FR",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "FR",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/CZ",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "CZ",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/HU",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "HU",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/PL",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "PL",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/IT",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "IT",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/AT",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "AT",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/SE",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "SE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/ES",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "ES",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/EE",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "EE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/NL",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "NL",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/BE",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "BE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000945-19/results",
            "title": "A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "View results",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/DE",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "DE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/GB",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "GB",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/FR",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "FR",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/CZ",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "CZ",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/HU",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "HU",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/PL",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "PL",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/AT",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "AT",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/SE",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "SE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/ES",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "ES",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/EE",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "EE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/NL",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "NL",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/BE",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "BE",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000946-39/results",
            "title": "A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection",
            "country": "View results",
            "timestamp": "2011-11-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001878-25/BG",
            "title": "A Randomized, Double-Blind Study to Evaluate the Safety and Antiviral Activity of IDX184 in Combination with Pegylated Interferon and Ribavirin for 12 Weeks in Treatment-Naïve Subjects with Genotyp...",
            "country": "BG",
            "timestamp": "2011-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001878-25/results",
            "title": "A Randomized, Double-Blind Study to Evaluate the Safety and Antiviral Activity of IDX184 in Combination with Pegylated Interferon and Ribavirin for 12 Weeks in Treatment-Naïve Subjects with Genotyp...",
            "country": "View results",
            "timestamp": "2011-11-17"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14027467",
            "timestamp": "2011-11-16",
            "title": "Radical cure of vivax malaria"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004693-29/IT",
            "title": "Pegylated interferon alfa-2a USE FOR CONTROLLING virological rebound after suspension of antiretroviral treatment  IN PATIENTS WITH CHRONIC HIV INFECTION",
            "country": "IT",
            "timestamp": "2011-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002041-36/GB",
            "title": "A Randomized, Double-Blind, Multi-Center Phase 3 Study of ADI-PEG\r\n20 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in\r\nSubjects With Advanced Hepatocellular Carcinoma (HCC) Who Have\r\nFai...",
            "country": "GB",
            "timestamp": "2011-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002041-36/IT",
            "title": "A Randomized, Double-Blind, Multi-Center Phase 3 Study of ADI-PEG\r\n20 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in\r\nSubjects With Advanced Hepatocellular Carcinoma (HCC) Who Have\r\nFai...",
            "country": "IT",
            "timestamp": "2011-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003475-11/GB",
            "title": "A phase II double-blind, randomised, placebo-controlled trial of neuroprotection with phenytoin in acute optic neuritis",
            "country": "GB",
            "timestamp": "2011-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003475-11/results",
            "title": "A phase II double-blind, randomised, placebo-controlled trial of neuroprotection with phenytoin in acute optic neuritis",
            "country": "View results",
            "timestamp": "2011-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023498-20/GB",
            "title": "Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)",
            "country": "GB",
            "timestamp": "2011-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023498-20/PL",
            "title": "Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)",
            "country": "PL",
            "timestamp": "2011-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023498-20/ES",
            "title": "Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)",
            "country": "ES",
            "timestamp": "2011-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023498-20/DE",
            "title": "Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)",
            "country": "DE",
            "timestamp": "2011-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023498-20/3rd",
            "title": "Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)",
            "country": "Outside EU/EEA",
            "timestamp": "2011-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023498-20/results",
            "title": "Assessment of the Pharmacokinetics of Boceprevir in Pediatric Subjects with Chronic Hepatitis C Genotype 1 (Phase 1b)",
            "country": "View results",
            "timestamp": "2011-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003299-36/IT",
            "title": "A Randomized, Partially Double-Blind, Active-Controlled, Dose-Ranging  Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of  Different Regimens of MK-5172 When Administered Concom...",
            "country": "IT",
            "timestamp": "2011-11-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003299-36/results",
            "title": "A Randomized, Partially Double-Blind, Active-Controlled, Dose-Ranging  Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of  Different Regimens of MK-5172 When Administered Concom...",
            "country": "View results",
            "timestamp": "2011-11-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001913-14/GB",
            "title": "A randomized crossover study of the effects of zinc sulphate supplementation on atazanavir/ritonavir-associated hyperbilirubinemia",
            "country": "GB",
            "timestamp": "2011-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002714-37/DE",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL GROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE OF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN COMBINATION WITH BOCEPREVIR...",
            "country": "DE",
            "timestamp": "2011-11-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002714-37/ES",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL GROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE OF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN COMBINATION WITH BOCEPREVIR...",
            "country": "ES",
            "timestamp": "2011-11-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002714-37/IT",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL GROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE OF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN COMBINATION WITH BOCEPREVIR...",
            "country": "IT",
            "timestamp": "2011-11-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002714-37/results",
            "title": "A PHASE II, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PARALLEL GROUP STUDY TO EVALUATE THE SUSTAINED VIROLOGIC RESPONSE OF THE HCV POLYMERASE INHIBITOR PRODRUG RO5024048 IN COMBINATION WITH BOCEPREVIR...",
            "country": "View results",
            "timestamp": "2011-11-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021337-31/GB",
            "title": "A Phase III open-label study to evaluate the safety, tolerability and efficacy of TMC435 plus PegIFNα-2a (Pegasys) and ribavirin (Copegus) triple therapy in chronic hepatitis C genotype-1 infected ...",
            "country": "GB",
            "timestamp": "2011-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021337-31/ES",
            "title": "A Phase III open-label study to evaluate the safety, tolerability and efficacy of TMC435 plus PegIFNα-2a (Pegasys) and ribavirin (Copegus) triple therapy in chronic hepatitis C genotype-1 infected ...",
            "country": "ES",
            "timestamp": "2011-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021337-31/PT",
            "title": "A Phase III open-label study to evaluate the safety, tolerability and efficacy of TMC435 plus PegIFNα-2a (Pegasys) and ribavirin (Copegus) triple therapy in chronic hepatitis C genotype-1 infected ...",
            "country": "PT",
            "timestamp": "2011-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021337-31/results",
            "title": "A Phase III open-label study to evaluate the safety, tolerability and efficacy of TMC435 plus PegIFNα-2a (Pegasys) and ribavirin (Copegus) triple therapy in chronic hepatitis C genotype-1 infected ...",
            "country": "View results",
            "timestamp": "2011-11-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN19562321",
            "timestamp": "2011-11-03",
            "title": "Clinical trial to assess the importance of nephrectomy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003484-30/ES",
            "title": "A multi-centre, open-label, non-randomised, parallel group clinical trial to assess the efficacy of fingolimod in naïve patients versus fingolimod in patients previously treated with interferons or...",
            "country": "ES",
            "timestamp": "2011-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-003484-30/results",
            "title": "A multi-centre, open-label, non-randomised, parallel group clinical trial to assess the efficacy of fingolimod in naïve patients versus fingolimod in patients previously treated with interferons or...",
            "country": "View results",
            "timestamp": "2011-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002853-77/ES",
            "title": "PROSPECTIVE, RANDOMISED, CROSSOVER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE LIPID-LOWERING EFFECT OF ADDING TENOFOVIR/EMTRICITABINE CO-FORMULATION VS PLACEBO TO HIV-1-INFECTED SUBJECTS...",
            "country": "ES",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002853-77/results",
            "title": "PROSPECTIVE, RANDOMISED, CROSSOVER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE LIPID-LOWERING EFFECT OF ADDING TENOFOVIR/EMTRICITABINE CO-FORMULATION VS PLACEBO TO HIV-1-INFECTED SUBJECTS...",
            "country": "View results",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023749-30/IT",
            "title": "Studio PKCT - Pharmacokinetics of chemotherapy when given concurrently with antiretroviral (Protocol no. CSL01).",
            "country": "IT",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023749-30/results",
            "title": "Studio PKCT - Pharmacokinetics of chemotherapy when given concurrently with antiretroviral (Protocol no. CSL01).",
            "country": "View results",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/GB",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "GB",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/CZ",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "CZ",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/LV",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "LV",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/HU",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "HU",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/FI",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "FI",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/DE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "DE",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/BE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "BE",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/SK",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "SK",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/AT",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "AT",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/NL",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "NL",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/LT",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "LT",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/EE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "EE",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/PT",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "PT",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/BG",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "BG",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/ES",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "ES",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/PL",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "PL",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/IT",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "IT",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020337-99/results",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "View results",
            "timestamp": "2011-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/SK",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "SK",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/BE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "BE",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/SE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "SE",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/DE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "DE",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/ES",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "ES",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/GB",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "GB",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/BG",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "BG",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/FR",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "FR",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/IE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "IE",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/IT",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "IT",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/CZ",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "CZ",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020315-36/results",
            "title": "A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Comparison To Interferon Beta-1a (Rebif®) In Patients With Relapsing Multiple Sc...",
            "country": "View results",
            "timestamp": "2011-10-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001060-21/IT",
            "title": "Safety and efficacy of switching a stable combined antiretroviral therapeutic regimen to atazanavir with ritonavir plus lamivudine in treatment experienced HIV positive patients with full and stabl...",
            "country": "IT",
            "timestamp": "2011-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022092-65/DE",
            "title": "A phase IIa, randomized, double-blind (subject and investigator blind, sponsor open) placebo-controlled trial to evaluate the safety, tolerability and antiviral activity of oral ACH-0141625 in comb...",
            "country": "DE",
            "timestamp": "2011-10-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022092-65/BE",
            "title": "A phase IIa, randomized, double-blind (subject and investigator blind, sponsor open) placebo-controlled trial to evaluate the safety, tolerability and antiviral activity of oral ACH-0141625 in comb...",
            "country": "BE",
            "timestamp": "2011-10-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022092-65/results",
            "title": "A phase IIa, randomized, double-blind (subject and investigator blind, sponsor open) placebo-controlled trial to evaluate the safety, tolerability and antiviral activity of oral ACH-0141625 in comb...",
            "country": "View results",
            "timestamp": "2011-10-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002911-27/IT",
            "title": "Effect of boceprevir therapy on HCV-specific T cell responses: perspectives of immune monitoring and immune therapy",
            "country": "IT",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/IE",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "IE",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/GB",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "GB",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/ES",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "ES",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/SE",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "SE",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/DK",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "DK",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/IT",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "IT",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/AT",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "AT",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/NL",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "NL",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/GR",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "GR",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000836-27/results",
            "title": "An Open-Label Re-treatment Study with Peg-Interferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Subjects With Chronic Hepatitis C\r\nRevised Protocol Number 05; Incorporates Ame...",
            "country": "View results",
            "timestamp": "2011-09-30"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN54001953",
            "timestamp": "2011-09-29",
            "title": "Effect of MIFepristone on COGnitive impairment in alcoholics"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002069-39/ES",
            "title": "Comparación de dos combinaciones de antirretrovirales en la Profilaxis Post-Exposición al VIH-1: TDF-FTC (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs TDF-FTC (Truvada ®) + Maraviroc (Celsentri ...",
            "country": "ES",
            "timestamp": "2011-09-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001919-31/DK",
            "title": "DALIAH\r\n\r\nA Danish Study of Low-dose Interferon Alpha Versus Hydroxyurea in the Treatment of Ph-negative Chronic Myeloid Neoplasias - A National Randomized Prospective Study With Focus on Efficacy,...",
            "country": "DK",
            "timestamp": "2011-09-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024152-29/DE",
            "title": "Canakinumab for Behçet`s Disease Resistant to Standard Treatment\r\n(CanBeDisT)",
            "country": "DE",
            "timestamp": "2011-09-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000385-35/IT",
            "title": "MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE PREDICTABILITY OF EARLY RESPONSE TO CERTOLIZUMAB PEGOL (IN COMBINATION WITH METHOTREXATE) AS CONFIRMED AT WEEK 52 IN SUBJECTS WITH MODERATE-SEVERE RHEU...",
            "country": "IT",
            "timestamp": "2011-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000385-35/results",
            "title": "MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE PREDICTABILITY OF EARLY RESPONSE TO CERTOLIZUMAB PEGOL (IN COMBINATION WITH METHOTREXATE) AS CONFIRMED AT WEEK 52 IN SUBJECTS WITH MODERATE-SEVERE RHEU...",
            "country": "View results",
            "timestamp": "2011-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021622-35/DE",
            "title": "A monocenter, non-controlled, non-randomized IST to compare bioavailability of Kaletra softgelcapsules or -suspension to Kaletra tablets in pediatric patients – C2T",
            "country": "DE",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021734-59/GB",
            "title": "Safety and Efficacy of 240 mg BI 201335 once daily in combination\r\nwith pegylated interferon alpha 2a and ribavirin for treatment of chronic\r\nHepatitis C (HCV) genotype 1 infection in HIV/HCV-co-in...",
            "country": "GB",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021734-59/ES",
            "title": "Safety and Efficacy of 240 mg BI 201335 once daily in combination\r\nwith pegylated interferon alpha 2a and ribavirin for treatment of chronic\r\nHepatitis C (HCV) genotype 1 infection in HIV/HCV-co-in...",
            "country": "ES",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021734-59/DE",
            "title": "Safety and Efficacy of 240 mg BI 201335 once daily in combination\r\nwith pegylated interferon alpha 2a and ribavirin for treatment of chronic\r\nHepatitis C (HCV) genotype 1 infection in HIV/HCV-co-in...",
            "country": "DE",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021734-59/IT",
            "title": "Safety and Efficacy of 240 mg BI 201335 once daily in combination\r\nwith pegylated interferon alpha 2a and ribavirin for treatment of chronic\r\nHepatitis C (HCV) genotype 1 infection in HIV/HCV-co-in...",
            "country": "IT",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021734-59/results",
            "title": "Safety and Efficacy of 240 mg BI 201335 once daily in combination\r\nwith pegylated interferon alpha 2a and ribavirin for treatment of chronic\r\nHepatitis C (HCV) genotype 1 infection in HIV/HCV-co-in...",
            "country": "View results",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001071-40/AT",
            "title": "A Phase IIa Safety study of oral administration of anti-CD3 monoclonal antibody in non-responder genotype-I chronic Hepatitis C subjects, a single-blind, randomized, controlled multi-center study",
            "country": "AT",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001071-40/PL",
            "title": "A Phase IIa Safety study of oral administration of anti-CD3 monoclonal antibody in non-responder genotype-I chronic Hepatitis C subjects, a single-blind, randomized, controlled multi-center study",
            "country": "PL",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001550-29/ES",
            "title": "A Phase II randomized double-blind study of Santostatin LAR in combination with Axitinib versus Placebo in patients with progressive advanced well-differentiated neuroendocrine carcinomas of non-pa...",
            "country": "ES",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001550-29/DE",
            "title": "A Phase II randomized double-blind study of Santostatin LAR in combination with Axitinib versus Placebo in patients with progressive advanced well-differentiated neuroendocrine carcinomas of non-pa...",
            "country": "DE",
            "timestamp": "2011-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000944-43/DE",
            "title": "A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly with GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naive Subjects with Chronic Genotype 1 HCV Infection",
            "country": "DE",
            "timestamp": "2011-08-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000944-43/results",
            "title": "A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly with GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naive Subjects with Chronic Genotype 1 HCV Infection",
            "country": "View results",
            "timestamp": "2011-08-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024652-28/ES",
            "title": "Estudio para evaluar la actividad y la tolerabilidad de la biterapia con lopinavir/ritonavir y 3TC en sustitución de una triple terapia que incluya lopinavir/ritonavir y 3TC ó FTC en pacientes con ...",
            "country": "ES",
            "timestamp": "2011-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017032-41/GB",
            "title": "An Open-Label, Randomized Study Evaluating a Switch from a Regimen of Two Nucleoside Reverse Transcriptase Inhibitors plus any Third Agent to either a Regimen of Atazanavir/Ritonavir Once Daily and...",
            "country": "GB",
            "timestamp": "2011-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017032-41/DE",
            "title": "An Open-Label, Randomized Study Evaluating a Switch from a Regimen of Two Nucleoside Reverse Transcriptase Inhibitors plus any Third Agent to either a Regimen of Atazanavir/Ritonavir Once Daily and...",
            "country": "DE",
            "timestamp": "2011-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017032-41/ES",
            "title": "An Open-Label, Randomized Study Evaluating a Switch from a Regimen of Two Nucleoside Reverse Transcriptase Inhibitors plus any Third Agent to either a Regimen of Atazanavir/Ritonavir Once Daily and...",
            "country": "ES",
            "timestamp": "2011-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017032-41/PL",
            "title": "An Open-Label, Randomized Study Evaluating a Switch from a Regimen of Two Nucleoside Reverse Transcriptase Inhibitors plus any Third Agent to either a Regimen of Atazanavir/Ritonavir Once Daily and...",
            "country": "PL",
            "timestamp": "2011-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017032-41/IT",
            "title": "An Open-Label, Randomized Study Evaluating a Switch from a Regimen of Two Nucleoside Reverse Transcriptase Inhibitors plus any Third Agent to either a Regimen of Atazanavir/Ritonavir Once Daily and...",
            "country": "IT",
            "timestamp": "2011-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017032-41/results",
            "title": "An Open-Label, Randomized Study Evaluating a Switch from a Regimen of Two Nucleoside Reverse Transcriptase Inhibitors plus any Third Agent to either a Regimen of Atazanavir/Ritonavir Once Daily and...",
            "country": "View results",
            "timestamp": "2011-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022413-26/DE",
            "title": "Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (IDEAL-Study)",
            "country": "DE",
            "timestamp": "2011-07-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN53253537",
            "timestamp": "2011-07-29",
            "title": "Study to compare two methods of treatment to prevent active tuberculosis (TB) in children"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN03274575",
            "timestamp": "2011-07-28",
            "title": "Enhanced recovery in liver resection surgery"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001303-13/DE",
            "title": "HIV postexposure prophylaxis with Darunavir/r (PEPDar)",
            "country": "DE",
            "timestamp": "2011-07-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001303-13/results",
            "title": "HIV postexposure prophylaxis with Darunavir/r (PEPDar)",
            "country": "View results",
            "timestamp": "2011-07-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001107-12/ES",
            "title": "Ensayo Clínico aleatorizado, abierto, de no inferioridad y con seguimiento a 96 semanas sobre la eficacia de azatanavir / ritonavir  + lamivudina como tratamiento de mantenimiento en pacientes con ...",
            "country": "ES",
            "timestamp": "2011-07-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000759-18/DE",
            "title": "A Randomized, Active-Controlled Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon ...",
            "country": "DE",
            "timestamp": "2011-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000759-18/BE",
            "title": "A Randomized, Active-Controlled Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon ...",
            "country": "BE",
            "timestamp": "2011-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000759-18/IT",
            "title": "A Randomized, Active-Controlled Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon ...",
            "country": "IT",
            "timestamp": "2011-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000759-18/results",
            "title": "A Randomized, Active-Controlled Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon ...",
            "country": "View results",
            "timestamp": "2011-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001220-38/GB",
            "title": "A multicenter, 12 week, randomized, double-blind, placebo-controlled biomarker study of secukinumab (AIN457) in rheumatoid arthritis patients followed by an open label extension",
            "country": "GB",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001220-38/DE",
            "title": "A multicenter, 12 week, randomized, double-blind, placebo-controlled biomarker study of secukinumab (AIN457) in rheumatoid arthritis patients followed by an open label extension",
            "country": "DE",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001220-38/BE",
            "title": "A multicenter, 12 week, randomized, double-blind, placebo-controlled biomarker study of secukinumab (AIN457) in rheumatoid arthritis patients followed by an open label extension",
            "country": "BE",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001220-38/results",
            "title": "A multicenter, 12 week, randomized, double-blind, placebo-controlled biomarker study of secukinumab (AIN457) in rheumatoid arthritis patients followed by an open label extension",
            "country": "View results",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/GB",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "GB",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/PT",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "PT",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/BE",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "BE",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/DE",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "DE",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/AT",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "AT",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/ES",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "ES",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021715-17/results",
            "title": "A phase III, randomised, double-blind and placebo controlled study of once daily BI 201335, 240 mg for 12 or 24 weeks in combination with pegylated interferon-α and ribavirin in patients with genot...",
            "country": "View results",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/GB",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "GB",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/PT",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "PT",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/DE",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "DE",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/AT",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "AT",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/BE",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "BE",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/ES",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "ES",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000141-20/results",
            "title": "A phase III, open-label study of once daily BI 201335 240 mg for 24 weeks in combination with pegylated interferon-α (PegIFN) and ribavirin (RBV) in patients with genotype 1 chronic hepatitis C inf...",
            "country": "View results",
            "timestamp": "2011-07-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN04929580",
            "timestamp": "2011-07-12",
            "title": "In vivo changes in haemostasis after intravenous administration of plasma-derived factor VII and recombinant factor VII(a)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024537-23/GB",
            "title": "A Prospective Single Arm, Open-Label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder boosted with Ritonavir (RTV) with an Optimize...",
            "country": "GB",
            "timestamp": "2011-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024537-23/PL",
            "title": "A Prospective Single Arm, Open-Label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder boosted with Ritonavir (RTV) with an Optimize...",
            "country": "PL",
            "timestamp": "2011-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024537-23/ES",
            "title": "A Prospective Single Arm, Open-Label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder boosted with Ritonavir (RTV) with an Optimize...",
            "country": "ES",
            "timestamp": "2011-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024537-23/3rd",
            "title": "A Prospective Single Arm, Open-Label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder boosted with Ritonavir (RTV) with an Optimize...",
            "country": "Outside EU/EEA",
            "timestamp": "2011-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024537-23/results",
            "title": "A Prospective Single Arm, Open-Label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder boosted with Ritonavir (RTV) with an Optimize...",
            "country": "View results",
            "timestamp": "2011-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001943-60/DK",
            "title": "Cellular immunity in adult Hepatitis B-vaccinated serologic non-responders",
            "country": "DK",
            "timestamp": "2011-06-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000107-40/GB",
            "title": "A Phase IIb, 12 week Randomized, Double-Blind, Parallel Group, Placebo-Controlled study to evaluate Efficacy, Safety and Tolerability of 2, 4 and 6 mg of Revamilast in patients with Active Rheumato...",
            "country": "GB",
            "timestamp": "2011-06-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000107-40/results",
            "title": "A Phase IIb, 12 week Randomized, Double-Blind, Parallel Group, Placebo-Controlled study to evaluate Efficacy, Safety and Tolerability of 2, 4 and 6 mg of Revamilast in patients with Active Rheumato...",
            "country": "View results",
            "timestamp": "2011-06-16"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN46445413",
            "timestamp": "2011-06-09",
            "title": "Hydroxychloroquine (HCQ) in patients with inflammatory osteoarthritis (OA) of the hands"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001956-12/CZ",
            "title": "Monitoring of MxA mRNA Expression as a Marker of Rresponse to Interferon ß Therapy in Patients with Multiple Sclerosis.",
            "country": "CZ",
            "timestamp": "2011-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023316-13/IT",
            "title": "Randomized multicenter study on security and efficacy of therapeutic switch to maraviroc + darunavir/ritonavir once daily  in patients who are in triple antiretroviral regimen with three drugs belo...",
            "country": "IT",
            "timestamp": "2011-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000728-14/NL",
            "title": "A Phase 2a, Randomized, Open-Label Study in Patients with Chronic Hepatitis C Viral Infection to Assess the Safety, Tolerability, Pharmacodynamics, and Antiviral Activity of ANA773 Tosylate Adminis...",
            "country": "NL",
            "timestamp": "2011-05-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/LV",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "LV",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/BE",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "BE",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/DE",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "DE",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/ES",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "ES",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/BG",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "BG",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/EE",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "EE",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/GB",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "GB",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/GR",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "GR",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/CZ",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "CZ",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024477-39/results",
            "title": "A Dose-Frequency Blinded, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis",
            "country": "View results",
            "timestamp": "2011-05-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14095893",
            "timestamp": "2011-05-06",
            "title": "Addition of Ipilumimab to Carboplatin and Etoposide chemotherapy for the first line treatment of extensive small cell lung cancer"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019585-90/AT",
            "title": "A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (Danoprevir/r) and Copegus®, in Com...",
            "country": "AT",
            "timestamp": "2011-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019585-90/DE",
            "title": "A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (Danoprevir/r) and Copegus®, in Com...",
            "country": "DE",
            "timestamp": "2011-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019585-90/GB",
            "title": "A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (Danoprevir/r) and Copegus®, in Com...",
            "country": "GB",
            "timestamp": "2011-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019585-90/IT",
            "title": "A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (Danoprevir/r) and Copegus®, in Com...",
            "country": "IT",
            "timestamp": "2011-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019585-90/ES",
            "title": "A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (Danoprevir/r) and Copegus®, in Com...",
            "country": "ES",
            "timestamp": "2011-05-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN01946535",
            "timestamp": "2011-04-28",
            "title": "Children with HIV in Africa - Pharmacokinetics and Adherence of Simple Antiretroviral Regimens (CHAPAS-2)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022568-11/DE",
            "title": "A Phase 2B, randomized study to evaluate the safety and efficacy of Pegylated Interferon Lambda (BMS-914143) administered with Ribavirin plus a single direct antiviral agent (BMS-790052 or BMS-6500...",
            "country": "DE",
            "timestamp": "2011-04-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022568-11/IT",
            "title": "A Phase 2B, randomized study to evaluate the safety and efficacy of Pegylated Interferon Lambda (BMS-914143) administered with Ribavirin plus a single direct antiviral agent (BMS-790052 or BMS-6500...",
            "country": "IT",
            "timestamp": "2011-04-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022568-11/ES",
            "title": "A Phase 2B, randomized study to evaluate the safety and efficacy of Pegylated Interferon Lambda (BMS-914143) administered with Ribavirin plus a single direct antiviral agent (BMS-790052 or BMS-6500...",
            "country": "ES",
            "timestamp": "2011-04-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022568-11/results",
            "title": "A Phase 2B, randomized study to evaluate the safety and efficacy of Pegylated Interferon Lambda (BMS-914143) administered with Ribavirin plus a single direct antiviral agent (BMS-790052 or BMS-6500...",
            "country": "View results",
            "timestamp": "2011-04-20"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN36672232",
            "timestamp": "2011-04-15",
            "title": "Polypill Prevention Trial 1"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN14703590",
            "timestamp": "2011-04-15",
            "title": "The effect of a Bacterial Extract on Asthma Control (BEAC)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023901-36/DE",
            "title": "Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study)\n- as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of ski...",
            "country": "DE",
            "timestamp": "2011-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022103-21/DE",
            "title": "Neoadjuvant treatment of locoregional metastases in malignant melanoma (AJCC stage IIIB/C) with Multiferon: a phase IIa DeCOG trial",
            "country": "DE",
            "timestamp": "2011-04-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007346-63/GB",
            "title": "Reumap: An Open Label phase II study of Bovine Intestinal Alkaline Phosphatase (bIAP), An Inflammation modulating moiety, in RA patients",
            "country": "GB",
            "timestamp": "2011-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/BE",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "BE",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/DE",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "DE",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/GB",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "GB",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/SE",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "SE",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/AT",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "AT",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/IE",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "IE",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/PL",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "PL",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/ES",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "ES",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/IT",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "IT",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021628-84/results",
            "title": "A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genot...",
            "country": "View results",
            "timestamp": "2011-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023602-12/IT",
            "title": "A FEASIBILITY STUDY EVALUATING THE EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR (HCC) CARCINOMA AND HIV INFECTION TREATED WITH HAART REGIMENS",
            "country": "IT",
            "timestamp": "2011-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023910-30/GB",
            "title": "A Prospective, Single-centre, Randomised Study Evaluating the Clinical, Imaging and Immunological Depth of Remission Achieved by Very Early versus Delayed Etanercept in patients with Rheumatoid Art...",
            "country": "GB",
            "timestamp": "2011-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023677-19/IT",
            "title": "Bio-molecular effects of interferon-beta and d-vitamin association",
            "country": "IT",
            "timestamp": "2011-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023560-40/SE",
            "title": "Haematopoetic Stem Cell Therapy for Patients with Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study",
            "country": "SE",
            "timestamp": "2011-03-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021651-79/IT",
            "title": "Studio degli effetti immuno-virologici dell’interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc",
            "country": "IT",
            "timestamp": "2011-03-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024515-13/NL",
            "title": "Phase 1-2 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer.",
            "country": "NL",
            "timestamp": "2011-03-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022589-29/GB",
            "title": "Investigation of pathways regulating cell survival and early antiangiogenic response to single agent Everolimus or Rapamycin in renal cancer",
            "country": "GB",
            "timestamp": "2011-03-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024017-31/IT",
            "title": "A 6-month, Randomized, Active Comparator, Open-label, Multi-Center Study to Evaluate Patient OutComes, Safety and Tolerability of Fingolimod (FTY720) 0.5 mg/day in Patients with Relapsing Remitting...",
            "country": "IT",
            "timestamp": "2011-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-024017-31/results",
            "title": "A 6-month, Randomized, Active Comparator, Open-label, Multi-Center Study to Evaluate Patient OutComes, Safety and Tolerability of Fingolimod (FTY720) 0.5 mg/day in Patients with Relapsing Remitting...",
            "country": "View results",
            "timestamp": "2011-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/PT",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "PT",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/BE",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "BE",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/GB",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "GB",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/DE",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "DE",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/ES",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "ES",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/AT",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "AT",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021716-42/results",
            "title": "A phase III, randomised, double-blind and placebo-controlled study of once daily BI 201335 120 mg for 12 or 24 weeks or BI 201335 240 mg for 12 weeks in combination with pegylated interferon-α and ...",
            "country": "View results",
            "timestamp": "2011-03-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022302-41/ES",
            "title": "Ensayo clínico prospectivo, aleatorizado, comparativo de la eficacia y seguridad del levofloxacino versus isoniazida en el tratamiento de la infección latente tuberculosa del trasplante hepático",
            "country": "ES",
            "timestamp": "2011-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023124-24/NL",
            "title": "Chemo-Immunotherapy, gemcitabine with pegylated interferon alpha-2b (Peg-Intron) with and without p53 synthetic long peptide (p53 SLP) vaccine, for patients with platinum resistant ovarian cancer.\n...",
            "country": "NL",
            "timestamp": "2011-03-02"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12205188",
            "timestamp": "2011-02-28",
            "title": "ADOPT"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/ES",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "ES",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/DE",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "DE",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/CZ",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "CZ",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/GB",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "GB",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/SK",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "SK",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/AT",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "AT",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/BE",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "BE",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/EE",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "EE",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/LT",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "LT",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/GR",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "GR",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/BG",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "BG",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/IT",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "IT",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023156-89/results",
            "title": "Ensayo clínico en fase III, aleatorizado y controlado con placebo para estudiar la seguridad y la eficacia de V212 en pacientes adultos con tumor sólido o neoplasia hematológica.\n\nA Phase III Rando...",
            "country": "View results",
            "timestamp": "2011-02-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN71212110",
            "timestamp": "2011-02-23",
            "title": "Prospective clinical study in children with severe haemophilia A to investigate clinical efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIII"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020423-51/DE",
            "title": "Remission Induction by Etanercept in Enthesitis related Arthritis JIA-Patients (juvenile undifferentiated Spondylarthropathy)",
            "country": "DE",
            "timestamp": "2011-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022067-35/DE",
            "title": "INFORM-SVR: A Randomized, Multi-Center Study of Interferon-Free Treatment with a Combination of a Polymerase Inhibitor (RO5024048) and a Ritonavir boosted HCV Protease\r\nInhibitor (RO5190591/r, DNV/...",
            "country": "DE",
            "timestamp": "2011-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022067-35/results",
            "title": "INFORM-SVR: A Randomized, Multi-Center Study of Interferon-Free Treatment with a Combination of a Polymerase Inhibitor (RO5024048) and a Ritonavir boosted HCV Protease\r\nInhibitor (RO5190591/r, DNV/...",
            "country": "View results",
            "timestamp": "2011-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/NL",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "NL",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/HU",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "HU",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/BE",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "BE",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/SE",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "SE",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/EE",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "EE",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/GB",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "GB",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/SK",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "SK",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/ES",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "ES",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/NO",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "NO",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/DE",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "DE",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/FI",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "FI",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/GR",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "GR",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/PT",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "PT",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/IT",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "IT",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/AT",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "AT",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/DK",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "DK",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/LT",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "LT",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023172-12/results",
            "title": "A multi-center double-blind parallel-group placebo-controlled study of the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis who are treated with interferon-beta.",
            "country": "View results",
            "timestamp": "2011-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/BE",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "BE",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/DE",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "DE",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/ES",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "ES",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/GB",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "GB",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/IT",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "IT",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/NL",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "NL",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/HU",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "HU",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020807-57/results",
            "title": "Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK iNhibitor INC424 tablets verSus bEst ...",
            "country": "View results",
            "timestamp": "2011-02-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/GB",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "GB",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/DE",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "DE",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/ES",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "ES",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/BE",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "BE",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/IT",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "IT",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/AT",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "AT",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023178-37/results",
            "title": "A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/...",
            "country": "View results",
            "timestamp": "2011-02-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023245-30/IT",
            "title": "Treatment with Peg-interferon alfa-2a and ribavirin in patients with hepatitis HCV-related, with or without HIV co-infection, and end stage renal disease on dialysis",
            "country": "IT",
            "timestamp": "2011-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016361-28/PL",
            "title": "A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the\nSafety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted with\nRitonavir (RTV) Liquid with an O...",
            "country": "PL",
            "timestamp": "2011-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016361-28/IT",
            "title": "A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the\nSafety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted with\nRitonavir (RTV) Liquid with an O...",
            "country": "IT",
            "timestamp": "2011-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016361-28/3rd",
            "title": "A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the\nSafety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted with\nRitonavir (RTV) Liquid with an O...",
            "country": "Outside EU/EEA",
            "timestamp": "2011-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016361-28/results",
            "title": "A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the\nSafety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted with\nRitonavir (RTV) Liquid with an O...",
            "country": "View results",
            "timestamp": "2011-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022248-19/SE",
            "title": "An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination ...",
            "country": "SE",
            "timestamp": "2011-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022248-19/DE",
            "title": "An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination ...",
            "country": "DE",
            "timestamp": "2011-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022248-19/NL",
            "title": "An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination ...",
            "country": "NL",
            "timestamp": "2011-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022248-19/CZ",
            "title": "An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination ...",
            "country": "CZ",
            "timestamp": "2011-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022248-19/results",
            "title": "An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination ...",
            "country": "View results",
            "timestamp": "2011-01-25"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN45526724",
            "timestamp": "2011-01-21",
            "title": "Evaluation of serum levels of chemokines during interferon beta treatment in multiple sclerosis patients"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN62678383",
            "timestamp": "2011-01-21",
            "title": "WT1 immunity via DNA vaccination in haematological malignancies by intramuscular injection and electroporation"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023503-10/ES",
            "title": "Ensayo clínico piloto, abierto, controlado y aleatorizado para evaluar la actividad de fosamprenavir frente al virus de la hepatitis C (VHC) genotipo 1 en pacientes coinfectados por el virus de la ...",
            "country": "ES",
            "timestamp": "2011-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023008-29/ES",
            "title": "Estudio Fase 3, Aleatorizado, Abierto, Controlado de Lopinavir/Ritonavir y Lamivudina versus terapia estándar en Pacientes Infectados con HIV-1 Naïve.",
            "country": "ES",
            "timestamp": "2011-01-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN32770468",
            "timestamp": "2011-01-10",
            "title": "Weekly administration of oral docetaxel in combination with ritonavir for the treatment of a variety of tumour types"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023023-19/IT",
            "title": "A 18-month, open-label, rater-blinded, randomized, multi-center, active-controlled, parallel-group pilot study to assess efficacy and safety of fingolimod (Gilenya) in comparison to interferon beta...",
            "country": "IT",
            "timestamp": "2010-12-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023023-19/DE",
            "title": "A 18-month, open-label, rater-blinded, randomized, multi-center, active-controlled, parallel-group pilot study to assess efficacy and safety of fingolimod (Gilenya) in comparison to interferon beta...",
            "country": "DE",
            "timestamp": "2010-12-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023023-19/results",
            "title": "A 18-month, open-label, rater-blinded, randomized, multi-center, active-controlled, parallel-group pilot study to assess efficacy and safety of fingolimod (Gilenya) in comparison to interferon beta...",
            "country": "View results",
            "timestamp": "2010-12-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/ES",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "ES",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/DE",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "DE",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/BE",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "BE",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/GB",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "GB",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/AT",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "AT",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/PL",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "PL",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/IT",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "IT",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021113-23/results",
            "title": "\"\"Estudio en fase III, aleatorizado, doble ciego y controlado con placebo para investigar la eficacia, la seguridad y la tolerabilidad de TMC435 frente a placebo como parte de una pauta con peginte...",
            "country": "View results",
            "timestamp": "2010-12-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018585-23/BG",
            "title": "AG-013736 (axitinib) for the treatment of metastatic renal cell cancer (mRCC)",
            "country": "BG",
            "timestamp": "2010-12-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022120-72/GB",
            "title": "The metabolic impact of Darunavir/ritonavir maintenance monotherapy after successful viral suppression with standard Atripla in HIV-1-infected patients (MIDAs).",
            "country": "GB",
            "timestamp": "2010-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022120-72/results",
            "title": "The metabolic impact of Darunavir/ritonavir maintenance monotherapy after successful viral suppression with standard Atripla in HIV-1-infected patients (MIDAs).",
            "country": "View results",
            "timestamp": "2010-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020387-38/DE",
            "title": "LIRA-B - Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus...",
            "country": "DE",
            "timestamp": "2010-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020387-38/IT",
            "title": "LIRA-B - Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus...",
            "country": "IT",
            "timestamp": "2010-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020387-38/NL",
            "title": "LIRA-B - Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus...",
            "country": "NL",
            "timestamp": "2010-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020387-38/results",
            "title": "LIRA-B - Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus...",
            "country": "View results",
            "timestamp": "2010-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019584-10/ES",
            "title": "Estudio aleatorizado, abierto, multicéntrico, de búsqueda de dosis y duración del tratamiento para evaluar la respuesta virológica mantenida del inhibidor de proteasa VHC Danoprevir (RO5190591) ref...",
            "country": "ES",
            "timestamp": "2010-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019584-10/DE",
            "title": "Estudio aleatorizado, abierto, multicéntrico, de búsqueda de dosis y duración del tratamiento para evaluar la respuesta virológica mantenida del inhibidor de proteasa VHC Danoprevir (RO5190591) ref...",
            "country": "DE",
            "timestamp": "2010-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019584-10/GB",
            "title": "Estudio aleatorizado, abierto, multicéntrico, de búsqueda de dosis y duración del tratamiento para evaluar la respuesta virológica mantenida del inhibidor de proteasa VHC Danoprevir (RO5190591) ref...",
            "country": "GB",
            "timestamp": "2010-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019584-10/AT",
            "title": "Estudio aleatorizado, abierto, multicéntrico, de búsqueda de dosis y duración del tratamiento para evaluar la respuesta virológica mantenida del inhibidor de proteasa VHC Danoprevir (RO5190591) ref...",
            "country": "AT",
            "timestamp": "2010-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019584-10/FR",
            "title": "Estudio aleatorizado, abierto, multicéntrico, de búsqueda de dosis y duración del tratamiento para evaluar la respuesta virológica mantenida del inhibidor de proteasa VHC Danoprevir (RO5190591) ref...",
            "country": "FR",
            "timestamp": "2010-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019584-10/IT",
            "title": "Estudio aleatorizado, abierto, multicéntrico, de búsqueda de dosis y duración del tratamiento para evaluar la respuesta virológica mantenida del inhibidor de proteasa VHC Danoprevir (RO5190591) ref...",
            "country": "IT",
            "timestamp": "2010-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022408-28/IT",
            "title": "A Phase 2B Pilot Study of Short-Term Treatment of BMS-790052 in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 2 or 3 Infection.",
            "country": "IT",
            "timestamp": "2010-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022408-28/DK",
            "title": "A Phase 2B Pilot Study of Short-Term Treatment of BMS-790052 in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 2 or 3 Infection.",
            "country": "DK",
            "timestamp": "2010-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022408-28/results",
            "title": "A Phase 2B Pilot Study of Short-Term Treatment of BMS-790052 in Combination with Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis C Genotype 2 or 3 Infection.",
            "country": "View results",
            "timestamp": "2010-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021430-64/GB",
            "title": "A randomised double blind placebo controlled clinical trial of anti B-cell therapy in patients with primary Sjögren’s syndrome.",
            "country": "GB",
            "timestamp": "2010-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021430-64/results",
            "title": "A randomised double blind placebo controlled clinical trial of anti B-cell therapy in patients with primary Sjögren’s syndrome.",
            "country": "View results",
            "timestamp": "2010-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/DE",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "DE",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/FR",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "FR",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/ES",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "ES",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/AT",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "AT",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/IT",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "IT",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/BE",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "BE",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/EE",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "EE",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/HU",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "HU",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/PL",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "PL",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/BG",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "BG",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/GB",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "GB",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021184-32/results",
            "title": "A randomized, double-blind, controlled study to evaluate pharmacokinetics, pharmacodynamics, safety and efficacy of GP2013 and rituximab in patients with rheumatoid arthritis refractory or intolera...",
            "country": "View results",
            "timestamp": "2010-11-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022842-26/NL",
            "title": "Autophagy inhibition using hydrochloroquine in breast cancer patients: a pilot study",
            "country": "NL",
            "timestamp": "2010-11-25"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN89222125",
            "timestamp": "2010-11-24",
            "title": "Switching to alternative tumour-necrosis factor (TNF)-blocking drugs or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-blocking drug"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020034-26/DE",
            "title": "A multicenter, randomized, open label, parallel-group phase IIB study on the efficacy and safety of oral regimens of DEB025 alone or in combination with ribavirin versus Standard of Care (peg-IFN a...",
            "country": "DE",
            "timestamp": "2010-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020034-26/PL",
            "title": "A multicenter, randomized, open label, parallel-group phase IIB study on the efficacy and safety of oral regimens of DEB025 alone or in combination with ribavirin versus Standard of Care (peg-IFN a...",
            "country": "PL",
            "timestamp": "2010-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020034-26/GB",
            "title": "A multicenter, randomized, open label, parallel-group phase IIB study on the efficacy and safety of oral regimens of DEB025 alone or in combination with ribavirin versus Standard of Care (peg-IFN a...",
            "country": "GB",
            "timestamp": "2010-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020034-26/BE",
            "title": "A multicenter, randomized, open label, parallel-group phase IIB study on the efficacy and safety of oral regimens of DEB025 alone or in combination with ribavirin versus Standard of Care (peg-IFN a...",
            "country": "BE",
            "timestamp": "2010-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020034-26/IT",
            "title": "A multicenter, randomized, open label, parallel-group phase IIB study on the efficacy and safety of oral regimens of DEB025 alone or in combination with ribavirin versus Standard of Care (peg-IFN a...",
            "country": "IT",
            "timestamp": "2010-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020034-26/results",
            "title": "A multicenter, randomized, open label, parallel-group phase IIB study on the efficacy and safety of oral regimens of DEB025 alone or in combination with ribavirin versus Standard of Care (peg-IFN a...",
            "country": "View results",
            "timestamp": "2010-11-18"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN11504121",
            "timestamp": "2010-11-12",
            "title": "Metabolic Impact of Darunavir monotherapy vs Atripla in HIV patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021002-38/ES",
            "title": "Estudio sobre los efectos metabólicos de atazanavir/ritonavir versus darunavir/ritonavir en combinación con tenofovir/emtricitabina en pacientes infectados por el VIH-1 sin tratamiento previo: ensa...",
            "country": "ES",
            "timestamp": "2010-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021159-25/ES",
            "title": "INTERACCIONES FARMACOLÓGICAS ENTRE LA SILIMARINA Y DARUNAVIR/RITONAVIR",
            "country": "ES",
            "timestamp": "2010-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021159-25/results",
            "title": "INTERACCIONES FARMACOLÓGICAS ENTRE LA SILIMARINA Y DARUNAVIR/RITONAVIR",
            "country": "View results",
            "timestamp": "2010-11-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021963-34/HU",
            "title": "A Phase 2, Randomized, Double-Blind, Comparator-Controlled, 12-week Trial of IMO-2125 plus Ribavirin in Patients Infected with Hepatitis C Virus who were Nonresponders to Pegylated-Interferon plus ...",
            "country": "HU",
            "timestamp": "2010-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-021963-34/BG",
            "title": "A Phase 2, Randomized, Double-Blind, Comparator-Controlled, 12-week Trial of IMO-2125 plus Ribavirin in Patients Infected with Hepatitis C Virus who were Nonresponders to Pegylated-Interferon plus ...",
            "country": "BG",
            "timestamp": "2010-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/DE",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "DE",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/NL",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "NL",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/ES",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "ES",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/SE",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "SE",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/CZ",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "CZ",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/GB",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "GB",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/LT",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "LT",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/IT",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "IT",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/BE",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "BE",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/PT",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "PT",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020150-34/results",
            "title": "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoiet...",
            "country": "View results",
            "timestamp": "2010-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/GB",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "GB",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/DE",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "DE",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/LV",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "LV",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/LT",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "LT",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/CZ",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "CZ",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/PT",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "PT",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/ES",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "ES",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/IT",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "IT",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020744-35/results",
            "title": "A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an  Inadequate Re...",
            "country": "View results",
            "timestamp": "2010-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023264-40/IT",
            "title": "Efficacy in the central nervous system (CNS) of two combination regimens with different penetration rank in HIV-positive na�ve patients",
            "country": "IT",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/FI",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "FI",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/NL",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "NL",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/DE",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "DE",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/DK",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "DK",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/BE",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "BE",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/IT",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "IT",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/LT",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "LT",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/EE",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "EE",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/LV",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "LV",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/AT",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "AT",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/PT",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "PT",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020328-23/results",
            "title": "A three-arm, randomized, double-blind, placebo controlled, multicenter,\r\nphase II study to evaluate the efficacy of Vigantol® oil as add-on\r\ntherapy in subjects with Relapsing-Remitting Multiple Sc...",
            "country": "View results",
            "timestamp": "2010-10-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015904-24/DE",
            "title": "An open, prospective study to compare the safety and efficacy of raltegravir vs. atazanavir / ritonavir, both in combination with tenofovir DF and emtricitabine, in the treatment of HIV-infection i...",
            "country": "DE",
            "timestamp": "2010-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018532-40/BE",
            "title": "A Phase 2b study to select a once daily oral dose of GSK2248761 in HIV-1 infected antiretroviral therapy experienced adults with non-nucleoside reverse transcriptase\ninhibitor (NNRTI) resistance",
            "country": "BE",
            "timestamp": "2010-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018532-40/ES",
            "title": "A Phase 2b study to select a once daily oral dose of GSK2248761 in HIV-1 infected antiretroviral therapy experienced adults with non-nucleoside reverse transcriptase\ninhibitor (NNRTI) resistance",
            "country": "ES",
            "timestamp": "2010-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018532-40/IT",
            "title": "A Phase 2b study to select a once daily oral dose of GSK2248761 in HIV-1 infected antiretroviral therapy experienced adults with non-nucleoside reverse transcriptase\ninhibitor (NNRTI) resistance",
            "country": "IT",
            "timestamp": "2010-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018532-40/results",
            "title": "A Phase 2b study to select a once daily oral dose of GSK2248761 in HIV-1 infected antiretroviral therapy experienced adults with non-nucleoside reverse transcriptase\ninhibitor (NNRTI) resistance",
            "country": "View results",
            "timestamp": "2010-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022110-29/GB",
            "title": "A randomised, double-blind, placebo-controlled Phase II study, comparing the efficacy and safety of inhaled SNG001 to placebo administered to COPD patients after the onset of a respiratory viral in...",
            "country": "GB",
            "timestamp": "2010-10-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020664-38/GR",
            "title": "Efficacy and safety of Bevacizumab/Temsirolimus combination after first-line Bevacizumab/IFN combination in advanced renal cell carcinoma",
            "country": "GR",
            "timestamp": "2010-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019689-10/DE",
            "title": "A multi-center, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and tolerability of KRP203 in patients with active subacute cutaneous lupus erythematosus",
            "country": "DE",
            "timestamp": "2010-09-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019689-10/IT",
            "title": "A multi-center, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and tolerability of KRP203 in patients with active subacute cutaneous lupus erythematosus",
            "country": "IT",
            "timestamp": "2010-09-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019689-10/GR",
            "title": "A multi-center, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and tolerability of KRP203 in patients with active subacute cutaneous lupus erythematosus",
            "country": "GR",
            "timestamp": "2010-09-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019689-10/results",
            "title": "A multi-center, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and tolerability of KRP203 in patients with active subacute cutaneous lupus erythematosus",
            "country": "View results",
            "timestamp": "2010-09-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/FR",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "FR",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/DE",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "DE",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/BE",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "BE",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/SE",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "SE",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/FI",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "FI",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/DK",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "DK",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/IT",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "IT",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018674-20/results",
            "title": "A Phase 3b, Randomized, Active Controlled Trial to Evaluate the Efficacy and Safety of\nAbatacept SC in Combination with Methotrexate in Inducing Clinical Remission\nCompared to Methotrexate Monother...",
            "country": "View results",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018361-33/SK",
            "title": "A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in P...",
            "country": "SK",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018361-33/HU",
            "title": "A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in P...",
            "country": "HU",
            "timestamp": "2010-09-10"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN21665331",
            "timestamp": "2010-09-06",
            "title": "Normalising sex hormone levels in obese hypogonadal men"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019367-11/FR",
            "title": "ANRS HB 06 PEGAN\nEssai de phase III, randomisé, multicentrique, sans insu, évaluant à S96 la perte de l’Ag HBs suite à un traitement de 48 semaines par l’interféron pégylé alpha 2a chez des patient...",
            "country": "FR",
            "timestamp": "2010-08-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019964-36/BE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects with Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy",
            "country": "BE",
            "timestamp": "2010-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019964-36/HU",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects with Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy",
            "country": "HU",
            "timestamp": "2010-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019964-36/CZ",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects with Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy",
            "country": "CZ",
            "timestamp": "2010-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019964-36/DE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects with Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy",
            "country": "DE",
            "timestamp": "2010-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012283-14/IE",
            "title": "A randomised open‐label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2‐3N(t)RTI backbone versus ritonavir boosted lopinavir and raltegravir in participants virological...",
            "country": "IE",
            "timestamp": "2010-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012283-14/FR",
            "title": "A randomised open‐label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2‐3N(t)RTI backbone versus ritonavir boosted lopinavir and raltegravir in participants virological...",
            "country": "FR",
            "timestamp": "2010-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012283-14/GB",
            "title": "A randomised open‐label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2‐3N(t)RTI backbone versus ritonavir boosted lopinavir and raltegravir in participants virological...",
            "country": "GB",
            "timestamp": "2010-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012283-14/DE",
            "title": "A randomised open‐label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2‐3N(t)RTI backbone versus ritonavir boosted lopinavir and raltegravir in participants virological...",
            "country": "DE",
            "timestamp": "2010-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014600-66/NL",
            "title": "A multicentre, prospective, randomized open-label pilot study to assess the feasibility and preliminary efficacy of interferon gamma in combination with Anidulafungin for the treatment of candidemia",
            "country": "NL",
            "timestamp": "2010-08-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016697-32/IT",
            "title": "PRotease-Inhibitors MOnotherapy Strategies as maintenance therapy in persons with fully suppressed HIV replication: results from an open-label randomized comparative trial (PRIMO Trial)",
            "country": "IT",
            "timestamp": "2010-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016697-32/results",
            "title": "PRotease-Inhibitors MOnotherapy Strategies as maintenance therapy in persons with fully suppressed HIV replication: results from an open-label randomized comparative trial (PRIMO Trial)",
            "country": "View results",
            "timestamp": "2010-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011121-13/DE",
            "title": "A phase II randomized, multicenter, open-label study of TG4040 (MVA-HCV) in combination with pegylated interferon alfa-2a and ribavirin versus pegylated interferon alfa-2a and ribavirin in treatmen...",
            "country": "DE",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011121-13/ES",
            "title": "A phase II randomized, multicenter, open-label study of TG4040 (MVA-HCV) in combination with pegylated interferon alfa-2a and ribavirin versus pegylated interferon alfa-2a and ribavirin in treatmen...",
            "country": "ES",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011121-13/PL",
            "title": "A phase II randomized, multicenter, open-label study of TG4040 (MVA-HCV) in combination with pegylated interferon alfa-2a and ribavirin versus pegylated interferon alfa-2a and ribavirin in treatmen...",
            "country": "PL",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011121-13/results",
            "title": "A phase II randomized, multicenter, open-label study of TG4040 (MVA-HCV) in combination with pegylated interferon alfa-2a and ribavirin versus pegylated interferon alfa-2a and ribavirin in treatmen...",
            "country": "View results",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016560-36/DE",
            "title": "A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated...",
            "country": "DE",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016560-36/IT",
            "title": "A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated...",
            "country": "IT",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016560-36/AT",
            "title": "A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated...",
            "country": "AT",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016560-36/ES",
            "title": "A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated...",
            "country": "ES",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016560-36/PL",
            "title": "A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated...",
            "country": "PL",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016560-36/SK",
            "title": "A long-term monitoring study to evaluate the persistence of direct acting antiviral (DAA) treatment-resistant mutations or the durability of sustained virological response (SVR) in patients treated...",
            "country": "SK",
            "timestamp": "2010-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020442-10/IT",
            "title": "Efficacy of atazanavir/ritonavir monotherapy as maintenance in patients with viral suppression. Randomized, open label non inferiority trial.  (MODAt STUDY)",
            "country": "IT",
            "timestamp": "2010-07-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020442-10/results",
            "title": "Efficacy of atazanavir/ritonavir monotherapy as maintenance in patients with viral suppression. Randomized, open label non inferiority trial.  (MODAt STUDY)",
            "country": "View results",
            "timestamp": "2010-07-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011888-37/DE",
            "title": "A 1-year, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of zoledronic acid 5 mg (Aclasta®) on bone mineral density in patients with multip...",
            "country": "DE",
            "timestamp": "2010-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011888-37/results",
            "title": "A 1-year, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of zoledronic acid 5 mg (Aclasta®) on bone mineral density in patients with multip...",
            "country": "View results",
            "timestamp": "2010-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009503-19/BE",
            "title": "A prospective, open label, non-randomised, clinical trial to determine if natalizumab (Tysabri) improves ambulatory measures in relapsing remitting multiple sclerosis (RRMS) patients.",
            "country": "BE",
            "timestamp": "2010-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009503-19/results",
            "title": "A prospective, open label, non-randomised, clinical trial to determine if natalizumab (Tysabri) improves ambulatory measures in relapsing remitting multiple sclerosis (RRMS) patients.",
            "country": "View results",
            "timestamp": "2010-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018339-16/DE",
            "title": "CRESCENDO (Compliance: Role Emerges for Success in CML: Evaluation aND Optimisation): A prospective, multi-center, phase IV study to assess the compliance in patients with Philadelphia chromosome-p...",
            "country": "DE",
            "timestamp": "2010-07-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018339-16/results",
            "title": "CRESCENDO (Compliance: Role Emerges for Success in CML: Evaluation aND Optimisation): A prospective, multi-center, phase IV study to assess the compliance in patients with Philadelphia chromosome-p...",
            "country": "View results",
            "timestamp": "2010-07-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019057-17/NL",
            "title": "A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Antiviral Activity of SPC3649 (miravirsen) Administered ...",
            "country": "NL",
            "timestamp": "2010-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019057-17/DE",
            "title": "A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Antiviral Activity of SPC3649 (miravirsen) Administered ...",
            "country": "DE",
            "timestamp": "2010-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019057-17/SK",
            "title": "A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Antiviral Activity of SPC3649 (miravirsen) Administered ...",
            "country": "SK",
            "timestamp": "2010-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019057-17/PL",
            "title": "A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Antiviral Activity of SPC3649 (miravirsen) Administered ...",
            "country": "PL",
            "timestamp": "2010-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018295-24/SE",
            "title": "A Phase 2b Study of BMS-790052 in Combination with Peg-Interferon\r\nAlfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis\r\nC Genotype 1 and 4 Infection\r\n\r\nRevised Protocol Number ...",
            "country": "SE",
            "timestamp": "2010-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018295-24/DE",
            "title": "A Phase 2b Study of BMS-790052 in Combination with Peg-Interferon\r\nAlfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis\r\nC Genotype 1 and 4 Infection\r\n\r\nRevised Protocol Number ...",
            "country": "DE",
            "timestamp": "2010-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018295-24/FR",
            "title": "A Phase 2b Study of BMS-790052 in Combination with Peg-Interferon\r\nAlfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis\r\nC Genotype 1 and 4 Infection\r\n\r\nRevised Protocol Number ...",
            "country": "FR",
            "timestamp": "2010-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018295-24/IT",
            "title": "A Phase 2b Study of BMS-790052 in Combination with Peg-Interferon\r\nAlfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis\r\nC Genotype 1 and 4 Infection\r\n\r\nRevised Protocol Number ...",
            "country": "IT",
            "timestamp": "2010-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018295-24/DK",
            "title": "A Phase 2b Study of BMS-790052 in Combination with Peg-Interferon\r\nAlfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis\r\nC Genotype 1 and 4 Infection\r\n\r\nRevised Protocol Number ...",
            "country": "DK",
            "timestamp": "2010-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018295-24/results",
            "title": "A Phase 2b Study of BMS-790052 in Combination with Peg-Interferon\r\nAlfa-2a and Ribavirin in Treatment Naive Subjects with Chronic Hepatitis\r\nC Genotype 1 and 4 Infection\r\n\r\nRevised Protocol Number ...",
            "country": "View results",
            "timestamp": "2010-07-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN65360827",
            "timestamp": "2010-07-09",
            "title": "Rituximab in patients with primary Sjögren's syndrome"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017013-29/GB",
            "title": "Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected children and adolescents aged 3 years and above",
            "country": "GB",
            "timestamp": "2010-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017013-29/ES",
            "title": "Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected children and adolescents aged 3 years and above",
            "country": "ES",
            "timestamp": "2010-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017013-29/FR",
            "title": "Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected children and adolescents aged 3 years and above",
            "country": "FR",
            "timestamp": "2010-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017013-29/IT",
            "title": "Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected children and adolescents aged 3 years and above",
            "country": "IT",
            "timestamp": "2010-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017013-29/results",
            "title": "Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected children and adolescents aged 3 years and above",
            "country": "View results",
            "timestamp": "2010-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018768-18/AT",
            "title": "An open-label, prospective, multicentre, phase I/II dose escalation study to determine the maximum tolerated dose and to assess the safety and efficacy of P1101, PEG-Proline-Interferon alpha-2b for...",
            "country": "AT",
            "timestamp": "2010-07-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018768-18/results",
            "title": "An open-label, prospective, multicentre, phase I/II dose escalation study to determine the maximum tolerated dose and to assess the safety and efficacy of P1101, PEG-Proline-Interferon alpha-2b for...",
            "country": "View results",
            "timestamp": "2010-07-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/DE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "DE",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/GB",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "GB",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/FR",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "FR",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/PT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "PT",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/BE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "BE",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/NL",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "NL",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/AT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "AT",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/ES",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "ES",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/DK",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "DK",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/IT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "IT",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/SE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "SE",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016758-42/results",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitab...",
            "country": "View results",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/DE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "DE",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/BE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "BE",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/NL",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "NL",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/FR",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "FR",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/PT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "PT",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/GB",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "GB",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/AT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "AT",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/ES",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "ES",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/DK",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "DK",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/IT",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "IT",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/SE",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "SE",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016759-22/results",
            "title": "A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of \r\nGS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered with Emtricitabine/Tenofovir Diso...",
            "country": "View results",
            "timestamp": "2010-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/IE",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "IE",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/NL",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "NL",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/FR",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "FR",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/GB",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "GB",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/ES",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "ES",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/PT",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "PT",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/BE",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "BE",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013648-35/DE",
            "title": "KONCERT \nA Kaletra ONCE daily Randomised Trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily lopinavir/ritonavir tablets dosed by weight as part of combination antir...",
            "country": "DE",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020435-40/BE",
            "title": "Phase I/II study of peptide vaccination associated with tumoral immunomodulation with proinflammatory cytokines and imiquimod in patients with advanced metastatic melanoma",
            "country": "BE",
            "timestamp": "2010-06-23"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN34974208",
            "timestamp": "2010-06-17",
            "title": "Comparison of efficacy and safety of Betesil® medicated plaster versus Daivobet®/Dovobet® ointment in the treatment of chronic plaque psoriasis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020063-21/DE",
            "title": "“A 20-week open-label study to assess the efficacy and safety of single doses of Ilaris® (Canakinumab, ACZ885) in patients with active, refractory urticarial vasculitis”",
            "country": "DE",
            "timestamp": "2010-06-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009608-38/DE",
            "title": "A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Co...",
            "country": "DE",
            "timestamp": "2010-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009608-38/AT",
            "title": "A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Co...",
            "country": "AT",
            "timestamp": "2010-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009608-38/IT",
            "title": "A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Co...",
            "country": "IT",
            "timestamp": "2010-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009608-38/FR",
            "title": "A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Co...",
            "country": "FR",
            "timestamp": "2010-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009608-38/results",
            "title": "A Randomized, Partially-blind Study to Evaluate the Safety, Tolerability and Effect on Virological Response of Treatment with the HCV Protease Inhibitor RO5190591 in combination with Pegasys and Co...",
            "country": "View results",
            "timestamp": "2010-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011099-31/HU",
            "title": "A Multi-center, Randomized, Double-blind, Comparator-controlled, Dose-escalation Safety Assessment Study of Combination Treatment with IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype...",
            "country": "HU",
            "timestamp": "2010-06-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019684-11/NL",
            "title": "Pharmacological Treatment in Osteoarthritis",
            "country": "NL",
            "timestamp": "2010-06-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012459-96/ES",
            "title": "VALORACIÓN INTENSIVA DE LA CINÉTICA DEL RNA DEL VIRUS DE LA HEPATITIS C COMO PREDICTOR PRECOZ DE AUSENCIA DE RESPUESTA VIROLÓGICA SOSTENIDA EN PACIENTES CON HEPATITIS CRÓNICA POR VHC TRATADOS CON I...",
            "country": "ES",
            "timestamp": "2010-06-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019446-38/ES",
            "title": "Estudio Exploratorio Transversal para Comparar la Eficacia Virológica en el LCR y el Estado Neurocognitivo en Pacientes Infectados por el VIH-1 en Tratamiento Prolongado (> 3 años) con Lopinavir/ri...",
            "country": "ES",
            "timestamp": "2010-06-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019446-38/results",
            "title": "Estudio Exploratorio Transversal para Comparar la Eficacia Virológica en el LCR y el Estado Neurocognitivo en Pacientes Infectados por el VIH-1 en Tratamiento Prolongado (> 3 años) con Lopinavir/ri...",
            "country": "View results",
            "timestamp": "2010-06-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/NL",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "NL",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/BE",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "BE",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/DE",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "DE",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/FR",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "FR",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/SE",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "SE",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/PL",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "PL",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/ES",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "ES",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/AT",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "AT",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/GB",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "GB",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/IT",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "IT",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012613-21/results",
            "title": "An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Copegus®) for subjects from the control group of the VX-950-TiDP2...",
            "country": "View results",
            "timestamp": "2010-06-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/SE",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "SE",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/FR",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "FR",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/BE",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "BE",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/DE",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "DE",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/AT",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "AT",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/GB",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "GB",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/LT",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "LT",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/PL",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "PL",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/ES",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "ES",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/CZ",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "CZ",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013053-15/results",
            "title": "A Phase II Open Label Study of MK-7009 Administered Concomitantly with Pegylated Interferon Alfa and Ribavirin to Patients with Chronic Hepatitis C Infection After Participation in Other MK-7009 Cl...",
            "country": "View results",
            "timestamp": "2010-05-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN81110147",
            "timestamp": "2010-05-28",
            "title": "Pharmacogenetics of human immunodeficiency virus therapy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018146-38/FR",
            "title": "Multicenter randomized controlled study comparing the efficacy and safety of natural Multi-subtype interferon alpha (Multiferon) in association with ribavirin versus retreatment with pegylated inte...",
            "country": "FR",
            "timestamp": "2010-05-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/ES",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "ES",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/FR",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "FR",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/SE",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "SE",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/IE",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "IE",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/DK",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "DK",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/PT",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "PT",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/AT",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "AT",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/DE",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "DE",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/GB",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "GB",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/PL",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "PL",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/IT",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "IT",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/BE",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "BE",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/NL",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "NL",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/HU",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "HU",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015113-44/GR",
            "title": "Ensayo abierto, aleatorizado, de dos años de duración, en el que se comparan dos regímenes de primera línea en sujetos infectados por el VIH que no han recibido tratamiento antirretroviral previo: ...",
            "country": "GR",
            "timestamp": "2010-05-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN73466214",
            "timestamp": "2010-05-18",
            "title": "Carboplatin with or without ZD4054 in patients with metastatic breast cancer"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015740-42/DE",
            "title": "A PHASE 3, MULTICENTER, RANDOMIZED, OPEN, PROSPECTIVE, CONTROLLED, PARALLEL-GROUP STUDY OF REDUCTION OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ONGOING REMISSION\r\nRETRO – REduction of Ther...",
            "country": "DE",
            "timestamp": "2010-05-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018332-41/DK",
            "title": "A Randomized, Open-label, Parallel Group, Multicenter Pilot Study Evaluating the Efficacy and Safety of Alternative Dosing of Ribavirin vs. Standard of Care Dosing in Combination with Peginterferon...",
            "country": "DK",
            "timestamp": "2010-05-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018332-41/FI",
            "title": "A Randomized, Open-label, Parallel Group, Multicenter Pilot Study Evaluating the Efficacy and Safety of Alternative Dosing of Ribavirin vs. Standard of Care Dosing in Combination with Peginterferon...",
            "country": "FI",
            "timestamp": "2010-05-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/FI",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "FI",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/SE",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "SE",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/GB",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "GB",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/DE",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "DE",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/ES",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "ES",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/CZ",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "CZ",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/PT",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "PT",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/HU",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "HU",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/NL",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "NL",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/SI",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "SI",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/LV",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "LV",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/AT",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "AT",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/IT",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "IT",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/DK",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "DK",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/GR",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "GR",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015556-15/results",
            "title": "A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon β 1a) to Natalizumab in Subjects wit...",
            "country": "View results",
            "timestamp": "2010-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018279-99/DE",
            "title": "Skin Topoproteome under Adalimumab (Humira®) Treatment\nin Patients with Moderate to Severe Psoriasis",
            "country": "DE",
            "timestamp": "2010-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017490-38/DE",
            "title": "Randomized Treatment Interruption of Natalizumab",
            "country": "DE",
            "timestamp": "2010-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017490-38/ES",
            "title": "Randomized Treatment Interruption of Natalizumab",
            "country": "ES",
            "timestamp": "2010-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017490-38/results",
            "title": "Randomized Treatment Interruption of Natalizumab",
            "country": "View results",
            "timestamp": "2010-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014772-22/NL",
            "title": "Chloroquine as an anti-autophagy drug in small cell lung cancer (SCLC) patients: A phase I trial to be followed by a phase II trial.",
            "country": "NL",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN21216199",
            "timestamp": "2010-04-29",
            "title": "Efficacy of tocilizumab in patients with rheumatoid arthritis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010939-40/NL",
            "title": "PLEASE Persistent Lyme Empiric Antibiotic Study Europe. A prospective, randomised study comparing two prolonged oral antibiotic strategies after initial intravenous ceftriaxone therapy for patients...",
            "country": "NL",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018197-66/PT",
            "title": "Safety, antiviral effect and pharmacokinetics of BI 207127 in combination with BI 201335 and with or without ribavirin for 4, 16, 24, 28 or 40 weeks in patients with chronic HCV genotype 1 infectio...",
            "country": "PT",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018197-66/FR",
            "title": "Safety, antiviral effect and pharmacokinetics of BI 207127 in combination with BI 201335 and with or without ribavirin for 4, 16, 24, 28 or 40 weeks in patients with chronic HCV genotype 1 infectio...",
            "country": "FR",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018197-66/DE",
            "title": "Safety, antiviral effect and pharmacokinetics of BI 207127 in combination with BI 201335 and with or without ribavirin for 4, 16, 24, 28 or 40 weeks in patients with chronic HCV genotype 1 infectio...",
            "country": "DE",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018197-66/AT",
            "title": "Safety, antiviral effect and pharmacokinetics of BI 207127 in combination with BI 201335 and with or without ribavirin for 4, 16, 24, 28 or 40 weeks in patients with chronic HCV genotype 1 infectio...",
            "country": "AT",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018197-66/ES",
            "title": "Safety, antiviral effect and pharmacokinetics of BI 207127 in combination with BI 201335 and with or without ribavirin for 4, 16, 24, 28 or 40 weeks in patients with chronic HCV genotype 1 infectio...",
            "country": "ES",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018197-66/results",
            "title": "Safety, antiviral effect and pharmacokinetics of BI 207127 in combination with BI 201335 and with or without ribavirin for 4, 16, 24, 28 or 40 weeks in patients with chronic HCV genotype 1 infectio...",
            "country": "View results",
            "timestamp": "2010-04-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007995-81/DE",
            "title": "A Phase 2a, 2-Part, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study of Telaprevir in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Su...",
            "country": "DE",
            "timestamp": "2010-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007995-81/FR",
            "title": "A Phase 2a, 2-Part, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study of Telaprevir in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Su...",
            "country": "FR",
            "timestamp": "2010-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007995-81/ES",
            "title": "A Phase 2a, 2-Part, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study of Telaprevir in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Su...",
            "country": "ES",
            "timestamp": "2010-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007995-81/results",
            "title": "A Phase 2a, 2-Part, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study of Telaprevir in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Su...",
            "country": "View results",
            "timestamp": "2010-04-28"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN53233058",
            "timestamp": "2010-04-22",
            "title": "ADDITIONS"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018326-39/IE",
            "title": "An open-label, randomised pilot study comparing the efficacy, safety and tolerability of raltegravir with protease inhibitor-based therapy in treatment-naïve, HIV/Hepatitis C co-infected injecting ...",
            "country": "IE",
            "timestamp": "2010-04-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018014-20/GB",
            "title": "A Randomised Phase II Study Evaluating Cediranib vs. Cediranib and Saracatanib in patients with relapsed metastatic clear cell renal cancer",
            "country": "GB",
            "timestamp": "2010-04-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-018014-20/results",
            "title": "A Randomised Phase II Study Evaluating Cediranib vs. Cediranib and Saracatanib in patients with relapsed metastatic clear cell renal cancer",
            "country": "View results",
            "timestamp": "2010-04-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016678-34/GB",
            "title": "Exploring the Relationship Between Insulin Resistance and Interferon Resistance: Options to Overcome HCV Non-Response to Pegylated Interferon",
            "country": "GB",
            "timestamp": "2010-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/IE",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "IE",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/FR",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "FR",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/DE",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "DE",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/CZ",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "CZ",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/HU",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "HU",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/FI",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "FI",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/SE",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "SE",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/ES",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "ES",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/GB",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "GB",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/GR",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "GR",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/IT",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "IT",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/DK",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "DK",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/SI",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "SI",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012500-11/results",
            "title": "Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β...",
            "country": "View results",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017003-28/IT",
            "title": "Relationship between IL-6 and TNF-α polymorphism and flu-like syndrome development in multiple sclerosis patients treated with Interferon-beta 1a i.m.  Open label multicentre study",
            "country": "IT",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017003-28/results",
            "title": "Relationship between IL-6 and TNF-α polymorphism and flu-like syndrome development in multiple sclerosis patients treated with Interferon-beta 1a i.m.  Open label multicentre study",
            "country": "View results",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014249-10/FI",
            "title": "A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma.",
            "country": "FI",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014249-10/DE",
            "title": "A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma.",
            "country": "DE",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014249-10/IT",
            "title": "A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma.",
            "country": "IT",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014249-10/GB",
            "title": "A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma.",
            "country": "GB",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014249-10/results",
            "title": "A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma.",
            "country": "View results",
            "timestamp": "2010-04-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN39045408",
            "timestamp": "2010-04-06",
            "title": "Anti-tumour necrosis factor (anti-TNF) therapy over two years increases body fat mass in early rheumatoid arthritis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016824-29/DK",
            "title": "REsPons på interferon-Alfa hos InterfeRon-β-neutraliserende antistof-positive patienter med multipel sklerose",
            "country": "DK",
            "timestamp": "2010-04-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN18563749",
            "timestamp": "2010-03-31",
            "title": "A phase II study of Gemcitabine and Bexarotene (GemBex) in the treatment of cutaneous T-cell lymphoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN44746369",
            "timestamp": "2010-03-25",
            "title": "Safety and clinical effects of IDX320 in Hepatitis C infection"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007765-23/IT",
            "title": "MoLO study - Evaluation of cost/efficacy ratio of monotherapy with lopinavir/ritonavir versus standard in patients treated with protesi inhibotors in virologic suppressison.",
            "country": "IT",
            "timestamp": "2010-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014732-38/ES",
            "title": "Ensayo clínico fase IV.II para el análisis de los factores moleculares de pronóstico de respuesta y beneficio clínico en pacientes con cáncer renal metastásico o avanzado, tratados con bevacizumab ...",
            "country": "ES",
            "timestamp": "2010-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018523-26/IT",
            "title": "Immediate versus delayed treatment with Entecavir in patients with active chronic hepatitis B (CHB): impact on liver fibrosis.",
            "country": "IT",
            "timestamp": "2010-03-17"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN45190901",
            "timestamp": "2010-03-08",
            "title": "Collaborative H1N1 Adjuvant Treatment pilot trial"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017480-42/GB",
            "title": "A randomised, double-blind, placebo-controlled Phase II study, comparing the efficacy and safety of inhaled SNG001 to placebo administered to asthmatic subjects after the onset of a respiratory vir...",
            "country": "GB",
            "timestamp": "2010-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018517-29/DE",
            "title": "Topoproteome-Analysis of Psoriasis under Fumarate-Treatment.",
            "country": "DE",
            "timestamp": "2010-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/BE",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "BE",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/DE",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "DE",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/FR",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "FR",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/HU",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "HU",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/ES",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "ES",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/LT",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "LT",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/AT",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "AT",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/CZ",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "CZ",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/NL",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "NL",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016068-35/results",
            "title": "A randomized double blind-placebo controlled dose ranging study to evaluate the efficacy and safety of SAR153191 in patients with Ankylosing Spondylitis (AS)",
            "country": "View results",
            "timestamp": "2010-02-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN50655730",
            "timestamp": "2010-02-19",
            "title": "The safety and efficacy of CCX354-C in subjects with rheumatoid arthritis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015007-97/IT",
            "title": "Retinal Nerve Fiber Layer (RNFL) as measured by Optical Coherence Tomography (OCT) to      Depict axonal loss in Early RRMS treated with difFEreNt dosage of subCutaneous IFN bEta 1a",
            "country": "IT",
            "timestamp": "2010-02-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014373-41/GB",
            "title": "A randomised Phase II trial of Imatinib (IM) versus Hydroxychloroquine (HCQ) and Imatinib (IM) for patients with Chronic Myeloid Leukaemia (CML) in Cytogenetic Response (CyR) with residual disease ...",
            "country": "GB",
            "timestamp": "2010-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014373-41/DE",
            "title": "A randomised Phase II trial of Imatinib (IM) versus Hydroxychloroquine (HCQ) and Imatinib (IM) for patients with Chronic Myeloid Leukaemia (CML) in Cytogenetic Response (CyR) with residual disease ...",
            "country": "DE",
            "timestamp": "2010-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014373-41/FR",
            "title": "A randomised Phase II trial of Imatinib (IM) versus Hydroxychloroquine (HCQ) and Imatinib (IM) for patients with Chronic Myeloid Leukaemia (CML) in Cytogenetic Response (CyR) with residual disease ...",
            "country": "FR",
            "timestamp": "2010-02-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014373-41/results",
            "title": "A randomised Phase II trial of Imatinib (IM) versus Hydroxychloroquine (HCQ) and Imatinib (IM) for patients with Chronic Myeloid Leukaemia (CML) in Cytogenetic Response (CyR) with residual disease ...",
            "country": "View results",
            "timestamp": "2010-02-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN56886343",
            "timestamp": "2010-02-05",
            "title": "COSAK trial"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/HU",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "HU",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/FR",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "FR",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/PL",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "PL",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/CZ",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "CZ",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/IT",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "IT",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/BG",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "BG",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013219-37/GB",
            "title": "A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma",
            "country": "GB",
            "timestamp": "2010-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015647-16/IE",
            "title": "The pharmacokinetics of once daily Kaletra and methadone in a population of HIV positiive drug users.",
            "country": "IE",
            "timestamp": "2010-01-28"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN29259563",
            "timestamp": "2010-01-22",
            "title": "Short versus standard treatment with pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011816-39/GB",
            "title": "A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects.\n‘The First Failure Study’ : ‘FAST’",
            "country": "GB",
            "timestamp": "2010-01-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011816-39/results",
            "title": "A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects.\n‘The First Failure Study’ : ‘FAST’",
            "country": "View results",
            "timestamp": "2010-01-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN60408425",
            "timestamp": "2010-01-20",
            "title": "The effect of fluticasone and formoterol in combination administered through Dry Powder Inhaler (DPI) versus budesonide and formoterol in combination (Symbicort Turbuhaler) in the maintenance treatment of asthma in adults."
        },
        {
            "url": "https://www.isrctn.com/ISRCTN93019988",
            "timestamp": "2010-01-18",
            "title": "Multicentre open-label study of neurotransmitters and neuropeptides in schizophrenia"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN64847145",
            "timestamp": "2010-01-15",
            "title": "Exploring the effect of disturbance in insulin metabolism on the treatment response of hepatitis C virus to find options to  improve response rate"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/DE",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "DE",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/BE",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "BE",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/AT",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "AT",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/SE",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "SE",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/GR",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "GR",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/IT",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "IT",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/GB",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "GB",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010582-23/results",
            "title": "A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept ...",
            "country": "View results",
            "timestamp": "2010-01-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008554-23/SE",
            "title": "Neutralizing Antibodies to Interferon beta in patients treated with Rebif New Formulation",
            "country": "SE",
            "timestamp": "2009-12-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN03247616",
            "timestamp": "2009-12-21",
            "title": "Effect of concomitant treatment with an androgen on sexual functioning in women using an oral contraception"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN06414473",
            "timestamp": "2009-12-21",
            "title": "Effects of concomitant treatment with an androgen on androgen metabolism, biochemical parameters, mood, fat, muscle and bone in women using an oral contraception"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016087-37/ES",
            "title": "Estudio farmacogenético exploratorio, multinacional, multicéntrico y con una sola toma de muestras de sangre del ensayo REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease).\n \nA multination...",
            "country": "ES",
            "timestamp": "2009-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016087-37/IE",
            "title": "Estudio farmacogenético exploratorio, multinacional, multicéntrico y con una sola toma de muestras de sangre del ensayo REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease).\n \nA multination...",
            "country": "IE",
            "timestamp": "2009-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016087-37/FR",
            "title": "Estudio farmacogenético exploratorio, multinacional, multicéntrico y con una sola toma de muestras de sangre del ensayo REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease).\n \nA multination...",
            "country": "FR",
            "timestamp": "2009-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016087-37/GB",
            "title": "Estudio farmacogenético exploratorio, multinacional, multicéntrico y con una sola toma de muestras de sangre del ensayo REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease).\n \nA multination...",
            "country": "GB",
            "timestamp": "2009-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016087-37/IT",
            "title": "Estudio farmacogenético exploratorio, multinacional, multicéntrico y con una sola toma de muestras de sangre del ensayo REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease).\n \nA multination...",
            "country": "IT",
            "timestamp": "2009-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016087-37/results",
            "title": "Estudio farmacogenético exploratorio, multinacional, multicéntrico y con una sola toma de muestras de sangre del ensayo REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease).\n \nA multination...",
            "country": "View results",
            "timestamp": "2009-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014430-25/ES",
            "title": "Ensayo clínico abierto, aleatorizado, para comparar la calidad de vida de los pacientes VIH+ que inician monoterapia con comprimidos de LPV/r vs triple terapia que contengan un IP potenciado",
            "country": "ES",
            "timestamp": "2009-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016090-14/ES",
            "title": "Análisis de los cambios en el tejido adiposo de pacientes con infección VIH y lipoatrofia en tratamiento con análogos de nucleósidos timidínicos, tras el cambio a monoterapia con Lopinavir/ritonavir",
            "country": "ES",
            "timestamp": "2009-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015502-19/FI",
            "title": "A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Mu...",
            "country": "FI",
            "timestamp": "2009-12-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015502-19/SE",
            "title": "A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Mu...",
            "country": "SE",
            "timestamp": "2009-12-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015502-19/DE",
            "title": "A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Mu...",
            "country": "DE",
            "timestamp": "2009-12-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015502-19/BE",
            "title": "A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Mu...",
            "country": "BE",
            "timestamp": "2009-12-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015502-19/GB",
            "title": "A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Mu...",
            "country": "GB",
            "timestamp": "2009-12-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015502-19/results",
            "title": "A multinational, multicenter, single visit, exploratory pharmacogenetic trial and long-term follow-up of the PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Mu...",
            "country": "View results",
            "timestamp": "2009-12-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013284-19/AT",
            "title": "Immune tolerance induction in MS patients with neutralizing antibodies against interferon-beta",
            "country": "AT",
            "timestamp": "2009-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015121-37/FR",
            "title": "Etude multicentrique randomisée ouverte comparant la réduction virale et la tolérance\nde l’association IFN alpha-2b XL + ribavirine versus IFN peg alpha-2b + ribavirine chez des\npatients atteints d...",
            "country": "FR",
            "timestamp": "2009-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016455-21/ES",
            "title": "PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF SWITCHING PROTEASE INHIBITOR TO ETRAVIRINE IN HIV-1-INFECTED SUBJECTS WITH VIREMIA SUPPRESSION (ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD ...",
            "country": "ES",
            "timestamp": "2009-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-016455-21/results",
            "title": "PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF SWITCHING PROTEASE INHIBITOR TO ETRAVIRINE IN HIV-1-INFECTED SUBJECTS WITH VIREMIA SUPPRESSION (ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD ...",
            "country": "View results",
            "timestamp": "2009-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-015978-35/FR",
            "title": "Etude ouverte de phase 2 de 52 semaines visant à établir l'efficacité et la tolérance du Belimumab (HGS1006, LymphoStat-B), un anticorps monoclonal humanisé anti-BLys (BAFF), chez des patients att...",
            "country": "FR",
            "timestamp": "2009-11-30"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN18445519",
            "timestamp": "2009-11-27",
            "title": "Combination therapy in rheumatoid arthritis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004408-29/DE",
            "title": "ESTABLISH TOLERANCE IN MS WITH PEPTIDE-PULSED, PERIPHERAL BLOOD MONONUCLEAR CELLS - A MRI-CONTROLLED, SINGLE CENTER, BASELINE-TO-TREATMENT CROSS-OVER, PHASE I/IIA TRIAL IN RELAPSING-REMITTING MS PA...",
            "country": "DE",
            "timestamp": "2009-11-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004408-29/results",
            "title": "ESTABLISH TOLERANCE IN MS WITH PEPTIDE-PULSED, PERIPHERAL BLOOD MONONUCLEAR CELLS - A MRI-CONTROLLED, SINGLE CENTER, BASELINE-TO-TREATMENT CROSS-OVER, PHASE I/IIA TRIAL IN RELAPSING-REMITTING MS PA...",
            "country": "View results",
            "timestamp": "2009-11-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN61568166",
            "timestamp": "2009-11-19",
            "title": "Imatinib (IM) versus hydroxychloroquine (HCQ) and IM for patients with chronic myeloid leukaemia (CML) in cytogenetic response (CyR) with residual disease detectable by quantitative polymerase chain reaction (Q-PCR)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014742-28/FR",
            "title": "Essai randomisé multicentrique de phase III évaluant chez des patients en primo-infection VIH-1 l’impact sur les réservoirs (par quantification de l’ADN-VIH-1 dans les PBMC) d’une combinaison compr...",
            "country": "FR",
            "timestamp": "2009-11-18"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN90038418",
            "timestamp": "2009-11-16",
            "title": "Clinical study to investigate the long-term safety and efficacy of human cell line recombinant Factor VIII (human-cl rhFVIII) in previously treated patients with severe haemophilia A"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/DE",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "DE",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/ES",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "ES",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/IE",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "IE",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/BE",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "BE",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/FR",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "FR",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/AT",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "AT",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/IT",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "IT",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/GB",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "GB",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014296-40/results",
            "title": "PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF 2 DOSES OF CP-690,550 IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON BACKGROUND METHOTREXATE WITH INADEQUA...",
            "country": "View results",
            "timestamp": "2009-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013265-26/ES",
            "title": "INTERACCIONES FARMACOLÓGICAS ENTRE ECHINACEA PURPUREA Y DARUNAVIR/RITONAVIR",
            "country": "ES",
            "timestamp": "2009-11-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013265-26/results",
            "title": "INTERACCIONES FARMACOLÓGICAS ENTRE ECHINACEA PURPUREA Y DARUNAVIR/RITONAVIR",
            "country": "View results",
            "timestamp": "2009-11-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013223-37/CZ",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS",
            "country": "CZ",
            "timestamp": "2009-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013223-37/HU",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS",
            "country": "HU",
            "timestamp": "2009-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013223-37/ES",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS",
            "country": "ES",
            "timestamp": "2009-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013223-37/results",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS",
            "country": "View results",
            "timestamp": "2009-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013657-14/DE",
            "title": "Randomized, Open label, Multiple-Dose Study to Evaluate the Pharmacodynamics,\nSafety and Pharmacokinetics of BMS-663068 in HIV-1 Infected Subjects",
            "country": "DE",
            "timestamp": "2009-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013657-14/results",
            "title": "Randomized, Open label, Multiple-Dose Study to Evaluate the Pharmacodynamics,\nSafety and Pharmacokinetics of BMS-663068 in HIV-1 Infected Subjects",
            "country": "View results",
            "timestamp": "2009-11-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006129-29/DE",
            "title": "A multicentre, randomized, double-blind, placebo-controlled study to evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to ...",
            "country": "DE",
            "timestamp": "2009-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006129-29/NL",
            "title": "A multicentre, randomized, double-blind, placebo-controlled study to evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to ...",
            "country": "NL",
            "timestamp": "2009-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006129-29/BG",
            "title": "A multicentre, randomized, double-blind, placebo-controlled study to evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to ...",
            "country": "BG",
            "timestamp": "2009-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006129-29/PL",
            "title": "A multicentre, randomized, double-blind, placebo-controlled study to evaluate the safety, preliminary clinical activity and immunogenicity of multiple doses of MOR103 administered intravenously to ...",
            "country": "PL",
            "timestamp": "2009-11-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-020659-30/IT",
            "title": "COMBINED THERAPY WITH PEG-INTERFERON-α, RIBAVIRIN AND RITUXIMAB OF HEPATITIS C VIRUS-RELATED   MIXED CRYOGLOBULINEMIA",
            "country": "IT",
            "timestamp": "2009-10-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/DE",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "DE",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/BE",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "BE",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/GB",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "GB",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/DK",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "DK",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/FR",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "FR",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/IT",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "IT",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/NL",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "NL",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010714-30/results",
            "title": "A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sar...",
            "country": "View results",
            "timestamp": "2009-10-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013695-46/FR",
            "title": "ETUDE MULTICENTRIQUE, RANDOMISEE EN DOUBLE AVEUGLE VERSUS PLACEBO EVALUANT L’EFFICACITE D’UN TRAITEMENT ADDITIONNEL PAR CHOLECALCIFEROL (VITAMINE D3) CHEZ DES PATIENTS ATTEINTS DE SCLEROSE EN PLAQU...",
            "country": "FR",
            "timestamp": "2009-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013695-46/results",
            "title": "ETUDE MULTICENTRIQUE, RANDOMISEE EN DOUBLE AVEUGLE VERSUS PLACEBO EVALUANT L’EFFICACITE D’UN TRAITEMENT ADDITIONNEL PAR CHOLECALCIFEROL (VITAMINE D3) CHEZ DES PATIENTS ATTEINTS DE SCLEROSE EN PLAQU...",
            "country": "View results",
            "timestamp": "2009-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014216-35/IT",
            "title": "REYAGEN study. Optimization of unboosted atazanavir dosing, when associated with tenofovir,\nguided by pharmacogenetics profile of HIV-patients",
            "country": "IT",
            "timestamp": "2009-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005428-99/GB",
            "title": "A randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guerin or standard therapy in patients with recurrence of non-muscle invasive b...",
            "country": "GB",
            "timestamp": "2009-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005428-99/results",
            "title": "A randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guerin or standard therapy in patients with recurrence of non-muscle invasive b...",
            "country": "View results",
            "timestamp": "2009-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012344-17/IT",
            "title": "A  randomized, open label, single center, phase IIa controlled trial to assess tolerability, safety and effect of treatment with deferasirox plus standard antiviral therapy versus standard antivira...",
            "country": "IT",
            "timestamp": "2009-10-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013442-86/BE",
            "title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of 48 Weeks of GS-9190 in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Previously Untreated Subjects w...",
            "country": "BE",
            "timestamp": "2009-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013442-86/IE",
            "title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of 48 Weeks of GS-9190 in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Previously Untreated Subjects w...",
            "country": "IE",
            "timestamp": "2009-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013442-86/AT",
            "title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of 48 Weeks of GS-9190 in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Previously Untreated Subjects w...",
            "country": "AT",
            "timestamp": "2009-10-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013442-86/results",
            "title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of 48 Weeks of GS-9190 in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Previously Untreated Subjects w...",
            "country": "View results",
            "timestamp": "2009-10-02"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17842302",
            "timestamp": "2009-10-01",
            "title": "The effect of nutritional supplementation on retinal function"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010611-33/ES",
            "title": "Ensayo clínico para evaluar el efecto sobre la grasa subcutánea del cambio de EFV por LPV/r en pacientes infectados por VIH que desarrollaron lipoatrofia que sigue siendo clínicamente evidente a pe...",
            "country": "ES",
            "timestamp": "2009-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013287-39/ES",
            "title": "RANDOMISED AND PROSPECTIVE CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LOPINAVIR/RITONAVIR MONOTHERAPY VS DARUNAVIR/RITONAVIR MONOTHERAPIES AS SIMPLIFICATION SWITCHING STRATEGIES OF PI/NN...",
            "country": "ES",
            "timestamp": "2009-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013287-39/results",
            "title": "RANDOMISED AND PROSPECTIVE CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LOPINAVIR/RITONAVIR MONOTHERAPY VS DARUNAVIR/RITONAVIR MONOTHERAPIES AS SIMPLIFICATION SWITCHING STRATEGIES OF PI/NN...",
            "country": "View results",
            "timestamp": "2009-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013482-26/FR",
            "title": "« Rotation ou Changement de biothérapie dans la polyarthrite rhumatoïde en cas d’échec à un anti-TNF »",
            "country": "FR",
            "timestamp": "2009-09-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN37737787",
            "timestamp": "2009-09-22",
            "title": "Europe - Africa Research Network for Evaluation of Second-line Therapy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-018870-19/IT",
            "title": "randomized study for hcv recurrence treatment in liver transplant patients with ribavirin pre-treatment for 8 weeks follwed by stadard therapy (48 weeks) with interferon pegylated and ribavirin vs ...",
            "country": "IT",
            "timestamp": "2009-09-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/LT",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "LT",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/SE",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "SE",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/DE",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "DE",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/BE",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "BE",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/GB",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "GB",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/CZ",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "CZ",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/AT",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "AT",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/FR",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "FR",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000150-12/results",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability  and  Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and ...",
            "country": "View results",
            "timestamp": "2009-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012223-29/BE",
            "title": "A phase II, open, single centre, exploratory study to evaluate the safety and immunogenicity of one booster dose of a GSK Biologicals’ Hepatitis B vaccine Engerix™-B or a of GSK Biologicals’ HIV ca...",
            "country": "BE",
            "timestamp": "2009-09-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012223-29/results",
            "title": "A phase II, open, single centre, exploratory study to evaluate the safety and immunogenicity of one booster dose of a GSK Biologicals’ Hepatitis B vaccine Engerix™-B or a of GSK Biologicals’ HIV ca...",
            "country": "View results",
            "timestamp": "2009-09-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN92328241",
            "timestamp": "2009-08-28",
            "title": "Head to head study of influenza H1N1 vaccines in adults"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/HU",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "HU",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/DE",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "DE",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/BE",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "BE",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/CZ",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "CZ",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/FR",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "FR",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/SI",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "SI",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/ES",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "ES",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/SE",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "SE",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/SK",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "SK",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/LT",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "LT",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/NL",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "NL",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/LV",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "LV",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/GR",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "GR",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/DK",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "DK",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/IT",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "IT",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/3rd",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "Outside EU/EEA",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012520-84/results",
            "title": "A 2-Part Open-label Study to Assess the Clinical Benefit and Long-term Safety of Etanercept in Children and Adolescents With Extended Oligoarticular Juvenile Idiopathic Arthritis, Enthesitis-Relate...",
            "country": "View results",
            "timestamp": "2009-08-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN93000276",
            "timestamp": "2009-08-19",
            "title": "Mangosteen juice blend for the reduction of inflammation in obese subjects"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN98817459",
            "timestamp": "2009-08-19",
            "title": "Immunomodulatory effects of a proprietary Arabinogalactan extract"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011206-42/CZ",
            "title": "A Randomized, Double Blind, Placebo Controlled, Dose Ranging, Parallel Group, Phase 2 Study of INCB028050 Compared to Background Therapy in Patients with Active Rheumatoid Arthritis with Inadequate...",
            "country": "CZ",
            "timestamp": "2009-08-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011206-42/results",
            "title": "A Randomized, Double Blind, Placebo Controlled, Dose Ranging, Parallel Group, Phase 2 Study of INCB028050 Compared to Background Therapy in Patients with Active Rheumatoid Arthritis with Inadequate...",
            "country": "View results",
            "timestamp": "2009-08-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012705-19/HU",
            "title": "A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Determine the Safety and Efficacy of Daily Orally Administered LX3305 in Subjects with Active Rheumatoi...",
            "country": "HU",
            "timestamp": "2009-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012705-19/CZ",
            "title": "A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Determine the Safety and Efficacy of Daily Orally Administered LX3305 in Subjects with Active Rheumatoi...",
            "country": "CZ",
            "timestamp": "2009-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012705-19/BG",
            "title": "A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Determine the Safety and Efficacy of Daily Orally Administered LX3305 in Subjects with Active Rheumatoi...",
            "country": "BG",
            "timestamp": "2009-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012705-19/results",
            "title": "A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Determine the Safety and Efficacy of Daily Orally Administered LX3305 in Subjects with Active Rheumatoi...",
            "country": "View results",
            "timestamp": "2009-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012499-28/IT",
            "title": "Efficacy of the treatment with hydroxychloroquine in non responders HIV-infected HAART-treated patients",
            "country": "IT",
            "timestamp": "2009-08-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012010-52/DK",
            "title": "Bevacizumab, Interleukin-2 and Interferon-alpha in metastathic renal cell carcinoma",
            "country": "DK",
            "timestamp": "2009-08-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012579-90/DE",
            "title": "Antiviral effect and safety of once daily BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve patients for 12 or 24 weeks as combination therapy with pegylated interferon-α 2a and...",
            "country": "DE",
            "timestamp": "2009-08-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012579-90/FR",
            "title": "Antiviral effect and safety of once daily BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve patients for 12 or 24 weeks as combination therapy with pegylated interferon-α 2a and...",
            "country": "FR",
            "timestamp": "2009-08-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012579-90/AT",
            "title": "Antiviral effect and safety of once daily BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve patients for 12 or 24 weeks as combination therapy with pegylated interferon-α 2a and...",
            "country": "AT",
            "timestamp": "2009-08-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012579-90/results",
            "title": "Antiviral effect and safety of once daily BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve patients for 12 or 24 weeks as combination therapy with pegylated interferon-α 2a and...",
            "country": "View results",
            "timestamp": "2009-08-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013333-24/IT",
            "title": "Multicenter, open-label, 12 weeks Phase IV study to  assess adherence to treatment in relapsing multiple  sclerosis (RMS) subjects switching from other  injectable DMDs using ReBiSmart to self-inje...",
            "country": "IT",
            "timestamp": "2009-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-013333-24/results",
            "title": "Multicenter, open-label, 12 weeks Phase IV study to  assess adherence to treatment in relapsing multiple  sclerosis (RMS) subjects switching from other  injectable DMDs using ReBiSmart to self-inje...",
            "country": "View results",
            "timestamp": "2009-08-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011868-11/ES",
            "title": "ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD Y EFICACIA DE CAMBIAR EL ITINAN O EL IP A MARAVIROC EN PACIENTES INFECTADOS POR EL VIH-1 CON CARGA VIRAL INDETECTABLE Y DISLIPEMIA ASOCIADA A LOS ANT...",
            "country": "ES",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011868-11/results",
            "title": "ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD Y EFICACIA DE CAMBIAR EL ITINAN O EL IP A MARAVIROC EN PACIENTES INFECTADOS POR EL VIH-1 CON CARGA VIRAL INDETECTABLE Y DISLIPEMIA ASOCIADA A LOS ANT...",
            "country": "View results",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/GB",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "GB",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/DE",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "DE",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/NL",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "NL",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/FR",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "FR",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/ES",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "ES",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/IT",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "IT",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004097-32/results",
            "title": "An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients with Metastatic Malignant Melanoma",
            "country": "View results",
            "timestamp": "2009-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006603-20/HU",
            "title": "A Phase 2, 2-Part, Multicenter, Randomized, Double-blind,\nParallel-group, Placebo-controlled, Proof-of-concept, dose-finding\nStudy Evaluating the Efficacy and Safety of CNTO 136\nAdministered Subcut...",
            "country": "HU",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006603-20/results",
            "title": "A Phase 2, 2-Part, Multicenter, Randomized, Double-blind,\nParallel-group, Placebo-controlled, Proof-of-concept, dose-finding\nStudy Evaluating the Efficacy and Safety of CNTO 136\nAdministered Subcut...",
            "country": "View results",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/SK",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "SK",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/DE",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "DE",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/ES",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "ES",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/FR",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "FR",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/IT",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "IT",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/GR",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "GR",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/GB",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "GB",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000660-17/results",
            "title": "TPL108392:  An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligibl...",
            "country": "View results",
            "timestamp": "2009-07-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011182-86/BG",
            "title": "480 Study: Phase 2b Open-label, Randomized Study in Treatment Naïve Subjects with HCV Genotype 1 to Compare the Efficacy, Safety, and Tolerability of  the 480 µg  Dose of Locteron™  Plus Ribavirin ...",
            "country": "BG",
            "timestamp": "2009-07-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/ES",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "ES",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/BE",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "BE",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/IT",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "IT",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/HU",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "HU",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/FR",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "FR",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/DE",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "DE",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/AT",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "AT",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/GB",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "GB",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010806-12/results",
            "title": "Estudio multicéntrico, aleatorizado, abierto, controlado para comparar la Respuesta Virológica Sostenida durante el tratamiento con Sandimmun Neoral® o tacrolimus en el mantenimiento de receptores ...",
            "country": "View results",
            "timestamp": "2009-07-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009776-13/FR",
            "title": "Essai clinique comparant l’efficacité et la tolérance de deux stratégies thérapeutiques de maintenance: monothérapie par lopinavir/ritonavir ou trithérapie en comprimé unique quotidien par efaviren...",
            "country": "FR",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009995-11/DE",
            "title": "A randomized, adaptive-design dose finding study to assess the antiviral efficacy and\nsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infecte...",
            "country": "DE",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009995-11/ES",
            "title": "A randomized, adaptive-design dose finding study to assess the antiviral efficacy and\nsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infecte...",
            "country": "ES",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009995-11/IT",
            "title": "A randomized, adaptive-design dose finding study to assess the antiviral efficacy and\nsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infecte...",
            "country": "IT",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009995-11/BE",
            "title": "A randomized, adaptive-design dose finding study to assess the antiviral efficacy and\nsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infecte...",
            "country": "BE",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009995-11/NL",
            "title": "A randomized, adaptive-design dose finding study to assess the antiviral efficacy and\nsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infecte...",
            "country": "NL",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009995-11/results",
            "title": "A randomized, adaptive-design dose finding study to assess the antiviral efficacy and\nsafety of NIM811 administered in combination with Standard of Care (SOC) for 12 weeks in relapsed HCV-1 infecte...",
            "country": "View results",
            "timestamp": "2009-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012000-10/BE",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Rib...",
            "country": "BE",
            "timestamp": "2009-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012000-10/DE",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Rib...",
            "country": "DE",
            "timestamp": "2009-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012000-10/GB",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Rib...",
            "country": "GB",
            "timestamp": "2009-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012000-10/AT",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Rib...",
            "country": "AT",
            "timestamp": "2009-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012000-10/ES",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Rib...",
            "country": "ES",
            "timestamp": "2009-07-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-012000-10/results",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Rib...",
            "country": "View results",
            "timestamp": "2009-07-13"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN02452400",
            "timestamp": "2009-07-10",
            "title": "PENTA18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009214-40/HU",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INF...",
            "country": "HU",
            "timestamp": "2009-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009214-40/FR",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INF...",
            "country": "FR",
            "timestamp": "2009-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009214-40/ES",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INF...",
            "country": "ES",
            "timestamp": "2009-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009214-40/BE",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INF...",
            "country": "BE",
            "timestamp": "2009-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009214-40/DE",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INF...",
            "country": "DE",
            "timestamp": "2009-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-009214-40/results",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FILIBUVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT NAÏVE, HCV GENOTYPE 1 INF...",
            "country": "View results",
            "timestamp": "2009-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/GB",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "GB",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/DE",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "DE",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/BE",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "BE",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/SE",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "SE",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/AT",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "AT",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/PL",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "PL",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/CZ",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "CZ",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/NL",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "NL",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/DK",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "DK",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/ES",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "ES",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/IT",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "IT",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010788-18/results",
            "title": "An Extension Protocol For Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab",
            "country": "View results",
            "timestamp": "2009-07-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/IE",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "IE",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/GB",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "GB",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/FR",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "FR",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/ES",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "ES",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/IT",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "IT",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/3rd",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "Outside EU/EEA",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004631-37/results",
            "title": "A Phase II, open-label trial, to evaluate pharmacokinetics, safety, tolerability and antiviral activity of DRV/rtv once daily in treatment-naïve HIV 1 infected adolescents aged between 12 and < 18 ...",
            "country": "View results",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007649-30/DE",
            "title": "SELECT-2: Phase 2B, Partially Blinded, Randomized Study In Treatment Naïve Subjects With HCV Genotype 1 To Compare The Efficacy, Safety, And Tolerability Of Three Doses of Locteron™ Plus Ribavirin ...",
            "country": "DE",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007649-30/BG",
            "title": "SELECT-2: Phase 2B, Partially Blinded, Randomized Study In Treatment Naïve Subjects With HCV Genotype 1 To Compare The Efficacy, Safety, And Tolerability Of Three Doses of Locteron™ Plus Ribavirin ...",
            "country": "BG",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007649-30/FR",
            "title": "SELECT-2: Phase 2B, Partially Blinded, Randomized Study In Treatment Naïve Subjects With HCV Genotype 1 To Compare The Efficacy, Safety, And Tolerability Of Three Doses of Locteron™ Plus Ribavirin ...",
            "country": "FR",
            "timestamp": "2009-06-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010887-41/FR",
            "title": "A randomized, exploratory, open-label 48-week trial with a 2-week Pre-Treatment Phase to investigate the pharmacokinetics, safety, tolerability and antiviral activity of etravirine (ETR) in combina...",
            "country": "FR",
            "timestamp": "2009-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010887-41/results",
            "title": "A randomized, exploratory, open-label 48-week trial with a 2-week Pre-Treatment Phase to investigate the pharmacokinetics, safety, tolerability and antiviral activity of etravirine (ETR) in combina...",
            "country": "View results",
            "timestamp": "2009-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/LV",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "LV",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/EE",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "EE",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/DE",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "DE",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/BE",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "BE",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/NL",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "NL",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/ES",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "ES",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/CZ",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "CZ",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/BG",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "BG",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/GR",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "GR",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/GB",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "GB",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006333-27/results",
            "title": "A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple ...",
            "country": "View results",
            "timestamp": "2009-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002694-13/ES",
            "title": "Estudio piloto, fase IV para analizar la seguridad de los combos Truvada vs Kivexa como parte de un TARGA basado en Kaletra. Estudio COMBOKA",
            "country": "ES",
            "timestamp": "2009-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007038-24/DE",
            "title": "PILOT STUDY OF NOVEL COMBINATION OF MARAVIROC + ATAZANAVIR/RITONAVIR VS ATAZANAVIR/RITONAVIR + EMTRICITABINE/TENOFOVIR FOR THE TREATMENT OF TREATMENT NAÏVE HIV-INFECTED PATIENTS WITH R5 HIV-1",
            "country": "DE",
            "timestamp": "2009-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007038-24/ES",
            "title": "PILOT STUDY OF NOVEL COMBINATION OF MARAVIROC + ATAZANAVIR/RITONAVIR VS ATAZANAVIR/RITONAVIR + EMTRICITABINE/TENOFOVIR FOR THE TREATMENT OF TREATMENT NAÏVE HIV-INFECTED PATIENTS WITH R5 HIV-1",
            "country": "ES",
            "timestamp": "2009-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007038-24/GB",
            "title": "PILOT STUDY OF NOVEL COMBINATION OF MARAVIROC + ATAZANAVIR/RITONAVIR VS ATAZANAVIR/RITONAVIR + EMTRICITABINE/TENOFOVIR FOR THE TREATMENT OF TREATMENT NAÏVE HIV-INFECTED PATIENTS WITH R5 HIV-1",
            "country": "GB",
            "timestamp": "2009-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007038-24/results",
            "title": "PILOT STUDY OF NOVEL COMBINATION OF MARAVIROC + ATAZANAVIR/RITONAVIR VS ATAZANAVIR/RITONAVIR + EMTRICITABINE/TENOFOVIR FOR THE TREATMENT OF TREATMENT NAÏVE HIV-INFECTED PATIENTS WITH R5 HIV-1",
            "country": "View results",
            "timestamp": "2009-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005560-13/DE",
            "title": "A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interfeorn-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis- The ...",
            "country": "DE",
            "timestamp": "2009-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005560-13/GR",
            "title": "A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interfeorn-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis- The ...",
            "country": "GR",
            "timestamp": "2009-06-12"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN36517335",
            "timestamp": "2009-05-29",
            "title": "Efficacy of the antimalarial drugs recommended by the National Malaria Control Programme in Madagascar"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN85785327",
            "timestamp": "2009-05-28",
            "title": "HYMN"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/BE",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "BE",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/FI",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "FI",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/ES",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "ES",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/DE",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "DE",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/GB",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "GB",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/GR",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "GR",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/IT",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "IT",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/SE",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "SE",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/PT",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "PT",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/IE",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "IE",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/EE",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "EE",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/NO",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "NO",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/AT",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "AT",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006439-12/CZ",
            "title": "Strategic Timing of AntiRetroviral Treatment(START)",
            "country": "CZ",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008211-26/IT",
            "title": "Peptide-based vaccine in combination or not with chemotherapy in melanoma patients: a phase II randomized clinical study.",
            "country": "IT",
            "timestamp": "2009-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007788-17/CZ",
            "title": "PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS",
            "country": "CZ",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007788-17/DE",
            "title": "PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS",
            "country": "DE",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007788-17/BG",
            "title": "PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS",
            "country": "BG",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007788-17/results",
            "title": "PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF 2 DOSES OF CP 690,550 MONOTHERAPY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS",
            "country": "View results",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/DE",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "DE",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/GB",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "GB",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/ES",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "ES",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/PT",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "PT",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/IT",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "IT",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/FR",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "FR",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004392-19/results",
            "title": "A PHASE 2B MULTICENTER, RANDOMIZED, COMPARATIVE TRIAL OF UK-453,061 VERSUS ETRAVIRINE IN COMBINATION WITH DARUNAVIR/RITONAVIR AND A NUCLEOTIDE/NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR FOR THE TRE...",
            "country": "View results",
            "timestamp": "2009-05-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006239-11/NL",
            "title": "Augmenting response to entecavir using a temporary peginterferon alpha-2a add-on strategy for the treatment of HBeAg-positive chronic hepatitis B (ARES study)",
            "country": "NL",
            "timestamp": "2009-05-15"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN85736336",
            "timestamp": "2009-05-15",
            "title": "Controlled study of hepatitis B virus level alteration in hepatocellular carcinoma while treating with transcatheter arterial chemoembolisation alone or in combination with interferon-alpha"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-011273-32/IT",
            "title": "Pilot study for the evaluation of the safety and the feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in patients on stable treatment with two NRTIs + atazanavir/ritonav...",
            "country": "IT",
            "timestamp": "2009-05-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001137-99/GB",
            "title": "CHANGE TO:\nA PILOT RANDOMISED STUDY TO COMPARE COMBINATION ANTIBIOTIC THERAPY (CIPROFLOXACIN AND DOXYCYCLINE) WITH STANDARD THERAPY (BUDESONIDE) IN THE TREATMENT OF ACTIVE CROHN'S DISEASE",
            "country": "GB",
            "timestamp": "2009-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006414-19/GB",
            "title": "Dynamic contrast enhanced MRI (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-α in patients with advanced renal cell carcinoma.",
            "country": "GB",
            "timestamp": "2009-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006414-19/results",
            "title": "Dynamic contrast enhanced MRI (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-α in patients with advanced renal cell carcinoma.",
            "country": "View results",
            "timestamp": "2009-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005525-11/DE",
            "title": "A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera) and tocilizumab (Actemra) v...",
            "country": "DE",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005525-11/ES",
            "title": "A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera) and tocilizumab (Actemra) v...",
            "country": "ES",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005525-11/NL",
            "title": "A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera) and tocilizumab (Actemra) v...",
            "country": "NL",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005525-11/GB",
            "title": "A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera) and tocilizumab (Actemra) v...",
            "country": "GB",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005525-11/FR",
            "title": "A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera) and tocilizumab (Actemra) v...",
            "country": "FR",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005525-11/GR",
            "title": "A randomized, placebo controlled, double-blind, parallel group study to compare the safety and reduction in disease activity with the combination of rituximab (MabThera) and tocilizumab (Actemra) v...",
            "country": "GR",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006917-25/DE",
            "title": "A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast with Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients with Active Rheumatoid Arthritis (RA).",
            "country": "DE",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006917-25/PL",
            "title": "A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast with Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients with Active Rheumatoid Arthritis (RA).",
            "country": "PL",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006917-25/CZ",
            "title": "A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast with Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients with Active Rheumatoid Arthritis (RA).",
            "country": "CZ",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006917-25/GB",
            "title": "A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast with Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients with Active Rheumatoid Arthritis (RA).",
            "country": "GB",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006917-25/BG",
            "title": "A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast with Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients with Active Rheumatoid Arthritis (RA).",
            "country": "BG",
            "timestamp": "2009-04-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN16202527",
            "timestamp": "2009-04-24",
            "title": "Study to investigate the combination of methylprednisolone and interferon-beta in the treatment of multiple sclerosis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN08193901",
            "timestamp": "2009-04-23",
            "title": "Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-alpha in patients with advanced renal cell carcinoma"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006366-29/IT",
            "title": "IMMUNOTHERAPY OF MAINTENANCE IN THE PATIENTS WITH METASTATIC MELANOMA, CLINICAL BENEFIT AFTER CHEMOTHERAPY",
            "country": "IT",
            "timestamp": "2009-04-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010912-14/IT",
            "title": "MAraviroc In HIV/ HCV Coinfection and Liver fibrosis",
            "country": "IT",
            "timestamp": "2009-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008190-58/DE",
            "title": "A Phase IIa, open-label, randomized trial in treatment-naïve HIV-1-infected subjects to determine the antiviral activity of 14 days of monotherapy with 4 different dose regimens of TMC310911 co-adm...",
            "country": "DE",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008190-58/results",
            "title": "A Phase IIa, open-label, randomized trial in treatment-naïve HIV-1-infected subjects to determine the antiviral activity of 14 days of monotherapy with 4 different dose regimens of TMC310911 co-adm...",
            "country": "View results",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004760-39/DE",
            "title": "A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterfer...",
            "country": "DE",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004760-39/BE",
            "title": "A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterfer...",
            "country": "BE",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004760-39/IT",
            "title": "A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterfer...",
            "country": "IT",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004760-39/FR",
            "title": "A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterfer...",
            "country": "FR",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004760-39/results",
            "title": "A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterfer...",
            "country": "View results",
            "timestamp": "2009-04-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN31487459",
            "timestamp": "2009-04-03",
            "title": "The efficacy of treatment with St Johns Wort for premenstrual syndrome (PMS)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/SE",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "SE",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/DE",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "DE",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/GB",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "GB",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/ES",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "ES",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/NL",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "NL",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/IT",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "IT",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006182-88/results",
            "title": "A single arm, multicenter, single-stage phase II trial of RAD001 in Advanced and Metastatic Silent neuro-Endocrine Tumours in Europe",
            "country": "View results",
            "timestamp": "2009-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003011-12/GB",
            "title": "Prospective Randomised Double-Blind Placebo Controlled Study Assessing the Efficacy of Tocilizumab with Synovial Analysis in Patients with Rheumatoid Arthritis",
            "country": "GB",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003011-12/results",
            "title": "Prospective Randomised Double-Blind Placebo Controlled Study Assessing the Efficacy of Tocilizumab with Synovial Analysis in Patients with Rheumatoid Arthritis",
            "country": "View results",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008258-21/AT",
            "title": "A Randomized, Double-blinded, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination with Pegas...",
            "country": "AT",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008258-21/DE",
            "title": "A Randomized, Double-blinded, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination with Pegas...",
            "country": "DE",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008258-21/ES",
            "title": "A Randomized, Double-blinded, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination with Pegas...",
            "country": "ES",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008258-21/FR",
            "title": "A Randomized, Double-blinded, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination with Pegas...",
            "country": "FR",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008258-21/GB",
            "title": "A Randomized, Double-blinded, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination with Pegas...",
            "country": "GB",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-008258-21/IT",
            "title": "A Randomized, Double-blinded, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination with Pegas...",
            "country": "IT",
            "timestamp": "2009-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007446-54/NL",
            "title": "LOWERING VIRAL LOAD WITH NUCLEOS(T)IDE ANALOGUES PRIOR TO PEG-INTERFERON ALFA-2B TREATMENT TO INCREASE SUSTAINED RESPONSE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (PADD-STUDY)",
            "country": "NL",
            "timestamp": "2009-03-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004761-26/IT",
            "title": "PILOT MULTICENTER OPEN STUDY TO EVALUATE EFFICACY AND TOLERABILITY OF PEG-INTERFERON ALFA-2A IN PATIENTS WITH ANTI-HBE POSITIVE CHRONIC HEPATITIS B WHO PRESENT RESIDUAL VIREMIA OR VIROLOGICAL REBOU...",
            "country": "IT",
            "timestamp": "2009-03-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/ES",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "ES",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/DE",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "DE",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/HU",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "HU",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/CZ",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "CZ",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/IT",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "IT",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/GR",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "GR",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/FR",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "FR",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/BE",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "BE",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/GB",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "GB",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006226-34/results",
            "title": "Estudio multicéntrico, aleatorizado, de grupos paralelos, ciego para el evaluador, que compara la efectividad y seguridad de teriflunomida e interferón beta-1a en pacientes con esclerosis múltiple ...",
            "country": "View results",
            "timestamp": "2009-03-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004544-37/FR",
            "title": "Etude ouverte, non comparative, évaluant chez des patients infectés par le VIH-1, ayant une charge virale indétectable avec un traitement comportant un inhibiteur de la protéase potentialisé par du...",
            "country": "FR",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/CZ",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "CZ",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/FI",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "FI",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/EE",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "EE",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/AT",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "AT",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/GB",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "GB",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/DE",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "DE",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/ES",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "ES",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/NO",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "NO",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/BE",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "BE",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/PT",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "PT",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/IT",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "IT",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/GR",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "GR",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/FR",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "FR",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/SE",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "SE",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/BG",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "BG",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003706-33/results",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of oral cladribine in subjects with a first clinical event at high risk of converting to MS",
            "country": "View results",
            "timestamp": "2009-03-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN57377482",
            "timestamp": "2009-03-18",
            "title": "A prospective, multicentre, open label, exploratory study to investigate the ability of the Heidelberg assay panel and the B-Cell/antibody response panel to predict the clinical effect of Octagam® 5% in subjects with relapsing/remitting multiple sclerosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010189-48/IT",
            "title": "Randomised trial comparing the introduction of an immediate or deferred new HAART regimen in failing HIV infected patients: the role of lamivudine monotherapy",
            "country": "IT",
            "timestamp": "2009-03-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-010189-48/results",
            "title": "Randomised trial comparing the introduction of an immediate or deferred new HAART regimen in failing HIV infected patients: the role of lamivudine monotherapy",
            "country": "View results",
            "timestamp": "2009-03-13"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN21534255",
            "timestamp": "2009-03-11",
            "title": "Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN70702834",
            "timestamp": "2009-03-11",
            "title": "Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006208-52/DE",
            "title": "Mono-centre, open-label study to investigate the multi-dose pharmacokinetics, efficacy and safety of Interferon alpha-2b Cream in women with a history of cytological diagnosed  Pap IIID, with a con...",
            "country": "DE",
            "timestamp": "2009-03-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN66756285",
            "timestamp": "2009-03-09",
            "title": "Can Valaciclovir delay the need for initiation of human immunodeficiency virus (HIV) treatment in HIV – infected individuals"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005859-16/DE",
            "title": "Prospective randomized Multicenter study \r\nin first-line treatment\r\nof Advanced progredIeNT follicular And other IndoleNt  \r\nand mantle cell lymphomas",
            "country": "DE",
            "timestamp": "2009-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005859-16/AT",
            "title": "Prospective randomized Multicenter study \r\nin first-line treatment\r\nof Advanced progredIeNT follicular And other IndoleNt  \r\nand mantle cell lymphomas",
            "country": "AT",
            "timestamp": "2009-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004627-28/IT",
            "title": "Switch from a current boosted rtv PI to ATV/rtv based HAART regimen. Effect on metabolic and hepatic toxicity in HIV/HCV coinfected patients (COAT Study).",
            "country": "IT",
            "timestamp": "2009-02-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006287-11/IT",
            "title": "Virologic efficacy of Maraviroc in adult naive HIV patients with HIV-RNA>= 1000 copies/ml",
            "country": "IT",
            "timestamp": "2009-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007004-29/IT",
            "title": "Maraviroc in HIV Acute INfection",
            "country": "IT",
            "timestamp": "2009-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007510-30/HU",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS  OF 12 WEEKS OF TREATMENT WITH ...",
            "country": "HU",
            "timestamp": "2009-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007510-30/PL",
            "title": "A PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS  OF 12 WEEKS OF TREATMENT WITH ...",
            "country": "PL",
            "timestamp": "2009-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005871-92/SE",
            "title": "En fas 1 studie av effekt av Tysabri (natalizumab), en IgG4 humaniserad monoklonal antikropp specifik mot VLA-4 (integrin alfa-4), administrerad som infusion  1 gång/månad under 3 månader hos patie...",
            "country": "SE",
            "timestamp": "2009-02-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN41541516",
            "timestamp": "2009-02-05",
            "title": "Exercise Intervention for Multiple Sclerosis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN87293301",
            "timestamp": "2009-02-03",
            "title": "Clinical study to investigate the pharmacokinetics, efficacy, safety and immunogenicity of human-cl rhFVIII in previously treated patients with severe haemophilia A"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006644-19/IT",
            "title": "Evaluation of inflammatory immune parameters predicting cardiovascular risk in HIV-1-infected antiretroviral therapy naive patients treated with atazanavir/ritonavir versus lopinavir/ritonavir base...",
            "country": "IT",
            "timestamp": "2009-01-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004611-35/NL",
            "title": "Phase I/II study: on the toxicity and effects of combining the p53 synthetic long peptides vaccine with either Imiquimod or Interferon-alfa to induce polarized p53-specific immunity in patients tre...",
            "country": "NL",
            "timestamp": "2009-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004885-24/FR",
            "title": "Essai pilote multicentrique évaluant la capacité d’une stratégie de traitement antirétroviral intermittent à maintenir une stabilité immunologique chez des patients infectés par le VIH-1, jamais tr...",
            "country": "FR",
            "timestamp": "2009-01-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN50861407",
            "timestamp": "2009-01-16",
            "title": "Development and evaluation of an exercise intervention programme to improve cardiovascular fitness and vascular responses in patients with rheumatoid arthritis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-006227-31/DE",
            "title": "Inflammatory Topoproteome of Psoriasis under Etanercept Treatment",
            "country": "DE",
            "timestamp": "2009-01-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003098-42/CZ",
            "title": "A Multicenter, Open-Label, Immunogenicity and Safety Study of Avonex® (Interferon Beta-1a) 30 mcg Administered Subcutaneously to Subjects With Relapsing Multiple Sclerosis",
            "country": "CZ",
            "timestamp": "2009-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003098-42/results",
            "title": "A Multicenter, Open-Label, Immunogenicity and Safety Study of Avonex® (Interferon Beta-1a) 30 mcg Administered Subcutaneously to Subjects With Relapsing Multiple Sclerosis",
            "country": "View results",
            "timestamp": "2009-01-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005656-24/ES",
            "title": "ENSAYO CLÍNICO SOBRE LA EVOLUCIÓN Y EL IMPACTO DEL TRATAMIENTO FARMACOLÓGICO EN LA PERDIDA AXONAL PROGRESIVA EN PACIENTES QUE CON ESCLEROSIS MÚLTIPLE QUE HAN PRESENTADO UN PRIMER EPISODIO DESMIELIN...",
            "country": "ES",
            "timestamp": "2008-12-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN78584791",
            "timestamp": "2008-12-23",
            "title": "Pilot study of simplification with fosamprenavir/ritonavir (FPV/r) monotherapy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007637-39/DE",
            "title": "Effects of NSAIDs on RAdiographic Damage in AS (ENRADAS) \n– a prospective randomised controlled trial - Amendment 2",
            "country": "DE",
            "timestamp": "2008-12-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/DE",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "DE",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/ES",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "ES",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/FR",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "FR",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/PL",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "PL",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/IT",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "IT",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/GR",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "GR",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/GB",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "GB",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002039-34/results",
            "title": "An open-label, randomized, multicenter, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon al...",
            "country": "View results",
            "timestamp": "2008-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/CZ",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "CZ",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/AT",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "AT",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/FI",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "FI",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/ES",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "ES",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/PT",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "PT",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/EE",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "EE",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/DE",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "DE",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/BE",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "BE",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/LV",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "LV",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/GR",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "GR",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/IT",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "IT",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/FR",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "FR",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/BG",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "BG",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/PL",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "PL",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/SK",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "SK",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004954-34/results",
            "title": "Double-blind extension of the study 27025 (REFLEX) to obtain long-term follow-up data in patients with clinically definite MS and patients with a first demyelinating event at high risk of convertin...",
            "country": "View results",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004527-31/IE",
            "title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS-9190, in Combination with Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and...",
            "country": "IE",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004527-31/GB",
            "title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS-9190, in Combination with Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and...",
            "country": "GB",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004527-31/DE",
            "title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS-9190, in Combination with Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and...",
            "country": "DE",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004527-31/BE",
            "title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS-9190, in Combination with Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and...",
            "country": "BE",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004527-31/results",
            "title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS-9190, in Combination with Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and...",
            "country": "View results",
            "timestamp": "2008-12-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/GB",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "GB",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/BE",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "BE",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/FR",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "FR",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/ES",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "ES",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/BG",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "BG",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/DE",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "DE",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/GR",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "GR",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/3rd",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "Outside EU/EEA",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003704-35/results",
            "title": "A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection",
            "country": "View results",
            "timestamp": "2008-12-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007075-16/NL",
            "title": "The effect of peroxisome proliferator activator receptor γ agonist pre-treatment on pegylated interferon-α2a and ribavirin efficacy in hepatitis C patients, previously resistant to treatment with p...",
            "country": "NL",
            "timestamp": "2008-12-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000928-71/IT",
            "title": "TWIST. RANDOMIZED PROSPECTIVE PHASE II STUDY OF TEMSIROLIMUS WITH OR WITHOUT LOW-DOSE INTERFERON ALPHA IN METASTATIC NON-CLEAR RENAL CELL CARCINOMA: GOIRC STUDY 02/2008",
            "country": "IT",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/BE",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "BE",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/DE",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "DE",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/SE",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "SE",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/FR",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "FR",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/AT",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "AT",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/IT",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "IT",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/GB",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "GB",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/ES",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "ES",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/NL",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "NL",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000533-22/results",
            "title": "A randomized, double-blind, placebo-controlled, Phase III trial of 2 regimens of telaprevir (with and without delayed start) combined with pegylated interferon alfa-2a (Pegasys®) and ribavirin (Cop...",
            "country": "View results",
            "timestamp": "2008-11-14"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN76548641",
            "timestamp": "2008-11-13",
            "title": "Intracellular boosting of human immunodeficiency virus (HIV) protease inhibitors"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005473-35/ES",
            "title": "PILOT STUDY TO ASSESS THE ROLE OF IMMUNE ACTIVATION AND APOPTOSIS AS A MARKER FOR TREATMENT INTENSIFICATION WITH RALTEGRAVIR IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY WITH LONG-TERM VIRAL ...",
            "country": "ES",
            "timestamp": "2008-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-005473-35/results",
            "title": "PILOT STUDY TO ASSESS THE ROLE OF IMMUNE ACTIVATION AND APOPTOSIS AS A MARKER FOR TREATMENT INTENSIFICATION WITH RALTEGRAVIR IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY WITH LONG-TERM VIRAL ...",
            "country": "View results",
            "timestamp": "2008-11-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003917-29/GB",
            "title": "A Phase 1B Study of the Safety and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (GS-9137/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Treatment-Experienced Adolescents",
            "country": "GB",
            "timestamp": "2008-11-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003917-29/results",
            "title": "A Phase 1B Study of the Safety and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (GS-9137/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Treatment-Experienced Adolescents",
            "country": "View results",
            "timestamp": "2008-11-11"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN83977250",
            "timestamp": "2008-11-10",
            "title": "A preliminary study of the safety, immunogenicity and clinical efficacy of TroVax® given in conjunction with interleukin 2 (IL-2) in the treatment of stage IV renal cell cancer"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003366-33/IT",
            "title": "A phase II, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability and efficacy study of add-on Cladribine tablet therapy with Rebif New Formulation in Multiple Scleroris S...",
            "country": "IT",
            "timestamp": "2008-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003366-33/ES",
            "title": "A phase II, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability and efficacy study of add-on Cladribine tablet therapy with Rebif New Formulation in Multiple Scleroris S...",
            "country": "ES",
            "timestamp": "2008-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003366-33/results",
            "title": "A phase II, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability and efficacy study of add-on Cladribine tablet therapy with Rebif New Formulation in Multiple Scleroris S...",
            "country": "View results",
            "timestamp": "2008-10-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/EE",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "EE",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/LT",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "LT",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/CZ",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "CZ",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/NL",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "NL",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/PT",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "PT",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/GB",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "GB",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/FI",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "FI",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/SE",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "SE",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/DE",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "DE",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/GR",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "GR",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/IT",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "IT",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006611-23/results",
            "title": "Open-label, single-arm, phase II study of bevacizumab (AVASTIN®) in combination with low-dose interferon as first-line treatment of nephrectomised patients with metastatic clear cell renal cell car...",
            "country": "View results",
            "timestamp": "2008-10-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN01405766",
            "timestamp": "2008-10-27",
            "title": "Open multicentre, phase IV study to evaluate efficacy and safety of pegylated interferon alpha-2a (40 KD) plus ribavirin for chronic hepatitis C with normal transaminases in human immunodeficiency virus-infected patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002383-34/IT",
            "title": "A randomised, controlled, open-label trial to compare brachial artery reactivity and cardiovascular risk of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple...",
            "country": "IT",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002383-34/results",
            "title": "A randomised, controlled, open-label trial to compare brachial artery reactivity and cardiovascular risk of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple...",
            "country": "View results",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/SK",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "SK",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/BE",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "BE",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/GB",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "GB",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/CZ",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "CZ",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/HU",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "HU",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/ES",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "ES",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/DE",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "DE",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/IT",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "IT",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/FR",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "FR",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/NL",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "NL",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000077-38/results",
            "title": "A randomized, open label, multi-center phase II study to compare bevacizumab plus RAD001 versus interferon alfa-2a and bevacizumab for the first-line treatment of patients with metastatic clear cel...",
            "country": "View results",
            "timestamp": "2008-10-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN54923521",
            "timestamp": "2008-10-09",
            "title": "STI571 Prospective International RandomIsed Trial 2"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN84821453",
            "timestamp": "2008-10-09",
            "title": "Open randomised study for evaluation of an active hepatitis B vaccination (HBVAXPRO) in combination with a passive immunisation with hepatitis B immunoglobulins (Hepatect) for subjects who did not show any or an adequate reaction to a previous sole active hepatitis B immunisation"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/DE",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "DE",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/ES",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "ES",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/FR",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "FR",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/NL",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "NL",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/PT",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "PT",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/GB",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "GB",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/AT",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "AT",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/CZ",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "CZ",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003538-11/results",
            "title": "Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pe...",
            "country": "View results",
            "timestamp": "2008-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000706-36/DE",
            "title": "Optimization of treatment for patients with chronic hepatitis C infected with HCV-genotype 2 or 3: 12 vs. 24 weeks of treatment extension for patients without rapid virological response",
            "country": "DE",
            "timestamp": "2008-09-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002022-10/ES",
            "title": "Protocolo multicéntrico abierto en el que se proporciona interferón pegilado alfa-2a (PEGASYS®) en monoterapia o en combinación con ribavirina (COPEGUS®) a pacientes con hepatitis C crónica que han...",
            "country": "ES",
            "timestamp": "2008-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002022-10/AT",
            "title": "Protocolo multicéntrico abierto en el que se proporciona interferón pegilado alfa-2a (PEGASYS®) en monoterapia o en combinación con ribavirina (COPEGUS®) a pacientes con hepatitis C crónica que han...",
            "country": "AT",
            "timestamp": "2008-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002022-10/FR",
            "title": "Protocolo multicéntrico abierto en el que se proporciona interferón pegilado alfa-2a (PEGASYS®) en monoterapia o en combinación con ribavirina (COPEGUS®) a pacientes con hepatitis C crónica que han...",
            "country": "FR",
            "timestamp": "2008-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002022-10/IT",
            "title": "Protocolo multicéntrico abierto en el que se proporciona interferón pegilado alfa-2a (PEGASYS®) en monoterapia o en combinación con ribavirina (COPEGUS®) a pacientes con hepatitis C crónica que han...",
            "country": "IT",
            "timestamp": "2008-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002022-10/DE",
            "title": "Protocolo multicéntrico abierto en el que se proporciona interferón pegilado alfa-2a (PEGASYS®) en monoterapia o en combinación con ribavirina (COPEGUS®) a pacientes con hepatitis C crónica que han...",
            "country": "DE",
            "timestamp": "2008-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002022-10/results",
            "title": "Protocolo multicéntrico abierto en el que se proporciona interferón pegilado alfa-2a (PEGASYS®) en monoterapia o en combinación con ribavirina (COPEGUS®) a pacientes con hepatitis C crónica que han...",
            "country": "View results",
            "timestamp": "2008-09-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002627-90/GB",
            "title": "Intracellular boosting of HIV protease inhibitors through inhibition of transport - a novel strategy for potentiating HIV therapy",
            "country": "GB",
            "timestamp": "2008-09-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003748-12/ES",
            "title": "“Estudio Fase IV-III, comparativo, aleatorizado y abierto para evaluar\nla eficacia para la recuperación de grasa periférica (o de extremidades) de\nlopinavir/ritonavir en monoterapia versus abacavir...",
            "country": "ES",
            "timestamp": "2008-09-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005306-49/DK",
            "title": "A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia",
            "country": "DK",
            "timestamp": "2008-09-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005306-49/SE",
            "title": "A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia",
            "country": "SE",
            "timestamp": "2008-09-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005306-49/NL",
            "title": "A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia",
            "country": "NL",
            "timestamp": "2008-09-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005306-49/GB",
            "title": "A Phase II Study of Vorinostat in Patients with Polycythaemia Vera and Essential Thrombocythaemia",
            "country": "GB",
            "timestamp": "2008-09-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002043-16/ES",
            "title": "Estudio fase IV, abierto, aleatorizado, controlado, para evaluar el efecto sobre el perfil lipídico del cambio de un régimen TARGA estable de dosis fija de abacavir/lamivudina (Kivexa) más lopinavi...",
            "country": "ES",
            "timestamp": "2008-09-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002043-16/DE",
            "title": "Estudio fase IV, abierto, aleatorizado, controlado, para evaluar el efecto sobre el perfil lipídico del cambio de un régimen TARGA estable de dosis fija de abacavir/lamivudina (Kivexa) más lopinavi...",
            "country": "DE",
            "timestamp": "2008-09-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002043-16/AT",
            "title": "Estudio fase IV, abierto, aleatorizado, controlado, para evaluar el efecto sobre el perfil lipídico del cambio de un régimen TARGA estable de dosis fija de abacavir/lamivudina (Kivexa) más lopinavi...",
            "country": "AT",
            "timestamp": "2008-09-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002043-16/IT",
            "title": "Estudio fase IV, abierto, aleatorizado, controlado, para evaluar el efecto sobre el perfil lipídico del cambio de un régimen TARGA estable de dosis fija de abacavir/lamivudina (Kivexa) más lopinavi...",
            "country": "IT",
            "timestamp": "2008-09-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002043-16/results",
            "title": "Estudio fase IV, abierto, aleatorizado, controlado, para evaluar el efecto sobre el perfil lipídico del cambio de un régimen TARGA estable de dosis fija de abacavir/lamivudina (Kivexa) más lopinavi...",
            "country": "View results",
            "timestamp": "2008-09-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003438-12/ES",
            "title": "Ensayo Clínico aleatorizado para comparar la combinación ZDV + 3TC + ABC (Trizivir) frente a Lopinavir/R (Kaletra) en monoterapia en pacientes con supresión viral en tratamiento previo con ZDV + 3T...",
            "country": "ES",
            "timestamp": "2008-08-29"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN37909269",
            "timestamp": "2008-08-29",
            "title": "Understanding the mechanism of the acute phase response following intravenous (IV) bisphosphonates and its prevention"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/FR",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "FR",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/PT",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "PT",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/ES",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "ES",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/IT",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "IT",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/BE",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "BE",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/DE",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "DE",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/GB",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "GB",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005151-42/results",
            "title": "A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin",
            "country": "View results",
            "timestamp": "2008-08-28"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN66931248",
            "timestamp": "2008-08-28",
            "title": "The role and modulation of the adaptive immune response in human limb ischaemia reperfusion injury by ischaemic preconditioning"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000224-41/DE",
            "title": "A\ndouble-blind, multicentre, parallel group, randomised, controlled trial\nto evaluate the possible benefit of isoniazid dose adjustment according\nto the genotype for NAT2 (arylamine N-acetyltransfe...",
            "country": "DE",
            "timestamp": "2008-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000224-41/BG",
            "title": "A\ndouble-blind, multicentre, parallel group, randomised, controlled trial\nto evaluate the possible benefit of isoniazid dose adjustment according\nto the genotype for NAT2 (arylamine N-acetyltransfe...",
            "country": "BG",
            "timestamp": "2008-08-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/ES",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "ES",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/FR",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "FR",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/DE",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "DE",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/AT",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "AT",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/DK",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "DK",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/CZ",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "CZ",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000149-72/results",
            "title": "A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naïve Pati...",
            "country": "View results",
            "timestamp": "2008-08-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/DE",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "DE",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/GB",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "GB",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/NL",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "NL",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/BE",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "BE",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/ES",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "ES",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/IT",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "IT",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/PT",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "PT",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/FR",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "FR",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004225-26/results",
            "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)\r\nEach Administered With a Backgrou...",
            "country": "View results",
            "timestamp": "2008-08-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000121-19/DE",
            "title": "A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Resected Pancreatic Adenocarcinoma Treated with Interferon Alpha-2b and 5-FU Alone or in Combination with Either ...",
            "country": "DE",
            "timestamp": "2008-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000121-19/results",
            "title": "A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Resected Pancreatic Adenocarcinoma Treated with Interferon Alpha-2b and 5-FU Alone or in Combination with Either ...",
            "country": "View results",
            "timestamp": "2008-08-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005707-18/DK",
            "title": "Clinical study of cerebral function in chronic hepatitis C virus patients treated with pegylated interferon alpha-2a and ribivirin",
            "country": "DK",
            "timestamp": "2008-08-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/ES",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "ES",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/DE",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "DE",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/AT",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "AT",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/SK",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "SK",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/CZ",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "CZ",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/FI",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "FI",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/SE",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "SE",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/HU",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "HU",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/GB",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "GB",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/BE",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "BE",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/GR",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "GR",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/IT",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "IT",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/NL",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "NL",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005460-28/results",
            "title": "Estudio multicéntrico, abierto, de acceso expandido de RAD001, en pacientes con carcinoma renal metastásico que han progresado a pesar de la terapia con  inhibidor de tirosina quinasas del receptor...",
            "country": "View results",
            "timestamp": "2008-07-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000881-22/FR",
            "title": "A Randomized, Open-label, Study of Lopinavir/ritonavir 400/100 mg Tablet Twice-Daily + Co-formulated Emtricitabine/Tenofovir Disoproxil Fumarate 200/300 mg Once-Daily Versus Lopinavir/ritonavir 400...",
            "country": "FR",
            "timestamp": "2008-07-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000881-22/ES",
            "title": "A Randomized, Open-label, Study of Lopinavir/ritonavir 400/100 mg Tablet Twice-Daily + Co-formulated Emtricitabine/Tenofovir Disoproxil Fumarate 200/300 mg Once-Daily Versus Lopinavir/ritonavir 400...",
            "country": "ES",
            "timestamp": "2008-07-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000881-22/IT",
            "title": "A Randomized, Open-label, Study of Lopinavir/ritonavir 400/100 mg Tablet Twice-Daily + Co-formulated Emtricitabine/Tenofovir Disoproxil Fumarate 200/300 mg Once-Daily Versus Lopinavir/ritonavir 400...",
            "country": "IT",
            "timestamp": "2008-07-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000881-22/results",
            "title": "A Randomized, Open-label, Study of Lopinavir/ritonavir 400/100 mg Tablet Twice-Daily + Co-formulated Emtricitabine/Tenofovir Disoproxil Fumarate 200/300 mg Once-Daily Versus Lopinavir/ritonavir 400...",
            "country": "View results",
            "timestamp": "2008-07-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003997-24/GB",
            "title": "Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiram...",
            "country": "GB",
            "timestamp": "2008-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003997-24/AT",
            "title": "Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiram...",
            "country": "AT",
            "timestamp": "2008-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003997-24/ES",
            "title": "Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiram...",
            "country": "ES",
            "timestamp": "2008-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003997-24/IT",
            "title": "Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiram...",
            "country": "IT",
            "timestamp": "2008-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003997-24/results",
            "title": "Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiram...",
            "country": "View results",
            "timestamp": "2008-07-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001340-39/IT",
            "title": "Hydroxychloroquine as Steroid-Sparing Agent in pulmonary Sarcoidosis (HySSAS). A multicenter, prospectic, controlled, randomized trial.",
            "country": "IT",
            "timestamp": "2008-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001611-38/ES",
            "title": "Estudio piloto prospectivo de la farmacocinética y farmacodinamia de la interaciión entre tipranavir/ritonavir y raltegravir en pacientes infectados por el VIH-1",
            "country": "ES",
            "timestamp": "2008-06-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN96199656",
            "timestamp": "2008-06-26",
            "title": "A double blind, placebo controlled study to evaluate the safety and immunogenicity of escalating doses of 10^8 colony forming units (CFU), 10^9 CFU and 10^10 CFU of M04NM11 in patients who have chronic hepatitis B infection"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007018-12/ES",
            "title": "“Estudio prospectivo, abierto, aleatorizado y cruzado sobre el efecto de la Hidroxicloroquina, 200mg al día, en factores inflamatorios y metabólicos relacionados con la enfermedad cardiovascular en...",
            "country": "ES",
            "timestamp": "2008-06-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006527-13/BG",
            "title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotre...",
            "country": "BG",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006527-13/results",
            "title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotre...",
            "country": "View results",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000743-34/BE",
            "title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients with Rheumatoid Arthritis Who Have Failed at Least One Biologic",
            "country": "BE",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000743-34/FR",
            "title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients with Rheumatoid Arthritis Who Have Failed at Least One Biologic",
            "country": "FR",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000743-34/DE",
            "title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients with Rheumatoid Arthritis Who Have Failed at Least One Biologic",
            "country": "DE",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000743-34/IT",
            "title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients with Rheumatoid Arthritis Who Have Failed at Least One Biologic",
            "country": "IT",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001749-25/IE",
            "title": "An open label safety study of fosamprenavir/ritonavir (FPV/rtv (Telzir)) administered to HIV/HCV co-infected patients over 96 weeks",
            "country": "IE",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001749-25/ES",
            "title": "An open label safety study of fosamprenavir/ritonavir (FPV/rtv (Telzir)) administered to HIV/HCV co-infected patients over 96 weeks",
            "country": "ES",
            "timestamp": "2008-06-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000355-94/DE",
            "title": "AN OPEN-LABEL, PARALLEL GROUP, SINGLE AND MULTIPLE DOSE STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERATION OF MARAVIROC ADMINISTERED TO SUBJECTS WITH VARIOUS DEGREES OF RENAL IMPAIRED AN...",
            "country": "DE",
            "timestamp": "2008-06-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000355-94/results",
            "title": "AN OPEN-LABEL, PARALLEL GROUP, SINGLE AND MULTIPLE DOSE STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERATION OF MARAVIROC ADMINISTERED TO SUBJECTS WITH VARIOUS DEGREES OF RENAL IMPAIRED AN...",
            "country": "View results",
            "timestamp": "2008-06-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000328-16/ES",
            "title": "Efecto del tratamiento con dosis altas de Ribavirina frente a dosis estándar en pacientes infectados con el virus de la Hepatitis C Crónica genotipo 3 y carga viral alta sin respuesta en semana 4.",
            "country": "ES",
            "timestamp": "2008-06-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000170-20/FR",
            "title": "A Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Evaluate the\nClinical Efficacy and Safety of BMS-582949 Given Orally to Subjects with Rheumatoid\nArthritis Having an Inadequa...",
            "country": "FR",
            "timestamp": "2008-06-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000170-20/CZ",
            "title": "A Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Evaluate the\nClinical Efficacy and Safety of BMS-582949 Given Orally to Subjects with Rheumatoid\nArthritis Having an Inadequa...",
            "country": "CZ",
            "timestamp": "2008-06-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000170-20/ES",
            "title": "A Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Evaluate the\nClinical Efficacy and Safety of BMS-582949 Given Orally to Subjects with Rheumatoid\nArthritis Having an Inadequa...",
            "country": "ES",
            "timestamp": "2008-06-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000170-20/results",
            "title": "A Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Evaluate the\nClinical Efficacy and Safety of BMS-582949 Given Orally to Subjects with Rheumatoid\nArthritis Having an Inadequa...",
            "country": "View results",
            "timestamp": "2008-06-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007859-14/HU",
            "title": "A 12-WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO CONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF ARRY-438162, ADMINISTERED ORALLY DAILY IN PATIENTS WI...",
            "country": "HU",
            "timestamp": "2008-05-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007859-14/PL",
            "title": "A 12-WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO CONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF ARRY-438162, ADMINISTERED ORALLY DAILY IN PATIENTS WI...",
            "country": "PL",
            "timestamp": "2008-05-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007859-14/results",
            "title": "A 12-WEEK, PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO CONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF ARRY-438162, ADMINISTERED ORALLY DAILY IN PATIENTS WI...",
            "country": "View results",
            "timestamp": "2008-05-22"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN79802092",
            "timestamp": "2008-05-22",
            "title": "Comparison of three different therapies (radio-, chemo- and immunotherapy) in patients with resected pancreatic adenocarcinoma"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000327-25/ES",
            "title": "\"ESTUDIO DE FASE 2A ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS DE CE-224,535, UN ANTAGONISTA DEL RECEPTOR P2X7, EN EL TRATAMIENTO DE LOS SIGNOS Y SÍNTOMAS DE LA ARTRITI...",
            "country": "ES",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000327-25/CZ",
            "title": "\"ESTUDIO DE FASE 2A ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS DE CE-224,535, UN ANTAGONISTA DEL RECEPTOR P2X7, EN EL TRATAMIENTO DE LOS SIGNOS Y SÍNTOMAS DE LA ARTRITI...",
            "country": "CZ",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000327-25/PL",
            "title": "\"ESTUDIO DE FASE 2A ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS DE CE-224,535, UN ANTAGONISTA DEL RECEPTOR P2X7, EN EL TRATAMIENTO DE LOS SIGNOS Y SÍNTOMAS DE LA ARTRITI...",
            "country": "PL",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000327-25/results",
            "title": "\"ESTUDIO DE FASE 2A ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS DE CE-224,535, UN ANTAGONISTA DEL RECEPTOR P2X7, EN EL TRATAMIENTO DE LOS SIGNOS Y SÍNTOMAS DE LA ARTRITI...",
            "country": "View results",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/HU",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "HU",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/ES",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "ES",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/FR",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "FR",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/BE",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "BE",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/PT",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "PT",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/CZ",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "CZ",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/DE",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "DE",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/SK",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "SK",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/NL",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "NL",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/IT",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "IT",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/GB",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "GB",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003793-26/results",
            "title": "Phase 3b, Randomized, Open-Label Study of Bevacizumab + Temsirolimus\nvs. Bevacizumab + Interferon-Alfa as First-Line Treatment in Subjects With Advanced Renal Cell Carcinoma",
            "country": "View results",
            "timestamp": "2008-05-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000417-18/GB",
            "title": "A phase III, randomised, mulicentre dose escalation, efficacy and safety study examining the effects of treatment with peginterferon alfa-2a in patients with Child's A or B cirrhosis in chronic hep...",
            "country": "GB",
            "timestamp": "2008-05-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000140-13/GB",
            "title": "A Phase I/II Open–Label study to Assess the Safety, Tolerability and Preliminary Efficacy of FP-1201 (Recombinant Human Interferon Beta) in the treatment of patients with Acute Lung Injury and Acut...",
            "country": "GB",
            "timestamp": "2008-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/FR",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "FR",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/GB",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "GB",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/DE",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "DE",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/ES",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "ES",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/CZ",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "CZ",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/SK",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "SK",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/DK",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "DK",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/BE",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "BE",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/NL",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "NL",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/FI",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "FI",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/BG",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "BG",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/IT",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "IT",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-006338-32/results",
            "title": "Phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 do...",
            "country": "View results",
            "timestamp": "2008-05-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004391-39/FR",
            "title": "A Phase I/II multi-center, open label study  of TKI258 administered orally on an intermittent schedule in adult patients with advanced or metastatic Renal Cell Cancer (RCC)",
            "country": "FR",
            "timestamp": "2008-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004391-39/NL",
            "title": "A Phase I/II multi-center, open label study  of TKI258 administered orally on an intermittent schedule in adult patients with advanced or metastatic Renal Cell Cancer (RCC)",
            "country": "NL",
            "timestamp": "2008-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004391-39/DE",
            "title": "A Phase I/II multi-center, open label study  of TKI258 administered orally on an intermittent schedule in adult patients with advanced or metastatic Renal Cell Cancer (RCC)",
            "country": "DE",
            "timestamp": "2008-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004391-39/results",
            "title": "A Phase I/II multi-center, open label study  of TKI258 administered orally on an intermittent schedule in adult patients with advanced or metastatic Renal Cell Cancer (RCC)",
            "country": "View results",
            "timestamp": "2008-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005385-12/BG",
            "title": "A Phase 2 Randomized, Open Label, Multi-center, Therapeutic Trial of the Efficacy, Immunogenicity, and Safety of GI-5005; an Inactivated Recombinant Saccharomyces cerevisiae Expressing a Hepatitis ...",
            "country": "BG",
            "timestamp": "2008-04-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000604-88/GB",
            "title": "A phase IV, two-arm, open-label, single-centre randomised pilot study to assess the feasibility of immeidate or deferred switching of HIV-infected individuals intolerant of efavirenz, ritonavir-boo...",
            "country": "GB",
            "timestamp": "2008-04-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN55552928",
            "timestamp": "2008-03-31",
            "title": "Combination therapy with rheumatoid arthritis (COBRA)-light study, an open randomised trial comparing a modified COBRA therapy with the COBRA therapy according to treatment strategies for rheumatoid arthritis (BeSt) in early rheumatoid arthritis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN48248159",
            "timestamp": "2008-03-27",
            "title": "A randomised, controlled, factorial pilot study investigating omacor and/or fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapy"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN52111135",
            "timestamp": "2008-03-26",
            "title": "Comparison of three diagnostic tools for latent tuberculosis in haemodialysis patients"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN18543567",
            "timestamp": "2008-03-20",
            "title": "MINDACT (Microarray In Node-negative Disease may Avoid Chemotherapy)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005344-25/NL",
            "title": "High-dose versus standard-dose weight-based ribavirin in combination with peginterferon alfa-2a for patients infected with hepatitis C virus genotype 1 or 4",
            "country": "NL",
            "timestamp": "2008-03-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/ES",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "ES",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/EE",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "EE",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/CZ",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "CZ",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/IT",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "IT",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/SK",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "SK",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/LT",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "LT",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/BG",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "BG",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/DE",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "DE",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005450-23/results",
            "title": "Estudio multinacional, multicéntrico, randomizado, de grupos paralelos realizado en pacientes con Esclerosis Múltiple Remitente Recurrente (RRMS) para evaluar la eficacia, seguridad y tolerabilidad...",
            "country": "View results",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006673-24/FR",
            "title": "Etude pilote multicentrique de phase IV, en ouvert, randomisée, en groupe parallèles destinée à évaluer l'éfficacité d'un protocole de rééducation fonctionnelle des patients atteints d'une forme ré...",
            "country": "FR",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006673-24/results",
            "title": "Etude pilote multicentrique de phase IV, en ouvert, randomisée, en groupe parallèles destinée à évaluer l'éfficacité d'un protocole de rééducation fonctionnelle des patients atteints d'une forme ré...",
            "country": "View results",
            "timestamp": "2008-03-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004993-15/AT",
            "title": "A Randomized, Open-Label,  Multicenter Study Examining the Effects of 24 Versus 48 Weeks of Combination Therapy with  PEGASYS® (Peginterferon alfa-2a 40KD) plus COPEGUS® (Ribavirin) on Sustained Vi...",
            "country": "AT",
            "timestamp": "2008-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004993-15/BE",
            "title": "A Randomized, Open-Label,  Multicenter Study Examining the Effects of 24 Versus 48 Weeks of Combination Therapy with  PEGASYS® (Peginterferon alfa-2a 40KD) plus COPEGUS® (Ribavirin) on Sustained Vi...",
            "country": "BE",
            "timestamp": "2008-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004993-15/DE",
            "title": "A Randomized, Open-Label,  Multicenter Study Examining the Effects of 24 Versus 48 Weeks of Combination Therapy with  PEGASYS® (Peginterferon alfa-2a 40KD) plus COPEGUS® (Ribavirin) on Sustained Vi...",
            "country": "DE",
            "timestamp": "2008-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004993-15/results",
            "title": "A Randomized, Open-Label,  Multicenter Study Examining the Effects of 24 Versus 48 Weeks of Combination Therapy with  PEGASYS® (Peginterferon alfa-2a 40KD) plus COPEGUS® (Ribavirin) on Sustained Vi...",
            "country": "View results",
            "timestamp": "2008-03-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007744-98/IT",
            "title": "INTERFERON alpha2 (IFN alpha2) as anti-angiogenic agent for the treatment of neovascular age-related macular degeneration: a pilot study.",
            "country": "IT",
            "timestamp": "2008-03-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001260-36/IT",
            "title": "Terapia PEG-Interferone alfa 2B+Ribavirina versus terapia PEG-Interferone alfa 2B + Ribavirina+ Terapia ormonale sostitutiva (TOS) nella prevenzione della progressione della fibrosi epatica nell’ep...",
            "country": "IT",
            "timestamp": "2008-03-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007147-28/FR",
            "title": "A PHASE I/IIa DOSE ESCALATION STUDY OF REPEATED ADMINISTRATION OF “CYT107” (glyco-r-hIL-7) ADD ON TREATMENT IN GENOTYPE 1 or 4 HCV INFECTED PATIENTS RESISTANT TO PEGYLATED INTERFERON-ALPHA AND RIB...",
            "country": "FR",
            "timestamp": "2008-02-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/ES",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "ES",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/GB",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "GB",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/FR",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "FR",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/IT",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "IT",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/IE",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "IE",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/AT",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "AT",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/PL",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "PL",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005083-28/results",
            "title": "Estudio de fase II, aleatorizado, abierto, multicéntrico, para evaluar la eficacia de sorafenib solo y sorafenib en combinación con interferón alfa-2a a dosis bajas como tratamiento de segunda líne...",
            "country": "View results",
            "timestamp": "2008-02-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN83107787",
            "timestamp": "2008-02-27",
            "title": "Phase I study to assess the safety and tolerability of inhaled interferon-beta (IFN-beta1a) in controlled asthmatic male and female subjects"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000828-40/FR",
            "title": "A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFα Fab′fragment, certolizumab pegol, ad...",
            "country": "FR",
            "timestamp": "2008-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000828-40/DE",
            "title": "A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFα Fab′fragment, certolizumab pegol, ad...",
            "country": "DE",
            "timestamp": "2008-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000828-40/AT",
            "title": "A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFα Fab′fragment, certolizumab pegol, ad...",
            "country": "AT",
            "timestamp": "2008-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000828-40/IT",
            "title": "A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFα Fab′fragment, certolizumab pegol, ad...",
            "country": "IT",
            "timestamp": "2008-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000828-40/PL",
            "title": "A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFα Fab′fragment, certolizumab pegol, ad...",
            "country": "PL",
            "timestamp": "2008-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000828-40/results",
            "title": "A Phase IIIB, multi-centre, double-blind randomized, placebo-controlled, parallel group 52-week study to evaluate safety and efficacy of the PEGylated anti-TNFα Fab′fragment, certolizumab pegol, ad...",
            "country": "View results",
            "timestamp": "2008-02-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000932-19/GB",
            "title": "A phase IV study to assess the feasibility of substituting double ritonavir-boosted protease inhibitors (PI) with ritonavir-boosted darunavir (DRV/r) in HIV-infected individuals with viral suppress...",
            "country": "GB",
            "timestamp": "2008-02-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005057-36/GB",
            "title": "Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01)",
            "country": "GB",
            "timestamp": "2008-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005057-36/results",
            "title": "Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01)",
            "country": "View results",
            "timestamp": "2008-02-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006803-35/IT",
            "title": "An open-label, randomized, multicenter, active-controlled,\ndose-ranging study to evaluate the safety and efficacy of\nalbinterferon alfa-2b administered every 4 weeks plus\nribavirin in interferon al...",
            "country": "IT",
            "timestamp": "2008-02-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006803-35/results",
            "title": "An open-label, randomized, multicenter, active-controlled,\ndose-ranging study to evaluate the safety and efficacy of\nalbinterferon alfa-2b administered every 4 weeks plus\nribavirin in interferon al...",
            "country": "View results",
            "timestamp": "2008-02-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002132-26/GB",
            "title": "A randomized placebo-controlled, multicenter, blinded Phase I/II study of the safety of escalating single intravenous doses of ocrelizumab (Ro 496-4913, PRO70769, rhuMAb 2H7) in patients with moder...",
            "country": "GB",
            "timestamp": "2008-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002132-26/ES",
            "title": "A randomized placebo-controlled, multicenter, blinded Phase I/II study of the safety of escalating single intravenous doses of ocrelizumab (Ro 496-4913, PRO70769, rhuMAb 2H7) in patients with moder...",
            "country": "ES",
            "timestamp": "2008-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002132-26/results",
            "title": "A randomized placebo-controlled, multicenter, blinded Phase I/II study of the safety of escalating single intravenous doses of ocrelizumab (Ro 496-4913, PRO70769, rhuMAb 2H7) in patients with moder...",
            "country": "View results",
            "timestamp": "2008-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003133-16/IT",
            "title": "Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects",
            "country": "IT",
            "timestamp": "2008-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003133-16/ES",
            "title": "Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects",
            "country": "ES",
            "timestamp": "2008-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003133-16/PT",
            "title": "Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects",
            "country": "PT",
            "timestamp": "2008-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003133-16/DE",
            "title": "Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects",
            "country": "DE",
            "timestamp": "2008-02-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003133-16/results",
            "title": "Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects",
            "country": "View results",
            "timestamp": "2008-02-15"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN59318247",
            "timestamp": "2008-02-08",
            "title": "Study to evaluate Pegasys® Sustained Viral Load (SVR) in genotype 3 Hepatitis C Virus (HCV) infected cirrhotic patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003401-27/ES",
            "title": "Ensayo clínico controlado, aleatorizado, abierto, de 48 semanas de duración, para evaluar la seguridad, tolerabilidad y actividad de raltegravir en sustitución de los inhibidores de la proteasa (IP...",
            "country": "ES",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/FR",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "FR",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/ES",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "ES",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/DE",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "DE",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/PT",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "PT",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/IT",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "IT",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/GB",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "GB",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006417-32/results",
            "title": "Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)",
            "country": "View results",
            "timestamp": "2008-02-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN59761234",
            "timestamp": "2008-02-05",
            "title": "Pharmacokinetics and efficacy of dihydroartemisinin-piperaquine in the treatment of uncomplicated falciparum malaria in children in Burkina Faso"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004905-27/GB",
            "title": "Pharmacokinetic Interactions between Ciprofloxacin and Chloroquine / Proguanil Prophylaxis",
            "country": "GB",
            "timestamp": "2008-02-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN04857074",
            "timestamp": "2008-02-01",
            "title": "A randomised controlled trial of a strategy of switching to boosted protease inhibitor monotherapy versus continuing combination antiretroviral therapy for the long-term management of HIV-1 infected patients who have achieved sustained virological suppression on highly-active antiretroviral therapy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005218-38/FR",
            "title": "Essai prospectif Randomisé contre placebo  en double aveugle de l’hydroxychloroQUine dans le traitement du syndrome de sJOgren primitif (JOQUER)",
            "country": "FR",
            "timestamp": "2008-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004844-59/FR",
            "title": "A two part, randomized, placebo controlled study to evaluate the pharmacokinetics and cardiovascular pharmacodynamics of AEB071 in combination with ritonavir in healthy volunteers",
            "country": "FR",
            "timestamp": "2008-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004844-59/results",
            "title": "A two part, randomized, placebo controlled study to evaluate the pharmacokinetics and cardiovascular pharmacodynamics of AEB071 in combination with ritonavir in healthy volunteers",
            "country": "View results",
            "timestamp": "2008-01-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN64835265",
            "timestamp": "2008-01-25",
            "title": "Study of resistance to artesunate of malaria parasite"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17498868",
            "timestamp": "2008-01-25",
            "title": "Safety and immunogenicity of a new tuberculosis (TB) vaccine (MVA85A) in healthy volunteers in Cape Town"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN17027907",
            "timestamp": "2008-01-23",
            "title": "The efficacy of chloroquine in treatment of vivax malaria in southern Laos"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002937-11/BE",
            "title": "Etude randomisée, en double insu et multicentrique de l'association Interferon pégylé alpha 2b-Ribavirine versus l'association Interferon pégylé alpha 2b-placebo dans le traitement au long cours (3...",
            "country": "BE",
            "timestamp": "2008-01-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005979-34/ES",
            "title": "ESTUDIO PILOTO, ABIERTO, COMPARATIVO Y ALEATORIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE DARUNAVIR/RITONAVIR 900/100 MG UNA VEZ AL DIA COMO ESTRATEGIA DE SIMPLIFICACION DEL TRATAMIENTO ANTIRRETR...",
            "country": "ES",
            "timestamp": "2008-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005979-34/results",
            "title": "ESTUDIO PILOTO, ABIERTO, COMPARATIVO Y ALEATORIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE DARUNAVIR/RITONAVIR 900/100 MG UNA VEZ AL DIA COMO ESTRATEGIA DE SIMPLIFICACION DEL TRATAMIENTO ANTIRRETR...",
            "country": "View results",
            "timestamp": "2008-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004519-67/ES",
            "title": "ENSAYO CLÍNICO PROSPECTIVO, ABIERTO Y ALEATORIZADO, SOBRE LA SEGURIDAD HEPÁTICA DEL TRATAMIENTO ANTIRRETROVIRAL QUE INCLUYE KALETRA VS NEVIRAPINA EN PACIENTES COINFECTADOS VIH/VHC. ESTUDIO KANELA.",
            "country": "ES",
            "timestamp": "2008-01-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/BE",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "BE",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/GB",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "GB",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/HU",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "HU",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/FR",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "FR",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/AT",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "AT",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/ES",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "ES",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/IT",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "IT",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/DE",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "DE",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001939-61/results",
            "title": "A randomized, open-label trial to compare the efficacy, safety and tolerability of DRV/rtv (800/100 mg) q.d. versus DRV/rtv (600/100 mg) b.i.d. in early treatment-experienced HIV-1 infected subjects.",
            "country": "View results",
            "timestamp": "2008-01-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004617-34/GB",
            "title": "A phase I/II study of Invirase® boosted with Ritonavir in HIV infected infants and children 4 months to less than 6 years old",
            "country": "GB",
            "timestamp": "2008-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004617-34/results",
            "title": "A phase I/II study of Invirase® boosted with Ritonavir in HIV infected infants and children 4 months to less than 6 years old",
            "country": "View results",
            "timestamp": "2008-01-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/GB",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "GB",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/NL",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "NL",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/SE",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "SE",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/DE",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "DE",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/FR",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "FR",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/BE",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "BE",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/ES",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "ES",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/CZ",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "CZ",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/AT",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "AT",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/IT",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "IT",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/DK",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "DK",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/PL",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "PL",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001162-32/results",
            "title": "A Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Patie...",
            "country": "View results",
            "timestamp": "2007-12-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003544-30/ES",
            "title": "Estudio piloto, multicéntrico, aleatorizado y abierto, para evaluar el tratamiento concomitante de la co-infección por el VHC/VIH con peg-interferón + ribavirina, y lopinavir/r como único agente an...",
            "country": "ES",
            "timestamp": "2007-12-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001918-16/DE",
            "title": "Combined Treatment of Sorafenib and pegylated interferon α2b in stage IV metastatic melanoma: a prospective non-randomized, multicenter Phase II Study\nSoraPeg Trial",
            "country": "DE",
            "timestamp": "2007-12-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001958-99/FI",
            "title": "Collecalciferol as an Add-on Treatment to Subcutaneously-Administred Interferon-beta-1b for Treatment MS",
            "country": "FI",
            "timestamp": "2007-12-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003066-18/ES",
            "title": "Estudio piloto, aleatorizado, nacional, multicéntrico, de eficacia inmunológica, comparando un régimen TARGA de tres fármacos (Tenofovir + Emtricitabina + Lopinavir/r) y cuatro fármacos (Tenofovir ...",
            "country": "ES",
            "timestamp": "2007-12-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006604-11/AT",
            "title": "A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys...",
            "country": "AT",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006604-11/DE",
            "title": "A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys...",
            "country": "DE",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006604-11/FR",
            "title": "A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys...",
            "country": "FR",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006604-11/ES",
            "title": "A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys...",
            "country": "ES",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006604-11/IT",
            "title": "A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys...",
            "country": "IT",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006604-11/results",
            "title": "A Phase II, Randomized, Double-Blinded, Multicenter, Dose Finding Study Evaluating the Efficacy and Safety of the HCV Polymerase Inhibitor Prodrug (RO4588161) when given in combination with Pegasys...",
            "country": "View results",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/DE",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "DE",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/FR",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "FR",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/GR",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "GR",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/BE",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "BE",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/ES",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "ES",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/IT",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "IT",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/CZ",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "CZ",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/SK",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "SK",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/NL",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "NL",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000292-42/results",
            "title": "ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE)\nRandomised, placebo-controlled, multi-centre study to asses...",
            "country": "View results",
            "timestamp": "2007-12-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004825-35/ES",
            "title": "ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD DE LA REDUCCION DE DOSIS DE RITONAVIR EN PACIENTES INFECTADOS POR EL VIH EN TRATAMIENTO CON TIPRANAVIR/RITONAVIR 500/200 MG CADA 12 HORAS.",
            "country": "ES",
            "timestamp": "2007-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004825-35/results",
            "title": "ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD DE LA REDUCCION DE DOSIS DE RITONAVIR EN PACIENTES INFECTADOS POR EL VIH EN TRATAMIENTO CON TIPRANAVIR/RITONAVIR 500/200 MG CADA 12 HORAS.",
            "country": "View results",
            "timestamp": "2007-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001130-13/SE",
            "title": "Hepatitis C in a cohort of patients with maintenance  therapy for opiate dependence - prevalence, severity and outcome of antiviral therapy",
            "country": "SE",
            "timestamp": "2007-12-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000814-35/ES",
            "title": "Eficacia de dosis bajas de interferón pegilado alfa-2a junto con ribavirina en el tratamiento de la hepatopatía crónica por virus C (genotipos 2 o 3) en pacientes coinfectados por el VIH (Efficacy ...",
            "country": "ES",
            "timestamp": "2007-12-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN07576538",
            "timestamp": "2007-11-29",
            "title": "A randomised, controlled, open-label, parallel-group study comparing the efficacy and safety of an oral artesunate-amodiaquine fixed-dose combination therapy over 3 subsequent days to an equivalent dose regimen of the individual drugs for the treatment of children with Plasmodium falciparum"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003922-70/DE",
            "title": "Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumab in patients with moderate to severe palmoplantar pustular psoriasis (PPP)",
            "country": "DE",
            "timestamp": "2007-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/FI",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "FI",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/FR",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "FR",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/GB",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "GB",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/CZ",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "CZ",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/BE",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "BE",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/EE",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "EE",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/AT",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "AT",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/PT",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "PT",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/NL",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "NL",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/DE",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "DE",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/DK",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "DK",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/IT",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "IT",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/GR",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "GR",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/LV",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "LV",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/LT",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "LT",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/BG",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "BG",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000381-20/results",
            "title": "A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple...",
            "country": "View results",
            "timestamp": "2007-11-16"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN40223079",
            "timestamp": "2007-11-15",
            "title": "Efficacy and safety of artesunate and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria and chloroquine for the treatment of vivax malaria in Nangarhar, Takhar and Faryab provinces, Afghanistan"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/ES",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "ES",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/FR",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "FR",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/BE",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "BE",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/NL",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "NL",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/IT",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "IT",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/CZ",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "CZ",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/GB",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "GB",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/SK",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "SK",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/DE",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "DE",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004946-17/results",
            "title": "Estudio multicéntrico aleatorizado, controlado con placebo, para evaluar la eficacia y la seguridad de eltrombopag en sujetos trombocitopénicos infectados por el virus de la hepatitis C (VHC) que, ...",
            "country": "View results",
            "timestamp": "2007-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003069-42/EE",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SUPERIORITY OF CRX-102 OVER EACH OF ITS COMPONENTS WHEN GIVEN TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)",
            "country": "EE",
            "timestamp": "2007-10-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003069-42/GB",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SUPERIORITY OF CRX-102 OVER EACH OF ITS COMPONENTS WHEN GIVEN TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)",
            "country": "GB",
            "timestamp": "2007-10-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003069-42/HU",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SUPERIORITY OF CRX-102 OVER EACH OF ITS COMPONENTS WHEN GIVEN TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)",
            "country": "HU",
            "timestamp": "2007-10-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003069-42/LT",
            "title": "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SUPERIORITY OF CRX-102 OVER EACH OF ITS COMPONENTS WHEN GIVEN TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)",
            "country": "LT",
            "timestamp": "2007-10-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN32763606",
            "timestamp": "2007-10-31",
            "title": "Receptor for Hyaluronan-Mediated Motility (RHAMM [CD168]) peptide vaccination for patients with haematological malignancies"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN05620936",
            "timestamp": "2007-10-30",
            "title": "Development of a simple protocol to enhance compliance in home management of malaria"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007162-32/IT",
            "title": "ADVANCED MRI STUDY ON INFLAMMATORY AND DEGENRATIVE DAMAGE IN MULTIPLE SCLEROSIS",
            "country": "IT",
            "timestamp": "2007-10-30"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN00680126",
            "timestamp": "2007-10-25",
            "title": "A randomised, open-label, multicentre, efficacy and safety study examining the effects on viral kinetics of all-trans retinoic acid (Tretinoin) (VESANOID®) in combination with pegylated interferon alpha-2a (PEGASYS®) and ribavirin (COPEGUS®) therapy in patients with genotype 1-chronic hepatitis C and non-response to a previous course of peg-interferon alpha/ribavirin combination (ATRACTION)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN42223114",
            "timestamp": "2007-10-17",
            "title": "MUltiple Sclerosis and Extract of Cannabis (MUSEC)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN30271509",
            "timestamp": "2007-09-28",
            "title": "The pharmacological basis for the increase in visual time constants induced by single oral doses of sildenafil"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003584-45/ES",
            "title": "Estudio piloto de simplificación a Fosamprenavir/ritonavir (FPV/r) en monoterapia",
            "country": "ES",
            "timestamp": "2007-09-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN19938041",
            "timestamp": "2007-09-25",
            "title": "Prospective, multi-center, one-arm pilot trial of Trizivir plus Tenofovir in adult HIV-infected antiretroviral-naive patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001283-37/IT",
            "title": "Chronic hepatitis C in illicit drug users and the role of antiviral therapy: the ARNICA project (Antiviral tReatment for chroNic\nhepatItis C in Active substance users)",
            "country": "IT",
            "timestamp": "2007-09-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000602-23/PT",
            "title": "A randomized double blind, placebo controlled study to evaluate the efficacy and security of immunotherapy with a depigmented and polymerized allergen extract of Dermatophagoides pteronyssinus in p...",
            "country": "PT",
            "timestamp": "2007-09-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005256-33/ES",
            "title": "Ensayo clínico multicéntrico, aleatorizado y abierto para evaluar tres dosis de Tipranavir potenciado con dosis bajas de ritonavir (500mg/200mg una vez al día, 250mg/100 mg dos veces al día y 500 m...",
            "country": "ES",
            "timestamp": "2007-09-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005256-33/DE",
            "title": "Ensayo clínico multicéntrico, aleatorizado y abierto para evaluar tres dosis de Tipranavir potenciado con dosis bajas de ritonavir (500mg/200mg una vez al día, 250mg/100 mg dos veces al día y 500 m...",
            "country": "DE",
            "timestamp": "2007-09-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005256-33/IT",
            "title": "Ensayo clínico multicéntrico, aleatorizado y abierto para evaluar tres dosis de Tipranavir potenciado con dosis bajas de ritonavir (500mg/200mg una vez al día, 250mg/100 mg dos veces al día y 500 m...",
            "country": "IT",
            "timestamp": "2007-09-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005256-33/results",
            "title": "Ensayo clínico multicéntrico, aleatorizado y abierto para evaluar tres dosis de Tipranavir potenciado con dosis bajas de ritonavir (500mg/200mg una vez al día, 250mg/100 mg dos veces al día y 500 m...",
            "country": "View results",
            "timestamp": "2007-09-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002138-13/GB",
            "title": "A placebo controlled, parallel group, randomised withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term GW-1000-02 (Sativex®).",
            "country": "GB",
            "timestamp": "2007-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002138-13/results",
            "title": "A placebo controlled, parallel group, randomised withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term GW-1000-02 (Sativex®).",
            "country": "View results",
            "timestamp": "2007-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003037-32/LT",
            "title": "A two-arm, randomized, double-blind, control group-compared, multicenter, phase IIIb study with monthly MRI and biomarker assessments to evaluate the efficacy, safety, and tolerability of Rebif® Ne...",
            "country": "LT",
            "timestamp": "2007-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003037-32/DE",
            "title": "A two-arm, randomized, double-blind, control group-compared, multicenter, phase IIIb study with monthly MRI and biomarker assessments to evaluate the efficacy, safety, and tolerability of Rebif® Ne...",
            "country": "DE",
            "timestamp": "2007-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003037-32/EE",
            "title": "A two-arm, randomized, double-blind, control group-compared, multicenter, phase IIIb study with monthly MRI and biomarker assessments to evaluate the efficacy, safety, and tolerability of Rebif® Ne...",
            "country": "EE",
            "timestamp": "2007-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003037-32/IT",
            "title": "A two-arm, randomized, double-blind, control group-compared, multicenter, phase IIIb study with monthly MRI and biomarker assessments to evaluate the efficacy, safety, and tolerability of Rebif® Ne...",
            "country": "IT",
            "timestamp": "2007-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003037-32/ES",
            "title": "A two-arm, randomized, double-blind, control group-compared, multicenter, phase IIIb study with monthly MRI and biomarker assessments to evaluate the efficacy, safety, and tolerability of Rebif® Ne...",
            "country": "ES",
            "timestamp": "2007-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003037-32/results",
            "title": "A two-arm, randomized, double-blind, control group-compared, multicenter, phase IIIb study with monthly MRI and biomarker assessments to evaluate the efficacy, safety, and tolerability of Rebif® Ne...",
            "country": "View results",
            "timestamp": "2007-09-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005500-14/DE",
            "title": "A Randomized, Open-label, Multicenter, Efficacy and Safety Study Examining the Effects on Viral Kinetics of All-trans Retinoic Acid  (Tretinoin) (VESANOID®)in Combination with PEG-IFN alfa 2a (PEGA...",
            "country": "DE",
            "timestamp": "2007-09-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN38934710",
            "timestamp": "2007-08-30",
            "title": "SORCE"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002104-18/FR",
            "title": "Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated either with an Inactivated Influenza Vaccine Administered via the Intradermal Route or an I...",
            "country": "FR",
            "timestamp": "2007-08-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002104-18/results",
            "title": "Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated either with an Inactivated Influenza Vaccine Administered via the Intradermal Route or an I...",
            "country": "View results",
            "timestamp": "2007-08-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003166-18/FR",
            "title": "Tolérance et efficacité du Rituximab dans le syndrome du Sjögren",
            "country": "FR",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/GB",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "GB",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/DE",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "DE",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/CZ",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "CZ",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/SE",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "SE",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/FR",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "FR",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/PL",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "PL",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001161-14/results",
            "title": "A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in treatment Naïve Patients with Rela...",
            "country": "View results",
            "timestamp": "2007-08-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN74137878",
            "timestamp": "2007-08-23",
            "title": "A study to evaluate the different levels of attention and VALence direction for erotic stimuli, in relation to genital and subjective sexual arousal in healthy female subjects and healthy female subjects with female sexual dysfunction"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN72024361",
            "timestamp": "2007-08-23",
            "title": "Short course interferon-gamma for human immunodeficiency virus (HIV)-associated cryptococcal meningitis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002743-24/GB",
            "title": "Study to evaluate different duration of treatment regimes of 40kD pegylated interferon alfa 2a (Pegasys) plus ribavirin on sustained virological responses (SVR) in Genotype 3 HCV infected cirrhotic...",
            "country": "GB",
            "timestamp": "2007-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002743-24/results",
            "title": "Study to evaluate different duration of treatment regimes of 40kD pegylated interferon alfa 2a (Pegasys) plus ribavirin on sustained virological responses (SVR) in Genotype 3 HCV infected cirrhotic...",
            "country": "View results",
            "timestamp": "2007-08-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003203-12/FR",
            "title": "Pharmacocinétique de l’atazanavir chez des patients infectés par le VIH, traités en première ligne par l’association atazanavir+ritonavir et emtricitabine+ténofovir en prise unique.",
            "country": "FR",
            "timestamp": "2007-08-17"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN80852505",
            "timestamp": "2007-08-13",
            "title": "The effect of vitamin A and zinc supplementation on the bacteriological response of persons with pulmonary tuberculosis in the Western Cape"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004511-21/GB",
            "title": "Upfront Sunitinib (SU011248)® therapy followed by surgery in patients with metastatic renal cancer: a pilot Phase II study [SuMR]",
            "country": "GB",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004511-21/results",
            "title": "Upfront Sunitinib (SU011248)® therapy followed by surgery in patients with metastatic renal cancer: a pilot Phase II study [SuMR]",
            "country": "View results",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/BE",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "BE",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/DE",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "DE",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/ES",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "ES",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/FR",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "FR",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/IT",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "IT",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/AT",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "AT",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001044-44/results",
            "title": "A Phase IIa randomized, open-label study of telaprevir (VX-950) administered every 12 or every 8 hours in combination with either Peg-IFN alfa2a (Pegasys®) and ribavirin (Copegus®) or Peg-IFN alfa2...",
            "country": "View results",
            "timestamp": "2007-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002698-29/ES",
            "title": "Efectos del tratamiento inicial con 2 pautas antirretrovirales estándares actuales sobre el metabolismo lipídico",
            "country": "ES",
            "timestamp": "2007-07-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002405-47/GB",
            "title": "A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral r...",
            "country": "GB",
            "timestamp": "2007-07-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-002405-47/results",
            "title": "A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral r...",
            "country": "View results",
            "timestamp": "2007-07-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001968-78/GB",
            "title": "A Phase II, Randomised, Double-Blind, Placebo-Controlled Pilot Efficacy Study of ADC4022 (Theophylline Solution for Inhalation) on Markers of Pulmonary Inflammation in Subjects with Moderate to Sev...",
            "country": "GB",
            "timestamp": "2007-07-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001968-78/results",
            "title": "A Phase II, Randomised, Double-Blind, Placebo-Controlled Pilot Efficacy Study of ADC4022 (Theophylline Solution for Inhalation) on Markers of Pulmonary Inflammation in Subjects with Moderate to Sev...",
            "country": "View results",
            "timestamp": "2007-07-20"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN01449944",
            "timestamp": "2007-07-16",
            "title": "A non-controlled trial of anti-Tumour Necrotising Factor alpha (anti-TNFa) chimeric monoclonal antibody (Infliximab, Remicade®) in exudative age-related macular degeneration"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/FR",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "FR",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/ES",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "ES",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/DE",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "DE",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/GR",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "GR",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/PT",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "PT",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/IT",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "IT",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/BE",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "BE",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001866-15/results",
            "title": "A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in  three-clas...",
            "country": "View results",
            "timestamp": "2007-07-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004476-12/FR",
            "title": "A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection.",
            "country": "FR",
            "timestamp": "2007-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004476-12/IE",
            "title": "A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection.",
            "country": "IE",
            "timestamp": "2007-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004476-12/DE",
            "title": "A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection.",
            "country": "DE",
            "timestamp": "2007-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004476-12/GB",
            "title": "A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection.",
            "country": "GB",
            "timestamp": "2007-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006268-42/ES",
            "title": "Tratamiento antirretroviral una vez al día en pacientes con infección por el VIH-1 no tratados previamente y con cifras de linfocitos CD4+ inferiores a 100 céls/mm3. Estudio prospectivo aleatorizad...",
            "country": "ES",
            "timestamp": "2007-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-003896-38/IT",
            "title": "PHARMACOKINETICS AND PHARMACODYNAMICS IN THE OPTIMIZATION OF ANTIRETROVIRAL TREATMENT.",
            "country": "IT",
            "timestamp": "2007-07-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN20946776",
            "timestamp": "2007-06-29",
            "title": "A phase I/II trial to compare the immunogenicity and safety of three DNA C prime followed by one NYVAC C boost to two DNA C prime followed by two NYVAC C boost"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001063-30/CZ",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "CZ",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001063-30/ES",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "ES",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001063-30/GB",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "GB",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001063-30/GR",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "GR",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001063-30/results",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "View results",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001061-14/CZ",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "CZ",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001061-14/ES",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "ES",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001061-14/GB",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "GB",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001061-14/GR",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "GR",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001061-14/results",
            "title": "A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Pa...",
            "country": "View results",
            "timestamp": "2007-06-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007934-21/IT",
            "title": "Intracellular concentration of Antiretrovirals)INCA STADY",
            "country": "IT",
            "timestamp": "2007-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006161-13/DE",
            "title": "A single arm Phase II study to assess efficacy and safety of bevacizumab in combination with the standard therapy (interferon alfa-2a and vinblastine) as first-line treatment for patients with meta...",
            "country": "DE",
            "timestamp": "2007-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006161-13/results",
            "title": "A single arm Phase II study to assess efficacy and safety of bevacizumab in combination with the standard therapy (interferon alfa-2a and vinblastine) as first-line treatment for patients with meta...",
            "country": "View results",
            "timestamp": "2007-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006323-39/DE",
            "title": "Sunphenon (Epigallocatechin-Gallate) in relapsing-remitting multiple sclerosis",
            "country": "DE",
            "timestamp": "2007-06-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006297-23/GB",
            "title": "A study of the pharmacokinetics of new formulation lopinavir/ritonavir in the genital tract and plasma of HIV infected women in pregnancy",
            "country": "GB",
            "timestamp": "2007-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006297-23/results",
            "title": "A study of the pharmacokinetics of new formulation lopinavir/ritonavir in the genital tract and plasma of HIV infected women in pregnancy",
            "country": "View results",
            "timestamp": "2007-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005972-42/FR",
            "title": "A randomized, multicenter, two-arm, open-label, phase IIIb study to evaluate the satisfaction in relapsing Multiple Sclerosis subjects transitioning to Rebif® New Formulation (RNF) from Rebif® (Int...",
            "country": "FR",
            "timestamp": "2007-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005972-42/DE",
            "title": "A randomized, multicenter, two-arm, open-label, phase IIIb study to evaluate the satisfaction in relapsing Multiple Sclerosis subjects transitioning to Rebif® New Formulation (RNF) from Rebif® (Int...",
            "country": "DE",
            "timestamp": "2007-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005972-42/results",
            "title": "A randomized, multicenter, two-arm, open-label, phase IIIb study to evaluate the satisfaction in relapsing Multiple Sclerosis subjects transitioning to Rebif® New Formulation (RNF) from Rebif® (Int...",
            "country": "View results",
            "timestamp": "2007-06-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003134-14/DE",
            "title": "A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide...",
            "country": "DE",
            "timestamp": "2007-06-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003134-14/IT",
            "title": "A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide...",
            "country": "IT",
            "timestamp": "2007-06-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003134-14/ES",
            "title": "A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide...",
            "country": "ES",
            "timestamp": "2007-06-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003134-14/results",
            "title": "A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide...",
            "country": "View results",
            "timestamp": "2007-06-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN34104704",
            "timestamp": "2007-05-31",
            "title": "Improving the management of childhood MAlaria"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN53817258",
            "timestamp": "2007-05-31",
            "title": "Second-line Anti-Retroviral therapy in Africa"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004335-29/GB",
            "title": "A randomised controlled factorial pilot study investigating Omacor and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapy.",
            "country": "GB",
            "timestamp": "2007-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004335-29/results",
            "title": "A randomised controlled factorial pilot study investigating Omacor and/or Fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapy.",
            "country": "View results",
            "timestamp": "2007-05-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/GB",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "GB",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/BE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "BE",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/DE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "DE",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/AT",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "AT",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/CZ",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "CZ",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/ES",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "ES",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/SK",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "SK",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/SE",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "SE",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/NL",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "NL",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/IT",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "IT",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/FR",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "FR",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005177-21/results",
            "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Ant...",
            "country": "View results",
            "timestamp": "2007-05-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/ES",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "ES",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/DE",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "DE",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/GB",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "GB",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/DK",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "DK",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/IT",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "IT",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/PT",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "PT",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000783-25/results",
            "title": "A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus KALETRA™ in HIV-Infected   Patients Switched from a Stable KALE...",
            "country": "View results",
            "timestamp": "2007-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006985-41/ES",
            "title": "Estudio piloto en fase III, mutlicéntrico, aleatorizado, controlado y abierto, sobre la eficacia de Interferón Pegilado alfa-2a a dosis de 90 mcg semanal en retrasar la aparición del primer evento ...",
            "country": "ES",
            "timestamp": "2007-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006588-21/IT",
            "title": "Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection",
            "country": "IT",
            "timestamp": "2007-05-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001190-28/GB",
            "title": "Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis",
            "country": "GB",
            "timestamp": "2007-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001190-28/results",
            "title": "Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis",
            "country": "View results",
            "timestamp": "2007-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005036-24/SE",
            "title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE T...",
            "country": "SE",
            "timestamp": "2007-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005036-24/SK",
            "title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE T...",
            "country": "SK",
            "timestamp": "2007-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005036-24/CZ",
            "title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE T...",
            "country": "CZ",
            "timestamp": "2007-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005036-24/HU",
            "title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE T...",
            "country": "HU",
            "timestamp": "2007-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005036-24/BG",
            "title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE T...",
            "country": "BG",
            "timestamp": "2007-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005036-24/results",
            "title": "A PHASE 2B, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE 6 DOSE REGIMENS OF CP 690,550 VS. PLACEBO, EACH COMBINED WITH METHOTREXATE, ADMINISTERED FOR 6 MONTHS IN THE T...",
            "country": "View results",
            "timestamp": "2007-05-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN58830535",
            "timestamp": "2007-05-02",
            "title": "Group training for hepatitis C patients to improve quality of life"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/BE",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "BE",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/FR",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "FR",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/SE",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "SE",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/GB",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "GB",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/DE",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "DE",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/ES",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "ES",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002704-34/results",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "View results",
            "timestamp": "2007-04-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006076-38/GB",
            "title": "The Liverpool HIV TDM Registry: Studying influences upon plasma HIV drug exposure",
            "country": "GB",
            "timestamp": "2007-04-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN94367569",
            "timestamp": "2007-04-24",
            "title": "Treatment of uncomplicated falciparum malaria in Bobo-Dioulasso, Burkina Faso"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000955-90/IT",
            "title": "Randomized, single-blind, clinical and MRI study  for evaluation of safety and efficacy of N-Acetyl Cysteine (NAC) associated with high-dose beta-Interferon in Relapsing-Remitting (RR) multiple scl...",
            "country": "IT",
            "timestamp": "2007-04-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006041-13/ES",
            "title": "“ESTUDIO EN FASE IV de la Pauta de Rescate a través de OptimizacióN y simplificacióN de las dosis de Ritonavir en un régimen que contiene Tipranavir como parte del tratamiento”",
            "country": "ES",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/FI",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "FI",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/BE",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "BE",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/IE",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "IE",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/FR",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "FR",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/AT",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "AT",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/SE",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "SE",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/ES",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "ES",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/DE",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "DE",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/HU",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "HU",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/LV",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "LV",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/SI",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "SI",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/NL",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "NL",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/GR",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "GR",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/IT",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "IT",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005270-47/results",
            "title": "International, multicenter, Phase IIIb study of subcutaneous every-other-day treatment of patients with relapsing multiple sclerosis with (Phase A) double-blind Betaseron/Betaferon 250 µg or 500 µg...",
            "country": "View results",
            "timestamp": "2007-04-23"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN18863931",
            "timestamp": "2007-04-20",
            "title": "Phase II, multi-centre, randomised, two-part pilot study (Part 1 open, uncontrolled; Part 2 double-blind, placebo controlled) to determine the efficacy, safety, tolerability and preliminary pharmacokinetics of PSD502 in the management of pain from donor sites in burns subjects undergoing skin grafts"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/DE",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "DE",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/BE",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "BE",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/GB",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "GB",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/FR",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "FR",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/ES",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "ES",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/IT",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "IT",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005579-16/results",
            "title": "Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects.",
            "country": "View results",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001601-16/NL",
            "title": "A Phase IIa, Double-blind, Randomised, Placebo-Controlled Dose Escalation Study to Evalulate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects wit...",
            "country": "NL",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001601-16/DE",
            "title": "A Phase IIa, Double-blind, Randomised, Placebo-Controlled Dose Escalation Study to Evalulate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects wit...",
            "country": "DE",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001601-16/FR",
            "title": "A Phase IIa, Double-blind, Randomised, Placebo-Controlled Dose Escalation Study to Evalulate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects wit...",
            "country": "FR",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001601-16/results",
            "title": "A Phase IIa, Double-blind, Randomised, Placebo-Controlled Dose Escalation Study to Evalulate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects wit...",
            "country": "View results",
            "timestamp": "2007-04-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000438-38/GB",
            "title": "Efficacy of Lopinavir in Pregnancy: Pharmacokinetic and Virological Studies with Kaletra melt extruded tablet formulation",
            "country": "GB",
            "timestamp": "2007-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000438-38/results",
            "title": "Efficacy of Lopinavir in Pregnancy: Pharmacokinetic and Virological Studies with Kaletra melt extruded tablet formulation",
            "country": "View results",
            "timestamp": "2007-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/NL",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "NL",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/ES",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "ES",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/DK",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "DK",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/BE",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "BE",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/FR",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "FR",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/DE",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "DE",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/IT",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "IT",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/GB",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "GB",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004022-87/results",
            "title": "A PHASE III RANDOMIZED, DOUBLE-BLIND STUDY OF SUNITINIB (SU011248, SUTENT®) VERSUS PLACEBO IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC WELL-DIFFERENTIATED PANCREATIC ISLET CELL TUMORS",
            "country": "View results",
            "timestamp": "2007-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004665-33/DE",
            "title": "A Phase 2 Study of Telaprevir (VX-950) in Combination with Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Subjects with Genotype 1 Hepatitis C Who Have Not Achieved Sustained Viral R...",
            "country": "DE",
            "timestamp": "2007-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004665-33/NL",
            "title": "A Phase 2 Study of Telaprevir (VX-950) in Combination with Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Subjects with Genotype 1 Hepatitis C Who Have Not Achieved Sustained Viral R...",
            "country": "NL",
            "timestamp": "2007-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004665-33/results",
            "title": "A Phase 2 Study of Telaprevir (VX-950) in Combination with Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Subjects with Genotype 1 Hepatitis C Who Have Not Achieved Sustained Viral R...",
            "country": "View results",
            "timestamp": "2007-04-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003425-81/GB",
            "title": "Host genetic factors influencing drug disposition and response to HIV treatment",
            "country": "GB",
            "timestamp": "2007-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005473-29/DE",
            "title": "Randomisierte Phase III-Studie zur Primärtherapie von fortgeschrittenen follikulären Lymphomen bei älteren Patienten (>65 J.) und jüngeren Patienten, die nicht für eine Hochdosistherapie mit autolo...",
            "country": "DE",
            "timestamp": "2007-03-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-005332-83/IT",
            "title": "Combined therapy with Adefovir and Interferon-Pegylated alfa 2a vs Adefovir alone, in patients affected by chronic hepatitis B, HbeAg negative (The PAC (Peg Adefovir Combination) Study).",
            "country": "IT",
            "timestamp": "2007-03-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000670-23/FR",
            "title": "Essai pilote évaluant un traitement antirétroviral associant le MK-0518, le darunavir/ritonavir (TMC114/r) et l’etravirine (TMC125) chez les patients infectés par le VIH-1, en échec virologique et ...",
            "country": "FR",
            "timestamp": "2007-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/DE",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "DE",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/CZ",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "CZ",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/AT",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "AT",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/FR",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "FR",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/GB",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "GB",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/ES",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "ES",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002703-13/results",
            "title": "A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or P...",
            "country": "View results",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004709-24/NL",
            "title": "Mycophenolate sodium (Myfortic®) in the Treatment of Uveitis: a Pilot Study.",
            "country": "NL",
            "timestamp": "2007-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-007056-18/GB",
            "title": "The Discoid Lupus Research Project",
            "country": "GB",
            "timestamp": "2007-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-007056-18/results",
            "title": "The Discoid Lupus Research Project",
            "country": "View results",
            "timestamp": "2007-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005023-33/FR",
            "title": "Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot e...",
            "country": "FR",
            "timestamp": "2007-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005023-33/PT",
            "title": "Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot e...",
            "country": "PT",
            "timestamp": "2007-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005023-33/ES",
            "title": "Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot e...",
            "country": "ES",
            "timestamp": "2007-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005023-33/DE",
            "title": "Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot e...",
            "country": "DE",
            "timestamp": "2007-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005023-33/IT",
            "title": "Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot e...",
            "country": "IT",
            "timestamp": "2007-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005023-33/results",
            "title": "Safety and efficacy study of TPV boosted with low dose ritonavir (TPV/r) 500 mg/200 mg BID in antiretroviral treatment experienced HIV positive patients with HCV or HBV co-infection, with a pilot e...",
            "country": "View results",
            "timestamp": "2007-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006200-11/FR",
            "title": "Prévention de la transmission du VIH-1 de la mère à l’enfant sans utilisation d’analogue nucléosidique",
            "country": "FR",
            "timestamp": "2007-03-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000870-63/FR",
            "title": "A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chro...",
            "country": "FR",
            "timestamp": "2007-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000870-63/DE",
            "title": "A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chro...",
            "country": "DE",
            "timestamp": "2007-03-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000870-63/results",
            "title": "A phase IV, 2x2 factorial, double blind study of 24 versus 48 weeks and 90 versus 180 mcg doses of pegylated interferon alfa 2a 40KD (PEG IFN, Ro 25-8310) in adult patients with HBeAg positive chro...",
            "country": "View results",
            "timestamp": "2007-03-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN07772084",
            "timestamp": "2007-02-22",
            "title": "German Acute Hepatitis B Study"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005264-86/DE",
            "title": "Safety, efficacy and Pharmacokinetics of tipRanavir boosted with low-dose ritonavir (TPV/r) 500 mg/200 mg BID IN a racially and Gender diverse HIV positive treatment experienced population with a p...",
            "country": "DE",
            "timestamp": "2007-02-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005264-86/ES",
            "title": "Safety, efficacy and Pharmacokinetics of tipRanavir boosted with low-dose ritonavir (TPV/r) 500 mg/200 mg BID IN a racially and Gender diverse HIV positive treatment experienced population with a p...",
            "country": "ES",
            "timestamp": "2007-02-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005264-86/IT",
            "title": "Safety, efficacy and Pharmacokinetics of tipRanavir boosted with low-dose ritonavir (TPV/r) 500 mg/200 mg BID IN a racially and Gender diverse HIV positive treatment experienced population with a p...",
            "country": "IT",
            "timestamp": "2007-02-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005264-86/results",
            "title": "Safety, efficacy and Pharmacokinetics of tipRanavir boosted with low-dose ritonavir (TPV/r) 500 mg/200 mg BID IN a racially and Gender diverse HIV positive treatment experienced population with a p...",
            "country": "View results",
            "timestamp": "2007-02-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN70900209",
            "timestamp": "2007-02-21",
            "title": "Use of interferon gamma as adjuvant to chemotherapy in patients with pulmonary atypical mycobacteriosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000995-41/DE",
            "title": "A double-blind, randomized, placebo-controlled multi-centre, phase II parallel dose-ranging study to assess the antifibrotic activity of GI262570 in chronic hepatitis C subjects with hepatic fibros...",
            "country": "DE",
            "timestamp": "2007-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000995-41/CZ",
            "title": "A double-blind, randomized, placebo-controlled multi-centre, phase II parallel dose-ranging study to assess the antifibrotic activity of GI262570 in chronic hepatitis C subjects with hepatic fibros...",
            "country": "CZ",
            "timestamp": "2007-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000995-41/results",
            "title": "A double-blind, randomized, placebo-controlled multi-centre, phase II parallel dose-ranging study to assess the antifibrotic activity of GI262570 in chronic hepatitis C subjects with hepatic fibros...",
            "country": "View results",
            "timestamp": "2007-02-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-000503-15/IT",
            "title": "Experimental clinical open study, randomized, experimental group vs control group, for the evaluation of tolerability and the effects on magnetic resonance parameters and cognitive functions of mem...",
            "country": "IT",
            "timestamp": "2007-02-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/BE",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "BE",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/GB",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "GB",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/HU",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "HU",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/DK",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "DK",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/DE",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "DE",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/PT",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "PT",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/ES",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "ES",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/AT",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "AT",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/IT",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "IT",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006437-40/results",
            "title": "A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination ...",
            "country": "View results",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006117-32/IT",
            "title": "Tipranavir/ritonavir 500/100 mg bid as a simplification strategy in HIV-1 infected subjects with an ongoing Tipranavir 500mg/Ritonavir 200mg bid regimen and undetectable viral load.",
            "country": "IT",
            "timestamp": "2007-02-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005996-17/IT",
            "title": "A pilot, open label, multicenter, randomized clinical trial on Lopinavir/ritonavir-monotherapy vs Lopinavir/ritonavir plus selected Nucs, in HIV/HCV ARV-naive coinfected patients with chronic hepat...",
            "country": "IT",
            "timestamp": "2007-02-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006042-33/IT",
            "title": "A pilot, open label, multicenter, randomized clinical trial on Lopinavir/Ritonavir-monotherapy vs Lopinavir/Ritonavir plus selected Nucs, in HIV/HCV  coinfected patients with chronic hepatitis C or...",
            "country": "IT",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/FI",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "FI",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/HU",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "HU",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/BE",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "BE",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/DE",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "DE",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/FR",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "FR",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/IT",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "IT",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/ES",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "ES",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000880-27/results",
            "title": "A Phase II Study Of Oral LBH589 In Adult Patients With Refractory Cutaneous T-Cell Lymphoma",
            "country": "View results",
            "timestamp": "2007-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006157-24/DE",
            "title": "A multicenter open label phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma",
            "country": "DE",
            "timestamp": "2007-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006157-24/AT",
            "title": "A multicenter open label phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma",
            "country": "AT",
            "timestamp": "2007-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006186-16/NL",
            "title": "IMPROVED: Induction therapy with Methotrexate and Prednisone in Rheumatoid Or Very Early arthritic Disease\n\nA randomized clinical trial in patients with recent-onset arthritis to compare the effica...",
            "country": "NL",
            "timestamp": "2007-01-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-007100-42/FI",
            "title": "Viral Inception of Asthma: Prospective study from infancy to early school-age.",
            "country": "FI",
            "timestamp": "2007-01-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/HU",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "HU",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/NL",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "NL",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/SE",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "SE",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/DE",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "DE",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/BE",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "BE",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/DK",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "DK",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/FR",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "FR",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/GB",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "GB",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005507-41/results",
            "title": "Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ...",
            "country": "View results",
            "timestamp": "2007-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002275-40/SE",
            "title": "Prospective study of patients treated with pegylated interferon-alpha 2b (PegIntron) for metastasizing ileal/coecal carcinoids",
            "country": "SE",
            "timestamp": "2007-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002275-40/DK",
            "title": "Prospective study of patients treated with pegylated interferon-alpha 2b (PegIntron) for metastasizing ileal/coecal carcinoids",
            "country": "DK",
            "timestamp": "2007-01-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003025-93/FR",
            "title": "Etude de la réduction des poussées de lupus érythémateux systémique par adaptation de la posologie de l'hydroxychloroquine à sa concentration sanguine. Etude randomisée multicentrique nationale.",
            "country": "FR",
            "timestamp": "2007-01-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/DK",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "DK",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/BE",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "BE",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/NL",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "NL",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/FR",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "FR",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/GB",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "GB",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/DE",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "DE",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/IT",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "IT",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000881-35/results",
            "title": "A phase II, multicentre study of oral LBH589 in patients with chronic phase chronic myeloid leukemia with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors",
            "country": "View results",
            "timestamp": "2007-01-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004547-35/DE",
            "title": "Phase IV study to investigate neutrophil downregulation of Thy-1 by Raptiva® (Efalizumab) as a potential responder predictor in patients with moderate to severe plaque psoriasis",
            "country": "DE",
            "timestamp": "2007-01-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004547-35/results",
            "title": "Phase IV study to investigate neutrophil downregulation of Thy-1 by Raptiva® (Efalizumab) as a potential responder predictor in patients with moderate to severe plaque psoriasis",
            "country": "View results",
            "timestamp": "2007-01-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004822-97/GB",
            "title": "A Phase I / II Trial to Evaluate the Combination of Infliximab and Sorafenib in the Treatment of Renal Cell Carcinoma",
            "country": "GB",
            "timestamp": "2007-01-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004822-97/results",
            "title": "A Phase I / II Trial to Evaluate the Combination of Infliximab and Sorafenib in the Treatment of Renal Cell Carcinoma",
            "country": "View results",
            "timestamp": "2007-01-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12365646",
            "timestamp": "2006-12-28",
            "title": "The effects of low dose 1,25-dihydroxyvitamin D3 on the polarising of cellular immune reactivity towards type two immunity"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000935-86/DE",
            "title": "Randomized, multicentric, partially double blind placebo-controlled phase II study for examining the influence of Ribavirin on the initial virological response in previous untreated patients with c...",
            "country": "DE",
            "timestamp": "2006-12-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000935-86/results",
            "title": "Randomized, multicentric, partially double blind placebo-controlled phase II study for examining the influence of Ribavirin on the initial virological response in previous untreated patients with c...",
            "country": "View results",
            "timestamp": "2006-12-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-006716-30/IT",
            "title": "Randomized, controlled, multicentric trial to evaluate efficacy and safety of the switch from a LPV/r based therapy to an ATV/r or a NVP based treatment in association with ABC/3TC, in HIV patient ...",
            "country": "IT",
            "timestamp": "2006-12-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005370-49/EE",
            "title": "Baltic Post-marketing Program of PEGASYS® (Peg interferon alpha-2a 40KD) in Patients with HBeAg-positive Chronic Hepatitis B",
            "country": "EE",
            "timestamp": "2006-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005370-49/LT",
            "title": "Baltic Post-marketing Program of PEGASYS® (Peg interferon alpha-2a 40KD) in Patients with HBeAg-positive Chronic Hepatitis B",
            "country": "LT",
            "timestamp": "2006-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005370-49/LV",
            "title": "Baltic Post-marketing Program of PEGASYS® (Peg interferon alpha-2a 40KD) in Patients with HBeAg-positive Chronic Hepatitis B",
            "country": "LV",
            "timestamp": "2006-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005370-49/results",
            "title": "Baltic Post-marketing Program of PEGASYS® (Peg interferon alpha-2a 40KD) in Patients with HBeAg-positive Chronic Hepatitis B",
            "country": "View results",
            "timestamp": "2006-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/BE",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "BE",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/CZ",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "CZ",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/AT",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "AT",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/LT",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "LT",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/SK",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "SK",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/DE",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "DE",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/FI",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "FI",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/FR",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "FR",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/EE",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "EE",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/DK",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "DK",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/IT",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "IT",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/GR",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "GR",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/PT",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "PT",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/ES",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "ES",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/results",
            "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis",
            "country": "View results",
            "timestamp": "2006-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-005609-76/GB",
            "title": "EFFECT OF DIFFERENT MEALS ON THE PHARMACOKINETIC PROFILE OF SAQUINAVIR AT STEADY STATE IN HIV-INFECTED PATIENTS TREATED WITH SAQUINAVIR/RITONAVIR 1000/100 mg BID.",
            "country": "GB",
            "timestamp": "2006-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003163-31/GB",
            "title": "Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine with or without Tenofovir on the Pharmacokinetics of Atazanavir when given with Ritonavir in HIV-Infected Subjec...",
            "country": "GB",
            "timestamp": "2006-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003163-31/results",
            "title": "Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine with or without Tenofovir on the Pharmacokinetics of Atazanavir when given with Ritonavir in HIV-Infected Subjec...",
            "country": "View results",
            "timestamp": "2006-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000606-23/ES",
            "title": "Post-authorization safety study to check the potential association between the safety\nprofile of beta interferon 1a and the body mass index or pharmacodynamics during the\ntitration phase",
            "country": "ES",
            "timestamp": "2006-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000606-23/results",
            "title": "Post-authorization safety study to check the potential association between the safety\nprofile of beta interferon 1a and the body mass index or pharmacodynamics during the\ntitration phase",
            "country": "View results",
            "timestamp": "2006-11-23"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN38002730",
            "timestamp": "2006-11-21",
            "title": "A research study of the role of chloroquine in treating patients with dengue"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003409-18/SE",
            "title": "An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Ch...",
            "country": "SE",
            "timestamp": "2006-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003409-18/DK",
            "title": "An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Ch...",
            "country": "DK",
            "timestamp": "2006-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-003409-18/FI",
            "title": "An Open-label, Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 weeks pegylated interferon alfa-2a 40 kD (PEGASYS®) Combination Therapy with Ribavirin (Copegus®) in Patients with Ch...",
            "country": "FI",
            "timestamp": "2006-11-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/GB",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "GB",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/FR",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "FR",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/IT",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "IT",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/DE",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "DE",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/BE",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "BE",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/NL",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "NL",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004003-18/results",
            "title": "A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...",
            "country": "View results",
            "timestamp": "2006-11-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/GB",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "GB",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/DE",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "DE",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/ES",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "ES",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/BE",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "BE",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/AT",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "AT",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/HU",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "HU",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/PT",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "PT",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/GR",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "GR",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/IT",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "IT",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000704-17/results",
            "title": "A 12-month double-blind, randomized, multicenter, active controlled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...",
            "country": "View results",
            "timestamp": "2006-10-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002070-21/DE",
            "title": "A randomized, double-blind, placebo-controlled, multicenter phase III study to compare the safety and efficacy of RAD001 plus Best Supportive Care (BSC) versus BSC plus Placebo in patients with met...",
            "country": "DE",
            "timestamp": "2006-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002070-21/NL",
            "title": "A randomized, double-blind, placebo-controlled, multicenter phase III study to compare the safety and efficacy of RAD001 plus Best Supportive Care (BSC) versus BSC plus Placebo in patients with met...",
            "country": "NL",
            "timestamp": "2006-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002070-21/AT",
            "title": "A randomized, double-blind, placebo-controlled, multicenter phase III study to compare the safety and efficacy of RAD001 plus Best Supportive Care (BSC) versus BSC plus Placebo in patients with met...",
            "country": "AT",
            "timestamp": "2006-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002070-21/FR",
            "title": "A randomized, double-blind, placebo-controlled, multicenter phase III study to compare the safety and efficacy of RAD001 plus Best Supportive Care (BSC) versus BSC plus Placebo in patients with met...",
            "country": "FR",
            "timestamp": "2006-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002070-21/IT",
            "title": "A randomized, double-blind, placebo-controlled, multicenter phase III study to compare the safety and efficacy of RAD001 plus Best Supportive Care (BSC) versus BSC plus Placebo in patients with met...",
            "country": "IT",
            "timestamp": "2006-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002070-21/results",
            "title": "A randomized, double-blind, placebo-controlled, multicenter phase III study to compare the safety and efficacy of RAD001 plus Best Supportive Care (BSC) versus BSC plus Placebo in patients with met...",
            "country": "View results",
            "timestamp": "2006-10-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002696-40/DE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Multiple Doses of ACH-0137171 in Subjects w...",
            "country": "DE",
            "timestamp": "2006-10-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007882-19/IT",
            "title": "A pilot, randomized trial to evaluate the lipid profile after antiretroviral \nregimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals",
            "country": "IT",
            "timestamp": "2006-10-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN83525871",
            "timestamp": "2006-09-29",
            "title": "Evaluation of the inflammatory response to minilaparotomy compared to conventional laparotomy in the surgical resection of colorectal cancer including its influence on long term survival and local recurrence"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002864-24/NL",
            "title": "Drug interactions between ATOvaquone used in MAlaria prophylaxis and antiretroviral agents in HIV-1 infected patients (ATOMA)",
            "country": "NL",
            "timestamp": "2006-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002864-24/results",
            "title": "Drug interactions between ATOvaquone used in MAlaria prophylaxis and antiretroviral agents in HIV-1 infected patients (ATOMA)",
            "country": "View results",
            "timestamp": "2006-09-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002695-17/IT",
            "title": "A multi-centre, randomised, double-blind, placebo-controlled escalating dose ranging phase II study on the efficacy of DEBIO-025 to reduce HCV viral load in combination with PEGASYS  180  g/week  i...",
            "country": "IT",
            "timestamp": "2006-09-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002695-17/results",
            "title": "A multi-centre, randomised, double-blind, placebo-controlled escalating dose ranging phase II study on the efficacy of DEBIO-025 to reduce HCV viral load in combination with PEGASYS  180  g/week  i...",
            "country": "View results",
            "timestamp": "2006-09-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003876-39/BE",
            "title": "A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patient...",
            "country": "BE",
            "timestamp": "2006-09-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003876-39/results",
            "title": "A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patient...",
            "country": "View results",
            "timestamp": "2006-09-19"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN77073364",
            "timestamp": "2006-09-15",
            "title": "Response and markers of response in chronic hepatitis B patients treated with peg-interferon alfa-2a and adefovir"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN38456328",
            "timestamp": "2006-09-15",
            "title": "Fluoxetine in progressive multiple sclerosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004330-40/DE",
            "title": "Open-label, randomised clinical trial to compare the virological efficacy and safety of Atazanavir/Ritonavir on a background of Tenofovir and Emtricitabine vs. Nevirapine on same background, in HIV...",
            "country": "DE",
            "timestamp": "2006-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004330-40/PT",
            "title": "Open-label, randomised clinical trial to compare the virological efficacy and safety of Atazanavir/Ritonavir on a background of Tenofovir and Emtricitabine vs. Nevirapine on same background, in HIV...",
            "country": "PT",
            "timestamp": "2006-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004330-40/IT",
            "title": "Open-label, randomised clinical trial to compare the virological efficacy and safety of Atazanavir/Ritonavir on a background of Tenofovir and Emtricitabine vs. Nevirapine on same background, in HIV...",
            "country": "IT",
            "timestamp": "2006-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004330-40/GB",
            "title": "Open-label, randomised clinical trial to compare the virological efficacy and safety of Atazanavir/Ritonavir on a background of Tenofovir and Emtricitabine vs. Nevirapine on same background, in HIV...",
            "country": "GB",
            "timestamp": "2006-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004330-40/ES",
            "title": "Open-label, randomised clinical trial to compare the virological efficacy and safety of Atazanavir/Ritonavir on a background of Tenofovir and Emtricitabine vs. Nevirapine on same background, in HIV...",
            "country": "ES",
            "timestamp": "2006-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004330-40/results",
            "title": "Open-label, randomised clinical trial to compare the virological efficacy and safety of Atazanavir/Ritonavir on a background of Tenofovir and Emtricitabine vs. Nevirapine on same background, in HIV...",
            "country": "View results",
            "timestamp": "2006-09-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001286-17/PT",
            "title": "Exploratory trial to evaluate the risk-benefit ratio of the use of mitoxantrone in patients under treatment with high dose interferon-beta-1a for relapsing-remitting or relapsing secondary progresi...",
            "country": "PT",
            "timestamp": "2006-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005751-18/GB",
            "title": "A multi-centre randomised study to evaluate the efficacy of Betaferon-interferon-beta-1b (IFNB-1B) 500 mcg therapy in the induction of tolerance to IFNB in MS patients with neutralising antibodies ...",
            "country": "GB",
            "timestamp": "2006-09-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005751-18/results",
            "title": "A multi-centre randomised study to evaluate the efficacy of Betaferon-interferon-beta-1b (IFNB-1B) 500 mcg therapy in the induction of tolerance to IFNB in MS patients with neutralising antibodies ...",
            "country": "View results",
            "timestamp": "2006-09-07"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN62432886",
            "timestamp": "2006-09-04",
            "title": "Individually adapted therapy duration from 24 to 72 weeks for the treatment of a chronic hepatitis C genotype one infection with peginterferon alfa-2b plus ribavirin in dependence of the initial concentration and the decline of the hepatitis C virus ribonucleic acid"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000820-34/PT",
            "title": "Comparison of Three Regimens of PEG-Intron plus Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients",
            "country": "PT",
            "timestamp": "2006-08-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000820-34/results",
            "title": "Comparison of Three Regimens of PEG-Intron plus Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients",
            "country": "View results",
            "timestamp": "2006-08-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN11801541",
            "timestamp": "2006-08-23",
            "title": "Consecutive blood letting and peginterferon alfa-2a/ribavirin standard treatment compared to peginterferon alfa-2a/ribavirin standard treatment alone for naive patients with hepatitis C virus genotype one and elevated ferritin levels"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-004937-13/IT",
            "title": "multicentee randomized controlled study of azathioprine versus  iterferon beta in relapsing remitting multiple sclerosis",
            "country": "IT",
            "timestamp": "2006-08-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/CZ",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "CZ",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/BE",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "BE",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/ES",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "ES",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/DE",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "DE",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/IE",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "IE",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/PT",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "PT",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/GR",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "GR",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/IT",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "IT",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/GB",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "GB",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000748-14/results",
            "title": "A Phase 3, Randomized, Open-label Study of Lopinavir/ritonavir Tablets 800/200 mg Once-daily Versus 400/100 mg Twice-daily when Coadministered with Nucleoside/Nucleotide Reverse Transcriptase Inhib...",
            "country": "View results",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006179-11/GB",
            "title": "A Phase II, open-label trial, to investigate pharmacokinetics, safety, tolerability and antiviral activity of TMC114/rtv b.i.d. in treatment-experienced HIV-1 infected children and adolescents.",
            "country": "GB",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006179-11/ES",
            "title": "A Phase II, open-label trial, to investigate pharmacokinetics, safety, tolerability and antiviral activity of TMC114/rtv b.i.d. in treatment-experienced HIV-1 infected children and adolescents.",
            "country": "ES",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006179-11/IT",
            "title": "A Phase II, open-label trial, to investigate pharmacokinetics, safety, tolerability and antiviral activity of TMC114/rtv b.i.d. in treatment-experienced HIV-1 infected children and adolescents.",
            "country": "IT",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006179-11/3rd",
            "title": "A Phase II, open-label trial, to investigate pharmacokinetics, safety, tolerability and antiviral activity of TMC114/rtv b.i.d. in treatment-experienced HIV-1 infected children and adolescents.",
            "country": "Outside EU/EEA",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006179-11/results",
            "title": "A Phase II, open-label trial, to investigate pharmacokinetics, safety, tolerability and antiviral activity of TMC114/rtv b.i.d. in treatment-experienced HIV-1 infected children and adolescents.",
            "country": "View results",
            "timestamp": "2006-08-14"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN87827353",
            "timestamp": "2006-08-08",
            "title": "A randomised, open comparative study of Dihydroartemisinin-piperaquine versus Chloroquine for the treatment of Vivax malaria"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN64793756",
            "timestamp": "2006-08-08",
            "title": "Evaluating the potential role of oral activated charcoal as an adjunct treatment for severe bacterial infections and severe malaria - a preliminary safety study"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002212-13/GB",
            "title": "A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma",
            "country": "GB",
            "timestamp": "2006-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002212-13/CZ",
            "title": "A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma",
            "country": "CZ",
            "timestamp": "2006-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002212-13/BE",
            "title": "A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma",
            "country": "BE",
            "timestamp": "2006-08-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002212-13/results",
            "title": "A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma",
            "country": "View results",
            "timestamp": "2006-08-08"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN48965919",
            "timestamp": "2006-08-04",
            "title": "Hookworm infestation as therapy in Crohn's disease"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002585-19/GB",
            "title": "A 24-week, randomised, open-label, 2-arm study to compare the tolerability and efficacy of saquinavir tablets with ritonavir versus lopinavir/ritonavir tablets in HIV 1 infected adults switching fr...",
            "country": "GB",
            "timestamp": "2006-08-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000446-20/IE",
            "title": "A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection",
            "country": "IE",
            "timestamp": "2006-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000446-20/ES",
            "title": "A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection",
            "country": "ES",
            "timestamp": "2006-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000446-20/results",
            "title": "A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection",
            "country": "View results",
            "timestamp": "2006-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000853-23/CZ",
            "title": "Prospektivní, otevřená, randomizovaná multicentrická studie hodnotící účinnost a bezpečnost pegylovaného interferonu alfa 2a (Pegasys) v adjuvantní léčbě rizikového primárního kožního melanomu",
            "country": "CZ",
            "timestamp": "2006-07-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002582-39/IT",
            "title": "A multicenter, randomized, prospective, controlled study to evaluate the efficacy and the tolerability of a switch to a two different-dosed, nevirapine-based HAARTs in HIV-1 infected patients with ...",
            "country": "IT",
            "timestamp": "2006-07-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003145-13/GB",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "GB",
            "timestamp": "2006-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003145-13/DE",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "DE",
            "timestamp": "2006-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003145-13/results",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "View results",
            "timestamp": "2006-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005849-19/GB",
            "title": "Finite duration treatment in pre-cirrhotic chronic hepatitis B virus (HBV) infection: Phase IV study of Lamivudine priming of Pegasys treatment in HBeAg positive patients",
            "country": "GB",
            "timestamp": "2006-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002805-30/IT",
            "title": "Strategic long term, immunologically driven treatment interruptions in previously naive patients starting HAART: a controlled, randomized, multicenter study",
            "country": "IT",
            "timestamp": "2006-06-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/SE",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "SE",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/ES",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "ES",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/DE",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "DE",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/NL",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "NL",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/BE",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "BE",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/IT",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "IT",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001247-64/results",
            "title": "An open label, stratified, single-arm phase II study of RAD001 in patients with advanced pancreatic neuroendocrine tumor (NET) after failure of cytotoxic chemotherapy",
            "country": "View results",
            "timestamp": "2006-06-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000524-14/SE",
            "title": "Comparison of virological response during high and low-dose regimen with natural IFN α in combination with ribavirin in patients with genotype 1 chronic hepatitis C who have experienced an incomple...",
            "country": "SE",
            "timestamp": "2006-06-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/BE",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "BE",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/DE",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "DE",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/ES",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "ES",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/FR",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "FR",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/IT",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "IT",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/PT",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "PT",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001287-23/results",
            "title": "An open-label trial with TMC125 as part of an ART including TMC114/rtv and an investigator-selected OBR in HIV-1 infected subjects who participated in a DUET trial (TMC125-C206 or TMC125-C216).",
            "country": "View results",
            "timestamp": "2006-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000666-37/GB",
            "title": "A Randomised, Controlled, Open-Label, 48-Week, Study To Asses Differences in Changes In Plasma Lipid Profile Between Patients On Saquinavir/Ritonavir Or Atazanavir/Ritonavir In Combination With Ten...",
            "country": "GB",
            "timestamp": "2006-06-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000666-37/DE",
            "title": "A Randomised, Controlled, Open-Label, 48-Week, Study To Asses Differences in Changes In Plasma Lipid Profile Between Patients On Saquinavir/Ritonavir Or Atazanavir/Ritonavir In Combination With Ten...",
            "country": "DE",
            "timestamp": "2006-06-05"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN12471415",
            "timestamp": "2006-06-02",
            "title": "Effectiveness of patient support programme for the treatment of hepatitis C"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/GB",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "GB",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/BE",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "BE",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/FI",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "FI",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/IE",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "IE",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/DE",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "DE",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/AT",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "AT",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/SE",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "SE",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/HU",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "HU",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/DK",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "DK",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/CZ",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "CZ",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/ES",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "ES",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/IT",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "IT",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/GR",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "GR",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004061-41/results",
            "title": "An Open-label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801 o...",
            "country": "View results",
            "timestamp": "2006-06-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/GB",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "GB",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/NL",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "NL",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/DE",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "DE",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/AT",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "AT",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/FI",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "FI",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/ES",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "ES",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001742-16/results",
            "title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthri...",
            "country": "View results",
            "timestamp": "2006-05-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001136-47/ES",
            "title": "ESTUDIO PILOTO, ABIERTO, COMPARATIVO Y RANDOMIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE SAQUINAVIR/RITONAVIR EN MONOTERAPIA \n vs TERAPIA HAART ESTÁNDAR  COMO TERAPIA DE MANTENIMIENTO",
            "country": "ES",
            "timestamp": "2006-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-001136-47/results",
            "title": "ESTUDIO PILOTO, ABIERTO, COMPARATIVO Y RANDOMIZADO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE SAQUINAVIR/RITONAVIR EN MONOTERAPIA \n vs TERAPIA HAART ESTÁNDAR  COMO TERAPIA DE MANTENIMIENTO",
            "country": "View results",
            "timestamp": "2006-05-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005119-76/ES",
            "title": "Phase IIIb Multicenter, Single Arm, Open-label Pilot Study to Evaluate the Effectiveness and Safety of Maintenance with Atazanavir/ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Inf...",
            "country": "ES",
            "timestamp": "2006-05-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005119-76/results",
            "title": "Phase IIIb Multicenter, Single Arm, Open-label Pilot Study to Evaluate the Effectiveness and Safety of Maintenance with Atazanavir/ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Inf...",
            "country": "View results",
            "timestamp": "2006-05-24"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN81525828",
            "timestamp": "2006-05-15",
            "title": "A phase II, randomised, double-blind, placebo-controlled pilot study of the safety, tolerability and activity of intramuscularly administered a-Epi-Br (HE2000) in late stage human immunodeficiency virus-infected patients at risk for opportunistic infections"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000591-33/GB",
            "title": "A Phase II study of Gemcitabine and Bexarotene (GemBex) in the treatment of cutaneous T-cell lymphoma",
            "country": "GB",
            "timestamp": "2006-05-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000591-33/results",
            "title": "A Phase II study of Gemcitabine and Bexarotene (GemBex) in the treatment of cutaneous T-cell lymphoma",
            "country": "View results",
            "timestamp": "2006-05-10"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN81765620",
            "timestamp": "2006-05-10",
            "title": "Effectiveness and safety of the treatment of chronic hepatitis C in patients infected with the human immunodeficiency virus comparing two types of pegylated interferon and ribavirin"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002437-13/LT",
            "title": "Early access of TMC114 in combination with low-dose ritonavir (RTV) and other antiretrovirals (ARVs) in highly treatment experienced HIV-1 infected subjects with limited to no treatment options.",
            "country": "LT",
            "timestamp": "2006-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002437-13/IT",
            "title": "Early access of TMC114 in combination with low-dose ritonavir (RTV) and other antiretrovirals (ARVs) in highly treatment experienced HIV-1 infected subjects with limited to no treatment options.",
            "country": "IT",
            "timestamp": "2006-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002437-13/results",
            "title": "Early access of TMC114 in combination with low-dose ritonavir (RTV) and other antiretrovirals (ARVs) in highly treatment experienced HIV-1 infected subjects with limited to no treatment options.",
            "country": "View results",
            "timestamp": "2006-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000977-31/GB",
            "title": "PHASE IIIB, RANDOMIZED, OPEN LABEL STUDY OF PEGYLATED INTERFERON ALFA-2A IN COMBINATION WITH LAMIVUDINE OR ENTECAVIR COMPARED WITH UNTREATED CONTROL PATIENTS IN CHILDREN WITH HBEAG POSITIVE CHRONIC...",
            "country": "GB",
            "timestamp": "2006-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000977-31/DE",
            "title": "PHASE IIIB, RANDOMIZED, OPEN LABEL STUDY OF PEGYLATED INTERFERON ALFA-2A IN COMBINATION WITH LAMIVUDINE OR ENTECAVIR COMPARED WITH UNTREATED CONTROL PATIENTS IN CHILDREN WITH HBEAG POSITIVE CHRONIC...",
            "country": "DE",
            "timestamp": "2006-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000977-31/BE",
            "title": "PHASE IIIB, RANDOMIZED, OPEN LABEL STUDY OF PEGYLATED INTERFERON ALFA-2A IN COMBINATION WITH LAMIVUDINE OR ENTECAVIR COMPARED WITH UNTREATED CONTROL PATIENTS IN CHILDREN WITH HBEAG POSITIVE CHRONIC...",
            "country": "BE",
            "timestamp": "2006-05-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000753-22/GB",
            "title": "A phase I/II feasability trial to assess the safety, immunological activity and efficacy of TroVax plus interferon alpha in patients with advanced or metastatic renal cell cancer.",
            "country": "GB",
            "timestamp": "2006-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000753-22/results",
            "title": "A phase I/II feasability trial to assess the safety, immunological activity and efficacy of TroVax plus interferon alpha in patients with advanced or metastatic renal cell cancer.",
            "country": "View results",
            "timestamp": "2006-05-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004531-22/HU",
            "title": "Efficacy and Safety of Continuing for a Total of  48 or Prolonging for a Total of  72 weeks of Combined Treatment of Patients Receiving Pegasys and Copegus who are Biochemical Responders but Virolo...",
            "country": "HU",
            "timestamp": "2006-05-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005506-23/ES",
            "title": "Estudio de fase IV, multicéntrico, aleatorizado y doble ciego para comparar la seguridad y eficacia de 180 µg de Pegasys® más 1000 ó 1200 mg de Copegus® con la combinación actualmente aprobada de 1...",
            "country": "ES",
            "timestamp": "2006-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005506-23/PT",
            "title": "Estudio de fase IV, multicéntrico, aleatorizado y doble ciego para comparar la seguridad y eficacia de 180 µg de Pegasys® más 1000 ó 1200 mg de Copegus® con la combinación actualmente aprobada de 1...",
            "country": "PT",
            "timestamp": "2006-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005506-23/results",
            "title": "Estudio de fase IV, multicéntrico, aleatorizado y doble ciego para comparar la seguridad y eficacia de 180 µg de Pegasys® más 1000 ó 1200 mg de Copegus® con la combinación actualmente aprobada de 1...",
            "country": "View results",
            "timestamp": "2006-04-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005375-15/BE",
            "title": "Efficacy of maintenance therapy with rituximab after induction chemotherapy (R-CHOP vs R-FC) for elderly patients with mantle cell lymphoma not suitable for autologous stem cell transplantation",
            "country": "BE",
            "timestamp": "2006-04-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002562-19/IT",
            "title": "Immunoablation with Cyclophosphamide at high dosage and Rabbit antithymoglobulin followed by autologous hematopoietic stem cell transplantation in severe multiple sclerosis",
            "country": "IT",
            "timestamp": "2006-04-21"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN59358441",
            "timestamp": "2006-04-04",
            "title": "Interferon (IFN) induction followed by PEG-interferon combined with ribavirin and amantadine for treatment of naive chronic hepatitis C patients with genotype 1 or 4"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000096-16/GB",
            "title": "A Randomized, Double-Blind, Phase II Study Comparing the Anti-Retroviral Safety and Efficacy of Dexelvucitabine (DFC) 200 mg Once Daily to Lamivudine (3TC) 300 mg Once Daily in Addition to Optimize...",
            "country": "GB",
            "timestamp": "2006-03-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005989-37/FI",
            "title": "CogniMS: observational study to assess cognition in patients with early Multiple Sclerosis",
            "country": "FI",
            "timestamp": "2006-03-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/GB",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "GB",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/SK",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "SK",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/CZ",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "CZ",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/SE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "SE",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/ES",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "ES",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/IE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "IE",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/AT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "AT",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/NL",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "NL",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/BE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "BE",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/IT",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "IT",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/EE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "EE",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/LV",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "LV",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003558-83/results",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects with Rheumatoid Arthritis",
            "country": "View results",
            "timestamp": "2006-03-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000334-12/DE",
            "title": "A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND, CROSS-OVER, MONOCENTER STUDY TO EVALUATE THE EFFECT OF A 7-DAY MONTELUKAST TREATMENT ON AIRWAY INFLAMMATION AND FUNCTION BY MEANS OF BRONCHOPROVOCATI...",
            "country": "DE",
            "timestamp": "2006-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-000334-12/results",
            "title": "A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND, CROSS-OVER, MONOCENTER STUDY TO EVALUATE THE EFFECT OF A 7-DAY MONTELUKAST TREATMENT ON AIRWAY INFLAMMATION AND FUNCTION BY MEANS OF BRONCHOPROVOCATI...",
            "country": "View results",
            "timestamp": "2006-03-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/GB",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "GB",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/IE",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "IE",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/SK",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "SK",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/LT",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "LT",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/EE",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "EE",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/AT",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "AT",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/CZ",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "CZ",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/IT",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "IT",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/GR",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "GR",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/HU",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "HU",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/LV",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "LV",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004078-25/results",
            "title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or...",
            "country": "View results",
            "timestamp": "2006-03-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003771-37/HU",
            "title": "A double-blind, randomized, placebo controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with active rheumatoid arthrit...",
            "country": "HU",
            "timestamp": "2006-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003771-37/results",
            "title": "A double-blind, randomized, placebo controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with active rheumatoid arthrit...",
            "country": "View results",
            "timestamp": "2006-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/SE",
            "title": "A Scandinavian, randomized, rater-blinded study of single and double-dose (2x250 mcg e.o.d.) Betaferon in patients with early secondary progressive multiple sclerosis.",
            "country": "SE",
            "timestamp": "2006-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/DK",
            "title": "A Scandinavian, randomized, rater-blinded study of single and double-dose (2x250 mcg e.o.d.) Betaferon in patients with early secondary progressive multiple sclerosis.",
            "country": "DK",
            "timestamp": "2006-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/results",
            "title": "A Scandinavian, randomized, rater-blinded study of single and double-dose (2x250 mcg e.o.d.) Betaferon in patients with early secondary progressive multiple sclerosis.",
            "country": "View results",
            "timestamp": "2006-03-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN20254161",
            "timestamp": "2006-03-03",
            "title": "Islet autoantigen-derived peptides eluted from Human Leucocyte Antigen (HLA) class II molecules as vaccines for the immunotherapy of type 1 diabetes"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004403-37/DE",
            "title": "Eine monozentrische, randomisierte, kontrollierte Studie zur Untersuchung von Interferon-beta zur Behandlung der Multiplen-Sklerose (MS)-assoziierten und primären Uveitis intermedia im Vergleich zu...",
            "country": "DE",
            "timestamp": "2006-02-27"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN81536220",
            "timestamp": "2006-02-14",
            "title": "Retreatment of chronic hepatitis C patients with pegylated interferon (IFN), ribavirin and amantadine; a pilot study to establish if initial drop in viral load is predictive for sustained virological response"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005670-71/IT",
            "title": "Dose-finding and Phase II study of the Combination of Bevacizumab  rhuMAb VEGF plus low- dose Immunotherapy and Chemotherapy in patients with   metastatic Renal Cell Cancer.",
            "country": "IT",
            "timestamp": "2006-02-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/GB",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "GB",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/DE",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "DE",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/AT",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "AT",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/BE",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "BE",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/PT",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "PT",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/ES",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "ES",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/DK",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "DK",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/IT",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "IT",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001895-11/results",
            "title": "A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/ritonavir with Lopinavir/ritonavir, Each in Combination with Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment...",
            "country": "View results",
            "timestamp": "2006-02-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004761-42/ES",
            "title": "First line treatment with Rituximab asociated to CVP plus Interferon in Follicular Lymphoma. Phase II study.\nAsociación de Rituximab al esquema CVP + Interferón en el tratamiento de primera línea d...",
            "country": "ES",
            "timestamp": "2006-02-06"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN35124268",
            "timestamp": "2006-02-06",
            "title": "A randomised phase II study comparing capecitabine plus streptozocin with or without cisplatin in the treatment of unresectable or metastatic gastroentero-neuroendocrine tumours of the foregut, pancreatic neuroendocrine tumours and neuroendocrine tumours of unknown primary site"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004698-39/DE",
            "title": "Randomized, double-blind, placebo-controlled 7 day monotherapy Phase IIa study to evaluate the antiviral activity and safety of  oral administered RTV-boosted BILR 355 (75 mg and 150 mg twice daily...",
            "country": "DE",
            "timestamp": "2006-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004698-39/results",
            "title": "Randomized, double-blind, placebo-controlled 7 day monotherapy Phase IIa study to evaluate the antiviral activity and safety of  oral administered RTV-boosted BILR 355 (75 mg and 150 mg twice daily...",
            "country": "View results",
            "timestamp": "2006-02-03"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN22508774",
            "timestamp": "2006-02-01",
            "title": "A single dose two-phase crossover study to assess the tolerability and pharmacokinetic parameters of a fixed dose formulation of artesunate-mefloquine and standard dose artesunate and mefloquine as loose tablets in healthy normal volunteers (Thailand)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005022-31/GB",
            "title": "Effect of a High-Fat or a Light Meal Relative to Fasting Conditions on the Pharmacokinetics of Atazanavir when Administered with Ritonavir in Healthy Subjects",
            "country": "GB",
            "timestamp": "2006-01-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005022-31/results",
            "title": "Effect of a High-Fat or a Light Meal Relative to Fasting Conditions on the Pharmacokinetics of Atazanavir when Administered with Ritonavir in Healthy Subjects",
            "country": "View results",
            "timestamp": "2006-01-31"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN45284754",
            "timestamp": "2006-01-27",
            "title": "HAART followed by maintenance with monotherapy - Kaletra (MAIMOKA)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN65586975",
            "timestamp": "2006-01-27",
            "title": "Fluoxetine therapy in multiple sclerosis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004289-18/FI",
            "title": "A Multi-centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Minocycline versus placebo as add-on therapy in patients who are on treatment with Interferon-beta-1...",
            "country": "FI",
            "timestamp": "2006-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004289-18/SE",
            "title": "A Multi-centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Minocycline versus placebo as add-on therapy in patients who are on treatment with Interferon-beta-1...",
            "country": "SE",
            "timestamp": "2006-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004289-18/DK",
            "title": "A Multi-centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Minocycline versus placebo as add-on therapy in patients who are on treatment with Interferon-beta-1...",
            "country": "DK",
            "timestamp": "2006-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004289-18/results",
            "title": "A Multi-centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Minocycline versus placebo as add-on therapy in patients who are on treatment with Interferon-beta-1...",
            "country": "View results",
            "timestamp": "2006-01-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/HU",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "HU",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/AT",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "AT",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/DE",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "DE",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/GB",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "GB",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/DK",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "DK",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/ES",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "ES",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/BE",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "BE",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/IT",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "IT",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/PT",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "PT",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/GR",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "GR",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002486-36/results",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects.\n\nA substudy of...",
            "country": "View results",
            "timestamp": "2006-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001192-34/ES",
            "title": "Open pilot study phase IV to treat co infected HCV-HIV patients after their relapse with interferon therapy.\nTratamiento de los pacientes con hepatitis crónica C infectados por el VIH que han recaí...",
            "country": "ES",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003930-16/SE",
            "title": "A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Mu...",
            "country": "SE",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003930-16/FI",
            "title": "A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Mu...",
            "country": "FI",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003930-16/DK",
            "title": "A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Mu...",
            "country": "DK",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003930-16/results",
            "title": "A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Mu...",
            "country": "View results",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/GB",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "GB",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/ES",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "ES",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/DE",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "DE",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/AT",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "AT",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/BE",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "BE",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/SE",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "SE",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/GR",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "GR",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/CZ",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "CZ",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/SK",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "SK",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/IT",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "IT",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002827-15/results",
            "title": "Phase 3, open label, randomized, comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melanoma",
            "country": "View results",
            "timestamp": "2006-01-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005770-72/IT",
            "title": "RAPSODY - RANDOMIZED, PROSPECTIVE TRIAL OF TWO SCHEDULES OF SORAFENIB 800 mg DAILY AND INTERFERON ALPHA IN METASTATIC RENAL CELL CARCINOMA  MRCC   A GOIRC PHASE II STUDY",
            "country": "IT",
            "timestamp": "2006-01-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004809-29/IT",
            "title": "The steady state pharmacokinetics (PK) of atazanavir boosted with ritonavir during pregnancy and postpartum in HIV-1 infected pregnant women",
            "country": "IT",
            "timestamp": "2006-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002093-30/ES",
            "title": "Extension protocol for patients with Chronic Myelogenous Leukemia (CML), Malignant Melanoma (MM) or Renal Cell Carcinoma (RCC) that have responded to treatment with Pegylated-interferon α-2a (PEG-I...",
            "country": "ES",
            "timestamp": "2005-12-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002093-30/results",
            "title": "Extension protocol for patients with Chronic Myelogenous Leukemia (CML), Malignant Melanoma (MM) or Renal Cell Carcinoma (RCC) that have responded to treatment with Pegylated-interferon α-2a (PEG-I...",
            "country": "View results",
            "timestamp": "2005-12-22"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN46326316",
            "timestamp": "2005-12-20",
            "title": "Comparison between immune response to different modes of vaccination"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN84226319",
            "timestamp": "2005-12-20",
            "title": "High-dose cytarabin versus low-dose cytarabin plus interferon-alpha-2a both followed by maintenance with interferon-alpha-2a in chronic myeloid leukemia"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN74271466",
            "timestamp": "2005-12-20",
            "title": "Study on chronic hepatitis C treatment with interferon alpha, ribavirin and amantadine in naive patients."
        },
        {
            "url": "https://www.isrctn.com/ISRCTN06413384",
            "timestamp": "2005-12-20",
            "title": "A randomised phase III study on the effect of thalidomide combined with Adriamycin®, dexamethasone and high dose melphalan in patients with multiple myeloma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN82155239",
            "timestamp": "2005-12-20",
            "title": "Myelo-ablative chemo/radiotherapy and autologous stem cell transplantation as compared to only chemotherapy in patients with multiple myeloma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN90692740",
            "timestamp": "2005-12-20",
            "title": "Randomised phase III study in elderly patients with a multiple myeloma on the value of Thalidomide added to Melphalan plus Prednisone"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/DE",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "DE",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/GB",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "GB",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/PT",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "PT",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/ES",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "ES",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/IT",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "IT",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/BE",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "BE",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003160-32/results",
            "title": "A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...",
            "country": "View results",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004435-22/CZ",
            "title": "INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEAMOPHILIA A TREATED WITH OCTANATE",
            "country": "CZ",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004435-22/FR",
            "title": "INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEAMOPHILIA A TREATED WITH OCTANATE",
            "country": "FR",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004435-22/results",
            "title": "INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEAMOPHILIA A TREATED WITH OCTANATE",
            "country": "View results",
            "timestamp": "2005-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002826-70/GB",
            "title": "A Phase 2, open label, single arm study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ticilimumab in patients with advanced refractory and/or relapsed melanoma",
            "country": "GB",
            "timestamp": "2005-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002826-70/ES",
            "title": "A Phase 2, open label, single arm study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ticilimumab in patients with advanced refractory and/or relapsed melanoma",
            "country": "ES",
            "timestamp": "2005-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002826-70/DE",
            "title": "A Phase 2, open label, single arm study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ticilimumab in patients with advanced refractory and/or relapsed melanoma",
            "country": "DE",
            "timestamp": "2005-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002826-70/IT",
            "title": "A Phase 2, open label, single arm study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ticilimumab in patients with advanced refractory and/or relapsed melanoma",
            "country": "IT",
            "timestamp": "2005-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002826-70/results",
            "title": "A Phase 2, open label, single arm study to evaluate the efficacy, safety, tolerability and pharmacokinetics of ticilimumab in patients with advanced refractory and/or relapsed melanoma",
            "country": "View results",
            "timestamp": "2005-11-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/IE",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "IE",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/GB",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "GB",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/DE",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "DE",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/CZ",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "CZ",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/BE",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "BE",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/ES",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "ES",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/GR",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "GR",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/IT",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "IT",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001430-32/results",
            "title": "A Phase 3, Randomized, Open-label, Study of Lopinavir/ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, when Coadministered with NRTIs in Antiretroviral N...",
            "country": "View results",
            "timestamp": "2005-11-18"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/IE",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "IE",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/ES",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "ES",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/DE",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "DE",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/GB",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "GB",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/EE",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "EE",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/GR",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "GR",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-003495-38/results",
            "title": "A randomized, double-blind, placebo-controlled study to determine the efficacy and safety of 5 dose regimens of RO4402257 in patients with active rheumatoid arthritis (RA) on stable methotrexate (M...",
            "country": "View results",
            "timestamp": "2005-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001281-13/CZ",
            "title": "Observational Study of Early Interferon beta 1-a Treatment in High Risk Subjects after CIS (SET Study)",
            "country": "CZ",
            "timestamp": "2005-11-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-004430-41/GB",
            "title": "Effect of food on the pharmacokinetic profile of saquinavir at steady state in HIV-infected patients treated with saquinavir/ritonavir 1000/100 mg b.i.d.",
            "country": "GB",
            "timestamp": "2005-11-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001207-19/DE",
            "title": "Randomized multicenter open label trial comparing the efficacy and safety of 48 versus 72 weeks of Peginterferon-alfa-2a plus daily Ribavirin and Amantadinsulfat in patients with chronic Hepatitis ...",
            "country": "DE",
            "timestamp": "2005-11-04"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001207-19/results",
            "title": "Randomized multicenter open label trial comparing the efficacy and safety of 48 versus 72 weeks of Peginterferon-alfa-2a plus daily Ribavirin and Amantadinsulfat in patients with chronic Hepatitis ...",
            "country": "View results",
            "timestamp": "2005-11-04"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN45483324",
            "timestamp": "2005-11-03",
            "title": "A strategy to immunize young infants against measles"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001008-37/SE",
            "title": "Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy",
            "country": "SE",
            "timestamp": "2005-11-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN36731786",
            "timestamp": "2005-10-26",
            "title": "Dose finding for a safe and efficacious combination of chloroquine (CQ) and methylene blue in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN88008850",
            "timestamp": "2005-10-25",
            "title": "A phase III, randomised, multicentre, dose escalation, efficacy and safety study examining the effects of treatment with peginterferon alfa-2a with Child's A or B cirrhosis in Chronic Hepatitis C virus infection"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN75125874",
            "timestamp": "2005-10-21",
            "title": "Randomised phase III clinical trial in patients radically operated for stage III melanoma (American Joint Committee on Cancer [AJCC])"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001469-16/GB",
            "title": "A double-blind, randomized, placebo-controlled, multi-centre, dose-ranging, parallel group, phase II study to assess efficacy, safety/tolerability, and pharmacokinetics of a thrombopoietin receptor...",
            "country": "GB",
            "timestamp": "2005-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001469-16/DE",
            "title": "A double-blind, randomized, placebo-controlled, multi-centre, dose-ranging, parallel group, phase II study to assess efficacy, safety/tolerability, and pharmacokinetics of a thrombopoietin receptor...",
            "country": "DE",
            "timestamp": "2005-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001469-16/ES",
            "title": "A double-blind, randomized, placebo-controlled, multi-centre, dose-ranging, parallel group, phase II study to assess efficacy, safety/tolerability, and pharmacokinetics of a thrombopoietin receptor...",
            "country": "ES",
            "timestamp": "2005-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001469-16/results",
            "title": "A double-blind, randomized, placebo-controlled, multi-centre, dose-ranging, parallel group, phase II study to assess efficacy, safety/tolerability, and pharmacokinetics of a thrombopoietin receptor...",
            "country": "View results",
            "timestamp": "2005-10-20"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002969-37/SE",
            "title": "A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the CRP dose response relationship.",
            "country": "SE",
            "timestamp": "2005-10-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002969-37/ES",
            "title": "A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the CRP dose response relationship.",
            "country": "ES",
            "timestamp": "2005-10-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002969-37/DE",
            "title": "A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the CRP dose response relationship.",
            "country": "DE",
            "timestamp": "2005-10-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002969-37/results",
            "title": "A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the CRP dose response relationship.",
            "country": "View results",
            "timestamp": "2005-10-14"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN31557558",
            "timestamp": "2005-09-30",
            "title": "A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs Interferon Beta-1a in early active relapsing remitting Multiple Sclerosis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN71794661",
            "timestamp": "2005-09-30",
            "title": "Therapeutic vaccination in patients with chronic hepatitis C genotype 1 using four courses of 8 + 6 + 6 + 6 intramuscular injections of 50 µg E1y at 3 week intervals"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/IE",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "IE",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/GB",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "GB",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/ES",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "ES",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/LV",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "LV",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/DE",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "DE",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/EE",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "EE",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/IT",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "IT",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000865-21/results",
            "title": "A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase with Unboosted vs. Boosted Reyataz After an Induction Phase with Reyataz and Ritonavir ...",
            "country": "View results",
            "timestamp": "2005-09-28"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN45169013",
            "timestamp": "2005-09-26",
            "title": "Comparison of Three Regimens of PEG-Intron plus Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001688-74/GB",
            "title": "A prospective, randomized, double-blind, placebo controlled trial evaluating the effects of Mycophenolate Mofetil (MMF) on 'surrogate markers' for atherosclerosis in female patients with systemic l...",
            "country": "GB",
            "timestamp": "2005-09-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001688-74/results",
            "title": "A prospective, randomized, double-blind, placebo controlled trial evaluating the effects of Mycophenolate Mofetil (MMF) on 'surrogate markers' for atherosclerosis in female patients with systemic l...",
            "country": "View results",
            "timestamp": "2005-09-22"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN98373474",
            "timestamp": "2005-09-20",
            "title": "A double-blind placebo-controlled multicenter study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis (SPMS)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN87763194",
            "timestamp": "2005-09-12",
            "title": "ELISA-2 (Early or Late Intervention in unStable Angina)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001977-82/GB",
            "title": "A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dos...",
            "country": "GB",
            "timestamp": "2005-09-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001977-82/results",
            "title": "A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dos...",
            "country": "View results",
            "timestamp": "2005-09-09"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN51477478",
            "timestamp": "2005-09-09",
            "title": "Combination therapy using pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C virus (HCV) infection 3 to 120 months after liver transplantation"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN88729946",
            "timestamp": "2005-09-09",
            "title": "Treatment of acute hepatitis C infection"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN83587695",
            "timestamp": "2005-09-09",
            "title": "A multicenter randomised study comparing the efficacy of adefovir dipivoxil versus pegylated interferon alpha-2a plus placebo versus adefovir dipivoxil plus peglyated interferon alpha-2a for the treatment of chronic delta hepatitis"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/SE",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "SE",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/NO",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "NO",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/DE",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "DE",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/DK",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "DK",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/ES",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "ES",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/GB",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "GB",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/HU",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "HU",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/IT",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "IT",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002219-26/results",
            "title": "A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-react...",
            "country": "View results",
            "timestamp": "2005-09-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000162-40/SE",
            "title": "Treatment of genital warts with Interferon alpha-2b Cream:  \na randomized, double blind, placebo-controlled study",
            "country": "SE",
            "timestamp": "2005-09-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000162-40/DE",
            "title": "Treatment of genital warts with Interferon alpha-2b Cream:  \na randomized, double blind, placebo-controlled study",
            "country": "DE",
            "timestamp": "2005-09-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006071-12/IT",
            "title": "Evaluation of efficacy, safety and tolerability of an ADd-on therapy with Cianocabalamine  Vitamin B12  plus Calcium levofolinate in relapsing-remitting multiple sclerosis patients Already in treat...",
            "country": "IT",
            "timestamp": "2005-08-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/HU",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "HU",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/DE",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "DE",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/IE",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "IE",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/DK",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "DK",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/GB",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "GB",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/AT",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "AT",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001247-39/results",
            "title": "A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "View results",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/HU",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "HU",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/IE",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "IE",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/DK",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "DK",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/GB",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "GB",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/AT",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "AT",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/DE",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "DE",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001246-16/results",
            "title": "A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing opti...",
            "country": "View results",
            "timestamp": "2005-08-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-005161-11/IT",
            "title": "Treatment with leucocytic interferon-alpha more ribavirine towards peg-interferon to reduced doses more ribavirine in patients affections from positive chronic hepatitis HCV that in course of arran...",
            "country": "IT",
            "timestamp": "2005-08-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001431-30/GB",
            "title": "A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (...",
            "country": "GB",
            "timestamp": "2005-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001431-30/IE",
            "title": "A Randomized, Open Label Study Assessing Safety, Tolerability, and Efficacy of an Induction/Maintenance Treatment Strategy Including Lopinavir/ritonavir (LPV/r) plus Tenofovir Disoproxil Fumarate (...",
            "country": "IE",
            "timestamp": "2005-07-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001150-24/GB",
            "title": "A Phase IIB, Randomized, Multicenter, Parallel Group Study to Evaluate the Short-Term Safety, Pharmacokinetics and Antiviral Activity of Four Blinded Dosing Regimens of GW640385/Ritonavir Therapy C...",
            "country": "GB",
            "timestamp": "2005-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001150-24/DE",
            "title": "A Phase IIB, Randomized, Multicenter, Parallel Group Study to Evaluate the Short-Term Safety, Pharmacokinetics and Antiviral Activity of Four Blinded Dosing Regimens of GW640385/Ritonavir Therapy C...",
            "country": "DE",
            "timestamp": "2005-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001150-24/IT",
            "title": "A Phase IIB, Randomized, Multicenter, Parallel Group Study to Evaluate the Short-Term Safety, Pharmacokinetics and Antiviral Activity of Four Blinded Dosing Regimens of GW640385/Ritonavir Therapy C...",
            "country": "IT",
            "timestamp": "2005-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001150-24/PT",
            "title": "A Phase IIB, Randomized, Multicenter, Parallel Group Study to Evaluate the Short-Term Safety, Pharmacokinetics and Antiviral Activity of Four Blinded Dosing Regimens of GW640385/Ritonavir Therapy C...",
            "country": "PT",
            "timestamp": "2005-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001150-24/results",
            "title": "A Phase IIB, Randomized, Multicenter, Parallel Group Study to Evaluate the Short-Term Safety, Pharmacokinetics and Antiviral Activity of Four Blinded Dosing Regimens of GW640385/Ritonavir Therapy C...",
            "country": "View results",
            "timestamp": "2005-07-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004903-39/GB",
            "title": "A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs. Interferon Beta-1a in early active relapsing remitting Multiple Sclerosis.",
            "country": "GB",
            "timestamp": "2005-07-26"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN75303340",
            "timestamp": "2005-07-22",
            "title": "Randomised comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN22075368",
            "timestamp": "2005-07-22",
            "title": "Sulfadoxine-pyrimethamine combinations study"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN11805747",
            "timestamp": "2005-07-22",
            "title": "Measuring malaria transmission after drug treatment"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN30087513",
            "timestamp": "2005-07-22",
            "title": "Research to improve economical anti-rabies treatment"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002818-38/IT",
            "title": "ESPrES 500 - Evaluation of the safety profile of the new 500 mg film-coated tablet (FCT) formulation of boosted saquinavir (Invirase 500 mg)  in  HIV-1 infected patients",
            "country": "IT",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002818-38/results",
            "title": "ESPrES 500 - Evaluation of the safety profile of the new 500 mg film-coated tablet (FCT) formulation of boosted saquinavir (Invirase 500 mg)  in  HIV-1 infected patients",
            "country": "View results",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005120-41/GB",
            "title": "A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil  for the Treatment of HBeAg Positive Chronic Hepatitis B.",
            "country": "GB",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005120-41/DE",
            "title": "A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil  for the Treatment of HBeAg Positive Chronic Hepatitis B.",
            "country": "DE",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005120-41/CZ",
            "title": "A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil  for the Treatment of HBeAg Positive Chronic Hepatitis B.",
            "country": "CZ",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005120-41/ES",
            "title": "A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil  for the Treatment of HBeAg Positive Chronic Hepatitis B.",
            "country": "ES",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005120-41/IT",
            "title": "A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil  for the Treatment of HBeAg Positive Chronic Hepatitis B.",
            "country": "IT",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005120-41/results",
            "title": "A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil  for the Treatment of HBeAg Positive Chronic Hepatitis B.",
            "country": "View results",
            "timestamp": "2005-07-21"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001009-25/IT",
            "title": "Efficacy, safety and tolerability of Atorvastatin 40 mg in patients with Relapsing-remitting multIple sclerosis in treAtment with INterferoN-betA.",
            "country": "IT",
            "timestamp": "2005-07-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001026-89/DE",
            "title": "Phase IV, multicenter, open label, randomized study of Rebif® 44 mcg administered three times per week by subcutaneous injection compared with no treatment in the therapy of relapsing multiple scle...",
            "country": "DE",
            "timestamp": "2005-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001026-89/results",
            "title": "Phase IV, multicenter, open label, randomized study of Rebif® 44 mcg administered three times per week by subcutaneous injection compared with no treatment in the therapy of relapsing multiple scle...",
            "country": "View results",
            "timestamp": "2005-07-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-002202-28/DK",
            "title": "Hepatitis C virusdynamik og immunaktivering hos HCV/HIV-koinficerede patienter under behandling med pegyleret interferon a-2a og ribavirin",
            "country": "DK",
            "timestamp": "2005-07-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001264-31/IT",
            "title": "Peg-Intron/Rebetol vs Peg-Intron / SCH 503034 with and without Ribavirin in Chronic Hepatitis C HCV 1 Peginterferon alfa/Ribavirin Nonresponders: A SCH 503034 dose finding Phase 2 Study.",
            "country": "IT",
            "timestamp": "2005-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001264-31/DE",
            "title": "Peg-Intron/Rebetol vs Peg-Intron / SCH 503034 with and without Ribavirin in Chronic Hepatitis C HCV 1 Peginterferon alfa/Ribavirin Nonresponders: A SCH 503034 dose finding Phase 2 Study.",
            "country": "DE",
            "timestamp": "2005-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001264-31/results",
            "title": "Peg-Intron/Rebetol vs Peg-Intron / SCH 503034 with and without Ribavirin in Chronic Hepatitis C HCV 1 Peginterferon alfa/Ribavirin Nonresponders: A SCH 503034 dose finding Phase 2 Study.",
            "country": "View results",
            "timestamp": "2005-07-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001316-47/FI",
            "title": "Bevacizumab (Avastin™), dacarbazine and interferon α-2a (Roferon-A; IFN α-2a ) combination as a first-line therapy in patients with locally advancing or metastatic melanoma",
            "country": "FI",
            "timestamp": "2005-07-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005115-29/GB",
            "title": "A randomised, placebo-controlled, parallel group single dose study of SB681323 in patients with active RA to investigate the CRP dose response relationship",
            "country": "GB",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005115-29/DE",
            "title": "A randomised, placebo-controlled, parallel group single dose study of SB681323 in patients with active RA to investigate the CRP dose response relationship",
            "country": "DE",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-005115-29/results",
            "title": "A randomised, placebo-controlled, parallel group single dose study of SB681323 in patients with active RA to investigate the CRP dose response relationship",
            "country": "View results",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001658-10/GB",
            "title": "An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire tr...",
            "country": "GB",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001658-10/BE",
            "title": "An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire tr...",
            "country": "BE",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001658-10/IT",
            "title": "An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire tr...",
            "country": "IT",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001658-10/PT",
            "title": "An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire tr...",
            "country": "PT",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001658-10/ES",
            "title": "An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire tr...",
            "country": "ES",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001658-10/results",
            "title": "An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire tr...",
            "country": "View results",
            "timestamp": "2005-06-24"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002846-36/DE",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  ADMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATME...",
            "country": "DE",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002846-36/IT",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  ADMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATME...",
            "country": "IT",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002846-36/SK",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  ADMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATME...",
            "country": "SK",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002846-36/AT",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  ADMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATME...",
            "country": "AT",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002846-36/ES",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  ADMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATME...",
            "country": "ES",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002846-36/results",
            "title": "A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO COMPARE 3 DOSE LEVELS OF CP 690,550 VERSUS PLACEBO,  ADMINISTERED ORALLY TWICE DAILY (BID) FOR 6 WEEKS, IN THE TREATME...",
            "country": "View results",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001679-36/CZ",
            "title": "Prospektivní, otevřená, randomizovaná multicentrická studie hodnotící účinnost a bezpečnost kombinace isotretinoinu (Roaccutane® tobolky) a interferonu alfa 2a oproti samotnému interferonu alfa 2a ...",
            "country": "CZ",
            "timestamp": "2005-06-14"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/HU",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "HU",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/AT",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "AT",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/GB",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "GB",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/DE",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "DE",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/DK",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "DK",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/BE",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "BE",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/ES",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "ES",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/IT",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "IT",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000594-22/results",
            "title": "A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment-experienced HIV-1 infected subjects.",
            "country": "View results",
            "timestamp": "2005-06-13"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN70132716",
            "timestamp": "2005-06-07",
            "title": "Artesunate and Amodiaquine"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000867-24/DE",
            "title": "A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, \nOPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION...",
            "country": "DE",
            "timestamp": "2005-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000867-24/CZ",
            "title": "A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, \nOPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION...",
            "country": "CZ",
            "timestamp": "2005-05-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000867-24/results",
            "title": "A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, \nOPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION...",
            "country": "View results",
            "timestamp": "2005-05-23"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN27745631",
            "timestamp": "2005-05-16",
            "title": "Acetylsalicylic acid as an adjuvant therapy for schizophrenia"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004051-19/DE",
            "title": "A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...",
            "country": "DE",
            "timestamp": "2005-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004051-19/GB",
            "title": "A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...",
            "country": "GB",
            "timestamp": "2005-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004051-19/SE",
            "title": "A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...",
            "country": "SE",
            "timestamp": "2005-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004051-19/BE",
            "title": "A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...",
            "country": "BE",
            "timestamp": "2005-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004051-19/AT",
            "title": "A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...",
            "country": "AT",
            "timestamp": "2005-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004051-19/IT",
            "title": "A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy with Glucocorticosteroids vs. Placebo plus Gluc...",
            "country": "IT",
            "timestamp": "2005-05-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002740-10/GB",
            "title": "A PHASE IV, OPEN-LABEL, RANDOMIZED, MULTICENTER TRIAL ASSESSING A REYATAZ-BASED SUBSTITUTION APPROACH IN THE MANAGEMENT OF LIPODYSTROPHY SYNDROME.  \nPharmacogenetics Blood Sample Amendment 01, vers...",
            "country": "GB",
            "timestamp": "2005-05-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002740-10/DE",
            "title": "A PHASE IV, OPEN-LABEL, RANDOMIZED, MULTICENTER TRIAL ASSESSING A REYATAZ-BASED SUBSTITUTION APPROACH IN THE MANAGEMENT OF LIPODYSTROPHY SYNDROME.  \nPharmacogenetics Blood Sample Amendment 01, vers...",
            "country": "DE",
            "timestamp": "2005-05-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002740-10/IT",
            "title": "A PHASE IV, OPEN-LABEL, RANDOMIZED, MULTICENTER TRIAL ASSESSING A REYATAZ-BASED SUBSTITUTION APPROACH IN THE MANAGEMENT OF LIPODYSTROPHY SYNDROME.  \nPharmacogenetics Blood Sample Amendment 01, vers...",
            "country": "IT",
            "timestamp": "2005-05-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002740-10/ES",
            "title": "A PHASE IV, OPEN-LABEL, RANDOMIZED, MULTICENTER TRIAL ASSESSING A REYATAZ-BASED SUBSTITUTION APPROACH IN THE MANAGEMENT OF LIPODYSTROPHY SYNDROME.  \nPharmacogenetics Blood Sample Amendment 01, vers...",
            "country": "ES",
            "timestamp": "2005-05-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002740-10/results",
            "title": "A PHASE IV, OPEN-LABEL, RANDOMIZED, MULTICENTER TRIAL ASSESSING A REYATAZ-BASED SUBSTITUTION APPROACH IN THE MANAGEMENT OF LIPODYSTROPHY SYNDROME.  \nPharmacogenetics Blood Sample Amendment 01, vers...",
            "country": "View results",
            "timestamp": "2005-05-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004990-27/IT",
            "title": "The pharmacokinetic interaction between TMC114, lopinavir and ritonavir, in HIV-1 infected subjects.",
            "country": "IT",
            "timestamp": "2005-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004990-27/results",
            "title": "The pharmacokinetic interaction between TMC114, lopinavir and ritonavir, in HIV-1 infected subjects.",
            "country": "View results",
            "timestamp": "2005-05-09"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000549-13/SK",
            "title": "A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study of Two Doses of VX-702 in Subjects with Moderate to Severe Rheumatoid Arthritis",
            "country": "SK",
            "timestamp": "2005-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000549-13/CZ",
            "title": "A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study of Two Doses of VX-702 in Subjects with Moderate to Severe Rheumatoid Arthritis",
            "country": "CZ",
            "timestamp": "2005-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000549-13/results",
            "title": "A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study of Two Doses of VX-702 in Subjects with Moderate to Severe Rheumatoid Arthritis",
            "country": "View results",
            "timestamp": "2005-05-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000441-38/AT",
            "title": "Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)",
            "country": "AT",
            "timestamp": "2005-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000441-38/IT",
            "title": "Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)",
            "country": "IT",
            "timestamp": "2005-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000441-38/IE",
            "title": "Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)",
            "country": "IE",
            "timestamp": "2005-04-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001382-33/IT",
            "title": "An extension to a phase II study to determine the efficacy and the safety of STI571 in patients with chronic myeloid leukemia who are refractory to or intolerant of interferon-alpha",
            "country": "IT",
            "timestamp": "2005-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001382-33/results",
            "title": "An extension to a phase II study to determine the efficacy and the safety of STI571 in patients with chronic myeloid leukemia who are refractory to or intolerant of interferon-alpha",
            "country": "View results",
            "timestamp": "2005-04-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000336-25/IT",
            "title": "Longitudinal analysis of HBV-specific T cell responses in patients with HBeAg-negative chronic hepatitis B (CHB) treated with pegylated interferon alfa-2a (40 KD) (PEGASYS, Ro 25-8310).      Immuno...",
            "country": "IT",
            "timestamp": "2005-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000336-25/results",
            "title": "Longitudinal analysis of HBV-specific T cell responses in patients with HBeAg-negative chronic hepatitis B (CHB) treated with pegylated interferon alfa-2a (40 KD) (PEGASYS, Ro 25-8310).      Immuno...",
            "country": "View results",
            "timestamp": "2005-04-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002880-26/GB",
            "title": "A Phase IV, Multi-center, Cross-sectional study to evaluate the I50L substitution among subjects experiencing virologic failure on a HAART regimen containing atazanavir (ATV)\n\nProtocol: version 2.0...",
            "country": "GB",
            "timestamp": "2005-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002880-26/DE",
            "title": "A Phase IV, Multi-center, Cross-sectional study to evaluate the I50L substitution among subjects experiencing virologic failure on a HAART regimen containing atazanavir (ATV)\n\nProtocol: version 2.0...",
            "country": "DE",
            "timestamp": "2005-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002880-26/IT",
            "title": "A Phase IV, Multi-center, Cross-sectional study to evaluate the I50L substitution among subjects experiencing virologic failure on a HAART regimen containing atazanavir (ATV)\n\nProtocol: version 2.0...",
            "country": "IT",
            "timestamp": "2005-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002880-26/results",
            "title": "A Phase IV, Multi-center, Cross-sectional study to evaluate the I50L substitution among subjects experiencing virologic failure on a HAART regimen containing atazanavir (ATV)\n\nProtocol: version 2.0...",
            "country": "View results",
            "timestamp": "2005-04-06"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001164-32/IT",
            "title": "A RANDOMIZED STUDY, POSPECTIVE, ON THREE DIFFERENT STRATEGY OF HIV POSITIVE NAIVE FOR THE ANTIRETROVIRAL THERAPY",
            "country": "IT",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/FI",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "FI",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/NO",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "NO",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/BE",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "BE",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/IE",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "IE",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/AT",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "AT",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/CZ",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "CZ",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000242-20/GB",
            "title": "A randomised trial of the European and American Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy",
            "country": "GB",
            "timestamp": "2005-04-05"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001012-32/DE",
            "title": "A single agent Phase II study of depsipeptide (FK228) in the treatment of Cutaneous T-cell lymphoma",
            "country": "DE",
            "timestamp": "2005-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001012-32/GB",
            "title": "A single agent Phase II study of depsipeptide (FK228) in the treatment of Cutaneous T-cell lymphoma",
            "country": "GB",
            "timestamp": "2005-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001012-32/AT",
            "title": "A single agent Phase II study of depsipeptide (FK228) in the treatment of Cutaneous T-cell lymphoma",
            "country": "AT",
            "timestamp": "2005-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001012-32/results",
            "title": "A single agent Phase II study of depsipeptide (FK228) in the treatment of Cutaneous T-cell lymphoma",
            "country": "View results",
            "timestamp": "2005-03-31"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-007935-14/IT",
            "title": "RIFART",
            "country": "IT",
            "timestamp": "2005-03-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000881-10/LT",
            "title": "International, multicenter, randomised, open-labeled, 2-arm - Phase III Study comparing Imatinib (STI571, Glivec®) Standard Dose (400 mg/day) with Imatinib High Dose Induction (800 mg/day) followed...",
            "country": "LT",
            "timestamp": "2005-03-08"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000127-42/AT",
            "title": "Non Responder- STUDY: \nMULTICENTER STUDY TO EVALUATE THE EFFICACY OF SILYMARIN \nIN  ADDITION TO  COMBINATION-THERAPY WITH PEGYLATED INTERFERON ALFA 2A (PEG-IFN ALFA 2A) AND RIBAVIRIN IN PATIENTS WI...",
            "country": "AT",
            "timestamp": "2005-03-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004848-45/AT",
            "title": "HCV/HIV Coinfection- STUDY: \nMULTICENTER STUDY TO EVALUATE THE EFFICACY OF 48 WEEKS  COMBINATION-THERAPY WITH PEGYLATED INTERFERON ALFA 2A (PEG-IFN ALFA 2A) AND DIFFERENT DOSES OF RIBAVIRIN IN PATI...",
            "country": "AT",
            "timestamp": "2005-03-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004130-14/AT",
            "title": "A multicenter, randomized, rater-blind study to compare the efficacy and safety of natalizumab (300 mg IV every four weeks) with Interferon beta-1a (44 mcg SC three times a week) in subjects with r...",
            "country": "AT",
            "timestamp": "2005-02-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-004130-14/results",
            "title": "A multicenter, randomized, rater-blind study to compare the efficacy and safety of natalizumab (300 mg IV every four weeks) with Interferon beta-1a (44 mcg SC three times a week) in subjects with r...",
            "country": "View results",
            "timestamp": "2005-02-17"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN62866759",
            "timestamp": "2005-02-16",
            "title": "A phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003865-33/GB",
            "title": "A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regim...",
            "country": "GB",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003865-33/IT",
            "title": "A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regim...",
            "country": "IT",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003865-33/DE",
            "title": "A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regim...",
            "country": "DE",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003865-33/ES",
            "title": "A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regim...",
            "country": "ES",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003865-33/results",
            "title": "A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regim...",
            "country": "View results",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/SE",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "SE",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/LT",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "LT",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/IE",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "IE",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/DK",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "DK",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/GB",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "GB",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/ES",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "ES",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003799-13/results",
            "title": "A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif® (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis.",
            "country": "View results",
            "timestamp": "2005-02-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003749-42/ES",
            "title": "ESTUDIO DE LOS CAMBIOS EN EL RECUENTO DE LINFOCITOS CD4 TRAS LA SUSTITUCIÓN DE TENOFOVIR POR ABACAVIR EN PACIENTES CON UNA PAUTA HAART QUE INCLUYA DDI + TENOFOVIR Y CON SUPRESIÓN VIRAL",
            "country": "ES",
            "timestamp": "2005-02-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000029-31/IE",
            "title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon gamma-Ib in patients with Idiopathic Pulmonary Fibrosis \nThe INSPIRE Trial - International Stu...",
            "country": "IE",
            "timestamp": "2005-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001261-17/IE",
            "title": "An Open-Label Study of the Safety of Subcutaneous Recombinant Interferon gamma-1b in Patients with Idiopathic Pulmonary Fibrosis",
            "country": "IE",
            "timestamp": "2005-01-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001220-20/AT",
            "title": "Efficacy and Safety of PEG-Intron plus Rebetol  in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys",
            "country": "AT",
            "timestamp": "2005-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001220-20/GB",
            "title": "Efficacy and Safety of PEG-Intron plus Rebetol  in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys",
            "country": "GB",
            "timestamp": "2005-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001220-20/DE",
            "title": "Efficacy and Safety of PEG-Intron plus Rebetol  in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys",
            "country": "DE",
            "timestamp": "2005-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001220-20/ES",
            "title": "Efficacy and Safety of PEG-Intron plus Rebetol  in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys",
            "country": "ES",
            "timestamp": "2005-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001220-20/IT",
            "title": "Efficacy and Safety of PEG-Intron plus Rebetol  in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys",
            "country": "IT",
            "timestamp": "2005-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001220-20/results",
            "title": "Efficacy and Safety of PEG-Intron plus Rebetol  in Subjects with Chronic Hepatitis C Genotype 1 Non Responder to Pegasys",
            "country": "View results",
            "timestamp": "2005-01-25"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002376-42/IT",
            "title": "PHASE II TRIAL OF SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH CAPECITABINE PLUS INTERFERON ALPHA2a FOLLOWED BY IL-2 IN PATIENTS WITH METASTATIC KIDNEY CANCER",
            "country": "IT",
            "timestamp": "2005-01-12"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001718-15/IT",
            "title": "An open-label, multicenter protocol providing pegylated interferon alfa 2-a  PEGASYS as monotherapy or in combination with ribavirin  COPEGUS  for patients with chronic hepatitis C who have parteci...",
            "country": "IT",
            "timestamp": "2004-12-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001718-15/DE",
            "title": "An open-label, multicenter protocol providing pegylated interferon alfa 2-a  PEGASYS as monotherapy or in combination with ribavirin  COPEGUS  for patients with chronic hepatitis C who have parteci...",
            "country": "DE",
            "timestamp": "2004-12-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001718-15/AT",
            "title": "An open-label, multicenter protocol providing pegylated interferon alfa 2-a  PEGASYS as monotherapy or in combination with ribavirin  COPEGUS  for patients with chronic hepatitis C who have parteci...",
            "country": "AT",
            "timestamp": "2004-12-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003827-10/ES",
            "title": "A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor (PI) regimen of Fosamprenavir (FPV)/ Lopi...",
            "country": "ES",
            "timestamp": "2004-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003827-10/DE",
            "title": "A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor (PI) regimen of Fosamprenavir (FPV)/ Lopi...",
            "country": "DE",
            "timestamp": "2004-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003827-10/IT",
            "title": "A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor (PI) regimen of Fosamprenavir (FPV)/ Lopi...",
            "country": "IT",
            "timestamp": "2004-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003827-10/GB",
            "title": "A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor (PI) regimen of Fosamprenavir (FPV)/ Lopi...",
            "country": "GB",
            "timestamp": "2004-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003827-10/results",
            "title": "A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor (PI) regimen of Fosamprenavir (FPV)/ Lopi...",
            "country": "View results",
            "timestamp": "2004-12-16"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002985-39/IT",
            "title": "A multicenter, randomized, controlled study comparing the efficacy and safety of 48 weeks of 40kD branched pegylated interferon alfa-2a (PEGASYS, Ro 25-8310) versus 96 weeks of PEGASYS, alone or in...",
            "country": "IT",
            "timestamp": "2004-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002985-39/results",
            "title": "A multicenter, randomized, controlled study comparing the efficacy and safety of 48 weeks of 40kD branched pegylated interferon alfa-2a (PEGASYS, Ro 25-8310) versus 96 weeks of PEGASYS, alone or in...",
            "country": "View results",
            "timestamp": "2004-12-13"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003701-24/IT",
            "title": "A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES.",
            "country": "IT",
            "timestamp": "2004-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003701-24/DK",
            "title": "A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES.",
            "country": "DK",
            "timestamp": "2004-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-003701-24/results",
            "title": "A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES.",
            "country": "View results",
            "timestamp": "2004-12-10"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000664-27/ES",
            "title": "A 34 week, open label, single cohort, exploratory study to evaluate the effect of FTY720 on chronic Hepatitis C in patients who are non-responsive to, or intolerant of Interferon-based antiviral th...",
            "country": "ES",
            "timestamp": "2004-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000664-27/results",
            "title": "A 34 week, open label, single cohort, exploratory study to evaluate the effect of FTY720 on chronic Hepatitis C in patients who are non-responsive to, or intolerant of Interferon-based antiviral th...",
            "country": "View results",
            "timestamp": "2004-12-03"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002504-15/FI",
            "title": "A RANDOMIZED PHASE II STUDY COMPARING IMATINIB AND THE COMBINATION OF IMATINIB AND PEGYLATED INTERFERON ALPHA-2B IN NEWLY DIAGNOSED NON-HIGH RISK CHRONIC MYELOID LEUKEMIA PATIENTS IN COMPLETE HEMAT...",
            "country": "FI",
            "timestamp": "2004-12-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001323-37/ES",
            "title": "Phase IV-III, open-label, randomized, comparative study, to evaluate the safety and efficacy of the nucleoside supression of a triple therapy based on lopinavir-ritonavir vs. continuous triple ther...",
            "country": "ES",
            "timestamp": "2004-11-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002296-16/ES",
            "title": "Ensayo para evaluar la eficacia, seguridad y tolerabilidad, de una estrategia de simplificacion temprana a Trizivir, en pacientes con supresion virologica tras tratamiento antiretroviral con Combiv...",
            "country": "ES",
            "timestamp": "2004-11-26"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001246-33/AT",
            "title": "An open label trial of TMC114/RTV in HIV-1 infected subjects who were randomized in the trials TMC114-C201, TMC114-C207 or in sponsor selected Phase I trials.",
            "country": "AT",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001246-33/GB",
            "title": "An open label trial of TMC114/RTV in HIV-1 infected subjects who were randomized in the trials TMC114-C201, TMC114-C207 or in sponsor selected Phase I trials.",
            "country": "GB",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001246-33/IT",
            "title": "An open label trial of TMC114/RTV in HIV-1 infected subjects who were randomized in the trials TMC114-C201, TMC114-C207 or in sponsor selected Phase I trials.",
            "country": "IT",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001246-33/DK",
            "title": "An open label trial of TMC114/RTV in HIV-1 infected subjects who were randomized in the trials TMC114-C201, TMC114-C207 or in sponsor selected Phase I trials.",
            "country": "DK",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001246-33/results",
            "title": "An open label trial of TMC114/RTV in HIV-1 infected subjects who were randomized in the trials TMC114-C201, TMC114-C207 or in sponsor selected Phase I trials.",
            "country": "View results",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001426-24/HU",
            "title": "Multicenter, open, randomized study for first-line treatment of multiple myeloma: thalidomide/dexamethasone vs. MP for induction therapy and thalidomide/Intron A vs. Intron A for maintenance therapy",
            "country": "HU",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001426-24/results",
            "title": "Multicenter, open, randomized study for first-line treatment of multiple myeloma: thalidomide/dexamethasone vs. MP for induction therapy and thalidomide/Intron A vs. Intron A for maintenance therapy",
            "country": "View results",
            "timestamp": "2004-11-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001601-10/IT",
            "title": "MULTICENTTRIC, NATIONAL, SINGLE BLIND,CONTROLLED IN PARALLEL GROUP TO EVALUATE THE SAFETY AND EFFICACY OF THE SEQUENTIAL COMBINATION OF MITOXANTRONE AND BETA INTERFERON  REBIF 44 mcg X 3 TIMES WEEK...",
            "country": "IT",
            "timestamp": "2004-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001601-10/FR",
            "title": "MULTICENTTRIC, NATIONAL, SINGLE BLIND,CONTROLLED IN PARALLEL GROUP TO EVALUATE THE SAFETY AND EFFICACY OF THE SEQUENTIAL COMBINATION OF MITOXANTRONE AND BETA INTERFERON  REBIF 44 mcg X 3 TIMES WEEK...",
            "country": "FR",
            "timestamp": "2004-11-19"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002006-30/GB",
            "title": "Triple therapy in early active rheumatoid arthritis",
            "country": "GB",
            "timestamp": "2004-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002006-30/results",
            "title": "Triple therapy in early active rheumatoid arthritis",
            "country": "View results",
            "timestamp": "2004-11-17"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000786-35/IT",
            "title": "A phase III, open-label, randomized, comparative study of the antiviral efficacy of ARV therapy with Lopinavir/Ritonavir (LPV/r - Kaletra) in combination with Tenofovir versus SOC (Kaletra in combi...",
            "country": "IT",
            "timestamp": "2004-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000786-35/results",
            "title": "A phase III, open-label, randomized, comparative study of the antiviral efficacy of ARV therapy with Lopinavir/Ritonavir (LPV/r - Kaletra) in combination with Tenofovir versus SOC (Kaletra in combi...",
            "country": "View results",
            "timestamp": "2004-11-02"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000816-24/ES",
            "title": "A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen versus Lopinavir/Ritonavir in Combination with Lamivudine/Zidovudine in Antir...",
            "country": "ES",
            "timestamp": "2004-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000816-24/IT",
            "title": "A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen versus Lopinavir/Ritonavir in Combination with Lamivudine/Zidovudine in Antir...",
            "country": "IT",
            "timestamp": "2004-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000816-24/results",
            "title": "A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen versus Lopinavir/Ritonavir in Combination with Lamivudine/Zidovudine in Antir...",
            "country": "View results",
            "timestamp": "2004-10-28"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000773-60/LV",
            "title": "52 week multicenter, randomized, double-blind placebo-controlled trial evaluating\nthe efficacy and safety of SNMC in patients with chronic hepatitis C",
            "country": "LV",
            "timestamp": "2004-10-22"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000482-35/GB",
            "title": "A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arth...",
            "country": "GB",
            "timestamp": "2004-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000482-35/LT",
            "title": "A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arth...",
            "country": "LT",
            "timestamp": "2004-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000482-35/results",
            "title": "A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arth...",
            "country": "View results",
            "timestamp": "2004-10-11"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000408-41/GB",
            "title": "RANDOMIZED, DOUBLE–BLIND, MULTICENTER STUDY TO COMPARE THE SAFETY AND EFFICACY OF VIRAMIDINE TO RIBAVIRIN IN TREATMENT–NAïVE PATIENTS WITH CHRONIC HEPATITIS C",
            "country": "GB",
            "timestamp": "2004-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000408-41/IT",
            "title": "RANDOMIZED, DOUBLE–BLIND, MULTICENTER STUDY TO COMPARE THE SAFETY AND EFFICACY OF VIRAMIDINE TO RIBAVIRIN IN TREATMENT–NAïVE PATIENTS WITH CHRONIC HEPATITIS C",
            "country": "IT",
            "timestamp": "2004-10-07"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000948-25/ES",
            "title": "Determinación de niveles plasmáticos e intracelulares de los inhibidores de la transcriptasa inversa análogos a nucleósidos (NRTI) y del análogo a nucleótido tenofovir disoproxil fumarato (TDF) en ...",
            "country": "ES",
            "timestamp": "2004-10-01"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000948-25/results",
            "title": "Determinación de niveles plasmáticos e intracelulares de los inhibidores de la transcriptasa inversa análogos a nucleósidos (NRTI) y del análogo a nucleótido tenofovir disoproxil fumarato (TDF) en ...",
            "country": "View results",
            "timestamp": "2004-10-01"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN52566041",
            "timestamp": "2004-09-30",
            "title": "40kD pegylated interferon alpha 2a plus ribavirin compared to 40 kD pegylated interferon alpha 2a plus ribavirin and mycophenolate in the management of patients with refractory chronic HCV infection"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN67613327",
            "timestamp": "2004-09-30",
            "title": "A randomised trial of the EURopean and AMerican Osteosarcoma Study group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000282-35/CZ",
            "title": "A randomised, double-blind phase III study to evaluate the efficacy and safety of bevacizumab in combination with interferon alfa-2a (Roferon) versus interferon alfa-2a and placebo as first line tr...",
            "country": "CZ",
            "timestamp": "2004-09-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000282-35/GB",
            "title": "A randomised, double-blind phase III study to evaluate the efficacy and safety of bevacizumab in combination with interferon alfa-2a (Roferon) versus interferon alfa-2a and placebo as first line tr...",
            "country": "GB",
            "timestamp": "2004-09-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000282-35/IT",
            "title": "A randomised, double-blind phase III study to evaluate the efficacy and safety of bevacizumab in combination with interferon alfa-2a (Roferon) versus interferon alfa-2a and placebo as first line tr...",
            "country": "IT",
            "timestamp": "2004-09-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000282-35/results",
            "title": "A randomised, double-blind phase III study to evaluate the efficacy and safety of bevacizumab in combination with interferon alfa-2a (Roferon) versus interferon alfa-2a and placebo as first line tr...",
            "country": "View results",
            "timestamp": "2004-09-29"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001149-14/IT",
            "title": "A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma.",
            "country": "IT",
            "timestamp": "2004-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001149-14/ES",
            "title": "A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma.",
            "country": "ES",
            "timestamp": "2004-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001149-14/GB",
            "title": "A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma.",
            "country": "GB",
            "timestamp": "2004-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001149-14/results",
            "title": "A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma.",
            "country": "View results",
            "timestamp": "2004-09-27"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001827-39/IT",
            "title": "NATIONAL, MULTICENTER, RANDOMISED, OPEN STUDY TO VALUATE THE EFFICACY OF DIFFERENT THERAPEUTIC STRATEGIES TO AVOID THE IMMUNOLOGIC FAILURE IN MULTIRESISTENT HIV-1 INFECTED PATIENTS.",
            "country": "IT",
            "timestamp": "2004-09-15"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000337-12/HU",
            "title": "A multicentre, single arm, open-label, phase IV study to evaluate the immunogenicity and safety of subcutaneously administered r-hIFN beta-1a (Rebif) using clone 484-39 in the treatment of subjects...",
            "country": "HU",
            "timestamp": "2004-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000337-12/results",
            "title": "A multicentre, single arm, open-label, phase IV study to evaluate the immunogenicity and safety of subcutaneously administered r-hIFN beta-1a (Rebif) using clone 484-39 in the treatment of subjects...",
            "country": "View results",
            "timestamp": "2004-07-23"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000060-27/IT",
            "title": "A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908  700mg BID  plus ritonavir  100mg BID  Versus Lopinavir/ritonavir  400mg/100mg  BID  when Administered...",
            "country": "IT",
            "timestamp": "2004-06-30"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-000060-27/results",
            "title": "A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908  700mg BID  plus ritonavir  100mg BID  Versus Lopinavir/ritonavir  400mg/100mg  BID  when Administered...",
            "country": "View results",
            "timestamp": "2004-06-30"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN68218781",
            "timestamp": "2004-04-01",
            "title": "A Multi-center, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Methylprednisolone in Combination with Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN03626626",
            "timestamp": "2003-10-23",
            "title": "Phase IIa trial of interferon-beta-1a (Avonex) in patients with rheumatoid arthritis"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN34382898",
            "timestamp": "2003-09-12",
            "title": "Efficacy of subcutaneous interleukin-2 (IL-2) in the treament of advanced HIV-1 infections in persons with CD4+ T lymphoytes <100/mm3 and undetectable plasma viral load"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN53821378",
            "timestamp": "2003-08-11",
            "title": "Retreatment of hepatitis C non-responsive to Interferon"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN87885087",
            "timestamp": "2003-05-27",
            "title": "A phase II, randomised, open-label, three-arm study comparing low-and high-dose Campath® (MabCampath®) and high-dose Rebif® in patients with early, active relapsing-remitting Multiple Sclerosis (MS)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN24461054",
            "timestamp": "2003-04-25",
            "title": "Health benefits from anti-viral therapy for mild chronic hepatitis C"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN81939169",
            "timestamp": "2002-08-19",
            "title": "Marrow-ablative chemotherapy and autologous stem cell transplantation followed by interferon-alpha maintenance treatment versus interferon-alpha maintenance treatment alone for stage III and IV follicular Non-Hodgkin's lymphoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN46123985",
            "timestamp": "2002-08-19",
            "title": "Trial of alpha-interferon in chronic myeloid leukaemia and a comparison of busulphan and hydroxyurea for induction and maintenance"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN11978947",
            "timestamp": "2002-08-19",
            "title": "Interferon alpha in combination with thalidomide in the treatment of metastatic renal cell carcinoma - a randomised phase II study"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN95638591",
            "timestamp": "2002-08-19",
            "title": "A Randomised Trial of 5-Fluorouracil (5FU) and Leucovorin (LV) versus 5-Fluorouracil, leucovorin and Interferon-Alpha 2a for Advanced Colorectal Adenocarcinoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN13456221",
            "timestamp": "2002-08-19",
            "title": "A Randomised Study of Observation versus Adjuvant Low Dose Extended Duration Interferon Alpha-2a in High Risk Resected Malignant Melanoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN42493631",
            "timestamp": "2002-08-19",
            "title": "A Randomised Trial Comparing the Efficacy of Infusional 5-Fluorouracil (5-FU) to 5-FU plus Alpha Interferon in Patients with Unresectable Colorectal Cancer"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN53211392",
            "timestamp": "2002-08-19",
            "title": "Randomised Controlled Trial of CID versus CD for Induction of Remission in Low Grade Non-Hodgkin's Lymphoma and Randomised Controlled Assessment of Interferon as Maintenance Treatment after Remission Induction"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN46751362",
            "timestamp": "2002-08-19",
            "title": "A European randomised multicentre study of interferon alpha-2b versus no treatment after intensive therapy and Autologous hematopoeitic Stem Cell Transplantation (ASCT) for relapsing lymphoma patients"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN47723344",
            "timestamp": "2002-08-19",
            "title": "Medical Research Council sixth myelomatosis trial for previously untreated patients"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN53369512",
            "timestamp": "2002-08-19",
            "title": "Medical Research Council/ European Blood and Marrow Transplant Prospective Randomised Trial of Autograft in Chronic Myeloid Leukaemia (CML)"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN16387614",
            "timestamp": "2001-07-01",
            "title": "Adjuvant interleukin-2, interferon-alpha and 5-fluorouracil for patients with high risk of relapse after surgical treatment for renal cell carcinoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN59346371",
            "timestamp": "2001-05-18",
            "title": "A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400 mg daily versus imatinib 800 mg daily versus imatinib plus PEG interferon-alpha 2a (Pegasys) in patients with newly-diagnosed chronic phasechronic myeloid leukaemia"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN89397749",
            "timestamp": "2001-02-28",
            "title": "A randomised trial of alpha-interferon versus medroxyprogesterone acetate for metastatic renal carcinoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN46518965",
            "timestamp": "2000-11-08",
            "title": "A randomised controlled trial of Interferon-alpha (IFN-alpha), Interleukin-2 (IL-2) and 5 Fluorourcil (5-FU) versus Interferon-alpha alone in patients with advanced renal cell carcinoma"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN68784584",
            "timestamp": "2000-10-25",
            "title": "CML V - chronic phase Chronic Myeloid Leukaemia"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN61147621",
            "timestamp": "2000-10-25",
            "title": "CML IV - Chronic phase chronic myeloid leukaemia/CML 2000"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN66518389",
            "timestamp": "2000-10-25",
            "title": "Myeloma VII - myelomatosis therapy trial"
        },
        {
            "url": "https://www.isrctn.com/ISRCTN77346223",
            "timestamp": "2000-10-25",
            "title": "Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)"
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004645-16/DE",
            "title": "A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therap...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004645-16/NL",
            "title": "A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therap...",
            "country": "NL",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004645-16/ES",
            "title": "A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therap...",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-001399-13/FR",
            "title": "MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable NRAS Melanoma: A Phase Ib/II Trial of Trametinib plus Hydroxychloroquine in Patients with NRAS Melanoma. CHLORO TRAM MEL",
            "country": "FR",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/DE",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/HU",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "HU",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/FI",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "FI",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/BE",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "BE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/AT",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "AT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/GB",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "GB",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/EE",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "EE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/SK",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "SK",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/CZ",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "CZ",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/LT",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "LT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-019872-65/results",
            "title": "A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie...",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017438-32/DE",
            "title": "A 12-week, double-blind, randomized, parallel-group, placebo-controlled study of 4 doses of VX-509 in subjects with active rheumatoid arthritis",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017438-32/BE",
            "title": "A 12-week, double-blind, randomized, parallel-group, placebo-controlled study of 4 doses of VX-509 in subjects with active rheumatoid arthritis",
            "country": "BE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017438-32/HU",
            "title": "A 12-week, double-blind, randomized, parallel-group, placebo-controlled study of 4 doses of VX-509 in subjects with active rheumatoid arthritis",
            "country": "HU",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017438-32/PL",
            "title": "A 12-week, double-blind, randomized, parallel-group, placebo-controlled study of 4 doses of VX-509 in subjects with active rheumatoid arthritis",
            "country": "PL",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-017438-32/results",
            "title": "A 12-week, double-blind, randomized, parallel-group, placebo-controlled study of 4 doses of VX-509 in subjects with active rheumatoid arthritis",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000793-45/DE",
            "title": "Open-label safety study of TMC114 in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options.",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000793-45/IT",
            "title": "Open-label safety study of TMC114 in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options.",
            "country": "IT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000793-45/results",
            "title": "Open-label safety study of TMC114 in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options.",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000582-21/DE",
            "title": "A multicentre Phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic Castration Resistant Prostate Cancer (mCRPC), suitable for treatment with a taxane.",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000582-21/CZ",
            "title": "A multicentre Phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic Castration Resistant Prostate Cancer (mCRPC), suitable for treatment with a taxane.",
            "country": "CZ",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000582-21/HU",
            "title": "A multicentre Phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic Castration Resistant Prostate Cancer (mCRPC), suitable for treatment with a taxane.",
            "country": "HU",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002050-66/IE",
            "title": "Treatment Interruption in Children with Chronic HIV-Infection: the TICCH Trial",
            "country": "IE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-002050-66/ES",
            "title": "Treatment Interruption in Children with Chronic HIV-Infection: the TICCH Trial",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/CZ",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "CZ",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/FR",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "FR",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/PT",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "PT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/BG",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "BG",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/HU",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "HU",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/BE",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "BE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/SK",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "SK",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/GR",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "GR",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/DE",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/ES",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-003008-38/HR",
            "title": "An Open-Label, Randomized, Multicenter, Active-Controlled,\r\nParallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in\r\nPediatric Subjects Aged 10 to Less Than 18 Years f...",
            "country": "HR",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-022467-36/DE",
            "title": "A phase II study about interferon gamma 1b to therapy the steroid-refractory bronchiolitis obliterans after allogenic stem cell therapy",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000544-86/DE",
            "title": "A randomised, open-label, multi-center phase II study of first-line treatment with BAY 43-9006 (Sorafenib) versus standard treatment with Interferon alpha-2a in patients with unresectable and/or me...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000544-86/GB",
            "title": "A randomised, open-label, multi-center phase II study of first-line treatment with BAY 43-9006 (Sorafenib) versus standard treatment with Interferon alpha-2a in patients with unresectable and/or me...",
            "country": "GB",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-000544-86/results",
            "title": "A randomised, open-label, multi-center phase II study of first-line treatment with BAY 43-9006 (Sorafenib) versus standard treatment with Interferon alpha-2a in patients with unresectable and/or me...",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000516-22/PT",
            "title": "A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-\nArm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy\nand Safety of BG00012 and BIIB017 ...",
            "country": "PT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000516-22/EE",
            "title": "A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-\nArm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy\nand Safety of BG00012 and BIIB017 ...",
            "country": "EE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-000516-22/HU",
            "title": "A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-\nArm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy\nand Safety of BG00012 and BIIB017 ...",
            "country": "HU",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000495-24/DE",
            "title": "A Multicenter, Open-Label, Pilot Study to Explore the Safety and Efficacy of Intravenous Bortezomib in Patients with Hepatitis C",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001622-24/IE",
            "title": "Phase III,multicentre,open-label,prospective randomised trial comparing Imatinib alone at 400mg versus 800mg daily versus Imatinib 400mg daily plus PEG Interferon-alpha with newly diagnosed chronic...",
            "country": "IE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001622-24/results",
            "title": "Phase III,multicentre,open-label,prospective randomised trial comparing Imatinib alone at 400mg versus 800mg daily versus Imatinib 400mg daily plus PEG Interferon-alpha with newly diagnosed chronic...",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-005129-18/IT",
            "title": "Multi-centre, randomised, open label pragmatic trial to compare the effectiveness and safety of interferon beta-1a (IFN-beta-1a) weekly i.m. and glatiramer-acetate (GA) in paediatric patients affec...",
            "country": "IT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001397-92/GB",
            "title": "An extension to a phase II study to determine the efficacy and safety of STI571 in patients with chronic myeloid leukemia who are refractory to or intolerant of interferon-alpha",
            "country": "GB",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2004-001397-92/results",
            "title": "An extension to a phase II study to determine the efficacy and safety of STI571 in patients with chronic myeloid leukemia who are refractory to or intolerant of interferon-alpha",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2009-014724-32/DE",
            "title": "SAFETY, TOLERABILITY AND MECHANISM OF ACTION OF BOSWELLIC ACIDS (BA) IN MULTIPLE SCLEROSIS (MS) AND CLINICALLY ISOLATED SYNDROME (CIS):\nA MRI-CONTROLLED, MULTICENTER, BASELINE-TO-TREATMENT, 32-WEEK...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000728-97/NL",
            "title": "Regulation of the stress-axis by vitamin D3 in subjects with multiple sclerosis; a double-blinded, randomized, placebo-controlled study",
            "country": "NL",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/DE",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/ES",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/GB",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "GB",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/IT",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "IT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/AT",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "AT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/BE",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "BE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004724-35/results",
            "title": "Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004786-80/DE",
            "title": "A phase IIa, randomized, placebo-controlled, double-blind, cross-over study to evaluate safety and efficacy of subcutanous administration of anakinra in patients with cystic fibrosis.",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007015-32/DE",
            "title": "A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of rivastigmine (Exelon® patch 10 cm2) on cognitive deficits in patients with mul...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-007015-32/results",
            "title": "A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of rivastigmine (Exelon® patch 10 cm2) on cognitive deficits in patients with mul...",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000499-25/DE",
            "title": "International, multicenter, single-arm, open-label, 12-week phase IIIb study to evaluate RebiSmartTM suitability for self-injection of Rebif New Formulation (RNF) in  multidose cartridges in patien...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000499-25/SE",
            "title": "International, multicenter, single-arm, open-label, 12-week phase IIIb study to evaluate RebiSmartTM suitability for self-injection of Rebif New Formulation (RNF) in  multidose cartridges in patien...",
            "country": "SE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000499-25/ES",
            "title": "International, multicenter, single-arm, open-label, 12-week phase IIIb study to evaluate RebiSmartTM suitability for self-injection of Rebif New Formulation (RNF) in  multidose cartridges in patien...",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000499-25/IT",
            "title": "International, multicenter, single-arm, open-label, 12-week phase IIIb study to evaluate RebiSmartTM suitability for self-injection of Rebif New Formulation (RNF) in  multidose cartridges in patien...",
            "country": "IT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-000499-25/results",
            "title": "International, multicenter, single-arm, open-label, 12-week phase IIIb study to evaluate RebiSmartTM suitability for self-injection of Rebif New Formulation (RNF) in  multidose cartridges in patien...",
            "country": "View results",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-004699-38/DE",
            "title": "A prospective phase I/II, one-arm, multi-center, open label study of \npioglitazone in combination with sorafenib and low dose IFN alpha\nin metastatic, non-resectable renal clear cell carcinoma",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/GB",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "GB",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/LT",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "LT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/EE",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "EE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/ES",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/BE",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "BE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/PL",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "PL",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-004114-17/FI",
            "title": "REVEAL 2: A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation with CELLECTRA™ 5PSP for the Treatment of HPV-1...",
            "country": "FI",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-002264-41/FR",
            "title": "Etude randomisée multicentrique évaluant l’efficacité et la tolérance de l’infliximab comparativement au Cyclophosphamide dans les formes sévères de maladie de Behçet\n\" Multicenter, randomized, pro...",
            "country": "FR",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/DE",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "DE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/FR",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "FR",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/BE",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "BE",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/ES",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "ES",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/PL",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "PL",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/IT",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "IT",
            "timestamp": null
        },
        {
            "url": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-004605-34/results",
            "title": "A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic ...",
            "country": "View results",
            "timestamp": null
        }
    ]
}